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SUMMARY 
vi 
The genus Flavobacterium is characterized by high levels 
of resistance to a wide range of antibiotics. Clinical 
laboratories may experience difficulty in detecting this 
resistance, the underlying mechanisms of which are unknown. 
Genetically the genus is so diverse that it may eventually be 
subdivided into at least four genera. Furthermore within the 
genus some species are genetically heterogeneous and warrant 
subdivision into further species. To date these taxonomic 
reforms have not been possible because of a lack of 
phenotypic markers which can be correlated with the genetic 
differences. An additional taxonomic problem which requires 
clarification is the relationship of Flavobacterium to other 
genera, particularly Cytophaga and Bacteroides. 
In this study eighty nine Flavobacterium study strains and 
43 reference strains were tested to investigate the 
susceptibility of the genus to antibiotics. Cell-free beta-
lactamase preparations of selected strains were used to 
determine the substrate profiles, inhibitor profiles, 
inducibility and isoelectric points of the beta-lactamases of 
the genus and some related organisms. Preliminar~ data were 
obtained about the roles of beta-lactamases and outer membrane 
permeability in resistance to beta-l actam antibiotics. 
Although two standardised conventional antibiotic 
susceptibi l ity testing techniques showed poor correlation 
the antibiotic resistance patterns were nevertheless specific 
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for certain species and for groups of flavobacteria, 
indicating that antibiotic resistance is of taxonomic utility 
for this genus. Flavobacterium aquatile, !.· breve, !.· 
meningosepticum and F. odoratum could be readily delineated by 
their susceptibility patterns. Similarities in the 
antibiograms and beta-lactamases of!.· multivorum, !.· 
spiritivorum and!.· thalpophilum was further evidence of the 
relatedness of these species and supported suggestions that 
they be recognised as a separate genus. 
The beta-lactamases of the genus Flavobacterium are 
characteristically chromosomally mediated beta-lactamases of 
Richmond and Sykes Class IV. Many Flavobacterium beta-
lactamases were unusual in exhibiting activity against the new 
beta-lactamase resistant antibiotics cefoxitin and cefotaxime, 
and occasionally imipenem. This suggested that these enzymes 
are Class IV oxyiminocephalosporinases. This finding is of 
taxonomic significance. It is also of clinical and 
pharmaceutical significance in that it identifies 
Flavobacterium as a genus capable of inactivating the latest 
beta-lactam antibiotics and therefore requiring close 
examination by research chemists if they are to succeed in 
producing antibiotics which can evade the resistance 
mechanisms of pathogenic bacteria. 
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The heterogeneity of beta-lactamases within!· breve, !· 
gleum, !· meningosepticum, !· odoratum and Group IIb suggested 
that the beta-lactamases of the genus should be further 
investigated to delineate new taxa as they represent new 
phenotypic markers of the type needed for the taxonomic 
revision of the genus. 
1. LITERATURE REVIEW 
1 
a. Introduction 
In recent years many new beta-lactam antibiotics have been 
released for therapeutic use (Table 1) and many more are in 
the developmental stage. A number of these antibiotics are 
superior to previous agents in potency, resistance to 
inactivation by beta-lactamases, anCI in pharmacok:inetics 
(Winston et al., 1984; Dixson and Andrew, 1985). The market 
has become inundated with beta-lactam antibiotics, especially 
the cephalosporins, and there is much confusion as to which 
ag.ents are most appropriate for particular situations (Selwyn, 
1980). The release of even more of these antibiotics will 
exacerbate the confusion to the point where even infectious 
disease physicians, who are specially trained in the use of 
antibiotics, will be hard pressed to keep current in this 
expanding field (Avorn !:_!al., 1987). Notwithstanding this 
intellectual dilemma the spectrum of activity of the newer 
beta-lactam antibiotics has been so significantly expanded 
that there-is enthusiastic speculation about their future 
role. Looking to the future it appears that we may be on the 
brink of a new golden age of antibiotic therapy in which there 
will be a non-toxic beta-lactam antibiotic for every known 
bacterial infection (Richmond, 1981; Thomson and Ward, 1986). 
Most importantly this would mean that the therapy of severe 
infections will no longer depend on toxic agents such as the 
aminoglycosides and vancomycin. 
At present such optimism needs to be tempered w:i,th caution 
as there are reports documenting the development of resistance 
by certain species during therapy with the newer beta-lactam 
2 
TABLE 1 
Representative New Beta-lactam Antibiotics 
Second Generation Cephalosporins 
Cefamandole 
Cefoxi tin (*) 
Cefuroxime 
Cefotetan (*) 
Third Generation Cephalosporins 
Moxalactam (**) 
Cefotaxime 
Cefoperazone 
Ceftizoxime 
Geftriaxone 
Ceftazidime 
Cefsulodin 
Expanded Spectrum Penicillins 
Mezlocillin 
Azlocillin 
Piperacillin 
Monobactams 
Aztreonam 
Carbapenems 
Imipenem 
Clavams 
Clavulanic acid 
(*) also classified as methoxycephems or cephamycins 
(**) also classified as an oxacephem 
3 
antibiotics (Sanders and Sanders, 1985; Tipper, 1985). 
Furthermore the·re are reports of the failure of routine 
susceptibility .tests to predict when resistance is likely to 
occur (Sanders, 1984b). There have been unexpected treatment 
failures with these agents and as a consequence there are 
considerable reservations about their role as monotherapy for 
serious infections. It is therefore important that the 
resistance problems be overcome if the full potential of the 
new beta-lactam antibiotics is to be realised. 
So far resistance to these drugs involves two principal 
mechanisms - beta-lactamase mediated drug inactivation and 
reduced permeability of the bacterial outer cell membrane to 
the drugs (Bush et al., 1985; Werner et al., 1985; Sanders and 
Sanders, 1986a; Bakken et al., 1987). 
The attainment of a new era of safe beta-lactam 
therapy therefore seems to await two developm~nts - (1) 
' ' further increases in tne spectrum of antibacterial activity of 
these drugs, and (2) resolution of the resistance problems. 
Many researchers in industry, acadaemia and medicine have 
responded to this challenge ano currently seek to: 
I. elucidate the mechanisms of resistance to the new beta-
lactams- (Godfrey and Bryan, 1984; Sanders, 1984b; 
Murakami and Yoshida, 1985; Vu and Nikaido, 1985; 
Livermore et al., 1986), 
2. better define the therapeutic roles of the new drugs to 
minimize the development of resistance (Sander~ and 
Sanders, 1985; Tipper, 1985), 
3. produce new antibiotics which evade the current 
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resistance problems (Then and Anghern, 1985; Tipper, 
1985; Sanders, 1987), and 
4. develop convenient antibiotic susceptibility tests 
which predict when resistance is likely to occur (Sanders 
and Sanders, 1979; Thomson et al., 1984; Jorgensen, 
1985; Thomson and Ward, 1986). 
This thesis ·reports a study of some aspects of the 
beta-lactamases and antibiotic resistance of the genus 
Flavobacterium and related organisms. The reasons for the 
study are as follows. 
1. Members of the genus Flavob~cterium are resistant to 
therapeutic levels of many antibiotics including newer beta-
lactam antibiotics (lg?ri ~al., 1983; Holmes et al., 1984a; 
Rubin~ al., 1985; Strandberg ~.al., 1983; Burnakis ~al., 
1986). Their reported resistance to, and beta-lactamase-
mediated hydrolysis of, both imipenem and temocillin is 
particularly striking. Imipenem, a carbapenem, is one of the 
most potent broad-spectrum, beta-lactamase-stable antibiotics 
available (Freimer et al., 1985) and is hydrolysed by the 
beta-lactamases of very few bacteria,one of which is F. 
odoratum (Sato et al., 1985). Temocillin is even more 
resistant to hydrolysis by beta-lactamases. It is the first 
penicillin with high resistance to Gram-negative beta-
lactamases (Slocomb~ et al., 1981) and so far the only beta-
lactamase known to hydrolyse it is that of Flavobacterium 
strain 80 (Chen and Williams, 1982, 1985). To my knowledge 
there is only one other report of Flavobacterium beta-
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lactamases in the scientific literature. Raimondi et al. 
(1986) report that seven strains of Flavobacterium 
meningosepticum have three different types of beta-lactamase. 
The activity of these beta-lactamases is also unusual in being 
capable of hydrolysing tbe relatively stable 7-beta-
aminothiazole cephalosporins. 
The genus Flavobacterium thus contains orgqnisms of very 
unusual resistance to beta-lactam antibiotics and, in the case 
of Flavobacterium 80, appears to contain a unique beta-
lactamase. These studies, and the findings of Kono et al. 
(1980) that!· 'odoratum N299B contains a plasmid coding for 
resistance to ampicillin, carbenicillin and erythromycin, and 
of Nolte and S~ssmuth (1987) of chloramphenicol 
acetyltransferase in Flavobacterium CB60, appear to be the 
only reports of resistance mechanisms being identified in 
flavobacterium. 
In view of the broad multi-resistance of flavobacteria and 
the high level of current research into antibiotic resistance 
it seems surprising that the genus remains a virtual terra 
incognita. There is certainly much scope, on scientific 
grounds alone, for a systematic study of antibiotic resistance 
in Flavobacterium. In view of the interesting beta-lactamase~ 
just mentioned a survey of the beta-lactamases of the genus 
would provide an opportune starting point. 
2. There are also good clinical reasons for studying the 
beta-lactamases of Flavobacterium. Some flavobacteria are 
opportunistic pathogens of immunocompromised hosts (Holmes et 
6 
al., 1984a; Rubin et al., 1985). Today there are increasing 
numbers of immunocompromised patients arising from modern 
medical-and surgical practices and from disease states such as 
acquired immune deficiency syndrome (AIDS) and cancer. The 
increasing susceptibility of patients to infection has 
focussed attention on the increasing numbers of opportunistic 
Gram-negative pathogens, particularly those like flavobacteria 
which are resistant to a-wide .range of antibiotics (Finland et 
al., 1959; Rogers, 1959; Feeley~ al., 1975; Buckwoid and 
Ronald, 1979; McGowan, 1983; Fainstein and Bodey, 1985; 
Klastersky, 1985; Weinstein, 1985; Young, 1985). In this 
context an investigation of antibiotic resistance mechanisms ii'\ 
Flavobacterium seems timely as it would complement other work 
relevant to the future of antibiotic therapy in 
immunocomproniised patients. 
3. The search for more reliable susceptibility testing 
procedures is a key issue (Sanders, 1984a). Some curre'nt 
routine testing procedures ~re unreliable for flavobacteria 
(Von Graevenitz, 1981; Winslow and Pankey, 1982; Johny et 
al., 1983). If testing discrepancies for flavobacteria can be 
correlated with resistance mechanisms (e.g. beta-lactamases) 
it may be possible to use this knowledge to improve the 
accuracy of current tests or to develop better tests. 
4. In spite of recent advances in the taxonomy of 
Flavobacterium some aspects remain in an unsatisfactory state 
because: 
(a) heterogeneity within the genus precludes the 
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allocation of many flavobacteria to discrete species, 
and 
(b) the taxonomic relationships within the genus and with 
other genera are poorly understood (Holmes et al., 1984). 
Information about the antibiotic resistance of the genus will 
generate new data some of which may assist in resolving its 
taxonomic problems. 
To provide a background to this study it is necessary to 
review the literature of three complex fields of knowledge. 
The first of these is the mode of action and properties of 
beta-lactam antibiotics relevant to their interaction 
with Gram-negative bacteria. The second field is the range of 
mechanisms by ~hich Gram-negative bacteria resist these drugs, 
with particular emphasis on beta-lactamases, and the final 
field is the clinical and taxonomic features of the genus 
Flavobacterium and its interactions with beta-lactam 
antibiotics. 
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b. Beta-lactam Antibiotics 
Antibiotics of the beta-lactam group are the most 
frequently prescribed antiinfective agents in the world 
(Selwyn; 1980; Richmond 1981; Bush and Sykes, 1986). They are 
used predominantly because they couple effectiveness with 
safety at a level not usually found in therapeutic agents 
(Jackson, 1979: Selwyn, 1980; Richmortd,,1981). The beta-
lactam ring, which occupies a central position in all 
antibiotics of this group is crucial to antibacterial 
activity. However it also conveys vulnerability to beta-· 
lactamases which can inactivate the antibiotic by hydrolysis 
of the cyclic amide bond (Sykes and Matthew,1976; Richmond, 
1981; Cullman, 1985) or by binding to it without subsequent 
hydrolysis (Yokota and Azuma, 1980; Tnen and Anghern, 1982; 
Sanders and Sanders, 1986b). 
Since Fleming's original work on penicillin in 1928 
(Fleming, 1929) a variety of naturally occurring and 
semisynthetic beta-lactam antibiotics have been produced 
(Table 1). Generally they have been defined and classified by 
trivial nomenclature (e.g. as penicillins, cephalosporins 
etc.) on the basis of the producing organism and a chemical 
feature of the compound (Brown, 1982). However a more recent 
classification is based on a defined parent skeleton (Fig. 1). 
In this classification penicillins and cephalosporins are 
regarded as derivatives of the penam and cephem nuclei 
respectively. Clavulanic acid is derived from the clavam 
nucleus, imipenem and olivanic acid are carbapenems and the 
other beta-lactams are based on the penem, oxacephem and 
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Penam (Penicillins) 
4-Thia-l-azabicyclo(3.2.0)heptan-7-one 
op_) 
Cephem (Cephalosporins) 
5-Thia-l-azabicyclo(4.2.0)oct-2-en-8-one 
op~ 
Clavam (e.g. Clavulanic Acid) 
4-0xa-l-azabicyclo(3.2.0)heptan-7-one 
Carbapenem (e.g. Imipenem) 
l-Azabicyclo(3.2.0)hept-2-en-7-one 
)~JJ 
Penern (e.g. SCH 29482 a:id 'SCE .:14343) 
4-Thia-l-azabicyclo(2.2.0)hept-L-en-7-one 
op~ 
Oxacephem (e.g. Cefoxitin) 
5-0xa-l-azabicyclo(4.2.0)oct-2-en-8-one 
J !H 
0 
Monobactam (e.g. Aztreonam) 
Azetidin-2-one 
o.PJ 
Clavem 
4-0xa-azabicyclo(3.2.0)hept-2-en-7-one 
Fig. 1. Beta-lactam Skeletons 
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monobactam ring_ systems (Brown and Reading, 1983). The 
nomenclature in this review is mainly trivial because the 
fully systematic nomenclature is complex and cumbersome 
(Fig. 1). 
1. Penicillin Binding Proteins 
The targets for beta-lactam antibiotics are the penicillin 
binding proteins (PBPs) which are located on the cytoplasmic 
membrane of the cell. The interaction of the drug with one or 
more of the PBPs determines the antibacterial effects of beta-
lactam antibiotics. Drug potency and the nature of the 
effects the antibiotic has on the cell ultimately depend on 
PBP inhibition by acylation. To be effective against Gram-
negative pathogens a beta-lactam antibiotic must reach the 
infective site in the host, penetrate the outer layers of the 
cell envelope, survive the action of periplasmic beta-
lactamases and reach the PBPs in sufficient concentration to 
form the covalent complexes necessary for inhibition (Tomasz, 
1986). 
PBPs are quantitatively minor components of the plasma 
membrane. There are 1,000 to 10,000 PBPs per cell 'with copy 
numbers of individual PBPs sometimes as low as 20-30 molecules 
per cell. They have been most extensively studied in 
Escherichia coli, in which there are seven major groups of 
PBPs each having a different physiological function (Table 2). 
There is also an eighth major PBP (PBP IC) of uncertain 
significance. PBPs are numbered in order of decreasing 
molecular size - a convention by which similarly 
11 
numbered PBPs from different organisms are not necessarily 
related. 
In E. coli transpeptidase and transglycoslase activities, 
have been detected in PBP groups 1, 2 and 3 whereas D,D-
carboxypeptidase activities have been associated with PBP 
groups 4, 5 and 6. Most PBPs are thought to be penicillin-
sensitive enzymes catalyzing terminal stages in the assembly 
of the peptidoglycan network of bacterial cell walls. They 
are probably located strategically to perform as a 
'functionally integrated assembly line' (Tipper, 1985). 
The selective toxicity of beta-lactam antibiotics for 
bacterial cells but not for mammalian cells is explained by 
the substrate analogue theory (Tipper and Strominger, 1965). 
This is based on the structural similarity between the beta-
lactam ring and a transitional state conformation of the 
carboxy terminal D-alanyl-D-alanine residue in the natural 
substrate of these penicillin-sensitive enzymes. That is, 
PBPs which are essential for cell wall synthesis seem to 
mistakenly 'recognis~' beta-lactam antibiotic molecules as 
their natural substrate(s). It is not certain if cell 
viability requires complete or only partial activity from any 
PBP groups (Tipper, ·1985). 
Selective inhibition of individual PBPs is associated with 
.morphological changes arising from defects in cell wall 
synthesis. In!· coli cephaloridine and cefsulodin bind 
selectively to the hundreds of molecules in the multicomponent 
' 12 
Molecular 
PBP weight 
(kd) 
lA 92 
lB 90 
2 66 
3 60 
4 49 
5 42 
6 40 
TABLE 2 
Properties ~ E. coli PBPs 
Molecules 
per Selective inhibitors 
cell * 
200 
Cephaloridine, 
cefsulodin 
250 
20 Amdinocillin, 
clavulanic acid, 
imipenem 
50 Cephalexin, 
cefuroxime, 
aztreonam, 
furazlocillin 
110 
1800 
600 
Functions 
Essential for 
cylindrical cell 
wall synthesis 
Initiation of 
cylindrical wall 
growth at sites 
of septation 
Required for 
septum cross-
wall synthesis 
Peptidase 
activity on 
maturing 
peptidoglycan 
* The 'molecules per cell' are approximations based on 
measurement of bound radioactivity and assuming stoichiometric 
penicillin binding. 
(From Tipper, 1985) 
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PBPl complex, an event which can result in rapid and extensive 
killing of c~lls, degradation of cell wall material, and cell 
lysis (Tomasz,1986). Lysis, when it .occurs in response to 
beta-lactam antibiotics, results from inappropriate activation 
of autolytic peptidoglycan hydrolases. This is associated 
with inhibition of PBP lB (or lA plus lB) (Yousef et al., 
1985). Amdinocillin, clavulanic acid, and imipenem have a 
high selectivity for the 20 or so molecules of PBP2 and 
convert bacilli to osmotically sta~le spherical cells which 
may lose viability without extensive cell wall degradation. 
Piperacillin, mezlocillin and aztreonam bind selectively 
mainly to the hundreds of PBP3 molecules to i~hibit septation, 
leading to filamentation and limited lysis (Tomasz, 1986) but 
their activity is bactericidal. The low molecular weight and 
relatively abundant PBPs 4,5 and 6 are not lethal targets for 
beta-lactam antibiotics (Tipper, 1985). 
-----------------
2. Penams 
Penicillins are N-acylated derivatives of 6 beta-amino-
penicillanic acid (6-APA), whic,h is a derivative of the penam 
, nucleus (Fig. 1). Fig. 2 and Table 3 list penicillins 
representing the different types of antibacterial activity of 
the group. Variations in the side chains of the molecules 
greatly influence properties such as antibacterial activity, 
resistance to beta-lactamases and amidases, acid stability, 
protein binding, absorption, distribution and elimination 
(Selwyn, 1980). 
14 
FI<___ . 1 
c~ s s/5' 2 N.IH H 'C!CH3l2 H/ ·.Beta- Th1azolod1ne I 
. - - lactam . ring · 
7 •ong. h- N CH.COCH 
oV 4 3 
General formula 
(with conventional numbering) 
------------------------------------------------~------------. 
Side chain (R) of derivatives 
ot:: 
Q-cH-
tOONa 
~ 
C H -N N-C-NH-CH-
2 5 \ / 0 I 
I/\\ 0 IOi 
0 0 ~ 
Penicillin G 
Methicillin (Resistant 
to staphylococcal 
beta-lactamases) 
Ampic_illin 
(Broad spectrum) 
Carbenicillin 
(Anti-Pseudomonas) 
Piperacillin 
(Extended spectrum) 
Amdinocillin 
(Amdino renicillin) 
Temocillin - complete 
molecule 
(Resistant to 
Gram-negative 
beta-lactamases) 
Fig. 2. Structures of Rep~esentatives of Different 
Classes of Penams. 
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TABLE 3 
Classification of Penams by Antibacterial Spectrum 
Natural Penicillins Antipseudomonas Penicillins 
Penicillin G Carboxypenicillins 
Penicillin V Carbenicillin 
Phene thic illin Ticarcillin 
Indanyl carbenicillin 
Penicillina~e-Resistant Carfecillin 
Penicillins Acylamino Penicillins 
Methicillin Azlocillin 
Nafcillin Mezlocillin 
Isoxazolyl Penicillins Piperacillin 
Cloxacillin Apalcillin 
Dicloxacillin 
Fl ucloxac illin Amdino Penicillins 
Oxacillin Amdinocillin 
Pivampicillin 
Amino penicillins 
Ampicillin Gram-negative Beta-lactamase-
Amoxycillin Resistant Penicillins 
Bacampicillin Temocillin 
Cyclacillin BRL 36650 
Epicillin 
He tac ill in 
Pivampicillin 
Talampicillin 
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Benzyl Penicillin 
The first commercial penicillin was sodium benzyl 
penicillin, or penicillin G (Fig. 2), a natural fermentation 
product of Penicillium chrysogenum. Although it is primarily 
active against Gram-positive bacteria, Neisseria gonorrhoeae, 
!..:_ meningitidis, spirochaetes, borreliae and some anaerobes it 
is relatively inactive against most Gram-negative bacteria and 
lacks beta-lactamase stability. The early emergence of 
beta-lactamase-producing strains of Staphylococcus aureus, 
which were present before benzyl penicillin was used 
therapeutically, led to widespread resistance in hospitals 
within five or six years of its introduction into common use 
(Richmond, 1981). 
Methicillin and the Isoxazolyl Penicillins 
At the beginning of 1959 Beecham Laboratories began to 
produce relatively large quantities of the 6-APA making 
possible the synthesis of many new antibiotics by simple 
acylation (Batchelor et al., 1959). The first semi-synthetic 
penicillin, phenethicillin, was produced in 1959. It was soon 
followed by methicillin (2,6-dimethoxyphenyl penicillin) which 
was the first penicillin highly resistant to staphylococcal 
beta-lactamases (Rollinson et al., 1960), and the 
isoxazolyl penicillins cloxacillin (Knudsen~ al., 1962), 
oxacillin and dicloxacillin (Gravenkemper et al., 1965), also 
possessing resistance to staphylococcal beta-lactamases. 
Although methicillin and the isoxazolyl penicillins have 
little activity against Gram-negative bacteria they have high 
resistance to many Gram-negative beta-lactamases. This is not 
of therapeutic importance but is valuable in the 
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characterisation of beta-lactamases (Brown and Reading, 1983). 
Amino Penicillins 
Ampicillin, the first 'broad-spectrum' penicillin, was 
introduced in 1961. It is more active than benzyl penicillin 
against Gram-negative bacteria but less active against most 
Gram-positive bacteria (Rolinson and Stephens, 1961). 
Amoxycillin, a later analogue, is now more widely used because 
of .better oral absorption and possibly more rapid bactericidal 
action. Both ampicillin and amoxycillin are vulnerable to a 
wide range of beta-lactamases and amidases (Selwyn, 1980). 
Alpha-carboxy Penicillins 
Carbenicillin, the first penicillin with activity against 
Pseudomonas aeruginosa, was introduced in 1967. It is 
active against certain Gram-negative bacteria which are 
resistant to ampicillin but in general is inherently less 
) ' 
active than other penicillins against most bacteria (Knudsen 
et al., 1967). Ticarcillin, a more active analogue of 
carbenicillin, was introd~ced in 1973 (Rodriguez ~,al., 
Both carbenicillin and ticarcillin have very \ 
poor activity against Gram-positive bacteria. 
-
Acylamino Penicillins 
In 1981 three extended spectrum acylamino penicillins 
(acylureido-penicillins) were released - azlocillin, 
mezlocillin, and piperacillin. Apalcillin, a further 
acylamino penicillin, is still in the investigational stage. 
All are derivatives of ampicillin and are vulne~able to a wide 
range of beta-lactamases. Their spectrum of activity is . 
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similar to the less active, but more stable, alpha-carboxy 
penicillins. Their superior activity may arise from their 
affinity to PBP3 and their ability to rapidly inhibit 
septation at low concentrations (Brown and Reading, 1983). 
Amdino Penicillins 
Amdinocillin (mecillinam), which was released in early 
1985, has a spectrum limited essentially to a few 
Enterobacteriaceae. However its unusually selective binding 
to PBP2 (Spratt, 1975) produces osmotically stable spherical 
cells which lyse in appropriate environmental conditions. The 
spherical cells are especially vulnerable to beta-lactam 
antibiotics which bind to PBPl and/or PBP3 (Spratt, 1977). 
This vulnerability to double beta-lactam therapy is thought to 
stem from synergistic antibacterial activity through a 'two-
step-blockade' of cellular function (Eliopoulos, 1986). 
Sanders et al. (1987) report an additional mechanism by 
which amdinocillin appears to potentiate the activity of other 
beta-lactam antibiotics through causing leakage of beta-
lactamase through the outer cell membrane. The leakage of 
beta-lactamases from the periplasm depletes the cell's 
defences and permits beta-lactamase-vulnerable antibiotics to 
exert an antibacterial effect. This is a different mechanism 
from the 'two-step-blockade' and may arise from changes in 
outer membrane permeability as a result of PBP2 binding. The 
effectiveness of this mechanism has been demonstrated in 
animals. The success in animal trials suggests that it 
has considerable therapeutic potential for infections caused 
by those bacteria which develop resistance to the newer beta-
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lactams and thus may be a major breakthrough in the quest for 
a new golden age of antibiotic therapy. 
Future Penicillins 
Temocillin, a 6-alpha methoxy penicillin, is the first 
penicillin to combine broad spectrum activity with stability 
to- a broad range of bacterial beta-lactamases. The beta-
lactamase stability is attributed to the addition of a 6-alpha 
methoxy group to the ticarcillin molecule (Fuchs et·al., 
1984). Temocillin's activity against many Gram-nega~ive beta-
lactamase-producing bacteria has been gained at the expense of 
activity against Gram-positive organisms and P. aeruginosa 
(Eliopoulos, 1986). As previously mentioned Flavobacterium 
strain 80 is the only organism known to possess a beta-
lactamase which hydrolyses this antibiotic (Chen and Williams, 
1982, 1985). 
The novel 6-alpha formamido penicillin, BRL 36650, is an 
even more active, beta-lactamase stable, broad-spectrum 
penicillin. It is regarded as potentially useful in the 
treatment of infections by mutant bacteria which are 
derepressed beta-lactamase producers (Van Landuyt et al., 
1986). 
- ' 
3. Cephems 
Cephalosporins are N-acylated derivatives of 7 beta-
amino-cephalosporanic acid (7-ACA) which is derived from the 
cephem nucleus (Fig. 1). Fig. 3 lists a number of 
20 
R1'- ~ c~ 1 s ./ '--..2 General formula 
- / · Bela· Olhydro- . ' 
N.,H-. -CH CH2 
H lacaam I 1h1a1me I . (with conventional numbering) 
Fig. 3. 
ring ring 
Bc--N 3.J: _....R2 ~ 5"-t:/ ;;;cH2 
9tOQH 
Rl side chain and R2 side chain of derivatives 
Cephalothin (first generation) 
Cefuroxime (second generation) 
U c-/I NH S N,OCH 2 3 
Cefotaxime (third generation) 
Ceftazidime (third generation) 
,.;;O 
--o-c:I' 
'cH 3 
~o 
-o-c 
'\NH 
2 
0 
II 
-CH-0-C-CH3 
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Classes of Antibacterial Activity. 
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cephalosporins representing the three 'generations'. The 
division of cephalosporins into generations is an arbitrary 
but convenient guide which reflects the advances made with the 
introduction of each group. First-generation cephalosporins 
(i.e. the early cephalosporins) characteristically possess 
moderate anti-Gram-positive activity but restricted anti-Gram-
negative activity owing to vulnerability to beta-lactamases. 
The second-generation cephalosporins are more resistant to 
Gram-negative beta-lactamases and therefore more active 
against Enterobacteriaceae but tend to be less active against 
Gram-positive bacteria. Third-generation cephalosporins are 
the most active against Gram-negative bacteria and some agents 
have activity against.!'._· aeruginosa. However their anti-Gram-
positive activity varies from slight to moderate (Sanders and 
Sanders, 1986b). 
The presence of two side chains (Rl and R2 in Fig. 3) 
allows an even greater range of semi-synthetic cephalosporins 
than is possible for the penicillins which have only one side 
chain. Alterations at the 7-alpha carbon position affect the 
the antibacterial spectrum and beta-lactamase stability of the 
antibiotics. Beta-lactamase stability is also conveyed by a 
methoxy group at C-7. Substitution of an oxygen atom for the 
usual sulphur atom at position 1 increases antibacterial 
potency and beta-lactamase stability. Side chain alterations 
at C-3 affect pharmacokinetics and, to a lesser extent, 
antibacterial potency (Sanders and Sanders, 1986b). 
Emergence ~ Resistance During Therapy 
In 1984 Sanders (1984c) reviewed the newer cephalosporins 
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and expressed concern about their impact on the hospital 
environment, where they are· among the most frequently used 
antibiotics. Multiple beta-lactam resistance arising from use 
of the newer beta-lactam antibiotics appeared to be 
particularly associated with use of the newer cephalosporins 
and cephamycins. These drugs were identified as important 
inducers of chromosomally mediated beta-lactamases, a major 
factor in multiple beta-lactam resistance. In the same year 
reports appeared documenting the increasing incidence and 
impact of multiply beta-lactam resistant bacteria in 
Australian, American, and French hospitals. The increasing 
incidence of resistant organisms was associated with use of 
cefotaxime and moxalactam (Sanders and Sanders, 1986b). 
Future Cephalosporins 
Cefpirome and BMY 28142 have shown considerable promise 
during developmental stage testing. These aminothiazolyl-
alpha-methoxamino-cephalosporins are highly potent against 
beta-lactamase-producing Gram-positive and Gram-negative 
bacteria including.!'.: aeruginosa. Their potency is attributed 
to a very low affinity for beta-lactamases, a property which 
is thought to enhance access to PBPs (Phelps et al., 1986). 
Of particular interest is their apparent reduced potential to 
induce chromosomal beta-lactamases. These drugs have been 
proposed as the first members of the 'fourth generation' of 
cephalosporins. (Sanders and Sanders, 1986b). 
4. 2. Alpha-methoxycephems and oxacephems 
The cephamycins, or 7 alpha-methoxycephems, resemble 
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TABLE 4 
Classification of Cephems, Methoxycephems(*) 
and Oxacephems(**) by Generation 
First Generation 
Cefadroxyl 
Cep]Jazolin 
Cephalexin 
Cephaloridine 
Cephalothin 
Cephapirin 
Second Generation 
Cefaclor 
Cefamandole 
Cefme tazole ( 'b':) 
Cefonicid 
Ceforanide 
Cefotetan (**) 
Cefotiam 
Cefoxi tin ('"*) 
Cefuroxime 
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Third Generation 
Lacking Enhanced Anti-
Pseudomonas ActivitY 
Cefbuperazone (**) 
Cef menoxime 
Cefotaxime 
Ceftriaxone 
Moxalac tarn ( '") 
With Enhanced Anti-
Pseudomonas Activity 
Cef operazone 
Cefpimazole 
Cefpiramide 
Cefsulodin 
Ceftazidime 
'Fourth Generation' 
Cefpirome 
BMY 28142 
second generation cephalosporins in spectrum of activity but 
have enhanced potency against anaerobic bacteria. This 
similarity makes it convenient to sometimes group both classes 
of antibiotics together as in Table 1. The trivial 
nomenclature 'cephamycin' denotes the bacterial source of 
cephamycins (from Streptomyces spp.) rather than moulds. 
Cephamycin molecules differ from cephalosporins in having 
different substituents at the C-3 and 7 alpha positions. 
Analogous to 7-ACA and the cephalosporins, cephamycin C is the 
source of syntheti~ cephamycin derivatives. Cefoxitin, the 
first commercial derivative (Kosmidis ~al., 1973), possesses 
a 2-thienylmethyl group at the 7 beta position of cephamycin 
C. Cephamycins have a wider spectrum of activity and are more 
resistant to 'cephalosporinases' (beta-lactamases which 
preferentially hydrolyse cephalosporins) than first generation 
cephalosporins (Selwyn, 1980). This resistance is attributed 
to the methoxy group at the C-7 position (Brown and Reading, 
1983). 
If the sulphur atom of the cephem (Figs 1 and 3) is 
replaced with oxygen a series of analogues called oxacephems 
is produced. Moxalactam (latamoxef), the most notable, has 
activity resembling third generation 0t cephalosporins (Brown 
and Reading, 1983). 
5. Carbapenems and penems 
These are newly developed groups of beta-lactam 
antibiotics with chemical structures differing from penams, 
cephems, oxacephems, methoxycephems and monobactams (Figs 1, 
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4). The carbapenems are naturally occurring antibiotics (e.g. 
thienamycin is isolated from Streptomyces cattleya) whereas 
the penems are synthetic molecules. Both groups are very 
similar in possessing a very broad antibacterial spectrum, 
high resistance to beta-lactamases and susceptibility to 
hydrolysis by mammalian renal dipeptidases (Norrby, 1986). 
They exhibit high potency against most aerobic and anaerobic 
bacteria including multiply-resistant pathogens such as P. 
aeruginosa, Acinetobacter, B. fragilis and enterococci. 
Imipenem (N-formimidoyl-thienamycin), the first commercial 
carbapenem, has outstanding potency - a feature which is 
attributed to the relatively small number of antibiotic 
molecules required to bind to the 20 or so PBP2 molecules per 
bacterial cell. This is in contrast to the hundreds of 
molecules of other beta-lactam antibiotics usually required to 
bind to PBPs land/or 3 to be effective (Winston et al., 
1984). 
Beta-lactamase inhibition is a feature of all carbapenems. 
Beta-lactamase inhibition results from the high affinity of 
these antibiotics for many beta-lactamases leading to the 
formation of enzyme-inhibitor complexes which are not prone to 
hydrolysis (Brown and Reading, 1983). 
Initially clinicians hoped that imipenem, and subsequent 
carbapenems and penems, would resolve current resistance 
problems (Winston~ al., 1984). However treatment failures 
have occurred with imipenem during therapy of P. aeruginosa 
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General formula 
Antibiotic x y z 
Thienamycin * OH C CH2CH2NH3 
Imipenem * OH C CH2CH2CH=N 
SCH 29482 '~* OH S CH2CH3 
SCH 34343 *'': OH S CH2CH20CONH2 
'~ Carbapenem ** Penem 
(From Norrby, 1986) 
Fig. 4. Chemical structures of some carbapenems and penems. 
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infections (Winston et al., 1984; Quinn et al., 1986; Pedersen 
' -- --
et al., 1987). Furthermore a number of organisms in the 
hospital environment) some of them opportunistic pathogens, 
are resistant without previous exposure and may be selected by 
imipenem therapy. These include!· meningosepticum, !· 
multivorum, Flavobacterium Group !lb (O'Donnell~ al., 1982; 
Von Graevenitz and Bucher, 1982), I· odoratum (Von Graevenitz 
and Bucher, 1982; Sato~ al., 1985), ~· maltophilia, some 
strains of ~· cepacia, ~· pseudomallei, Corynebacterium spp. 
and Streptococcus faecium. An additional resistance problem 
is the ability of imipenem to induce beta-lactamase production 
in ~· aeruginosa causing increased resistance to other beta-
lactam antibiotics (Tausk ~al., 1985). 
In most respects the penems are similar to the 
carbapenems. However P. aeruginosa and enterococci are 
usually resistant to the penems while anaerobic bacteria are 
usually more susceptible to the penems than to the carbapenems 
(Norrby, 1986). The vulnerability of all compounds of these 
groups to hydrolytic inactivation by hydrolysis by the 
mammalian renal dipeptidase, dihyqropeptidase-I (DPH-I), is a 
major disadvantage which i$ currently overcome by combining 
the antibiotics with the DHP-I inhibitor cilastatin (Norrby, 
1986). 
5. Monobactams 
The monobactams are N-acyl derivatives of 3-amino-
monobactamic acid (Brown and Reading, 1983). They have a 
simple monocyclic structure in contrast to the bicyclic 
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Aztreonam 
COOH 
Clavulanic acid 
a ...... /lo 
'~S)<CH ),-~~ CH: 
COOH 
Sulbactain 
Fig. 5. Structures of Aztreonam, Clavulanic Acid 
and Sulbactam 
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molecules of other beta-lactam antibiotics (Fig. 1). 
Aztreonam, the first monobactam (Fig. 5), is relatively 
inactive against Gram-positive and anaerobic bacteria but has 
high potency against many aerobic Gram-negative bacteria, but 
not Flavobacterium, Acinetobacter, Achromobacter, Moraxella or 
Alcaligenes denitrificans and faecalis (Brogden and Heel, 
1986). It is also resistant to hydrolysis by many beta-
lactamases. Its narrower spectrum may be preferred to other 
newer beta-lactam antibiotics for specific therapy as there is 
less likelihood of emergence of resistant organisms and 
diarrhoea arising from disturbance to ~he natural gut flora. 
It is not a strong inducer of chromosomally mediated beta-
lactamases. Instead it tends to either inhibit them or to act 
as a poor substrate (Sykes and Bonner, 1985; Williams, 1986). 
Resistant strains of Pseudomonas have emerged during therapy 
(Greenberg et al., 1985; Sanders and Sanders, 1985). The 
mechanism of resistance in_!'... aeruginosa and other Gram-
negative bacteria possessing inducible chromosomal beta-
lactamases is the controversial non-hydrolytic beta-lactamase-
mediated inactivation (Sanders and Sanders, 1986c). 
Carumonam is a new monobactam with greater activity than 
aztreonam against some strains of Klebsiella oxytoca, 
Citrobacter freundii, ~· diversus, _!'... maltophilia, _!'... cepacia 
and Providencia stuartii. The greater activity against!· 
oxytoca is attributed to greater beta-lactamase stability 
(Fass and Helsel, 1985). 
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6. Beta-lactamase Inhibitors 
While the production of beta-lactamase is only one of 
several mechanisms by which bacteria resist beta-lactam 
antibiotics it is, for the majority of clinically important 
bacteria, the major mechanism of resistance (Reading, 1981; 
Gould and Wise, 1986). The difficulty in developing 
antibiotics, particularly oral antibiotics, with stability to 
a wide range of beta-lactamases has stimulated efforts to 
produce enzyme inhibitors which can be used either as 
antibiotics or as co-drugs to protect labile antibiotics 
from inactivation. To date most beta-lactamase inhibitors are 
beta-lactam compounds (Gould and Wise, 1986). 
The inhibitory activity is initiated by covalent binding 
to beta-lactamases to form long-lived complexes in which 
neither enzyme nor inhibitor have biological activity. The 
binding can be reversible or furtper binding can occur 
resulting in irreversible inhibition (suicide or progressive 
inhibitors) (Sanders, 1983; Gould and Wise, 1986). 
The first clinically significant beta-lactamase inhibitor, 
clavulanic acid (Fig. 5), was discovered in 1976 (Howarth~ 
al., 1976). It has little intrinsic antibacterial activity 
except against penicillin-susceptible B· gonorrhoeae and 
Legionella pneumophil .a. It is however a potent inhibitor of 
staphylococcal beta-lactamases and those of Richmond and Sykes 
Classes II-V (Gould and Wise, 1986). However it does not 
inhibit Class I beta-lactamases - enzymes which are associated 
with an increasing number of treatment failures (Sanders, 
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1983). Clavulanic acid is marketed in combination with 
amoxycillin and also in combination with ticarcillin. 
It now seems that clavulanic acid was incompletely 
investigated before its release for.clinical use. There are 
increasing reports of curious and unexpected effects ~rising 
from use of this compound. Sometimes it behaves as a potent 
co-drug with synergy arising from a mechanism other than beta-
lactamase inhibition. This is apparent when clavulanic acid 
potentiates the activity of beta-lactam antibiotics against 
bacteria possessing class I beta-lactamases, the only beta-
lactamases not inhibited by clavulanic acid (Clarke ~nd 
Zemcov, 1984; Tausk and Stratton, 1986). It can also 
potentiate antibiotics which are resistant to hydrolysis by 
beta-lactamases. This effect is attributed to the ability of 
clavulanic acid to s~lectively alter outer membrane 
permeability (Bakken et al., 1987). An even more curious and 
potentially disturbing effect of clavulanic acid is its 
ability to induce the production of beta-lactamases and 
enhance bacterial resistance. All reports of this effect 
concern bacteria possessing inducible class I beta-lactamases 
(Minami et al., 1980; Crump and' Cansdale, 1982; King~ al., 
1983; Bolivar~ al., 1984; Clarke and Zemcov, 1984; File~ 
al., 1984; Tausk and Stratton, 1986). The clinical 
significance of this effect is unclear (Tausk and Stratton, 
1986). In all clavulanic acid is biologically active in a 
variety of ways and should not be considered solely as a 
beta-lactamase inhibitor. There is consi~erable scope for 
further investigation into the complete range of biolog~cal 
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properties of this agent. 
Other beta-lactamase inhibitors include carbapenems, 
sulphated macrocyclic lactones (e.g. izumenolide), monobactams 
and penicillanic acid sulfones (e.g. sulbactam and YTR 0 30) 
(Gould and Wise, 1986). 
Like clavulanic acid, sulbactam is used commercially - in 
combination with ampicillin and with cefoperazone. Alone 
sulbactam has little antibacterial activity except against N. 
gonorrhoeae and Acinetobacter calcoaceticus. Its spectrum of 
inhibitory activity is similar to that of clavulanic acid but 
is two to five times less potent. It does however provide 
greater protection against the beta-lactamases of some strains 
of Proteus, Providencia, Citrobacter, Enterobacter and 
Serratia marcescens (Gould and Wise, 1983). 
The future clinical importance of beta-lactamase 
inhibitors is difficult to predict. The currently marketed 
preparations are not regarded as superior to conventional 
antibiotic therapy (Conner, 1985). They lack useful activity 
against some clinically important beta-lactamases and their 
pharmacokinetic properties are not always matched to their 
beta-lactam co-drugs. The future of this type of therapy 
therefore appears to depend on the development of new 
inhibitors (Gould and Wise, 1986). 
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c. Resistance of Gram-negative Bacteria to Beta-lactam 
Antibiotics. 
1. The Clinical Problem 
The production of antibiotics in Nature by microorganisms 
is presumably of survival value in reducing the population 
levels of competitors. Similarly the clinical use of 
antibiotics by man is aimed at enhancing survival through 
reducing bacterial numbers to either prevent or treat 
infection. However in both clinical and environmental 
settings antibiotics may be ineffective against bacteria which 
possess mechanisms for resistance (Lacey, 1980; Levy, 1982). 
Prior to the antibiotic era the majority of clinically 
encountered bacteria were susceptible to antibiotics. However 
since the introduction of sulphonamides in 1935 and penicillin 
in 1942 subsequent antibacterial therapy has created an 
intense selection pressure causing antibiotic resistant 
bacteria to proliferate at the expense of the susceptible 
majority (Finland, 1971; Lacey, 1980; Levy, 1982). This 
selection pressure has important implications for the outcome 
of antibiotic therapy, the microbial ecology of institutions 
and communities, and for the useful lifetimes of antibiotics 
(Murray and Moellering, 1978; Jackson, 1979; Gardner et. al., 
1980; Levy, 1982; McGowan, 1983; Sanders~· al., 1984; Acar, 
1985). Furthermore the emergence of antibiotic resistance has 
impacted on the types of infectious disease states encountered 
by contributing to an evolving state of infectious disorders. 
While minor changes in infectious diseases may have occurred 
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previously,.infectious diseases since the period 1935 to 1942 
have increased in frequency and changed in character to 
present new problems in a way not paralleled in other classes 
of diseases (Florey, 1956; Rogers, 1959; Buckwold and Ronald, 
1979; Weinstein, 1985; Acar, 1985). 
Prior to the introduction of antibiotics serious 
infections encountered in hospitals were caused predominantly 
by pneumococci, haemolytic streptococci and staphylococci 
(Buckwold and Ronald, 1979). Gram-negative bacteria were 
relatively infrequently involved with~ coli being the most 
important pathogen. Other Gram-negative pathogens encountered 
were primarily !.:._ meningitidis, !· gonorrhoeae, Klebsiella 
pneumoniae, Haemophilus influenzae, Salmonella spp. and 
Proteus mirabilis. Opportunistic pathogens such as 
Pseudomonas spp., Cardiobacterium hominis, Serratia spp., 
Providencia spp., Proteus. vulgaris, Morganella morganii, 
Acinetobacter spp., and Flavobacterium spp. were extremely 
rare causes of infection. Since the introduction of 
antibiotics these organisms have increased in incidence and 
importance as causes of nosocomial infection (Finland et al., 
1959; Rogers, 1959; Feeley et. al., 1975; Buckwold and Ronald, 
1979; McGowan, 1983; Fainstein and Bodey, 1985; Weinstein, 
1985;Young, 1985). 
As each new antibiotic has become available organisms have, 
with few exceptions, rapidly developed resistance. This trend 
has accelerated to the point where organisms such as Pseudomonas 
and Serratia are frequently resistant to most of the commonly 
used antibiotics. Since the late 1970s resista~ce has developed 
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in certain clinical settings with such rapidity that it 
threatens the ability of pharmaceutical companies to continue 
producing effective therapies (Levy, 1982; McGowan, 1983; 
Acar, 1985; Tipper, 1985; Weinstein, 1985). 
Antibiotic use has not been the sole determinant of the 
changing pattern of bacterial infection. Other modern medical 
practices have contributed by providing increasing numbers of 
patients especially vulnerable to infection. Such patients 
include: 
(i) an increasing number of older and sometimes 
debilitated patients, 
(ii) those with tumors and leukaemia who now survive 
longer, but because of immunosuppression due to 
disease or treatment are highly susceptible to 
invasion by almost any organism, and 
(iii) the increasing number who undergo immunocompromising 
procedures and therapies (Klastersky, 1985; 
Weinstein, 1985). 
Such infection-prone patients enhance the acquisition, 
multiplication and persistence of antibiotic-resistant 
bacteria and their subsequent transmission (Sherris, 1970). 
2. Resistance Mechanisms - Introduction 
The difference between the extracellular concentration of 
a beta-lactam antibiotic and its concentration at the target 
PBPs is determined by its rate of penetration and its 
susceptibility to beta-lactamases. The outer membrane of 
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Gram-negative bacteria (Fig. 6) is selectively permeable. 
Access 'to the periplasmic gel (Robot et al., 1984) is 
determined by the rate of passive diffusion through the 
exopolysaccharide layer and the outer membrane (Tipper, 1985; 
Nayler, 1987). In the case of hydrophilic molecules such as 
the majority of beta-lactam antibiotics the diffusion is 
largely through aqueous pores called porins (Nikaido, 1981; 
1985). Outer membrane permeability varies widely, being 
generally high in Neisseria, very low in Pseudomonas, and 
intermediate in Enterobacteriaceae. Beta-lactamases secreted 
into the periplasm can reach high concentrations. These along 
with other proteins and macromolecular solutes may modify or 
trap antibiotic molecules which traverse the outer membrane 
and thereby control the concentration of active antibiotic in 
the vicinity of the PBPs (Tipper, 1985; Nayler, 1987). While 
outer membrane permeability and beta-lactamases are important 
determinants of antibiotic resistance, the target PBPs may 
also affect resistance by undergoing mutational alterations 
which alter their affinity for antibiotics (Tipper, 1985; 
Tomasz, 1986). 
The rapidity and extent with which bacteria develop 
resistance varies widely depending on both the types of 
bacteria and antibiotics involved (Garrod et. al., 1973; 
Wilson and Miles, 1975; McGowan, 1983). 
3. Permeability 
The lipid bilayer, which comprises most biological 
membranes including the outer membrane of Gram-negative 
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Fig. 6 Interaction of beta-lactam antibiotics 
with Gram-negative cell. 
(Adapted from Normark and Lindberg, 1985) 
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bacteria (Fig. 6), usually has low permeability to hydrophilic 
solutes. It is necessary however for the bacteriu~ to take 
up nutrients from, and excrete waste products into, the 
external environment. These functions are achieved through 
porin channels which, in the cases of E. coli and S. 
typhimurium, allow the diffusion of any solute providing it is 
small, i.e. less than 600 daltons, and hydrophilic (Nikaido, 
1985). 
In most Gram-negative bacteria the porins are proteins of 
MW 35,000-40,000 which are often the most abundant cell 
proteins e.g. 105 molecules per cell. Studies comparing wild 
types and porin-deficient mutants have demonstrated that it is 
through the porin channels of !· coli and other 
Enterobacteriaceae t~at many beta-lactam antibiotics cross the 
outer membrane. The Enterobacteriaceae frequently produce 
m~ltiple types of porin. !· coli K-12 produces OmpF (outer 
membrane protein F) and OmpC porins. Salmonella typhimurium 
produces OmpF, OmpC and OmpD porins. Enterobacter cloacae 
also produces two porin types. All nonenteric species seem to 
produce a single porin type which is characteristic of the 
strain. Porins have been identified for ..!:· aeruginosa, _!:!. 
gonorrhoeae, Aeromonas salmonicida, Brucella spp., Chlamydia 
trachomatis, ..!:· mirabilis, f· vulgaris, Providencia rettgeri, 
Morganella morganii, Rhodopseudomonas capsulata and R. 
sphaeroides (Nikaido, 1985; Mitsuyama ~al., 1987). In 
general comparisons of permeability, and allowing for 
considerable differences between strains within species, H. 
influenzae (most permeable)) !_. coli > !· cloacae) P. 
aeruginosa (least permeable) (Nayler, 1987). 
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While porin channels do not exert configurational 
specificity the diffusion rates of solutes are greatly 
affected by their gross physicochemical properties. In E. 
coli the estimated diameters of the OmpF and OmpC channels are 
1.16 and 1.04 nm respectively. These are sizes close to the 
sizes of beta-lactam molecules. It is thus obvious that the 
rates of diffusion of the beta-lactam antibiotics is very 
dependent on interactions with the rims or walls of the porin 
channels. 
Since even very low beta-lactamase activity may inactivate 
a significant fraction of beta-lactams reaching the periplasm 
antibiotic efficacy is influenced by the balance between an 
antibiotic's rate of influx and its rate of removal by beta-
lactamases. Effective periplasmic concentrations are 
therefore not. necessarily indicative of high permeability. 
Many of the newer beta-lactams exhibit relatively poor 
permeability but are nevertheless quite potent because of 
relatively high resistance to beta-lactamases (Nikaido, 1985). 
Antibiotic Penetration in E. coli 
Rates of diffusion through the porin channels of E. coli, 
and other bacteria, are determined by solute attributes such 
as hydrophobicity, size and charge, each of which interact 
with each other. In general zwitterionic compounds penetrate 
extremely well while negative charges exert a retarding effect. 
Smaller molecules diffuse faster than larger molecules or 
similar sized molecules with bulky side chains. The substituted 
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oxime side chain on the alpha carbon of the substituent group at 
pos~tion 7 of the cephem nucleus causes a 10-fold decrease in 
penetration rate while the presence of a methoxy group at this 
position reduces penetration by 20%. Hydrophilicity enhances 
penetration (Nikaido, 1985)~ 
Porin production in !· coli K-12 is nutrient dependent. 
On ordinary laboratory media two porins, OmpF and OmpC are 
produced. The narrower OmpC channel is more selective in 
terms of hydrophobicity and molecular size. Cephalosporins 
penetrate two to three times faster than their more 
hydrophobic penicillin analogues (Nikaido, 1985). This does 
not mean that cephalosporins are more effective as penicillins 
are thought to also penetrate through non-porin pathways in!· 
coli and E. cloacae and possibly other species (Komatsu et' 
al., 1981; Sawai, Hiruma et al., 1982; Yamaguchi et al.,. 
1985). When starved for phosphate!· coli K-12 derepresses an 
additional porin, PhoE, which favours negatively charged beta-
lactam antibiotics. This porin is not however regarded as 
having clinical significance as serum phosphate concentrations 
are too high to invoke utilisation of PhoE (Yoshimura and 
Nikaido, 1985). 
The importance of size of solute molecules can be seen from 
the permeability of arabinose (MW 150) which penetrates 
approximately one hundred times fa~ter than disaccharides of MW 
342. Many beta-lactams have MWs in the range 350-450, a size 
range which significantly restricts diffusion through the 
porins, especially the narrower OmpC channel. Compounds of 
unusually large size, su~h as piperacillin and cefoperazone, 
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diffuse slower th~.ough the larger OmpF than predicted from their 
MWs and hydrophdbicity values, probably as a result of st~~ric 
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hindrance arising from their very large side chains. The 
smaller OmpC channel appears to be closed to compounds with 
molecular weights higher than 500 or those with bulky side 
chains such as cefoperazone (MW 644), ceftriaxone (MW 552) and 
ceftazidime (MW 545). Sometimes, however, diffusion rates do not 
correlate well with MW. For example, cephaloridine (MW 415) 
penetrates twice as rapidly as lactose (MW 342). This is 
perhaps explained by the compactness of the cephaloridine ring 
structure and its increased hydrophilicity due to zwitterionic 
charges. The most rapidly penetrating beta-lactam is imipenem, 
which combines small size (MW 299) and zwitterionic charges 
(Nikaido, 1985). 
Antibiotic Penetration in Other Bacteria 
Apart from the.~." gonorrhoeae channel, it seems that the 
porin channels of other bacteria behave similarly to those of E. 
coli. That is, cations penetrate faster than anions, and 
increasing molecular size and hydrophobicity retard penetration. 
The only difference is that these effects are less impor~ant in 
organisms with larger channels (Nikaido, 1985). 
The resistance of P. aeruginosa to a wide range of 
antimicrobials is attributed to poor permeability of the outer 
membrane - 12 to 100-fold lower permeability than the outer 
membrane of E. coli. Interestingli approximately 0.4% of the 
200,000 porin F channels of .!:· aeruginosa are large and allow 
passage of polysaccharides of several thousand daltons. However 
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the remaining 99.6% or so of protein F channels are small and 
almost impenetrable by beta-lactams (Hancock, 1986; Woodruff et 
al., 1986). 
The high resistance of .!'..· aeruginosa to many beta-lactams 
seems to be due to the very low permeability of its outer 
membrane coupled with rapid hydrolysis by its inducible 
chromosomal beta-lactamase. Those beta-lactams with enhanced 
anti-pseudomonal activity are probably efficacious because of 
properties such as high beta-lactamase resistance, inability to 
induce the chromosomal beta-lactamase, or high affinity for the 
target PBPs (Nikaido, 1985). 
Outer Membrane Protein Changes and Resistance 
Recent reports suggest that altered outer membrane 
proteins are increasing in incidence as mechanisms of 
resistance. Reports of clinical isolates of !· coli (Bakken 
et al., 1987), and ~· marcescens (Goldstein~ al., 1983; 
Sanders and Watanakunakorn,1986) follow numerous laboratory 
studies of resistance due to altered outer membrane proteins 
in!· coli (Komatsu~ al., 1981; Sawai, Hiruma et al., 1982), 
!.· pneumoniae (Sanders et al., 1984), !·cloacae (Sawai ~ 
' al., -1982; Then and Anghorn, 1986) .!'..· mirabilis (Sawai ~ al., 
1982) and P. aeruginosa (Rella and Haas, 1982) 
'De..velopment of resistance due to reductions in amounts of 
outer membrane proteins is a potentially important resistance 
mechanism especially to agents with low intrinsic rates of 
penetration e.g. cefoperazone, moxalactam, cefuroxime, 
cefotaxime and aztreonam (Jaffe et al., 1982; 1983). The 
associated development of resistance to other classes of 
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antibiotics is a very major cause for concern. Then and 
Anghern (1986) suggest that there will be increased occurrence 
of such mul~ply resistant mutants as a result of use of 
potent beta-lactamase stable beta-lactam antibiotics and new 
fluoroquinolone agents. 
4. PBP Mutations 
Clinically important resistance to beta-lactam antibiotics 
arising f~om alterations to PBPs occurs most frequently as 
methicillin resistance in S. aureus and penicillin resistance 
in ~· gonorrhoeae. This type of resistance has also, been 
documented in Streptococcus. pneumoniae, ~· faecium, H. 
influenzae and~· aeruginosa. To date it appears to be 
~onfined to strains of the more invasive human pathogens, 
particularly cocci, in which beta-lactamase production has not 
contributed significantly to resistance or has been highly 
restricted in substrate profile. This type of resistance, and 
mutations affecting outer membrane proteins, can be expected 
to become increasingly important in Gram-negative bacilli with 
increased use of beta-lactamase stable antibiotics such as 
moxalactam and aztreonam. To reverse this trend it may become 
necessary tor clinical laboratories to use a more molecular 
approach to routine susceptibility testing and investigate 
antibiotics appropriate to the outer membrane permeability, 
beta-lactamase substrate profile and PBP vulnerabilities of 
pathogens (Tipper, 1985; Tonin and Tomasz, 1986). 
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d. Beta-lactamases 
Although resistance due to beta-lactamase production was 
rare in clinical isolates at the time penicillin was first 
used widespread beta-lactamase-mediated resistance was soon 
encountered in hospital isolates of~· aureus (Munch-Peterson 
and Boundy, 1962). Similarly the initial effectiveness of 
broad-spectrum penicillins such as ampicillin and 
carbenicillin was rapidly reduced by the beta-lactamases of 
Gram-negative bacteria (Williams, 1977). 
Classically beta-lactamases hydrolyse the cyclic amide 
bond of susceptible beta-lactam antibiotics to produce acid 
derivatives which have no antibacterial activity. In 
hydrolysis a covalent bond is formed between the enzyme and 
the amide part of the beta-lactam ring. The beta-lactamase 
molecule envelopes the substrate molecule forming an acyl-
enzyme complex. Deacylation of the complex yields free enzyme 
and ring-opened (hydrolysed) substrate. The efficiency of 
beta-lactamases is high with many of them capable of 
hydrolysing thousands of labile substrate molecules per 
second. However when Class 1 enzymes react with "enzyme-
stable" beta-lactams the half-lives of the intermediate 
complexes may be very long (minutes to hours). The antibiotic 
is then biologically inactive while it is bound to the enzyme 
prior to release in hydrolysed form. Organisms which can 
synthesize enzyme rapidly enough to maintain an enzyme excess 
will be resistant primarily through non-hydrolytic trapping of 
the substrate by beta-lactamases rather than through 
hydrolysis. Maintenance of an enzyme excess may be achieved 
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and maintained by the interaction of enzyme induction and the 
restrictive effect of the outer cell membrane on antibiotic 
diffusion into the periplasm (Bakken and Sanders, 1987). 
1. Some Methods Used to Characterize Beta-lactamases 
---- --- -- ------- --------
The following review discusses relevant aspects of 
procedures used to classify beta-lactamases. Historically an 
understanding of the relatedness of beta-lactamases has 
developed gradually following advances in analytical 
procedures and the changing spectrum of beta-lactamase-
producing pathogens and beta-lactam substrates. The gradual 
and incomplete development of knowledge has resulted in a 
confusing array of classification schemes. It now seems 
probable that future classifications will incorporate both 
molecular data and evolutionary aspects and be less arbitrary 
than contemporary classifications (Bauernfeind, 1986). The 
future utility of some of the following procedures will almost 
certainly diminish. However to evaluate current 
investigations of beta-lactamases it is necessary to have some 
familiarity with the applications and limitations of these 
procedures. 
Screening Strains and Preparations for Beta-lactamase Activity 
The most convenient and sensitive screen for the beta-
lactamases of Gram-negative bacteria is the chromogenic 
cephalosporin or nitrocefin technique of O'Callaghan ~al. 
(1972). Nitrocefin working solution (500 mcg./ml.), which is 
initially straw-coloured, changes to red when its beta-lactam 
ring is hydrolysed. Occasionally beta-lactamases are not 
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readily detected by this method. The ROB-1 beta-lactamase 
discovered in H. influenzae exhibits a negative nitrocefin 
reaction unless tested with a very dense cell suspension 
(Medeiros, 1984) and Legionella micdadei beta-lactamase, which 
is regarded as nitrocefin-negative by some workers, hydrolyses 
nitrocefin slowly at a pH-dependent rate (Marre et al., 1982). 
Cell-free Beta-lactamase Preparations 
Beta-lactamase preparations are usually made from cells 
harvested from broth cultures (Matthew~ al., 1975) although 
some workers may scrape cells off plates (Eley and Greenwood, 
1986). The cells are washed at least once with phosphate 
buffer of neutral or almost neutral pH then lysed by 
sonication, sand grinding (Matthew et al., 1975), osmotic 
shock (Timewell ~al., 1981), repeated freezing and thawing 
(Cartwright and Waley, 1984) or French press (Aranoff and 
Shlaes, 1987). Cellular debris is removed by centrifugati?n 
and the resultant supernatant is used as a crude enzyme 
preparation. 
Many workers do not state whether or not enzyme 
preparations are used immediately or stored. Cuchural et al. 
(1986) report that an imipenem-hydrolysing metalloenzyme from 
~- fragilis loses 99% of its activity on freezing or prolonged 
exposure to room temperature. The majority of workers who 
describe storage procedures for beta-lactamase preparations 
0 
freeze preparations at -20 ·C (e.g. Cullman ~al., 1984), or 
-70°C (e.g. Levesque et al., 1983), or freeze dry preparations 
(e.g. Tuner et al., 1985). 
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Substrate Profile 
Many assay techniques have been used to measure beta-
lactamase activity because there is no technique s~itable for 
all applications. The main source of technical difficulty is 
the different types of breakdown products formed during 
hydrolysis of penicillins and cephalosporins. Penicillins are 
degraded to penicilloic acids which may be assayed directly. 
Cephalosporins however have a more complex breakdown pattern. 
The initial products are acetic acid and cep~alosporanic acids 
which rapidly decompose into smaller molecules, the 
stoichiometry of the reaction varying according to the nature 
of the cephalosporin (Selwyn, 1980). Thus while it is 
possible to assay for penicilloic acids there is no single 
stable reaction product to detect when cephalosporins are 
hydrolysed. When accurate assays are required to determine 
beta-lactamase activity against both penicillins and 
cephalosporins it is not possible to use the same methodology 
for both types of substrates and results for both types of 
substrates are therefore not directly comparable. 
The iodometric technique, originally described by Perret 
(1954) and subsequently modifi~d and refined by several 
workers~ is perhap~ the most reliable and convenient when 
attempting to assay for both penicillinase and 
cephalosporinase activity with a single methodology •. It is 
ideal for assaying most enzymes when using penicillins as 
substrates as it relies on the reaction of eight equivalents 
of iodine with the penicilloic acid produced by beta-lactamase 
action. In the microiodometric technique (Sykes and 
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Nordstrom, 1972; Sargent, 1968) the amount of iodine which has 
reacted with the penicilloic acid is estimated photometrically 
from the production of a blue starch-iodine complex. As 
previously mentioned this assay is less reliable for 
cephalosporin substrates and therefore unsuitable if absolute 
measurement of cephalosporinase activity is required (Sykes 
and Matthew, 1976). 
The spectrophotometric method of O'Callaghan ~~· (1968) 
is a good general assay for cephalosporinase activity. The 
rate of hydrolysis of the beta-lactam ring is followed by 
measuring the rate of decrease in optical density at the 
wavelength of maximum absorption of the ring. 
Another method for measuring both penicillinase and 
cephalosporinase activity is microbiological assay. This 
method is extremely sensitive, but not very accurate and very 
time consuming (Sykes and Matthew, 1976). Sometimes it may be 
necessary to use this technique in research as conventional 
hydrolysis assays are insensitive to low levels of hydrolysis. 
For example Levesque~ al. (1983) confirmed slow hydrolysis 
of cefoxitin by MULB-906 from "Achromobacter xylosoxidans" by 
bioassay. 
The 3-dimensional test (Thomson~ al., 1984) is an 
adaptation of the microbiological assay which is used in 
conjunction with routine disc diffusion antibiotic 
susceptibility tests to provide qualitative substrate profile 
information in the routine clinical laboratory. While there 
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is a need for such information in routine laboratories 
(Phillips, 1986) the sensitivity and specificity of this 
technique have not been fully evaluated ~nd 'it is not known if 
it is suitable for all beta-lactamases. HPLC studies (Aldous. 
~al., 1985) and microbiological assays (Thomson et al., 
1984) have demonstrated that positive 3-dimensional tests 
result from antibiotic inactivation. 
The clover leaf test (Kjellander and Myibach, 1964) is 
another qualitative microbiological assay technique and has 
been used to detect beta-lactamases, chloramphenicol ~cetyl­
transferase and erythromycin esterase (Andremont et al., 
1982). There is controversy about the significance of 
occasional positive clover leaf test_~esults produced by 
organisms which seem to lack particular antibiotic 
inactivating enzymes. Reig and Baquero (1984) regard these 
nonspecific results as evidence that the technique is 
unreliable for the detection of antibiotic inactivation by the 
genus Bacteroides. Jorgensen (1985) suggests that nonspecific 
results may arise from resistance mechanisms other than 
antibiotic inactivation, and also reports three strains of 
Enterobacteriaceae with positive clover leaf te~ts which 
required sonication to detect beta-lactamase activity by the 
nitrocefin reaction. This latter finding indicates that the 
clover leaf test may be even more sensitive than the 
nitrocefin reaction. 
Measuring the hydrolytic activity of an enzyme preparation 
against a number of beta-lactam substrates is usetul for 
comparing and classifying beta-lactamases. Comparisons of 
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substrate profiles avoid the inherent difficulties associated 
with comparing different cellp which may have wide differences 
in levels of beta-lactamase expression. Profiles are often 
expressed as ratios related to a value of 100 for a chosen 
substrate. Thus a profile of penicillin G 100, ampicillin 50, 
cephaloridine 200, indicates an enzyme with a rate of 
hydrolysis of ampicillin which is half that of penicillin G 
and for cephaloridine the rate is twice that of penicillin G. 
The quoting of relative enzyme activities can be misleading as 
the apparently firm values tend to obscure a background of 
inherent technical difficulties associated with the assays 
(Richmond and Sykes, 1973). 
Substrate profile alone is not a good parameter for beta-
lactamase classification as many enzymes, especially 
chromosomal beta-lactamases, have similar profiles. However 
substrate profiles provide very valuable information when used 
in conjunction with analytical isoelectric focussing (IEF). 
The two methods ~re complementary for classification purposes 
and IEF also is necessary to ensure purity of the enzyme 
preparations to be used for hydrolysis assays (Sykes and 
Matthew, 1976). 
If hydrolysis assays are performed to investigate the 
stability of various substrates in the presence of bacteria, 
~ 
assay procedures shouldltaken further than the just-mentioned 
procedures which are quite satisfactory for classification 
purposes. In specific stability studies it is necessary to 
provide kinetic data so that the Michaelis constant and the 
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maximum reaction velocity can be determined. The ratio of 
these characteristics is sometimes referred to as 
"physiological efficiency" or "efficiency of hydrolysis" and 
is ~egarded as predictive of the hydrolytic vulnerability of 
antibiotics in vivo (Bush and Sykes, 1986). 
Induction Studies 
The induction potential of various beta-lactam antibiotics 
varies with both the drug and the organism being induced. 
However all studies so far indicate that the cephamycins and 
imipenem are potent inducers. Results with other drugs vary. 
Some workers use antibiotic concentrations far in excess of 
the MIG to induce beta-lactamases and certain antibiotics 
appear to be potent inducers only when tested in this manner 
(Sanders and Sanders, 1986). The significance of such results 
is questionable as in vivo induction resulting in therapeutic 
failure is unlikely to occur when bacteria are exposed to 
superinhibitory levels of beta-lactam antibiotics. Instead, 
and as would seem logical, bacteria are more likely to be 
inhibited or killed (Aranoff and Shlaes, 1987). Clinically, 
results obtained in this way are irrelevant, and from a 
scientific viewpoint it can be argued that such results are 
artifacts arising from technical problems. That is the high 
levels of enzyme expression reported due to exposure of 
bacteria to superinhibitory antibiotic levels are not due to 
induction but rather are derived from computations based on 
data pertaining to damaged or dead cells in which protein 
synthesis has ceased or is impaired . Calculations of beta-
lactamase activity per unit protein are therefore likely to 
produce a misleading impression of high levels of beta-
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lactamase activity. Sanders and Sanders (1986c). who 
performed one of the first systematic investigations of this 
phenomenom, favour inducing with subinhibitory antibiotic 
concentrations of 1/4 the MIC or 100 mcg/ml, whichever is 
less. 
Ideally an inducer should be be neither toxic nor a 
substrate (Nordstrom and Sykes, 1974). Several non-beta-
lactam compounds possess a limited capacity to induce beta-
lactamases (Cullmann ~al., 1984) but at present antibiotics, 
particularly cefoxitin and imipenem, are the most potent 
inducers. 
Beta-lactamase induction is examined after cells have grown 
during log phase in the presence of an appropriate inducer. 
Peak induction usually occurs within two hours (Gootz and 
Sanders, 1983; Minami ~~., 1983). After induction cell-
free preparations are used to assay beta-lactamase activity. 
Inhibition of Enzyme Activity 
Chromosomal beta-lactamases are strongly inhibited by 
beta-lactamase stable penicillins such as the isoxazolyl 
penicillins. The plasmid-mediated TEM-type enzymes (Table 7) 
are also inhibited by these compounds but not as absolutely 
(Sykes and Matthew, 1976). Clavulanic acid is a potent 
inhibitor of non-chromosomal beta-lactamases (Gould and Wise, 
1986). By using a combination of clavulanic acid and a stable 
penicillin such as cloxacillin it is possible from inhibition 
studies to obtain preliminary evidence as to the genetic locus 
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of the enzyme. 
Chloride ions and p-chloromercuribenzoate (p-CMB) are non-
-beta-lac tam inhibitors which have been used in classifying 
beta-lactamases. P-CMB at 0.5 micromolar concentration 
completely inhibits enzymes with cysteine residues. However 
even experienced workers have reported misleading results with 
this agent as sulphydryl groups, even if present, may not be 
accessible to p-CMB (Sykes and Matthew, 1976; Sykes and Smith, 
1979). 
Analytical ,Isoelectric Focussing 
The application of flat-bed isoelectric focussing (IEF) in 
polyacrylamide gel to beta-lactamase characterisation was a 
major technological advance (Matthew et al., · 1975). This· 
technique is highly specific making it possible to identify 
different beta-lactamases within the one strain. The banding 
patterns obtained with IEF permit virtual fingerprinting of 
beta-lactamases through'side-by-side comparisons of unknown 
and reference beta-lactamases on the same gel. This technique 
is particularly useful to distinguish non-chromosomal beta-
lactamases which are otherwise difficult to classify. More 
recently agarose has been advocated as an alternative matrix 
to polyacrylamide for IEF. Agarose is regarded as more 
convenient to use-and less toxic. Apart from slight_ 
differences in the banding patterns of HMS-1 and PSE-1 beta-
lactamases (Table 35) agarose yields identical results to 
polyacrylamide (Medeiros, 1984). 
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The IEF banding patterns of plasmid mediated beta-
lactamases are unique, comprising a single major band with 
several accessory or satellite bands which appear late after 
application of the nitrocefin overlay. The significance of 
satellite bands is controversial and various explanations have 
been offered. Suggestions are that the satellite bands arise 
from isoenzymes (Labia et al., 1976; Brive et al., 1977), 
differences in the sialic content of the various bands 
(Jouvenot ~al., 1984), proteolysis and deamination of the 
enzyme after cell disruption (Brive et al., 1977; Kiss et al., 
1983) and binding of carbohydrate mot~ties to the enzyme (Gal 
et al., 1983). 
Another complication of IEF is lack of electrophoretic 
mobility of some beta-lactamases which results in poor 
separation into bands and failure to establish a reliable 
isoelectric point e.g. beta-lactamases of Legionella dumoffi, 
.!:· longbeachae (Marre ~al., 1982), Bacteroides 
melaninogenicus (Timewell et al., 1981) and the imipenem-
hydrolysing enzyme of ~· fragHis (Cuchural et al., 1986). 
This is suggestive of unusually large enzymes or binding of 
the enzymes to larger molecules e.g. membrane binding (Marre 
~al., 1982; Medeiros, 1984). 
The taxonomic value of IEF in characterizing chromosomal 
beta-lactamases is considerable, in some cases (e.g . 
.!:· pneumophila) being specific to subspecies level (Marre et 
al., 1982). Caution is however necessary in interpreting 
variations in IEF patterns within a species. Okonogi ~ al. 
(1986) warn that a range of isoelectric points, such as is 
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found in P. vulgaris (pl 6.9 to pl 9.0), may arise from 
variations in amino acid composition due to mutations in the 
beta-lactamase gene or from different post-translational 
processing in different strains. For taxonomic relevance it 
is necessary to relate pl variations within a species to other 
taxonomic features. 
Molecular Weight Determinations 
The molecular weights of beta-lactamases, ranging from 
14,000 to greater than 250,000, have usually been determined 
by the gel filtration method of Andrews (1964). Other methods 
used are sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) (Weber and Osborn, 1969), 
equilibrium centrifugation (Yphantis; 1964) or amino acid 
analysis. Sometimes different values are obtained by 
different methods e.g. the penicillinase of !· maltophilia has 
an apparent molecular weight of 118,000 by gel filtration and 
26,000 by SDS-PAGE. This type of result suggests that the 
enzyme consists of four sub-units (Saino et al., 1982). While 
molecular weight determinations are sometimes useful in 
identifying beta-lactamases it is more usual for enzymes to be 
clearly different in substrate profile, response to 
inhibitors, and isoelectric points and have molecular weights 
that do not differ by more than the error of the determination 
method used (Sykes and Matthew, 1976). 
Sequencing Techniques 
Amino acid and nucleotide sequencing techniques have 
yielded additional insights into the relationships between 
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beta-lactamases. These techniques have supplemented previous 
data to define three evolutionarily distinct classes of beta-
lactamases. 
Class A beta-lactamases have a serine residue at 
the active site, have molecular weights of around 29,000, 
show significant amino acid homology and preferentially 
hydrolyse penicillins. The active site of these beta-
lactamases shows homology with the amino acid sequence around 
the penicillin binding sites of the D-alanine 
carboxypeptidases of Bacillus stearothermophilus and B. 
subtilis. This supports the hypothesis that these beta-
lactamases may be derived from PBPs (Yocum et al., 1979; 
Waxman et al., 1982). Class B beta-lactamase is a 
metalloenzyme of molecular weight 23,000 with predominantly 
cephalosporinase activity and is produced by~· cereus 
(Ambler, 1980). Class C beta-lactamases are the 
chromosomally-mediated cephalosporinases of !· coli which 
show significant homology with those of Shigella species and 
less homology with Klebsiella, Salmonella, Serratia and 
Pseudomonas species. These enzymes have a comparatively high 
molecular weight of about 39~000 and also have a serine 
residue at the active site but have no sequence homology with 
class A beta-lactamases (Jaurin and Grundstrom, 1981; 
Bergstrom~ al., 1982; Knott-Hunziker~ al., 1982). 
2. Beta-lactamases of Gram-positive Bacteria 
Gram-positive and Gram-negative bacteria differ 
fundamentally in beta-lactamase production. Gram-positive 
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beta-lactamases are exoenzymes wher~as those of Gram-negative 
cells are usually retained in the cell (Sykes and Smith, 
1979). S. aureus mainly produces inducible plasmid-~ediated 
beta-lactamases which rapidly hydrolyse benzyl penicillin, 
aminopenicillins, carboxypenicillins, and 
acylaminopenicillins, but are only feebly active against the 
penicillinase-resistant penicillins and most cephalosporins. 
Staphylococcal penicillinases may be distinguished from each 
other serologically (Bauernfeind, 1986; Greenwood, 1986). 
In general streptococci are unable to develop resistance 
through beta-lactamase production although recent reports of 
some beta-lactamase-producing strains of Streptococcus 
faecalis and S. uberis are cause for concern. Nocardia spp., 
Clostridium s"pp. and Bacillus spp are other Gram-positive 
bacteria which produce beta-lactamases. Many Mycobacterium 
spp. have also been found to produce ~eta-lactamases 
(Bauernfeind, 1986; Greenwood, 1986). 
3. Richmond and Sykes Classification of Beta-lactamases of 
Gram-negative Bacteria 
In contrast Gram-negative bacteria prod~ce a wide varie~y 
of oeta-lactamases with a continuous spectr~m of hydrolytic 
activities ranging from predominantly penicillinase to 
predominantly cephalosporinase activity with a grad'.•a tion of 
enzymes hydrolysing both penicillins and cephalosporins 
between these extremes. As previously mentioned there are 
a number of different classification schemes for beta-
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lactamases and their lack of concordance in nomenclature makes 
the scientific literature c-onfusing (see table 7). 
To overcome the nomenclatural problems Sykes (1982) 
suggests that the original classification of Rich,mond and 
Sykes (1973) be retained as a reference system as it has been 
cited extensively in the literature and is still suitable as a 
common reference for future studies. 
In this scheme five broad classes of beta-lactamases are 
defined on the basis of substrate and inhibition profiles and 
the genetic location of the beta-lactamase genes (Table 5). 
Within each class there are different types of enzymes. Class 
I comprises chromosomally-mediated enzymes which are 
predominantly cephalosporinases. Class lI also contains 
chromosomally-mediated enzymes. These are however 
predominantly pen~cillinases. Class III enzymes are plasmid-
mediated and are broad spectrum enzymes having- similar 
activities against both penicillins and cephalosporins but 
being sensitive to inhibition by cloxacillin and resistant to 
inhibition by p-CMB. Class IV enzymes are chromosomally-
mediated and have similar activities to class III enzymes but 
are resistant to inhibition by cloxacillin and sensitive to 
inhibition by p-CMB. Some class IV enzymes hydrolyse 
cloxacillin. Class V enzymes are plasmid-mediated and have 
predominantly penicillinase activity, including activity 
against cloxacillin, and are resistant to p-CMB (Richmond and 
Sykes~ 1973; Sykes and Matthew, 1976; Sykes 1982). 
59 
Eichmgnd ~n&-2Yk~a £.l.Eaa~±i£~ii.2r!. Q± ~eta~l~~tam~a~a Q± 
Gra1T1-negat i ve Ba£.i~L~""" 
----~-----------------~--------------------------------------------------------------------------------------
Class Substrate c - --=-"- 6He lat11s_- ~- -Bflleiil:_!xpl'l!ssi.on - ReprHentative Bacteria 
---~---------~-------------------~-----------~~~---~~--------~--~----~~~~~--------------------~~--------
I thrDIDSllH _,-_ - -- --lulltihl!- -- -
JI1Ht Prefer penicillins Chro1oson Ind11tible 
Constitutive 
III"'_ Penicillins an~ uphalospori~s -Plasaid -- -- - _ - Co11stihtin 
I~ Penicillins and cephalosporins Cbro1oso1e 
V" Penicillins, isou.zolyl· Plas1if 
penicillins; cepbalosporins 
tons ti tuti ve 
Constitutive 
Enterobacter 
Citrobacter 
Serrati11, 
Indole~positive ~ 
f · aeruginosa 
f.· 11al tophilia 
f.. aer119inosa 
f.. thomasii 
Enterobacteriaceae 
H· _inUuenzae 
ti• qonorrhoeae 
f · aeruginosa 
'KlebsieUa 
Enterobacteriaceae 
f. aeru9inosa 
~ Rlch1ond and Sykes classification 1odified acco~ding to Saino !t al. 119821 and Bakken and Sanders 119871 
- Inhibited by potassiu1 clavulanate __ 
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Some aspects of the Richmond and Sykes classification are 
now inadequate or technically inconvenient (Sykes and Matthew, 
1976). The five classes contain very heterogeneous groups of 
enzymes. Some parameters such as p-CMB inhibition are 
difficult to determine with crude enzyme preparations. 
Furthermore with the proliferation of new types of beta-lactam 
antibiotics there is now a need for a more suitable system for 
describing substrate profiles to replace the concept of 
classifying beta-lactamases solely in terms of penicillinase 
and cephalosporinase activity. More comprehensive terms such 
as cefuroximase, cefotaximase, and imipenemase have appeared 
in the literature and these, and other appropriate terms, are 
needed to describe hydrolytic activity against compounds such 
as cephamycins, monobactams and carbapenems (Bauernfeind, 
1986). 
Of relevance to this study Mitsuhashi (1985) uses the term 
oxyiminocephalosporin beta-lactamase (CXase) for enzymes which 
hydrolyse the oxyiminocephalosporins (e.g. cefotaxime, 
ceftizoxime, cefoperazone, cefmenoxime, and moxalactam). Sato 
et al. (1985) report that F. odoratum produces a type II 
CXase. 
Sykes (1982) however rejects such terms. This rigid 
position is perhaps ill-considered as the enzymes to which the 
new terms pertain (Table 9), while not yet widely distributed 
among clinical isolates, are distinct from those grouped in 
earlier classifications and can be expected to increase in 
incidence in the future (Medeiros, 1984; Bauernfeind, 1986). 
It would therefore seem that workers would be better equipped 
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to work with such enzymes if there was a more appropriate 
nomenclature. 
Another problem with the Richmond and Sykes classification 
is that knowledge of the genetic location of the enzyme is not 
always particularly easy to determine. In addition the 
validity of this parameter is questionable. Prior to the 
discovery of transposons the importance of the parameter· was 
obvious. Beta-lactamase genes were either incorporated in_ 
chromosomal or plasmid DNA. There were kndwn to be hundreds 
of chromosomal beta-lactamases and more than twenty plasmid-
mediated beta-lactamases. However it is now known that if the 
genes on either structure are located on transposons, or 
'jumping genes', the genetic locus can be on either the 
chromosome or the plasmid. This mobility of genes has not yet 
greatly impinged on classification schemes. However 
transposons must eventually detract from the emphasis given to 
the genetic locus in current classifications (Pechere and 
Levesque, 1983; Bauernfeind, 1986). 
4. Chromosomally-mediated Beta-lactamases 
Using the increased sensitivity of analytical IEF to 
detect beta-lactamases Matthew and Harris (1976) surveyed a 
variety of Gram-positive and Gram-negative bacteria and 
concluded that virtually all bacteria produ~e at least one 
chromosomally-mediated beta-lactamase. In many organisms, 
particularly penicillin and ampicillin susceptible ones, the 
amount of beta-lactamase produced may be very low. Increased 
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enzyme production (hyperproduction) may be associated with 
resistance. 
Hyperproduction can result from induction (derepression), 
increases in ~he number of beta-lactamase genes on the 
chromosome, or alterations in gene regulation. Richmond and 
Sykes Class I enzymes are usually inducible with enzyme 
production under repressor control. They are usually produced 
at a low basal level until exposure of the bacterium to an 
inducer upon which enzyme synthesis can be increased over 
1,000-fold. After withdrawal of the inducer enzyme synthesis 
returns to the low basal level. Mutants occur in which the 
repressor is altered allowing transcription to occur freely 
and constitutive beta-lactamase production occurs at high 
levels. The frequency of mutations to the stably derepressed 
-7 _q 
state is often quoted as 10 to 10 . In E. cloacae however 
Korfmann et al. (1986) report a/high~~\ range of mutational 
_,.,, -7 
frequencies of 10 to 10 With some exceptions 
chromosomally-mediated beta-lactamases tend to be specific for 
' genus, species and subspecies exhibiting only slight 
variations in isoelectric point. They therefore constitute a 
potential framework for bacterial classification (Matthew and 
Harris, 1976; Sykes and Matthew, 1976; Sykes and Smith, 1979). 
The universal occurrence of beta-lactamase and the 
failure of laboratories to produce viable cells which lack 
beta-lactamase support the suggestion that the enzyme has an 
essential physiological role (Sykes and Matthew, 1976). 
Most chromosomally-mediated beta-lactamases are 
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cephalosporinases which hydrolyse cephalosporins at least five 
to ten times as rapidly as benzyl penicillin (Sykes and Smith, 
1979). Sawai, Kanno and Tsukamoto (1982) differentiate 
chromosomal cephalosporinases into two major groups on the 
basis of substrate specificity: 
(a) typical cephalosporinases with negligible 
penicillinase activity, and 
(b) cephalosporinases with broad substrate specificity 
which hydrolyse cephalosporins and labile 
penicillins. 
Typical cephalosporinases are produced by many species and 
include the constitutive enzymes produced by!· coli, !· 
cloacae and B. fragilis and the inducible beta-lactamases of 
!· cloacae, ~· marcescens and _!:.. aeruginosa. Broad spectrum 
cephalosporinases are typified by the inducible beta-lactamase 
of P. vulgaris. 
Very few strains of Gram-negative bacteria are reported to 
produce chromosomal penicillinases. Sykes and Matthew (1979) 
cite reports of penicillinase-producing strains of_!:.. 
mirabilis, !!· morganii (previously known as Proteus. 
morganii), Pseudomonas thomasii and_!:.. aeruginosa. In the 
former two organisms however the evidence for the genetic loci 
being chromosomal is not convincing. 
The 1-1 beta-lactamase of _!:.. maltophilia is an inducible 
penicillinase which appears to be chromosom ally mediated. It 
is not inhibited by clavulanic acid, but is almost completely 
inhibited by EDTA whereupon activity is recovered following 
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the addition of zinc ions, and to a lesser extent other 
divalent cations such as Mn2+ and Ca2+. L-1 is thus a zinc 
metalloenzyme like beta-lactamase II from B. cereus 569. L-1 
is unusual in its substrate profile, hydrolysing imipenem at a 
significant rate. It is also unusual in appearing to consist 
of four subunits (Saino et al., 1982) • 
.!'._. maltophilia contains a second beta-lactamase, L-2, an 
inducible cephalosporinase. This enzyme significantly 
hydrolyses monobactams and ceftizoxime which resist most beta-
lactamases. It is inhibited by clavulanic acid but not by 
EDTA. The combination of the L-1 and L-2 enzymes in.!'._. 
maltophilia may explain the high resistance of this organism 
to beta-lactam antibiotics (Saino ~al., 1984). 
Enzymes such as these with unusual hydrolytic activity 
against imipenem, monobactams, ·or third generation 
cephalosporins are rare in clinical specimens at the present 
time but can be expected to increase in occurrence. These are 
the previously-mentioned chromosomal CXases of Mitsuhashi 
(1985) which are divided into two subgroups on the basis of 
substrate and inhibition profiles (Table 6). Type t CXases 
are predominantly cephalosporinases whereas Type II CXases are 
predominantly penicillinases which also hydrolyse imipenem and 
are not inhibited by clavulanic acid. Apart from the 
Legionella gormanii enzyme the Type II CXases are 
metalloenzymes. 
Yersinia enterocolitica also exhibits unusual beta-
lactamase production with most strains producing two distinct 
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TABLE 6 
Classification of Mitsuhashi (1985) for Chromosomal 
Beta-lactamases Which Hydrolyse Newer Beta-lactams 
Type I CXases Type II CXases 
B. fragilis group F. odoratum 
P. vulgaris GN 7919 P. maltophilia 1-1 enzyme 
P. cepacia GN 11164 1. gormanii ATCC 33297 
P. maltophilia 1-2 enzyme B. fragilis TAL 2480 
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beta-lactamases which differ in inducibility, substrate 
profile, sensitivity to p-CMB 1 molecular weight and 
isoelectric point (Cornelis and Abraham, 1975). 
Occasionally there are differences of opinion about the 
substrate profiles of chromosomal beta-lactamases. An example 
is the broad spectrum beta-lactamase of !.· pneumoniae which is 
considered by some workers to be a penicillinase. There is 
also dispute about the chromosomal beta-lactamases of 
legionellae which Thornsberry and Kirven (1978) and Fu and Neu 
(1979) report to be primarily cephalosporinases. However 
Marre et al. (1982) report high penicillinase activity in all 
legionellae except ~· micdadei which appears to lack a beta-
lac tamase. 
5. Beta-lactamases Mediated by Plasmids and Transp_C?_s~ 
Beta-lactamases determined by plasmids and transposons are 
detected more fre~uently than chromosomal beta-lactamases. 
This is because they are constitutively produced in greater 
amounts than most chromosomal beta-lactamases (Medeiros,-1984; 
Bakken and Sanders, 1987). Qu&ntitative expression of 
plasmid-mediated beta-lactamase genes varies widely from 
strain to strain and species to species e.g. the same plasmid 
coding for Richmond and Sykes Type Vb enzyme codes for 
different levels of enzyme expression in!· coli artd P. 
mirabilis (about 1% of the E. coli level) (Richmond and Sykes, 
1973). 
The various schemes for classifying non-chromosomal beta~ 
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lactamases are particularly confusing (Table 7). Matthew 
(1979) and Matthew~ al. (1979) divide the plasmid-mediated 
beta-lactamases into three groups on the basis of substrate 
specificity: 
(a) broad spectrum penicillinases, 
(b) oxacillinases, and 
(c) carbenicillinases. 
With certain reservations, it is possible to identify 
plasmid-mediated beta-lactamases from their iso-electric 
points, or pl values (Sykes and Smith, 1979). Table 8 lists 
some of ·the properties used to characterize these beta-
lac tamases - isoelectric points, inhibition profiles using 
cloxacillin, p-CMB and sodium chloride, and molecular weight. 
Immunological cross-reactivity has been widely used to 
characterize beta-lactamases but some of the results are 
confusing, possibly because the beta-lactamase preparations 
used to raise antisera contained more than one beta-lactamase 
(Sykes and Matthew, 1976; Medeiros, 1984; Bauernfeind, 1986). 
Recent studies of clinical isolates have detected rare 
novel plasmid-mediated beta-lactamases. Some of these exhibit 
unusual features. The CEP-2 enzyme discovered in 
Achromobacter species preferentially hydrolyses 
cephalosporins (Medeiros, 1984), and the CTX-1 enzyme 
discovered in !· pneumoniae is more active against third 
generation cephalosporins than against cephalothin (Sirot et 
al., 1987). 
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TABLE 7 
Nomenclature of Plasmid-mediated Beta-lactamases* 
Matthew Mitsuhashi 
Penicillinases -
broad spectrum 
TEM-1 Type la 
TEM-2 Type-lb 
SHV-1 
HMS-! 
Oxacillinases 
OXA-1 Type II 
OXA-2 Type III 
OXA-3 
Carbenicillinases 
PSE-1 Type IV 
PSE-2 
PSE-3 
PSE-4 
Pitton 
TEM-1 
type 1 
TEM-1 
type 2 
* Adapted from Medeiros (1984) 
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Labia & 
Philippon 
CARB-2 
CARB-4 
CARB-1 
Richmond 
& Sykes 
Illa 
Illa 
IV 
Va 
Vb 
v 
v 
v 
v 
v 
TABLE 8 
I Some Plasmid- and Transposon-mediated Beta-lactamases 
-------------------------------------------------------------
Inhibited by Mol. Wt. pl Trans po son 
Cl ox pCMB NaCl mediated 
-------------------------------------------------------------
Penicillinases-
broad spectrum 
TEM-1 + 22,000 5.4 + 
TEM-2 + 23,500 5.6 + 
SHV-1 + +/- 17,000 7.6 + 
HMS-1 + + 21,000 5.2 
ROB-1~" 19,800 8.1 (5.55):1, 
LCR-1~': 44,000 6.5 (5.85)'3 
Oxacillinases 
OXA-1 +/- + 23,300 7.4 + 
OXA-2 + 44,600 7.45, 7.7 
OXA-3 + 41, 200 7.1 
OXA-4~': + 23,000 7.5 + 
OXA-57: + 27,000 7.62 + 
OXA-67: + 40,000 7.8 + 
OXA-7~" + 25,000 7.65 
Carbenicillinases 
PSE-1 + 26,500 5.7 + 
PSE-2 + 12,400 6.1 
PSE-3 12,000 6.9 
PSE-4 32,000 5.3 + 
AER-1~" 22,000 5.9 Tn 798 
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TABLE 8 (continued) 
Some Plasmid- and Transposon-mediated Beta-lactamasesl 
Inhibited by 
Clox pCMB NaCl 
Cephalosporinase 
CTX-1* 
CEP-2* 
* Novel beta-lactamases 
Mol. Wt. 
36' 2QQi 
pl 
6.3 
8.1 
Transposon 
mediated 
1. From Medeiros (1984), Medeiros et al. (1985), Sirot et 
al. (1987). 
2. 5.55 = additional nonmobile band of~· coli sonicate, 
possibly membrane-bound or unusually large molecule. 
3. 5.85 = pl obtained under different experimental conditions. 
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Transposons determine a number of the well established 
~ 
plasmid-mediated and novel beta-lactamases-of Gram-negative 
bacteria (Table 8). The mobility of genes on plasmids and 
transposons enables beta-lactamases to spread to different 
taxonomic groups of bacteria. This means that the prevalence 
of different beta-lactamases will· vary in time and place. 
The most frequently isolated strains with novel or more than 
one plasmid-mediated beta-lactamase are from South American 
and Asiatic countries - a finding which suggests that 
indiscriminate antibiotic prescribing in these regions has 
stimulated the bacterial flora to actively develop new 
resistance mechanisms (Medeiros, 1984). 
6. Beta-lactamases and Antibiotic Resistance of Gram-negative 
Bacteria 
In determining the contribution of beta-lactamases to 
the resistance of an organism it is necessary to consider the 
interaction of beta-lactamases, outer membrane permeability, 
and PBP alterations. In many Gram-negative organisms the 
beta-lactamase iB only a contributor to a highly complex 
defence system protecting the cell from the effects of beta-
lactam antibiotics (Sykes and Matthew, 1979). While high 
levels of beta-lactamase expression usually have a marked 
effect on resistance one cannot discount the role of very 
small quantities of beta-lactamase as very low enzyme levels 
have been shown to significantly contribute to resistance 
(Richmond and Syke$, 1973). Even low levels that may only be 
detected by IEF may be important (Nikaido, 1985). 
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Antibiotic 
Cef uroxime 
or 
Cefotaxime 
Ceftazidime 
Moxalactam 
Monobactams 
Imipenem 
TABLE 9 
Some Beta-lactamases Which Hydrolyse the 
New Beta-lactam Antibiotics 
Beta-lactamase Type 
Chromosomal Plasmid 
P. cepacia GN 11164 
P. vulgaris GN 7919 
B. fragilis MULB-1008 
K. oxytoca R 30 
K. aerogenes Kl 
(indole +) 
MULB 906 
L. gormanii 
K. oxytoca 
K. oxytoca 3859 
MULE 906 
L. gormanii 
K. oxytoca 3859 
K. aerogenes K-1 
(indole +) 
P. maltophilia L-2 
K. pneumoniae SC 10,436 
P. maltophilia GN 12873 
L. gormanii 
OXA-1 
OXA-4 
OXA-5 
OXA-6 
OXA-7 
PSE-1 
PSE-2 
CTX-1 
OXA-1 
OXA-2 
OXA-4 
OXA-5 
PSE-2 
PSE-3 
Adapted from Levesque et al. (1983), Medeiros (1984), Saino et 
al. (1983), Sirot et al. (1987). 
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e. The Genus Flavobacterium 
1. Introduction 
The genus Flavobacterium (Skerman et al., 1980; Holmes, 
Owen and McMeekin, 1984) is somewhat of a 'phylogenetic pot 
pourri' (Paster.!:.!_ al., 1985). Bacteria recognised by Holmes, 
Owen and McMeekin (1984) in Volume 1 of Bergey's Manual of 
Systematic Bacteriology and by Holmes et al. (1983) and 
CV 
Holmes, Owen et al. (1984f. as authentic Flavobacterium species 
are aerobic, yellow-pigmented, non-fermentative, nonmotile, 
oxidase-positive Gram-negative rods with a low DNA mol% G+C 
(range 31-46). However the Approved Lists of Bacterial Names 
(Skerman et al., 1980) includes a number of additional 
"flavobacteria" which clearly do not comply with the current 
genus description e.g, Gram-positive, motile, gliding and high 
G+C species. An additional problem is the decision of the 
Judicial Commission not to endorse the proposal (Holmes and 
Owen, 1979) to make Flavobacterium breve the type species of 
the genus (Wayne, 1982), but instead to retain as type species 
Flavobacterium aquatile, an organism of unclear relationship 
to other organisms in the genus. In all the taxo~omy of 
Flavobacterium is confused and refractory and there is 
considerable scope for clarification, reform and 
reconciliation. 
There are also unresolved phylogenetic considerations. 
Recent genetic evidence confirms close relationships between 
Flavobacterium and Cytophaga, a genus containing bacteria 
which glide on solid surfaces (Callies and Mannheim, 1980; 
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Bauwens and de Ley, 1981) and there is evidence of a 
previously unsuspected but specific genetic relationship 
between these bacteria and the anaerobic genus Bacteroides 
(Paster et al, 1985; Weisburg et al., 1985). The 
relationships of Flavobacterium species to gliding bacteria 
and Bacteroides species therefore require clarification. It 
appears likely that the resolution of these issues will lead 
to major taxonomic reform, possibly with the removal of 
previously "firm" taxonomic boundaries based on gliding 
motility. 
Our understanding of the roles of Flavobacterium species 
is limited. They can be however of considerable environmental 
and clinical importance. They are known to cause food 
spoilage, degrade a wide range of environmental and man-made 
substances (e.g. sewerage, pesticides and petroleum products) 
and cause uncommon but extrem~ly antibiotic resistant, 
infections - some of which are associated with high mortality 
rates (Du Moulin, 1979; Shewan and McMeekin, 1983; Holmes, 
198 7). 
2. Taxonomic History 
The genus Flavobacterium has been heterogeneous since its 
inception in the first edition of Bergey's Manual (Bergey et 
al., 1923' when flavobacteria often had little more than 
colour in common. This heterogeneity was reduced in_ 
subsequent editions of -Bergey's Manual with the deletion of 
polarly flagellated species in 1939 (Bergey et al.), Gram-
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positive bacteria in 1957 (Breed et al.), and organisms 
exhibiting gliding motility and spreading growth in 1974 
(Weeks). The latter revision left the genus in two distinct 
sections with Section I containing nonmotile low mol% DNA 
strains (range.32-43% G+C) and Section II containing high mol% 
DNA strains (range 63-70% G+C) which were either motile or 
nonmotile (Weeks, 1974). In the lst edition of Bergey's 
Manual of Systematic Bacteriology Holmes, Owen and McMeekin 
(1984) restrict the genus to low %G+C str~ins. Currently 
there are ten species, the heterogeneous taxon (Group IIb), 
and additional strains which do not belong to currently 
described taxa (Table 10). 
Environmental isolates, which grow at temperatures from 5-
0 30 C, are frequently difficult to identify whereas clinical 
isolates, which are usually capable of growth at 37°C, are 
easier to accomodate in described species (Owen and Holmes, 
1981; Thomson and McMeekin, 1981; Holmes, Owen and McMeekin, 
1984). 
Special genetic procedures have recently provided valuable 
insights into the phylogenetic relationships of th~ genus. 
There are three main procedures, each having a different role 
- DNA:DNA and DNA:rRNA hybridizations and comparative analysis 
of oligonucleotides of 16S rRNA. The DNA:DNA reassociation 
'technique is useful for investigating closest relationships. 
DNA:rRNA hybridization is used mainly to determine 
relationships at the intra-family level. Oligonucleotide 
sequence analysis allows detection of distant phylogenetic 
relationships (Ludwig et al., 1983). 
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3. Testing for Special Characters 
In routine laboratories Flavobacterium species may be 
misidentified as other taxa and vice versa. The separation of 
Flavobacterium from other taxa, particularly ~he yellow-
pigmented high %G+C bacteria and gliding bacteria, may be 
difficult. Certain tests are especially useful for 
differentiation but however may be difficult to assess. The 
problems associated with these tests are reviewed briefly in 
the following. 
Pigmentation 
The yellow pigment which is characteristic of the genus 
Flavobacterium is now thought to be of the flexirubin type 
described by Reichenbach ~ al. (1981). The hue and intensity 
of pigmentation of different strains viries considerably and 
may be influenced by the growth medium, temperature and 
duration of incubation, and by exposure to daylight (Holmes, 
Owen and McMeekin, 1984). Pigmentation may be enhanced by 
growth on casein, milk and starch agar. Flexirubins are 
widely distributed among strains of Flexibacter, Cytophaga and 
Flavobacterium (Fautz and Reichenbach, 1980; Reichenbach et 
a1., 1980; Reichenbach et al., 1981; Weeks, 1981)~ 
Gram Reaction and Morphology 
Some Gr9m-positive bacteria are easily decolourised during 
Gram staining and may appear to be Gram-negative (Hayes ~ 
al., 1979). Weeks (1974) recommends the Kopeloff-Beerman 
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TABLE 10 
0 
Species of the Genus Flavobacterium and Group Ilb, 
F. aqua tile F. odoratum 
F. breve F. multivorum 
F. balustinum F. spiritivoruin 
F. gleum F. thalpophilum ~ 
F. meningosepticum Group Ilb 
Species Incertae Sedis 
F. acidificum F. indoltheticum 
F. acidurans "F. lutescens" 
F. capsulatum F. oceanosedimentum 
--
F. devorans F. okeanokoites 
F. esteraromaticum F. resinovorum 
F. ferrugineum "F. rigense" 
F. halmophilum "F • tirrenicum" 
F. heparinurn F. ulig.inosurn 
Data of Holmes et al. (1983), Holmes, Owen and McMeekin 
(1984) and Holmes, Owen et al. (1984b) 
** Data of Holmes et al. (1983) 
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modification of Gram's procedure (Conn, 1957). Confirmation 
is possible by testing for growth on crystal violet agar (2.5 
-~ -6 
x 10 and 1 x 10 w/v) or by treating a thick cell 
suspension with a few drops of either sodium dodecyl sulphate 
(10% w/v) or potassium hydroxide (3% w/v) which will rapidly 
lyse Gram-negative cells to markedly increase viscosity 
°"" (Hoimes, Owen and McMeekin, 198~. 
Gliding Motility and Spreading Growth 
The demonstration of gliding motility and spreading growth 
on solid media, which distinguish Flavob~cterium from 
Cytophaga and Flexibacter, presen~s difficulties of technique 
and interpretation. It is essential to culture the organism 
on a medium of low nutrient concentration such as that of 
Anacker and Ordal (1959). Gliding motility is enhanced by 
surface moisture with best results obtained on freshly pou~ed 
plates incubated in a humid atmosphere (Henrichsen, 1972). 
Gliding may be observed by microscopic examination of the 
margin 9f growth using a high power dry lens (Henrichsen, 
1972) or by adding a coverslip and using oil (Hayes, 1977). 
Perry (1973) re.commends placing small glass beads on the agar 
to provide pools of_ l~quid of varying depths before overlaying 
with a coverslip. 
The interpretation of gliding varies. Henrichsen (1972) 
defines gliding as the orientation of bacteria into organised 
bundles with continuous movement in the direction of the long 
axis. Perry's (1973) definition includes movement which is, 
not continuous in one direction. He therefore records 
Flavobacteri~m aquatile as a glider, a controversial 
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interpretation at variance with other workers and the subject 
of considerable taxonomic speculation (Holmes, Owen and 
~ 
McMeekin, 1984~. 
In theory spreading colonies should be the manifestation 
of gliding motility. However this is not always the case. 
NCIB 9059 "Flavobacterium pectinovorum" (now regarded as 
Cytophaga johnsonae) shows true gliding motility but fails to 
spread (Lund, 1969; McMeekin ~al., 1971; Perry, 1973; Hayes, 
1977). This means that the observation of spreading growth 
alone is not sufficient to detect gliding motility. I~ is 
therefore necessary to use microscopic observation for 
reliable detection of this character. 
DNA Ba$e Composition 
The accurate determination of DNA base composition 
requires special equipment. For routine differentiation of 
high G+C-and low G+C strains it is convenient to use the 
ultr~violet (UV) light sensitivity test of McMeekin (1977). 
By calibrating a UV light source with known high and low G+C 
strains such as Pseudomonas paucimobilis (high G+C) and 
Flavobacterium breve (low G+C), it is possible to 
determine presumptively in which G+C category unknown strains 
belong. For example, McMeekin (1977) reports that by using an 
exposure time of 90 seconds, low G+C strains suffer at least a 
105 -fold kill whereas high G+C strains suffer less than a lOJ-
fold kill when placed 55 cm from a 15 watt germicidal lamp in 
a laminar flow cabinet prior to incubation. 
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Antibiotic Resistance 
Major discrepancies have been noted when disc diffusion 
and MIC techniques have been used in parallel for F. 
meningosepticum (Maderazo et al., 1974; Aber et al., 1978; 
Winslow and Pankey, 1982; Johny et al., 1983; Bruun, 1987) and 
Flavobacterium Group !lb (Von Graevenitz and Grehn, 1977). 
Von Graevenitz and Grehn (1977), Wins.low and Pankey (1982) and 
Johny et al, (1983) conclude that disc diffusion testing is 
likely to give a false impression of susceptibility and 
recommend that susceptibility detected by disc testing should 
be confirmed with MIC tests. 
Bruun (1987) however suggests that MIC testing is 
unnecessary for!.· meningosepticum as only two agents, 
vancomycin and fusidic acid, are responsible for major 
discrepancies and that accuracy can be achieved with disc 
tests if the interpretive criteria are modified. 
In this review results achieved with different testing 
methodologies, some of which are now considered suboptimal, 
have been combined. This was necessary to compile 
representative antibiograms for individual species from 
published reports many of which comprised only single or small 
numbers of strains. For the purpose of consistency and to 
avoid contradictions MICs have been interpreted according to 
NCCLS criteria (Thornsberry et al., 1985) which in some cases 
vary from the criteria originally reported. In some cases 
this has meant that some strains originally classified as 
susceptible are now classified otherwise. The requirement to 
analyse the literature in this manner points to the need for a 
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comprehensive study of the antimicrobial susceptibility of the 
genus using standardized methods and current antimicrobials. 
4. Flavobacterium aquatile 
Controversy surrounds.!.· aquatile, which is the type 
species of the genus despite never being formally proposed as 
such (Holmes and Owen, 1979). Only one strain (not an 
original strain) is maintained in culture collections 
strain Taylor F36 (Weeks, 1955) - and this strain does not 
conform to the description of .!.· aquatile which is described 
as motile and peritrichous (Bergey et al., 1923). A further 
problem is evidence that strain Taylor F36 may be an atypical 
cytophaga and not a strain of Flavobacterium (Shewan and 
Q..... 
McMeekin, l983; Holmes, Owen and McMeekin, 1984~. For these 
reasons Holmes and Owen (1979) regard.!.· aquatile to be so 
inappropriate as type species that they propose rejection of 
its name as a nomen dubium and its replacement as type species 
by.!.· breve with strain NCTC 11099 as the neo-type strain. 
This proposal was considered and rejected by the Judicial 
Commission (Wayne, 1982). 
, 
The evidence for a relationship with cytophagas is strong. 
Numerical taxonomic studies of phenotypic characteristics 
(Hayes, 1977), cellular fatty acids (Oyaizu and Komagata, 
1981), chemotaxonomic studies of rRNA cistrons (Bauwens and de 
Ley, 1981), oligonucleotide cataloguing (Paster;:.! al., 1985) 
and electron microscopic observations of nonflagellar 
appendages (Thomson~ al., 1981) all indicate that F. 
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aquatile is more closely related to strains of Cytophaga than 
to Flavobacterium species. 
5. Flavobacterium breve 
F. breve and!· aquatile have similar taxonomic histories. 
They are the only species of Flavobacterium surviving from the 
first edition of Bergey's Manual (Bergey et al., 1923). Both 
present problems in that the original descriptions were meagre 
and none·of the original strains are extant. The current 
revised description of!· breve is based on the study of 
Holmes et al. (1978) of strain ATCC 14234, a fish isolate 
described in the 8th edition of Bergey's Manual of 
Determinative Bacteriology (Weeks, 1974), and six subsequent 
isolates. 
DNA reassociation studies of ten strains of F. breve 
confirm that it "constitutes a relatively homogeneous species" 
and is distinguishable from allied bacteria (Owen and Holmes, 
1980). However only six of the ten strains are closely 
related while four, including ATCC 14234, show a high degree 
of base sequence divergence (48% divergence or greater). This 
genetic heterogeneity is attributed to the differences between 
strains of human clinical origin and those of animal origin 
(Owen and Holmes, 1980), a conclusion which is debatable since 
the homogeneous group of six strains is not entirely of human 
origin (five clinical strains and a strain from a snake) and 
the other group of strains is not entirely of animal origin 
(one clinical and three nonclinical strains). Inferences 
about the environmental determination of genetic heterogeneity 
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are difficult to justify on the basis of such small numbers of 
strains. 
The choice of clinical strain NCTC 11099 as the neotype 
strain of!: breve on the grounds that it is more 
representative than the previously described nonclinical 
strain ATCC 14234 represents a recent trend in Flavobacterium 
taxonomy. Since Holmes ·and various co-workers began the task 
of revising existing species descriptions and creating new 
species, descriptions of the species of Flavobacterium have 
been based largely on studies of small numbers of mainly 
clinical isolates (Holmes et al., 1977; 1978; 1981; 1982; 
1983; Holmes, Owen~ al., 1984). While this might seem 
oblivious of the fact that flavobacteria are only rarely 
isolated from clinical specimens (Von Graevenitz, 1981) and 
the large majority of strains occur in nonclinical 
environments, the reason for this trend is that nonclinical 
taxonomic workers have been relatively inactive and there has 
been a paucity of information about nonclinical strains. The 
taxonomy of the genus has thus moved by default in a clinical 
direction (Thomson and McMeekin, 1981). The inherent danger 
of this, i.e. developing a classification based on a minor, 
unrepresentative portion of the genus, has been realised in 
that a large number of environmental strains have proved 
impossible to identify using current species descriptions 
(Owen and Holmes, 1981; Thomson and McMeekin, 1981). 
Viewed in this context and with the benefit of hindsight 
it could be argued that the decision not to select the 
environmental ATCC 14234 as type strain of the species because 
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TABLE 11 
Susceptibility of ~ breve to 
Antimicrobial Agents 
1. Agents to Which Most Strains are Susceptible 
cephaloridine 
chloramphenicol 
erythromycin 
2. Agents ~ which most Strains are Resistant 
ampicillin gentamicin 
amikacin kanamycin 
carbenicillin penicillin 
cef amandole polymyxin B 
cephalothin rifampicin 
tobramycin 
3. Agents ~Which Susceptibility is Variable 
cefoxitin sulphonamides 
moxalactam tetracycline 
piperacillin 
Data of Holmes et al. (1978), Jooste et al. (1985) and 
Gilardi (1987). 
it is 'unrepresentative' was ill-considered. 
The original "short canal bacillus" (!_. breve) described 
by Mori (1888) was pathogenic for guinea pigs, mice and 
rabbits, but not for pigeons. Isolates conforming to the 
current species description (!_. breve) are not known to be 
pathogenic to man but have been isolated from a wide range of 
clinical specimens. Their resistance to most antibacterial 
agents indicates that treatment would be difficult if F. breve 
is found to cause infections (Table 11). The nonclinical 
strain ATCC 14234 however is far more susceptible (Holmes et 
al., 1978; Jooste et al., 1985; Gilardi, 1987). 
In a numerical taxonomic study which included antibiotic 
susceptibility tests, Jooste ~al. (1985) found that NCTC 
11099 and nine dairy strains of F. breve formed a well 
defined and distinct cluster only when data from the 
antibiotic susceptibility tests were included. This implies 
that antibiotic resistance is an important taxonomic attribute 
of F. breve and may explain why Holmes et al. (1986) failed to 
identify correctly five out of fourteen known F. breve strains 
using a computer-based probabilistic method which lacked 
antibiotic susceptibility data. 
6. Flavobacterium balustinum (and Group IIb) 
The the original description of F. balustinum (Harrison, 
1929) needs revision (Holmes and Owen, 1981). At present 
strain NCTC 11212 is the only authentic strain. Biochemically 
F. balustinum is regarded by some workers as indistinguishable 
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from Group Ilb but different in having a lower %G+C (Holmes 
and Owen, 1981). Other workers however report numerical 
taxonomic studies in which F. balustinum fails to cluster with 
Group Ilb strains (Yabuuchi et al., 1983; Jooste et al., 
1985). The latter workers clearly differentiated the F. 
balustinum-containing cluster from clusters containing the 
type strain of !· gleum and Group Ilb strains only when 
antibiotic susceptibility data were included in the 
comparisons. The!· balustinum-containing cluster was much 
more susceptible to streptomycin, carbenicillin, bacitracin, 
tetracyclfne and actinomycin D. This is further evidence of 
the taxonomic significa~ce of antibiotic resistance in 
Flavobacterium. 
The name Group Ilb (also known as King's or Weaver's or 
CDC Group Ilb or Pickett and Pedersen's group 2) was initially 
given to nine clinical strains similar to !· meningosepticum 
(King, 1959). Group Ilb has subsequently become a taxonomic 
repository for difficult-to-classify, heterogeneous, 
saccharolytic Flavobacterium strains and probably contains 
several species (Owen and Holmes, 1978). However the matching of 
phenotypic and genotypic differences to delineate the species 
within this group has so far proven difficult (Shewan and McMeekin, 
1983). Perhaps this stems from a reluctance to include 
antimicrobial susceptibility data in species descriptions. To 
date!· balustinum and !· gleum have been delineated from 
within Group Ilb and other taxa are in the process of being 
defined (Holmes, Owen et al., 1984). 
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Not all workers agree with Owen and Holmes (1978) and 
Holmes, Owen et al. (1984) that it is possible to identify 
species within Group IIb. Price and Pickett (1981) report 
that despite Group IIb's considerable heterogeneity it is 
impossible to find even two tests by which to delineate 
phenotypic subgroups. For this reason they consider it a 
single species for which they propose the name "F. aureum". 
Yabuuchi et al. (1983) a1so consider Group IIb a single 
species and propose the name "Flavobacterium indologenes". 
Holmes et al. (1986) advocate disregard for these proposals 
and retention of the original designation, Flavobacterium 
Group Ilb. 
In many respects Group IIb resembles !: meningosepticum 
(Table 18). Although Group IIb is more heterogeneous both taxa 
have.similar biochemical profiles, fatty acid patterns and 
antimicrobial susceptibility patterns. Their main difference 
is in hue of pigmentation with Group Ilb exhibiting a bright 
yellow pigment while !: meningosepticum is only weakly yellow 
(von Graevenitz and Grehn, 1977; Moss and Dees, 1978; Owen and 
Holmes, 1981). 
Group Ilb is 1·2·:;:~ probably the most frequently isolated 
Flavobacterium from clinical environments. It causes rare 
systemic and soft tissue infections in compromised patients. 
Widespread skin and respiratory tract colonisation may occur 
(Owen and Lapage, 1974; Stamm et al., 1975; Monteil et al., 
1979; Zajc-Satler et al., 1979; Owen and Holmes, 1981; Von 
Graevenitz, 1981). In one study Du Moulin (1979) reported the 
airway colonisation of 195 seriously ill patients in a 
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TABLE 12 
Susceptibility~ Group Ilb .E.£_ Antimicrobial Agents 
1. Agents to Which Most Strains are Susceptible 
- -- --
cef operazone ceftriaxone 
cefotetan moxalactam 
cefoxitin nalidixic acid 
ceftazidime vancomycin 
ceftizoxime 
2. Agents to Which Most Strains are Resistant 
- --
ampicillin kanamycin 
aztreonam nitrofurantoin 
carbenicillin penicillin G 
cefamandole polymyxin B 
col is tin streptomycin 
3. Agents to Which Su~ceptibility is Variable 
-
amikacin erythromycin 
cefotaxime gentamicin 
cephalothin imipenem 
chloramphenicol neomycin 
clindamycin sulphonamides 
cotrimoxazole tetracycline 
Data of Du Moulin, 1979; Price and Pickett, 1981; 
I 
O'Donnell et al., 1982; Yabuuchi et al., 1983; Husson et al., 
1985; Schell et al., 1985. 
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respiratory-surgical unit over a 70-month period with an 
organism which was assumed to be Group Ilb. However from its 
description it could have been either Group llb or!.· gleum. 
Epidemiological studies suggested that the municipal water 
supply was the source of the organism and that prior 
antibiotic therapy made the patients susceptible to 
colonization. 
Group Ilb is usually resistant to a wide range of 
antibacterial agents. Cefoxitin and some of the third 
generation cephalosporins are reported to have good in vitro 
activity (Table 12). 
7. Flavobacterium gleum 
!: gleum was described by Holmes et al. (1984b) on 
the basis of 12 Group Ilb strains which were phenotypically 
and genetically homogeneous. Most strains were clinical 
isolates of unknown significance with four of the 12 from 
vaginal specimens. Phenotypically F. gleum is similar to F. 
balustinum, !: meningosepticum, !.· indoltheticum and Group 
Ilb. From Du Moulin's description (1979) it is possible that 
F. gleum was involved in airway colonisation of 195 patients 
in a respiratory-surgical intensive care unit. Features which 
distinguish !.· gleum from the other Flavobacterium species are 
listed in Table 18. Differentiation from Group Ilb is not 
easy however because there are no tests for which both taxa 
are clearly different. 
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8. Flavobacterium meningosepticum 
King (1959) proposed the name!· meningosepticum for an 
organism previously designated as Group Ila, which was known 
to cause meningitis in the new-born (Shulman and Johnson, 
1944; Brody et al, 1958; Vandepitte et al., 1958). Unlike 
most other Flavobacterium species, !· meningosepticum may not 
produce conspicuous pigmentation - a feature which helps to 
distinguish it from the biochemically similar taxa F. 
balustinum, F. gleum and Group IIb (Holmes, Owen and McMeekin, 
1984; Holmes, Owen et al., 1984). Currently fifteen serovars 
(A to 0) of!_. meningosepticum are described (Holmes, 1987). 
The species is genetically heterogeneous. Using DNA:DNA 
reassociation studies Sottile et al. (1973) and others (Owen 
and Snell, 1976; Callies and Mannheim, 1930; Ursing and Bruun, 
1987) report that the type strain, NCTC 10016, is genetically 
atypical of the species. From a study of 52 strains 'Ursing 
and Bruun (1987) report two main hybridization groups within 
the species showing 40-55% relatedness. NCTC 10016 belongs to 
the minor group of four strains. Of particular clinical 
interest is the report that the larger group of 48 strains 
contained four subgroups with two of the subgroups containing 
95% of the strains isolated from cerebrospinal fluid (CSF) 
(Ursing and Bruun, 1987; Bruun and Ursing, 1987). This finding 
suggests that these two subgroups have an increased pathogenic 
potential. While there is currently insufficient phenotypic 
evidence to divide !_. meningosepticum into further species the 
CSF strains were different from other strains in two 
characteristics. They produced a weak yellow pigment and grew 
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at 40°C whereas non-CSF strains were non-pigmented and failed 
to grow at 40,0 c (Bruun and Ursing, 1987). A less clear-cut 
difference was noticed in susceptibility to antimicrobial 
agents. The CSF strains tended to more susceptible to beta-
lactam antibiotics and more resistant to most other agents 
(Bruun, 1987). 
Because of the potentially serious outcome of infections 
with!· meningosepticum, especially neonatal meningitis, it 
seems important to investigate this further. If future 
taxonomic studies delineate the pathogenic strains as a 
distinct species it will be possible to target it in 
surveillance studies and devise strategies to prevent or 
control its spread. 
The type strain NCTC 10016 is also atypical in its fatty 
acid pattern (Fautz et al., 1981) and it failed to cluster 
with other Flavobacterium strains in phenotypic analyses 
(McMeekin et al., 1972; Thomson 1982). Thus from a number of 
lines of evidence it is unrepresentative of the species. 
Strain NCTC 10585, on the other hand, is highly related to the 
majority pf !· meningosepticum strains and would perhaps be a 
more appropriate choice for type strain (Owen and Snell, 
1976). An additional doubt about the taxonomic position of 
NCTC 10016 is the light microscopic observations of Webster 
and Hugh (1979) that it possesses nonfunctional flagella. 
This however is not confirmed by Thomson!:!_ al. (1981), using 
electron microscopy, and until proven otherwise NCTC 10016 
should continue to be regarded as a non-flagellate bacterium. 
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Clinically!· meningosepticum causes meningitis in 
neonates and, less frequently, in adults (many authors, 
reviewed by Holmes, 1987). It also causes bacteraemia (George 
~al., 1961; Olsen et al., 1965), nosocomial pn_eumonia 
(George~ al., 1961; Teres, 1974), subacute bacterial 
endocarditis (Werthamer and Weiner, 1972; Yamakado et al., 
1975), endopltdialmitis following keratoplasty (Le Francois and 
Baum, 1976), bovine endocarditis (Giorgi et al., 1975) and 
feline meningitis (Sims, 1974). 
In neonatal meningitis the fatality rate is about 55%. 
Hydrocephalus is a complication in most survivors and it is 
rare to have no sequelae (Von Graevenitz, 1981; Holmes, 1987). 
Premature infants, defined as birth weigh~ of less than 2500 
grams, appear to be particularly vulnerable and comprise more 
than half the reported cases with mean onset age of 8 days 
(Eeckels et al.,' 1965). It is not confined to premature 
infants however and is reported in infants up to the age of 19 
months (Zappula et al., 1979). 
The high fatality rate in neonatal meningitis is probably 
a consequence of the resistance of !· meningosepticum to a 
wide range of antibiotics. Prior to the 1980s most strains of 
!· meningosepticum were found to be susceptible only to agents 
such as erythromycin, novobiocin and vancomycin which are 
commonly used against Gram-positive organisms (Holmes, 1987). 
Empiric therapy based on the microscopic observation of Gram-
negative rods was therefore unlikely to indicate the need for 
these drugs and correct therapy would have been delayed until 
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completion of accurate antibiotic susceptibility tests. 
Asymptomatic upper respiratory tract colonisation of 
neonates is comm~n during epidemics of !.· meningosepticum 
meningitis (Brody~ al., 1958; Cabrera and Davis, 1961; 
Seligmann et al., 1963; Hazuka et al., 1977). Colonisation is 
more prolonged in those receiving specific antibiotic therapy 
(Hazuka et al., 1977). However not all respiratory isolates 
are harmless. !.· meningosepticum is reported as the causative 
agent of pneumonia in five infants, four of whom died. These 
cases occurred during a nursery outbreak of meningitis due to 
serovar C. All five cases yielded positive blood cultures and 
one had meningitis (George et al., 1961). 
!.· meningosepticum infections in older persons are rare 
and usually milder. Infected adults tend to be debilitated or 
immunocompromised (Lapage and Owen, 1973; Mani~ al., 1978; 
von Graevenitz, 1981;· Burnakis et al., 1986; Hirsch~ al., 
1986). Despite the organism's opportunistic predisposition it 
has not yet been reported as a pathogen in AIDS patients. Not 
all adult cases are mild. Four of six adults with meningitis 
due to F. meningosepticum died (Holmes, 1987). 
Chloramphenicol treatment is reported as successful in 
nosocomial pneumonia in a fourteen year old girl who received 
ampicillin prior to isolation of !: meningosepticum (Teres et 
al., 1974). Nosocomial pneumonia is also reported in a 45-
year old patient with poliomyelitis on a respirator (Nadarajah 
?nd Tan, 1979). Forty three strains are reported in sputa and 
tracheal exudates of 30 patients in an intensive care unit 
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(Richard et al., 1979). 
In reviewing the clinical literature Holmes (1987) 
comments that "!· meningosepticum strains isolated from blood 
cultures are generally of no clinical significance". This 
observation is qualified by noting however that "significant 
isolates have been reported in association with neonatal 
meningitis". This generalization {s at variance with the 
author's review in which he cites fatal cases of nosocomial 
pneumonia in infants (George et al., 1961) and a fatal case of 
subacute bacterial endocarditis in a pr'.eviously healthy 18-
year old female (Yamakado et al., 1975), all of these 
fatalities being accompanied by positive blood cultures. 
While not resulting in fatalities there are other reports of 
significant bacteraemias (Burnakis e·t al., 1986; Hirsch ~ 
al., 1986). In view of these cases it would be prudent not to 
ignore F. meningosepticum in blood cultures. 
Wound isolates of !· meningosepticum are reported in 
association with contaminated chlorhexidine solutions (Coyle-
Gilchrist et al., 1976). Urinary isolates are rare and 
generally ~ot significant. Out of a total of 27,600 genital 
tract specimens, 88 strains of!· meningosepticum were 
isolated, mainly from the female urethra (Olsen and Ravn, 
1971). No clinical significance was attributed to F. 
meningosepticum in these cases but the possibility of the 
female genitals being a source of nosocomial infection with F. 
meningosepticum was conjectured. 
The previously mentioned suggestion that pathogenic 
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strains of !· meningosepticum may differ from non-pathogenic 
0 
strains in ability to grow at 40 C (Bruun and Ursing, 1987) is 
supported by other data. Olsen (1966) reports that seven 
environmental strains and thr~e strains from the blood of 
adult hyperthermic patients with self-limiting disease fail to 
grow at 38°C whereas King's original serotype A-F strains from 
infant meningitis and bacteraemia grow at temperatures up to 
41°C. In this study the non-meningitis/bacteraemia strains 
were from a temperate climate whereas the disease-causing 
strains were from warmer climates. In Holmes' review (1987) 
the majority of cases of neonatal meningitis were from warmer 
climates. Another interesting point is that Holmes quotes 
strong evidence that the pathogenic strains were of 
environmental (waterborne) origin rather than maternal origin, 
The evidence therefore points to geography being important in 
the epidemiology of!· meningosepticum neonatal meningitis 
with pathogenic strains being derived from waters of countries 
with warm climates (Olsen, 1966). 
In meningitis cases intravenous erythromycin therapy can 
be ineffective and resistance is known to develop (George ~ 
al., 1961; Hazuka ~al., 1977; Rios et al., 1978; Ferlauto 
and Wells, 1981). However successful therapy with intrathecal 
erythromycin and intrathecal vancomycin is reported (Plotkin 
and McKitrick, 1966), as is successful intrathecal and 
intravenous therapy with erythromycin (Maderazo et al., 1974) 
and cotrimoxazole ~Lapage and Owen, 1973). Intravenous and 
intraventricular rifampicin is also reported to be successful 
(Chandrika and Adler, 1982). Intravenous cotrimoxazole (Johny 
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~al., 1983) and combined intravenous erythromycin and 
clindamycin (Burnakis ~al., 1986) have been successful. 
AlthQugh some strains are susceptible to chloramphenicol its 
failure in combination with spiramycin is reported (Agarwal 
and Ray, 1971). 
It appears that intrathecal or intraventricular 
administration is necessary for reliable attainment of 
therapeutic CSF drug levels with these agents. Some of the 
newer beta-lactam agents may however prove more successful in 
coupling good activity against!· meningosepticum (Table 13) 
with better CSF penetration. Experience to date however 
emphasizes the need to be aware of: 
- the capability of!· meningosepticum to develop 
resistance during therapy, 
- the possibility of false susceptibilities being 
indicated by disc diffusion testing, 
- the possible need for intrathecal administration, and 
- the need for frequent monitoring of CSF drug levels 
(Holmes, 1987). Even though some of the new agents show good 
in vitro activity it would be wise to give consideration to 
these matters until the efficacy of the new agents is proven. 
The high mortality rate in meningitis cases precludes 
complacency ?bout the treatment of this condition when it is 
caused by F. meningosepticum. 
Details of resistance mechanisms in!· meningosepticum are 
largely unknown at present, especially mechanisms by which 
resistance develops during therapy. Hazuka et al. (1977) 
report the step-wise development of resistance to 
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sulphisoxazole, erythromycin and vancomycin during, or shortly 
after, a patient's therapy with these agents. Cross-
resistance to clindamycin also emerged concurrently. Although 
the isolates were referred to the Antimicrobics Investigations 
Section at the Centre for Disease Control (CDC) in Atlanta· the 
only investigations performed by CDC were confirmatory MIGs. 
No assessment of resistance mechanisms was made. Hazuka et 
al. (1977) postulated the acquisition of a resistance factor 
from some other organism in the environment. However this is 
most unlikely as no 'Other organisms were cultured from the 
patient's spinal fluid and the stepwise increments in 
resistance suggest the occurrence of at least three separate 
events. It therefore remains to be established how F. 
meningosepticum can develop resistance to sulphisoxazole, 
erythromycin, vancomycin and clindamycin during therapy. 
In other Gram-negative rods erythromycin resistance can 
develop in Enterobacteriaceae as a result of decreased cell 
wall permeability, alteration of the target site, or drug 
inactivation. In addition resistance to either one group of 
agents or cross resistance to all macrolides, lincosamines and 
streptogramines can occur in !· coli and B. fragilis by 
alteration of 23S ribosomal RNA which leads to reduced 
affinity between the antibiotics and the ribosome. The 
resistance can be either inducible or constitutive and may be 
temperature dependent (Callihan et al., 1984; Weisblum, 1984; 
Welch and Southern, 1984; Courvalin et al., 1985). No 
mechanisms of vancomycin resistance are known (Crossley, 
1986). Perhaps mechanisms of these types occur in F. 
98 
TABLE 13 
Susceptibility~!.:_ meningosepticum 
~ Antimicrobial Agents 
1. Agents to Which Most Strains are Susceptible 
cefoperazone 
cefoxitin 
ceftizoxime 
ciprofloxacin 
cotrimoxazole 
doxycycline 
lincomycin 
mezlocillin 
minocycline 
novobiocin 
piperacillin 
rifampicin 
triacetyloleandomycin 
2. Agents to Which Most Strains are Resistant 
ampicillin cephalexin nitrofurantoin 
aztreonam cephaloridine oxacillin 
bacitracin cephalothin penicillin G 
carbenicillin cloxacillin polymyxin B 
cef amandole colistin spectinomycin 
cef azolin imipenem temocillin 
cefsulodin kanamycin tobramycin 
cef tazidime methicillin viomycin 
cef uroxime netilmicin 
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TABLE 13 (cont) 
3. Agents to Which Susceptibility is Variable 
amikacin fusidic acid streptomycin 
cefotaxime gentamicin sulphonamides 
chloramphenicol moxalactam tetracycline 
clindamycin nalidixic acid vancomycin 
erythromycin neomycin 
Data of King (1959); Olsen~ al. (1965); Watson et al. 
(1966); Olsen (1969); Altmann and Bogokovsky (1971); Werthamer 
and Weiner ( 1972); Lapage and Owen (1973); Coyle-Gilchrist~ 
al. (1976); Hazuka ~ al. (1977); Aber et al. (1978); Mani et 
al. (1978); Price and Pickett (1981); Igari et al. (1983); 
Johny et al. (1983); Strandberg ~ al. (1983); Yabuuchi ~ al. 
(1983); Burnakis et al. (1986); Raimondi et al. (1986); Bruun 
(1987); Gilardi (1987). 
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meningosepticum. However the information provided by Hazuka . 
~al. (1977' is too scanty for evaluation and the development 
of resistance to vancomycin is suggestive of a previously 
unrecognised mechanism. 
Kelsey et al. (1982) report increasing rifampicin MIGs 
(from 1 to 128 ug/ml) in a patient with F. meningosepticum 
ventriculitis. The organism could not be eradicated from the 
CSF with combination rifampicin and erythromycin therapy but 
wqseradicated with combination mezlocillin and cefoxitin 
therapy. 
On the basis of the rarity of detectable plasmids and the 
broadness of antibiotic resistance, Holmes, Owen and McMeekin 
(1984) suggest that chromosomal genes may be involved in the 
resistance of Flavobacterium strains. 
There is only one report of beta-lactamases in F. 
meningosepticum. Raimondi ~al. (1986) report three 
different beta-lactamases in seven strains of F. 
meningosepticum, including reference strain NCTC 10585. The 
enzymes have a broad spectrum of hydrolytic activity including 
significant activity against the 7-beta-aminothiazole 
cephalosporins but are primarily penicillinases. They have 
similar molecular weights by gel filtration (approximately 
20,000 daltons) but differ in isoelectric patterns. Four 
strains have beta-lactamases with a major band at pl 7.9 and 
two minor bands for which pl values are not reported. A 
further two strains have a major band at pl 7.8 with a-minor 
band at 8.2 and the remaining strain has a major band at 7.65 
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(pers. comm.) and minor bands at 7.6 and 8.0. The beta-
lactamase of strain NGTG 10585 is not inducible. All beta-
lactamases are regarded as chromosomal because plasmids have 
not been detected in these strains. 
These enzymes are inhibited by clavulanic acid, 
cloxacillin and pGMB. The addition of clavulanic acid (2 
mcg./ml.) to various beta-lactam antibiotics reduces MIG 
values to varying degrees. Gephalosporin MIGs, particularly 
ceftazidime, are reduced much more than penicillin MIGs by 
clavulanic acid. This is unusual in an enzyme which is 
predominantly a penicillinase and is tho,ught by Raimondi et 
al. (1986) to be possibly due to the antibacterial activity of 
a subinhibitory amount of clavulanic acid. (All strains have 
an MIG of 8 mcg./ml. for clavulanic acid). 
Raimondi ~ al. (1986) conclude that!.· meningosepticum 
possesses a class IV enzyme of the Sykes and Matthew (1976) 
classification (presumably the same as class IV of the 
Richmond and Sykes classification) because it is 
chromosomally mediated, constitutive, has a broad substrate 
profile and is inhibited by pGMB and clavulanic acid. 
9. Flavobacterium odoratum 
Bacterium faecale aromaticum (Stutzer, 1923), later 
renamed F. odoratum (Stutzer and Kwaschnina, 1929) was 
originally isolated from the faeces of patients with 
intestinal infections. The name subsequently lapsed until 
Holmes~ al. (1977) revived it and proposed extant reference 
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strain ATCC 4651 (NCTC 11036) as neotype strain. 
Owen and Holmes (1978) report DNA relatedness of 7-100% in 
a study of ten strains of !· odoratum. Seven of the strains 
form a group with G+C of 31-32% and greater than 80% base 
pairing. Within this group two colony types occur after 
0 24 hours incubation on nutrient agar at 37 'C. These are: 
Colony type 1: effuse, spreading, 3-4 mm diameter, raised, 
shiny centre and dull mattsu-rfu..ce-. 
Colony type 2: like type 1 but smaller 1.0-1.5 mm and 
growth less luxuriant. 
The second group of three strains, which includes the neo-type 
strain, has G+C of 34-36% with less than 28% of nucleotide 
I 
sequences in common with the first group. These strains 
produce a third colony type: 
colony type 3: smooth, shiny, convex, 0.5-1.0 mm, no 
spreading edge but after 24 hr like type 1. 
On the basis of this heterogeneity Holmes, Owen and 
McMeekin (1984) suggest that it may be warranted to divide F. 
odoratum into two or three species. Considering that the G+C 
range of this species (4.7 mol%) substantially exceeds that of 
any of the other Flavobacterium species, and even the 
heterogeneous Group Ilb (range 3.5 mol%), subdivision of F. 
odoratum appears to be warranted. However the genetic 
differences cannot yet be correlated with phenotypic 
differences other than colonial morphology (Shewan and 
McMeekin, 1983). 
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!.· odoratum is a rare opportunistic pathogen which is most 
frequently isolated from urine but has also been isolated from 
peritoneal fluid and soft tissue infections (Holmes~ al., 
1977; Davis~ al., 1979; Kohut, 1979; Von Graevenitz, 1981). 
It caused ventriculitis in a six week-old infant with 
hydrocephalus (Macfarlane et al., 1985). In this case 
intravenous cefotaxime was unsuccessful and was discontinued, 
but intraventricular cefotaxime rapidly sterilized the 
ventricular fluid to effect a cure. F. odoratum may also be 
an indicator of pathological processes in the intestine as it 
has been isolated from the faeces of patients with abdominal 
typhus, acute gastroenteritis, and relapsing fever, but not 
from normal faeces (Stutzer and Kwaschnina, 1929). 
Even allowing for considerable strain variation!· 
odoratum has extremely broad antibiotic resistance (Table 14). 
To date there are no reports of discrepancies between MIC and 
disc diffusion methods for this species in tests of 
antimicrobial susceptibility. However from the literature 
some drugs appear to be more active in disc t~sts than in MIC 
tests. 
Kono~ al. (1980) report the presence of a plasmid of 
molecular weight 41.6 +/- 1.7 megadaltons in!· odoratum 
strain N299B isolated from infected urine. The plasmid coded 
for resistance to ampicillin, carbenicillin and erythromycin. 
An attempt to transform the plasmid into a strain of E. coli 
was unsuccessful. 
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TABLE 14 
Susceptibility of~ odoratum .!£.Antimicrobial Agents 
1. Agents to Which Most Strains are Susceptible 
josamycin nitrofurantoin 
rifampicin piperacillin 
2. Agents~ Which Most Strains are Resistant 
amikacin cef otetan kanamycin 
aztreonam ceftazidime penicillin G 
carbenicillin cephalothin polymyxin B 
cef amandole clindamycin streptomycin 
cefmenoxime colistin tetracycline 
cefoperazone gentamicin tobramycin 
cef otaxime imipenem 
3. Agents~ Which Susceptibility is Variable 
ampicillin cephaloridine erythromycin 
cefoxi tin ~·~ chloramphenicol moxalactam * 
ceftriaxone cotrimoxazole nalidixic acid 
Data of Kohut (1979), Holmes ~al. (1979), Sato et al. 
(1985), Schell et al. (1985), Andreoni (1986) 
and Gilardi (1987). 
* Most strains are reported as resistant to this agent in 
MIG studies and susceptible in disc diffusion studies. 
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There is only one report of a beta-lactamase in !.· 
odoratum. Strain GN 14053 constitutively produces a broad 
spectrum beta-lactamase with a molecular weight of about 
26,000 and a pl of 5.8 (Sato et al., 1985). This enzyme is 
more active against cephalosporins than penicillins and is 
unusual in its ability to rapidly hydrolyse some of the 
oxyiminocephalosporins and imipenem which makes it a 
Mitsuhashi type II CXase (Table 6). It does not hydrolyse 
cefsulodin, ceftazidime or moxalactam. The enzyme is 
inhibited by EDTA, iodine, pCMB, mercuric chloride and copper 
sulphate, but not by clavulanic acid, sulbactam, imipenem or 
cephamycin derivatives. Sato et al. conclude that the enzyme 
is a metalloenzyme because activity is restored after complete. 
inhibition by 5 mM EDTA by the addition of divalent cations 
(e.g. Zn2+, Fe2+). 
This beta-lactamase appears to be an important determinant 
of beta-lactam resistance as in eight strains of F. odoratum 
there is a direct correlation between MIC values and the 
amount of enzyme produced. 
10. Flavobacterium multivorum (King's or CDC Group Ilk, type 2 
"Sphingobacterium multivorum") 
The name!.· multivorum was proposed for Group Ilk-2 by 
Holmes!:..!. al. (1981) on the basis of its yellow pigmentation, 
low %G+C, menaquinones, extracellular DNase, cellular fatty 
acid profile, aerobic metabolism, oxidase and catalase 
production (Dees!:..!. al., 1979; Holmes!:..!. al., 1981; Pickett et 
al., 1981). A subsequent proposal that it be named 
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"Sphingobacterium mul tivorum" (Yab'quchi et al., 1983) was made 
on the basis of its production of high concentrations of 
sphingophospholipids as cellular lipids. These authors 
propose that all Flavobacterium species, like!.· multivorum, 
which produce high concentrations of sphingophospholipids as 
cellular lipids should be assigned to a separate genus, 
Sphingobacterium. 
F. multivorum is possibly unique among flavobacteria in 
possessing.a single nonfunctional flagellum (Levine et al., 
1980; Pickett et al., 1981). However this is a controversial 
issue as other workers have failed to observe the flagellum 
(Holmes et al., 1981; Yabuuchi et al., 1983; Hayward and Sly, 
1984). 
!· multivorum shows DNA (Levine!! al., 1980) and 
phenotypic heterogeneity (Weaver et al., 1972; Oberhofer, 
1979; Pickett et al~, 1981; Yabuuchi et al., 1981; Hayward and 
Sly, 1984; Gilardi, 1987). The environmental strains examined 
by Hayward and Sly (1984) are biochemically more active than 
the clinical strains examined by oth~r workers. Hayward and 
Sly (1984) point out that clinical isolates are not 
necessarily representative of the genus Flavobacterium which 
occurs in terrestrial and freshwater habitats and suggest that 
the descriptions of new species of Flavobacterium should not 
) 
place too much stress on a few biochemical features as these 
may merely reflect the source as well as the mode of isolation 
of the strains. As an example their biochemically more active 
strains were isolated from soil by culturing for bacteria 
capable of degrading dextran. It may therefore have been that 
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this technique detected only the more biochemically active 
strains of F. multivorum and not the less active ones. This 
type of consideration raises the question of Flavobacterium 
species descriptions having been based on biased sampling 
techniques, such as the recent clinical emphasis, and suggests 
that the current species des~riptions may be too restrictive. 
The 16 isolates examined by Hayward and Sly (1984) show 
asymmetric division. A small proportion of cells appear to 
bud to release spherical cells. This phenomenom was 
previously shown in electron micrographs of F. breve (Weeks, 
1981) and F. aquatile (Thomson, 1982). 
F. multivorum occurs in soil (Hayward and Sly, 1984; 
Pichinoty et al., 1985) where its ability to degrade dextran 
is another feature shared with Cytophaga (Hayward 1975; 
Janson, 1975). It is a rare pathogen which causes neonatal 
meningitis (Mizuta et al., 1974), peritonitis (Dhawan ~al., 
1980) and septicaemia (Potvliege et al., 1984; Freney ~al., 
1987). It is also recorded as occurring in cavity fluid, 
synovial fluid and the spleen (Yabuuchi et al., 1983). Like 
other Flavobacterium species it is resistant to a wide range 
of antimicrobial agents (Table 15). Freney ~al. (1987) 
report successful treatment of this organism in a 57 year old 
septicaemic lymphoma patient with a combination of the new 
quinolone perfloxacin and cotrimoxazole. Seven strains of F. 
multivorum showed endotoxin-like activity in limulus 
amoebocyte lysate testing (Smalley, 1982). 
103 
TABLE 15 
Susceptibility~!...:_ multivorum to Antimicrobial Agents 
I. Agents to Which Most Strains are Susceptible 
- --
azlocillin perf loxacin 
erythromycin piperacillin 
nalidixic acid rifampicin 
2. Agents to Which Most Strains are Resistant 
- --
ampicillin cephalothin 
amikacin gentamicin 
aztreonam kanamycin 
cef amandole penicillin G 
cefoxitin polymyxin B 
tobramycin 
3. Agents ~Which Susceptibility is Variable 
carbenicillin cotrimoxazole 
ceftazidime moxalactam 
ceftriaxone sulphonamides 
chloramphenicol tetracycline 
clindamycin vancomycin 
Data of Yabuuchi ~al. (1983), Freney et al. (1987), Gilardi 
(1987). 
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11. Flavobacterium spiritivorum (Group Ilk, type 3) 
The name!· spiritivorum was proposed by Holmes~ al. 
(1982) for thirteen strains which differed from.!'.· multivorum 
in producing acid from ethanol and mannitol. !.· spiritivorum 
is also closely related to !· thalpophilum, and~· mizutae 
(Yabuuchi ~al., 1983) through being less active 
proteolytically and producing high cellular concentrations of 
sphingophospholipids. This is considered adequate 
justification for these organisms to have separate generic 
status (Holmes and Owen, 1981; Holmes et al., 1983; Yabuuchi 
et al., 1983). F. spiritivorum is another organism which may 
provide additional evidence of a close relationship between 
Flavobacterium sp~cies and gliding bacteria. Yabuuchi et al. 
(1983) report that it spreads on 0.3% agar but does not seem 
to on 0.5% agar. However true gliding is unconfirmed. 
All strains of this species so far reported are of 
clinical origin, predominantly from blood, urine and the 
female genital tract (Holmes~ al., 1982; Yabuuchi ~al., 
1983). The clinical significance of the species is unknown 
but infections would be difficult to treat because it is 
resistant to a wide range of antimicrobial agents (Table 16). 
12. Flavobacterium thalpophilum 
The name!.· thalpophilum was proposed on the basis of 
seven strains which differed from F. multivorum in producing 
acid from adonitol, growth at 42°C and in having a 
significantly higher G+C range (44-46 mol%) (Holmes~ al., 
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TABLE 16 
Susceptibility~ F. spiritivorum ~Antimicrobial agents 
1. Agents~ Which Most strains are Susceptible 
cotrimoxazole 
piperacillin * 
rifampicin 
sulphonamides 
2. Agents~ Which Most Strains are Resistant 
ampicillin clindamycin penicillin G 
amikacin colistin polymyxin B 
carbenicillin erythromycin streptomycin 
cef amandole ·k gentamicin tetracycline 
cefoxi tin ~-: kanamycin tobramycin 
cephalothin moxalactam "k 
3. Agents to Which Susceptibility is Variable 
chloramphenicol 
nalidixic acid 
Data of Holmes et al. (1982), Yabuuchi et al. (1983), Gilardi 
( 198 7) 
* One strain only reported 
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TABLE 17 
Susceptibility~!...:_ thalpophilum to Antimicrobial Agents 
1. Agents to Which All Strains are Susceptible 
cotrimoxazole 
rifampicin 
2. Agents to Which All Strains are Resistant 
ampicillin gentamicin 
amikacin kanamycin 
cefamandole penicillin G 
chloramphenicol polymyxin B 
erythromycin tobramycin 
3. Agents to Which Susceptibility is Variable 
carbenicillin moxalactam 
cefoxi tin piperacillin 
cephalothin tetracycline 
Data of Holmes et al. (1983), Gilardi (1987). 
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TABLE 18 
Identification of Flavobacterium Taxa 
* 
-------------------------------------------------------------
Test 1 2 3 4 5 6 7 8 9 10. 
-------------------------------------------------------------
Acid produced from :a 
Glucose +b v + + + v + + + 
Adonitol n + 
Ethanol + v v v + 
Lactose +b v + + + 
Mannitol v + 
Raffinose + + + 
Sucrose +b v + + + 
Casein digestion + + + + + + + 
Esculin hydrolysis + + + + + + + 
Indole productionr_', + + + + v 
Nitrate reduction n + v n v + 
Nitrite reduction n v v v + 
Starch hydrolysis n v n 
Urease production v v v + + + + 
ONPG v v + + + + 
Growth at 42oC v n v + 
---------------------------------------~---------------------
Data of Holmes et al. (1983)' Holmes, Owen and McMeekin 
--
(1984)' Holmes et al. (19846). 
--
1. F. aqua tile 6. F. meningosepticum 
2. F. breve 7. F. odoratum 
3. F. balustinum 8. F. multivorum 
4. Group Ilb 9. F. spiritivorum 
5. F. gle1,1m 10. F. thalpophilum 
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TABLE 18 (Continued) 
a ammonium salt-sugar medium 
+b delayed reaction 
v variable 
n no result recorded 
e Ehrlich reagent 
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1983). Like F. multivorum and!· spiritivorum, F. 
thalpophilum is not markedly pigmented and is less active 
proteolytically than other Flavobacterium species. The 
inclusion of this species widens the breadth of the G+C range 
of the genus and increases the justification for a new genus 
comprising these species (Holmes and Owen, 1981; Holmes et 
al., 1983; Yabuuchi et al., 1983). However at present there 
are insufficient phenotypic characters to support the creation 
of a new genus (Holmes et al., 1983). 
The seven strains o~ which the species is based were from 
clinical specimens with blood and wounds the most common 
sources. Their clinical significance was not determined. 
However if!· thalpophilum proves to be pathogenic it may be 
difficult to treat because of its resistance to a wide range 
of antimicrobial agents (Table 17). 
13. Flavobacterium Species Incertae Sedis 
The species listed' in Table 10 as incertae sedis do not, 
in most cases, conform to the revised genus description 
(Holmes ~ al., 1982) and their ~nclusion in the Approved 
Lists of Bacterial Names (Skerman et al., 1980) is confusing. 
The majority of these species should be deleted for the 
following reasons. 
F. acidificum 
This organism is motile (Holmes and Owen, 1979) and is 
considered to be a strain 9f Erwinia herbicola (A.T.C.C., 
1980, cited Holmes and Owen,' 1981). The G+C composition is 
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52.7 mol% (Callies and Mannheim, 1978). 
F. acidurans 
The G+C composition is 66.3 mol% (Holmes and Owen, 1979). 
Holmes and Owen (1981) suggest that this organism could 
possibly be grouped with!_. oceanosedimentum, !_. okeanokoites 
and F. resinovorum in the same genus - possibly Empedobacter 
if that name i~ resurrected. 
F. capsulatum 
The G+C composition is 63 mol% (Weeks, 1974). Ribosomal 
RNA cistron analysis places it in a distinct rRNA superfamily 
that includes!· paucimobilis as its nearest taxon (Bauwens 
and De Ley, 1981). 
F. devorans (P. paucimobilis, CDC or Weaver's Group Ilk, 
biotype 1) 
This organism is motile and has a G+C composition of 
69 mol%. 
F. esteraromaticum 
This organism is Gram-positive and has a G+C composition 
of 69 mol% (Weeks, 1974). It is probably a coryneform 
(Bauwens, 1980). 
F. ferrugineum 
This organism contains menaquinones (Callies and Mannheim, 
1978) and its G+C composition is 48.6 mol %. Its taxonomic 
position based on rRNA cistron similarity is unclear but it is 
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not a member of the Flavobacterium/Cytophaga complex (Bauwens 
and De Ley, 1981). 
F. halmophilum 
The G+C composition is 49.7 mol% and its respiratory 
quinones are ubiquinones (Callies and Mannheim, 1978). 
Genetically it appears to be related to "Alcaligenes 
aquamarinus" (Bauwens and De Ley, lq81). 
F. heparinum (~. heparina) 
This is a gliding organism with a G+C composition of 49.7 
mol% (Perry, 1973). Although it was transferred to Cytophaga 
as~· heparina by Christensen (1980) DNA:rRNA hybridization 
data of Bauwens and De Ley (1981) indicates it may not belong 
to the Flavobacterium/Cytophaga complex. 
F. indoltheticum 
This organism is nonmotile and the G+C composition is 33.8 
mol% (Holmes and Owen, 1981). Numerical taxonomic analysis 
and the DNA base composition suggest that this species is 
very similar to and would be indistinguishable from!· breve. 
Holmes, Owen and McMeekin (1984) suggest that it may be 
considered a later synonym of F. breve. 
"F. lutescens" 
The G+C composition is 65 mol% (Weeks, 1974). DNA:rRNA 
hybridization evidence indicates it is a member of the genus 
Pseudomonas (Bauwens and De Ley, 1981). 
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F. oceanosedimentum 
The G+C composition is 67.5 mol% (Carty and Litchfield, 
1978). 
F. okeanokoites 
This organism is peritrichous (Holmes and Owen, 1979) and 
on the basis of DNA:rRNA hybridization data does not belong to 
the Flavobacterium/Cytophaga complex (Bauwens and De Ley, 
1981). 
F. resinovorum 
This organism is peritrichous and has a G+C composition of 
66.4 mol% (Holmes, Owen and McMeekin, 1984). 
"F. rigense" 
This organism is peritrichous and has a G+C composition of 
69 mol% (Weeks, 1974). 
"F. tirrenicum" 
This organism is nonmotile, has a G+C composition of 34.4 
mol% (Callies and Mannheim, 1978) and has rRNA cistron 
similarities to the!· aquatile sub-group of Bauwens and De 
Ley (1981). This species is not included in the Approved 
Lists (Skerman ~al., 1980) but if the name was revived "F. 
tirrenicum" could be included in the genus. The type strain 
is ATCC 15997. 
F. uliginosum 
This organism has a G+C composition of 32 mol% (Weeks, 
1974). DNA:rRNA hybridization data indicates it is related to 
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the gliding organisms ~· lytica, ~· marinoflava, ~· 
salmonicolor, !.· aurantiacus subsp. excathedrus and possibly 
McMeekin's yellow organism 42 (Bauwens and De Ley, 1981). 
A relationship to cytophagas is also indicated by the ability 
of F. uliginosum to degrade agar (Holmes and Owen, 1981). 
14. Genus Weeksella 
Holmes, Steigerwalt et al. (1986a, 1986b) propose a new 
genus Weeksella, comprising two species Weeksella virosa 
(previously Flavobacterium Group Ilf, or Pickett and Manclark 
Group 3, or Olsen and Ravn Group 1) and W. zoohelcum 
(previously Flavobacterium Group.Ilj). This proposal follows 
the suggestion of Holmes and Owen (1981) that these species be 
excluded from Flavobacterium on the basis of their greater 
susceptibility to antibiotics, their lack of saccharolytic 
activity, lack of obvious yellow pigmentation and because they 
tend to be parasites rather than free-living organisms. 
Weeksella is included in the family ·cytophagaceae. 
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f. Taxonomy and Antibiotic Resistance of the Genus 
Flavobacterium: Current and Future Status 
Since reviving F. odoratum as a species on the basis of 
nine clinical strains and one environmental strain (Holmes et 
al., 1977), Holmes and various co-workers have continued to 
publish species descriptions based on small collections of 
predominantly clinical strains. As a result the genus is now 
fashioned in a growth at 37°C positive, clinical direction 
with most species being genetically heterogeneous yet unable 
to accomodate many so-called atypical environmental strains. 
The major benefit to accrue from this has been the provision 
of a taxonomic framework for the genus. 
To elaborate briefly the problems with the present scheme, 
Bruun (1982) could not fit all of 184 clinical and 
environmental strains into existing taxa and rioted "that most 
of the different biochemical patterns represented gradually 
merged into each other, with certain patterns, however, 
occurring more frequently than others and corresponding to the 
already described taxa". Additional strains could have been 
accomodated in F. breve and F. odoratum by expansion of the 
species descriptions. However with other strains it was 
impossible to tell if they belonged to Group Ilb or to the F. 
multivorum-F. spiritivorum complex. Bruun compared the 
situation to that of "the green fluorescent pseudomonads 
where very many different biochemical patterns occur gradually 
merging into each other, but with some occurring more 
frequently than others; a situation which makes subdivision 
into stable, recognizable species extremely difficult". 
120 
Further study of the strains led Bruun (1983) to again express 
concern about the taxonomy of the genus commenting that 
"unfortunately the tentative groups can hardly be said to 
represent satisfactory taxonomic units as they stand, and 
further studies are undoubtedly needed before a better scheme 
for the arrangement of the genus Flavobacterium can be made". 
Hayward and Sly (1984) also experienced problems with the 
species description for!· multivorum being too restrictive 
for some dextranolytic strains from soil and Thomson (1982) 
reported strains intermediate between species' and strains 
which could not be assigned to described taxa. 
In discussing the heterogeneity within defined taxa, 
McMeekin and Shewan (1983) urged resistance to the temptation 
to erect new species until it is possible to relate the 
genetic differences to easily determined phenotypic traits. 
However this suggestion was ignored and two further species 
were described,!· thalpophilum (Holmes~~., 1983) and!· 
gleum (Holmes~ al., 1984b), again on the basis of small 
numbers of clinical strains. 
As a consequence of Holmes and co-workers plunging 
industriously into the taxonomic reconstruction of the genus 
there are now, and will continue to be, problems in 
accomodating strains, particularly non-clinical strains, into 
what are essentially clinical species. 
At this point in the history of the genus however it 
should not be the shortcomings of the present scheme which are 
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of prime importance but rather the future taxonomic direction 
of the genus. The gist of the matter is this. There is now a 
taxonomic framework which, although imperfect in some 
respects, supersedes the previously unwieldy classification of 
Weeks (1974) which contained two very different %G+C ranges 
(Weeks, 1974). However there still remains the confusing and 
enormously heterogeneous collection of Gram-positive and Gram-
negative Flavobacterium species of the Approved Lists (Skerman 
~al., 1980). The lack of taxonomic cohesion of this group 
is a disgrace. This type of taxonomic arrangement confuses 
undergraduates, makes their teachers blush, and either annoys 
or makes clinicians laugh. The important question therefore 
is not the taxonomic significance of relatively small studies 
of clinical strains but rather, now that we do have the first 
ever coherent taxonomic framework for the genus, how should it 
be most usefully employed? 
This question can be answered by reviewing those areas in 
which the current classification is complete and correct, 
those areas in which it is deficient, and considering the 
importance of points on which not all parties agree. This is 
done in the following: 
1. Heterogeneity Within Species. 
Most clinical species of Flavobacterium comprise a core of 
highly related strains with a number of 'outliers' (atypical 
strains). Food and environmental strains are often atypical 
(Owen and Holmes, 1981). The following taxa are genetically 
heterogeneous: F. breve (Owen and Holmes, 1980), F. 
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meningosepticum (Sottile et al., 1973; Owen and Snell, 1976; 
Callies and Mannheim, 1980; Ursing and Bruun, 1987), !· 
multivorum (Levine~ al., 1980), !· odoratum (Owen and Holmes, 
1978), and Group Ilb (Owen and Snell, 1976). From %G+C values 
!· odoratum (range 4.7 mol%) is the most diverse taxon of the 
genus and can be subdivided into two groups with less than 28% 
of nucleotide sequences in common. 
Most workers agree that further subdivision of the taxa is 
warranted but given the absence of good correlation between 
genetic differences and phenotypic markers it is not 
recommended at present. New phenotypic characters are 
required. Two species should be special priorities for 
subdivision, F. odoratum, because it is more genetically 
~ - ' 
diverse than the other taxa, and !· meningosepticum, because 
of the practical importance of the potenti~l correlation 
between pathogenicity and genotype, and also because the type 
strain NCTC 10016 is atypical of the species. 
2. Heterogeneity Within the Genus 
On the bas is o_f g~ene tic and phenotypic data the genus can be 
subdivided into distinct groups (Bauwens and De Ley, 1981; 
Holmes and Owen, 1981; Holmes ~ al., 1983; Yabuuchi et al., 
1983; -Holmes, Owen~ al., 1984~ which contain some bacteria 
not belonging to Flavobacterium: 
Group 1: !· aqu_atile (and"!· pectinovorum", "F. 
tirrenicum" and C. johnsonae) 
Group 2: F. odoratum 
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Groub 3: !· balustinum, !· breve, !· gleum, ~. 
meningosepticum and Group Ilb 
Group 4: !· multivorum, !· spiritivorum, F. thalpophilum 
(and S. mizu~ae). 
It is agreed by all except Oyaizu and Komagata (1981), who 
recommend that all Flavobacterium strains should be 
transferred to the genus Cytophaga, that generic status is 
appropriate for the groups (Bauwens and De Ley, 1981; Holmes 
; 
an.d Owen, 1981; Yabuuchi !!. al., 1983; Holmes, Owen and 
McMeekin, 1984). So far only one proposal has been made, that 
Group 4 become the genus Sphingobacterium (Yabuuchi ~al., 
1983). Holmes~ al. (1983) however argue against this 
maintaining that there are insufficient phenotypic characters 
to justify the new genus. 
If subdivision of the genus as a whole is to be delayed 
perhaps priority could be given to making Group l a separate 
genus at the earliest opportunity. !· aquatile is a type 
species which is atypical of Flavobacterium. Furthermore this 
group also contains _Q. johnsonae and !· pectinovorum which are 
both gliding bacteria and therefore also atypical of 
Flavobacterium. The rules of nomenclature would necessitate 
this group retaining the generic title Flavobacterium and the 
other species currently recognised as Flavobacterium would 
have to be renamed. 
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3. The Flavobacterium-Cytophaga Boundary _ 
In addition to evidence that l.· aquatile is an atypical 
cytophaga there is further evidence of a relationship between 
Flavobacterium and Cytophaga. Both genera have similar %G+C ' 
ranges, respira~ory quinones and cellular fatty acid 
compositions and there is strong genetic evidence of 
relationships between certain strains of both groups (Bauwens 
and De Ley, 1981; Paster et al., 1985). Overall the genetic 
diversity of the Flavobacterium/Cytophaga complex is as broad 
as the entire family of Enterobacteriaceae. However by 
DNA:rRNA hybridization studies, strains of Cytophaga and 
Flavobacterium cannot be separated f:rom each other (Bauwens 
and De Ley, 1981). Phenotypically the most reliable character 
for disting'uishing the genera is gliding motility but it is 
impossible to distinguish cytophagas which are aberrant in 
this trait from Flavobacterium (Holmes, Owen and McMeekin, 
1984). 
Although there is unanimity that the boundary between 
Flavobacterium and Cytopnaga is indistinct there is contention 
about the taxonomic implications of this. Oyaizu and Komagata 
(1981) recommend amalgamation of all taxa into an enormous, 
all-encompassing genus (Cytophaga) while other workers 
advocate subdivision of the complex into several genera. 
In essence the issue centres on one character - gliding 
motility. If new phenotypic characters can be found to better 
delineate the groups within the complex the emphasis and 
confusion about gliding motility should dissipate and any 
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nexus between Flavobacterium and Cytophaga should be seen in 
clearer perspective. 
4. Bacteroides 
Oligonucleotide cataloguing indicates that Flavobacterium, 
Cytophaga and Bacteroides "form a phylogenetically coherent 
and major cluster of eubacteria, a eubacterial 'phylum'" 
(Paster~ al., 1985). That this relationship was not 
previously su~pected is understandable since the 
Flavobacterium/Cytophaga complex and Bacteroides species 
are phenotypically very different and are characterized in 
very different ways. 
The more striking phenotypic differences between these two 
groups have masked the less obvious features they share. The 
majority of Bacteroides species have %G+C values in the same 
range as Flavobacterium and are also nonmotile. Both groups 
are unique in containing organisms which have sphingophospho-
lipids as a major membrane component. Like Flavobacterium, 
many Bacteroides species are phosphatase-positive and two 
Bacteroides species, !· ureolyticus and!• gracilis, resemble 
Cytophaga in their ability to spread and to pit into agar. It 
is also interesting that!· ureolyticus is oxidase-positive 
while!· gracilis demonstrates "twitching" movements. Further 
similarities exist in the antibiotic susceptibility patterns 
with many organisms of both groups susceptible to 
chloramphenicol, clindamycin, cefoxitin, erythromycin, 
minocycline an~ acylamino penicillins but resistant to 
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penicillin, arnoxycillin, colistin and arninoglycosides 
(Holdeman~ al., 1984; Tables 11 to 17). 
Many Bacteroides species produce beta-lactamases. It is 
striking that!· odoratum and!· fragilis TAL 2480 both 
possess rare imipenem-hydrolysing Mitsuhashi type II CXases 
(Table 6). More detailed investigation of these enzymes and 
investigations of the beta-lactamases of other species might 
provide further insights into the relationships of these 
organisms, particularly if the beta-lactamases are 
chromosomally-mediated. 
There is considerable scope for further investigations of 
this relationship. Because it is regarded as a distant 
relationship (Paster et al., 1985; Woese ~al., 1985) on the 
basis of oligonucleotide sequence studies of small numbers of 
strains, the Bacteroides connection should not impinge on 
taxonomic reform within the Flavobacteriurn/Cytophaga complex. 
However because studies to date are of such a limited nature 
it is not possible to preclude the possibility of a more 
intimate relationship. The sequences of only two 
environmental strains of Flavobacteriurn (E:_. aquatile and F. 
breve ATCC 14234) have been studied. Clinical strains of F. 
breve and strains of other Flavobacterium taxa need to be 
assessed. If more extensive studies indicate the relationship 
is more intimate than is currently suspected the taxonomic 
implications for these groups could be both fascinating and 
far-rea~hing. 
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6. The Significance_£!. Antibiotic Resistance in 
Flavobacterium 
Holmes, Owen and McMeekin (1984) suggest that antibiotic 
resistance in Flavobacterium is largely controlled by 
chromosomal genes. Marre ~al. (1982) note that IEF of 
chromosomal beta-lactamases can be of great taxonomic value, 
sometimes being specific to subspecies level. If the beta-
lactamases of Flavobacterium are chromosomal, a survey of the 
beta-lactamases of the genus could shed light on some of its 
relationships. In theory it should be possible to classify 
the entire genus according to its chromosomal beta-lactamases. 
This, then, might be a new approach for investigating the 
taxonomic affinities of the heterogeneous genotypes and the 
unclassified environmental strains. 
The Flavobacterium beta-lactamases which have been 
described so far are unlike those of most other bacteria. 
One beta-lactamase, that of Flavobacterium strain 80 (Chen and 
Williams, 1982, 1985) is unique in hydrolysing temocillin. 
Such unusual enzymes offer considerable potential as 
distinctive phenotypic markers. 
The taxonomic potential of other resistance mechanisms in 
Flavobacterium also needs to be assessed. Multiple antibiotic 
resistance is usually suggestive of a permeability barrier or 
multiple resistance mechanisms. Perhaps resistant 
Flavobacterium strains have narrower porins than other 
bacteria. How does F. meningosepticum develop resistance 
during therapy? These are issues which have been ignored by 
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researchers. 
The elucidation of the non-beta-lactamase mechanisms may 
be technically more difficult and less informative than a 
survey of beta-lactamases at the present time. The study of 
porins and antibiotic penetration rates is expensive, 
technically complex, and prone to error. Investigations of 
beta-lactamases can be less demanding technically and more 
likely to yield useful results because the taxonomic 
significance of beta-lactamases is established (Matthew and 
Harris, 1976; Marre ~al., 1982) and there is considerable 
literature to which new data can be related. 
With its ·high levels of resistance .and unusual beta-
lactamases the genus Flavobacterium is a hole in the spectrum 
of the new beta-lactam antibiotics. It can therefore be 
regarded as a yardstick by which to measure how much future 
progress is necessary in the development of beta-lactam 
antibiotics. Knowledge of the resistance mechanisms of the 
genus may lead to the development,of improved antibiotics by 
indicating the level of potency required, or new types of 
molecular configurations which will allow antibiotics to evade 
bacterial deience mechanisms. In this respect Flavobacterium 
is a terra incognita which if explored may yield new 
understandings about the interaction of antibiotics with 
bacteria. 
From the preceding it is obvious that a lengthy research 
agenda could be established ~o investigate the taxonomic 
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problems of the genus and the many implications of its antibiotic 
resistance. New approaches to these issues are 
required. It is important that the recent progress in both 
taxonomy and antibiotic therapy be consolidated. What is 
needed is a broadly based study which will point to the 
various areas of research which are likely to be most 
profitable. In this respect this thesis aims to further 
answer the question about how the current taxonomic framework 
of Flavobacterium can be most usefully employed by examining 
the genus in the light of antibiotic resistance data and 
better establishing the nature of relationships within 
Flavobacterium and also with some of the other bacteria of 
taxonomic interest. 
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II. MATERIALS AND METHODS 
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a. Bacterial Strains 
The names, origins and code numbers of the 43 reference 
and 89 study strains are shown in Table 19. The study strains 
had been previously described by Thomson (1982) except for 
strains R41, R42, R43, R47, R48, R49, R50, R51, R54, R55, R56, 
R58 and R59, and the MP strains which were donated by Prof. 
M.J. Pickett, University of California, Los Angeles. The 
reference strains were donated by Dr B. Holmes, National 
Collection of Type Cultures, Colindale, London, Dr H. 
Reichenbach, Gesellschaft fur Biotechnologische Forschung, 
Braunschweig, and Prof. C.C. Sanders, Creighton University, 
Omaha. 
b. Characterisation Tests 
Strains R41, R42, R43, R47, R48, R49, R50, R51, R54, R55, 
R56, R58 and R59 were subjected to the characterisation tests 
I 
listed in Table 20. The taxonomic reference strains, the 
antibiotic reference strains, the MP strains, and the 
previously described study strains were accepted as authentic 
on the basis of colonial morphology and a small number of 
confirmatory tests from Table 20 e.g. oxidase, phosphatase, UV 
sensitivity, motility, urease, indole production and acid 
production from glucose and raffinose. 
c. Antibiotics 
All antibiotic, discs except temocillin and augmentin were 
manufactured by Oxoid Limited, Basingstoke, England. The 
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temocillin and augmentin discs were manufactured by BBL, 
Cockeysville, USA. The aztreonam discs were a gift from the 
Squibb Institute, New Jersey and the temocillin discs were a 
gift from Beecham Research Laboratories, Victoria. Disc 
strengths were ampicillin 25 mcg, augmentin (amoxycillin 20 
mcg/ clavulanic acid 10 mcg), aztreonam 30 mcg, carbenicillin 
100 mcg, cefamandole 30 mcg, cefoperazone 30 mcg, cefotaxime 5 
mcg, cefoxitin 30 mcg, cefsulodin 30 mcg, ceftazidime 30 mcg, 
cefuroxime 30 mcg, cephaloridine 30 mcg, cephalothin 30 mcg, 
chloramphenicol 30 mcg, cloxacillin 10 mcg, erythromycin 
15mcg, gentamicin 10 mcg, imipenem 10 mcg, moxalactam 5 mcg, 
norfloxacin 10 mcg, sulphamethoxazole 300 mcg, temocillin 30 
mcg, ticarcillin 75 mcg, trimethoprim 2.5 mcg. 
All antibiotic diagnostic powders and tablets except 
penicillin and trimethoprim were gifts from their respective 
manufacturers. These included ampicillin, lithium 
clavulanate, ticarcillin (Beecham Research Laboratories, 
Victoria, Australia), cefamandole, cefoperazone (Pfizer Ltd, 
N.S.W., Australia), ceftazidime, cephalothin (Glaxo Australia 
Pty Ltd, Victoria), cefsulodin (Ciba-Geigy Ltd, Basle, 
Switzerland), cefotaxime, gentamicin (Roussell Pharmaceuticals 
Pty Ltd, N.S.W., Australia), cefoxitin, imipenem (Merck Sharp 
& Dohme (Australia) Pty Ltd, N.S.W.), aztreonam (The Squibb 
Institute, New Jersey), penicillin G potassium salt (Sigma 
Chemical Co., Missouri), trimethoprim (Burroughs Wellcome Co., 
Research Triangle Park, North Carolina), erythromycin 
(Faulding, South Australia), nitrocefin (Oxoid, England) and 
chloramphenicol (Parke-Davis Pty Ltd, N.S.W.). Standard 
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TABLE 19 . 
Origin of Strains Included in the Study 
1. Taxonomic Reference Strains 
Strain Code Name as Received Source or 
reference 
ATCC 15997 "F. tirrenicum" 1 
ATCC 17061 c. johnsonae 1 
ATCC 29551 c. aquatilis 1 
DSM 527 Flexibacter elegans 1 
NCIB 8694 F. aqua tile 2 
NCIB 10150 c. johnsonae 1 
NCTC 10016 F. meningosepticum 2 
NCTC 10585 F. meningosepticum 2 
NCTC 10795 F. gleum 2 
NCTC 11033 F. multivorum 2 
NCTC 11036 F. odoratum 2 
NCTC 11099 F. breve 2 
NCTC 11162 F. breve 2 
NCTC 11179 F. odoratum 2 
NCTC 11180 F. odoratum 2 
NCTC 11343 F. multivorum 2 
NCTC 11386 F. spiritivorum 2 
NCTC 11387 F. spiritivorum 2 
NCTC 11432 F. gleum 2 
Sources: 1. H. Reichenbach 2. B.Holmes 
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TABLE li (Continued) 
2. Antibiotic Reference Strains 
Strain Name as Received Enzyme Source or 
Code reference 
MISC 99 K. pneumoniae !Va 3 
MISC 100 E. coli Illa (TEM) 3 
MISC 101 E. coli lb 3 
MISC 102 E. cloacae la 3 
MISC 103 K. pneumoniae IVb 3 
MISC 104 P. mirabilis Ila 3 
MISC 105 K. pneumoniae Illa (TEM) 3 
MISC 111 E. cloacae P99+ la 3 
MISC 112 E. cloacae P99- lacks enzyme 3 
MISC 11 E. coli III (TEM 1) 3 
MISC 120 E. coli III (TEM 2) 3 
MISC 121 E. coli v (OXA-1) 3 
MISC 122 E. coli v (OXA-2) 3 
MISC 123 E. coli v (OXA:-3) 3 
MISC 1.24 P. aeruginosa III (PSE-1) 3 
MISC 125 P. aeruginosa V (PSE-2) 3 
MISC 12A P. aeruginosa III (PSE-3) 3 
MISC 127 E. coli III (HMS-1) 3 
MISC 128 E. coli III (SHV-1) 3 
MISC 130 P. aeruginosa III (PSE-4' 3 -
164 CD P. aeruginosa I cl 3 
ATCC 25922 E. coli 4 
ATCC 25923 s. aureus 4 
ATCC 27853 P. aeruginosa 4 
3. c.c. Sanders 4. American Type Culture Collection 
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TABLE ..!1 (Continued) 
3. Study Strains 
Name as Received Strain Code 
F. breve U3I 
F. gleum U62, R46, R48 
F. meningosepticum R43, R44, R58, MP8I6, MP8I7, MPBIB, 
MP8I9, MP820, MP894, MP963, MP966, 
MP903, MP969, MP970, MP972, MPI702, 
MPI742, MP22I5, MP2347, MP2348 
F. multi vorum R42, MPII70, MPII74, MPII77, MPII80, 
MPI20I, MPI204, MPI205, MPI2IO, MPI2I3, 
MPI23I, MPI236, MP2324 
F. odoratum U59, R25, R28, R37, R55, R59 
F. spiritivorum R4I, RSI, MP2242 
F. thalpophilum MP997, MPI207, MPI232 
Group Ilb UI, U37, U39, U42, U43, U58, U70, R34, 
R40, R45, R47, R49, R50, R54, R56, R862, 
MP7, MPB, MP305, MP525, MP547, MP548, 
MP582, MP592, MP6I6, MP628, MP639, 
MPI098, MPI409, MPI846 
Unclassified UIO, U33, U44, U93, UI05, R5, RIO, RI2, 
Strains RI9, R39 
Sources: 
I. R strains: 
R5 and RIO (received as ROSI and H026 ex J.M. Shewan), 
RI2 and R45 (received as 25 and un-named strain ex 
T.A. McMeekin) 
RI9, R43 received as NCTC II099 and NCTC IOOI6 from 
B. Holmes 
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TABLE 19 (Continued) 
Sources of Study Strains (Continued) 
R41, R42 'received as A2840 and A2841 ex M. Peel) 
R47 (received as un-named food strain ex R. Tucker) 
R58, R59 - American clinical strains (ex R. Clark) 
Other R strains - Australian clinical strains 
2. U strains - poultry processing water 
3. MP strains - M.J. Pickett (isolation sites not provided) 
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TABLE 20 
Morphological, Physiological and Biochemical 
Characterisation Tests 
Test Method Test 
Colonial morphology (a) Esc~lin hydrolysis 
Motility (b) Acid from adonitol 
Anaero·bic growth (c) Acid from glucose 
Pigmentation (a) Acid from maltose 
UV sensitivity (d) Acid from arabinose 
Oxidase (e) Acid from inositol 
0-F test (glucose) (f) Acid from salicin 
Phosphatase (g) Acid from sucrose 
Indole production (h) Acid from trehalose 
Nitrite reduction (i) Acid from dulcitol 
Urease ' (j) Acid from mannitol 
ONPG (k) Gelatin hydrolysis 
DNase (k) Arginine dihydrolase 
Method 
(k) 
(1) 
(1) 
(1) 
(1) 
(1) 
(1) 
(1) 
(1) 
(1) 
(1) 
(m) 
(n) 
H2S :pi;-oduction (k) Ornithine decarboxylase (n) 
Acid from lactose (k) Lysine decarboxylase (n) 
Acid from xylose (k) Catalase (i) 
Starch hydrolysis (i) Citrate utilisation (n) 
Pigment on tyrosine agar (i) Filament formation (o) 
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TABLE 20 (Continued) 
(a) nutrient agar, 48 hrs; (b( wet mount and motility test 
medium (BBL Microbiology Systems, Cockeyville, Maryland); 
(c) Oxoid Anaerobic System; (d) McMeekin (1977); (e) Kovacs 
(1956); (f) Hugh and Leifson (1953); (g) Barber and Kuper 
(1951); (h) 1% w/v tryptone water (Oxoid CM87); (i) Cowan and 
Steel (1970); (j) Christensen (1946), cited Cowan and Steel 
(1970); (k) Uni-N/F-Tek (Flow Laboratories, Inc., Virginia); 
(1) Ammonium-salt sugar medium; (m) Charcoal gelatin discs 
-(Oxoid BRlO), 7 days incubation; (n) API 20E, Montalieu-
Vercieu, France); (o) microscopic examination after overnight 
0 
incubation at 37 C in tryptone soya broth (Oxoid CM129) - a 
filament is defined as a cell for which the length is at least 
!Ox cell width. 
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solutions of each antibiotic were prepared on the day of use 
according to the manufacturer's instructions. 
d. Disc Diffusion Antibiotic Susceptibility Tests 
Isolates were tested according to the Calibrated 
Dichotomous Scheme (CDS) of Bell (1975; 1984). Brief~y, the 
inoculum was prepared from a subculture on nutrient agar 
(Oxoid CM3) by passing a sterile Nichrome SWG.24 wire of' 
diameter 0.56 mm vertically through a selected colony until it 
touched the surface of the agar. The inoculum was then 
suspended in 2.5 ml of sterile normal saline (this suspension 
~ 7 
contains lOj to l~~ cfu/ml) and 'evenly distributed ov~r a pre-
dried plate of depth 2 mm of Sensitest Agar (Oxoid CM409). 
The plate was then tilted to drain and excess inoculum drawn 
off with a Pasteur pipette. Aft~r the surface of the plate 
had been air-dried for 15 to 45 minutes the antibiotic discs 
were applied and the plate was incubated at 35°C for 18 hours. 
Annular radii of inhibition zones were measured with Vernier 
calipers and recorded. 
By this method rapidly growing bacteria are determined to 
be susceptible to an antibiotic if the annular radius of the 
inhibition zone is 6mm or greater and resis~ant if the zone is 
smaller. However this, and all disc tests, are known to yield 
inaccurate results with slow-growing strains (Bell, 1984). 
Therefore for slow-growing strains of Flavobacterium the 
validity of the 6 mm cut-off point to determine susceptibility 
was uncertain. 
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There were two further concerns with interpretation of 
this test. Some of the antibiotics (aztreonam, cefamandole, 
cefoperazone, cefoxitin, cefsulodin, ceftazidime, cefuroxime, 
cephalothin and erythromycin) had not been calibrated for 
Gram-negative bacteria. Furthermore some strains (NCIB 8694, 
NCIB 10150, ATCC 29551, Ul, UlO, U33, U37, U39, U42, U43, U44, 
U70, RlO, Rl2, R39, R40 and R45) could not be tested strictly 
according to the method as they failed to grow sufficiently at 
35°C. Four strains did not grow'sufficie~tly on Sensitest 
agar. NCIB 8694 was tested on Cytophaga agar, NCIB 10150 and 
ATCC 29551 were tested on Sensitest Agar with 5% defibrinated 
horse blood added and U70 and was tested on CLED medium (Oxoid 
CM301). While these technical problems may have led to 
antibiotic-organism interactions beyond the calibration of the 
CDS method this did not necessarily invalidate disc tests for 
these organisms' as disc testing was used in this study for 
additional purposes beyond strict interpretation of 
susceptibility. 
One important function of the disc tests was to screen 
strains and antibiotics for phenomena of potential interest 
for further testing. The second important function of the 
disc tests was their integral role in 3~dimensional 
susceptibility testing and clover leaf testing (see below). 
These considerations made it important to include disc testing 
in this study. 
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e. 3-Dimensional Testing 
Beta-lactam antibiotics were concurrently tested with both 
the CDS method and the 3-dimensional technique (Thomson et 
al., 1984) to investigate enzymatic drug inactivation. The 3-
dimensional inoculation was performed as follows just prior to 
placing the antibiotic discs on the plate. 
The point of a sterile number 11 scalpel blade was passed 
vertically into a selected typical colony of the test 
organism. The blade was then agitated to either side to give 
just visible inoculum on both sides of the point. the 
inoculum~laden scalpel was then used to inoculate the plate by 
means of the Pearce 3-Dimensional Inoculator (Biomedical 
Engineering Department, Repatriation General Hospital, Hobart, 
Australia). This inoculation involved stabbing the scalpel 
point eight times into the .agar in predete.rmined fashion (Fig. 
7). The plate was then rotated three times with the scalpel 
blade remaining inserted in the agar after the final stab-
inoculation. This provided an evenly distributed circular 
slit of inoculum (the 3-dimensional inoculation) extending 
from the surface of the agar to the bottom of the plate. 
After this the plate was removed from the Inoculator and the 
antibiotic discs were placed precisely on the agar 3 mm inside 
the circular 3-dimensional inoculation. An Oxoid Disc 
Dispenser Mark II was used to accurately place the discs. 
After incubation presumptive evidence of enzymatic 
inactivation of the antibiotics was detected at the margin of 
the inhibition zone adjacent to the 3-dimensional inoculation 
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(Figs 8, 9). Inactivation of. drug as it diffused through the 
slit resulted in a distortion or discontinuity in the usually 
circular inhibition zone. No distortion of the zone margin at 
the intercept with the slit indicated that there had been no 
significant inactivation of the antibiotic. 
This procedure was varied when testing drugs to which the 
antibiotic reference strains were resistant. For these tests 
the bacterial growth immediately adjacent to the disc masked 
any 3-dimensional effects. To overcome this a susceptible 
assay organism was used for the surface inoculation, i.e. E. 
coli ATCC 25922 or S. aureus ATCC 25923, and the one- and two-
disc procedure of Thomson et al. (1984) was used. This 
procedure entailed using the ~dge of a ruler as a guide for 
the scalpel blade to produce a straight-line 3-dimensional 
inoculation, after which one or two antibiotic discs were 
placed on the agar 3 mm to one side of the slit. 
This more sensitive procedure was initially employed only 
with the strains containing known beta-lactamases. It was 
important to assess the potential of the technique against a 
range of known beta-lactamase types. The more sensitive 
procedure was used only for study strains of ~articular 
interest. 
f. 3-Dimensional and Clover Leaf (3D+CL) Testing-
In clover leaf testing (Kjellander and Myrbach, 1964) an 
agar plate is spread with a susceptible assay strain and the 
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Fig. 7. Diagramatic representation of the 3-dimensional 
inoculation. Above: sideview showing the slit of inoculum 
extending from the surface to the bottom of the agar. 
Beneath: viewed from above, the circular slit of inoculum is 
3 mm outside the ring of antibiotic discs (one disc only 
shown). The numbers 1 to 8 indicate the sequence of stab 
inoculations of the test organism prior to the three rotations 
of the plate. During the rotations the bacterium-laden blade 
distributes the inoculum in a circular slit. 
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antibiotic disc placed in the centre. A heavy inoculum of the 
test strain was streaked radially from the disc and the plate 
was incubated under conditions suitable ·for growth of both test 
and assay strain. An indentation in the inhibition zone of 
the assay strain along the streak of the test strain indicated 
enzymatic inactivation of the antibiotic by the test strain. 
As the study progressed it was found that there were 
occasional differences between the results of the 3-
dimensional and the clover leaf tests. A combination of the 
two techniques was adopted to provide a more comprehensive 
presumptive test for beta-lactamase ~ediated drug 
-
inactivation. This was achieved by performing the more 
sensitive one- or two-disc 3-dimensional tests with a radial 
streak of test inoculum away from the disc on the opposite 
side to the 3-dimensional inoculation (Fig. 12). A positive 
result by either or both of the 3-dimensional or clover leaf 
tests was regarded as a positive 3D+CL test. Strains NCTC 
11099 and Rl9 were each tested five times to investigate the 
reproducibility of this technique. 
g. Minimum Inhibitory Concentration (MIC) Testing 
Strains for MIC testing were selected from those capable 
of growth at 35°C after CDS and 3-dimensional testing. The 
organisms were all reference strains of Flavobacterium and 
strains of species which complemented the reference strains by 
presenting, for each species, as wide a range of 
susceptibility to beta-lactam antibiotics as possible. By 
testing the most resistant, the most susceptible, and a median 
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strain for each species (plus other unusual strains) it was 
hoped to investigate any heterogeneity of the species in their 
interactions with beta-lactam antibiotics. Named species were 
preferred to Group IIb and unclassified strains to establish a 
framework by which difficult to classify strains might be 
compared with the taxonomic framework based on Holmes, Owen 
and McMeekin (1984). Control strains E. coli ATCC 25922 and 
P. aeruginosa ATCC 27853 were also included. 
The antimicrobials tested were chosen on the basis of 
published beta-lactamase stabilities and their potential 
taxonomic significance as determined by the disc tests in this 
study. 
MIGs were determined for each antibiotic using an agar 
dilution procedure. Antibiotic plates were prepared with 
5 
Mueller-Hinton agar (MHA) (BBL) and inoculated with 10'.~ cfu in 
Mueller-Hinton broth (MHB) (BBL) using a Steers replicating 
device (Steers~ al., 1959). The antibiotic concentrations 
ranged from 0.06 to 128 mcg/ml. All drugs were tested 
simultaneously and the MIG was defined as the lowest 
concentration preventing visible growth after incubation for 
18 hours at 35°C in air. The presence of five or fewer 
colonies was ignored. Differences in MIGs greater than 
twofold were considered significant. Results were defined as 
susceptible, moderately susceptible or resistant according to 
National Committee for Clinical Laboratory Standards (NCCLS) 
interpretive standards (Barry et al., 1981; Thornsberry et 
al., 1985). 
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Additional MIG tests were performed to investigate the 
roles of beta-lactamases and permeability in resistance to 
cephems using cefamandole and cefotaxime alone, with 2 mcg/ml 
lithium clavulanate added, with 1 inM disodium 
ethylenediaminetetraacetate (EDTA) added, and with both 
lithium clavulanate and EDTA added. For these MIG tests S. 
aureus ATCC 25923 was used as a control instead of P. 
aeruginosa ATCC 27853. Apart from this single difference the 
same organisms were tested in both MIG studies. 
h. Enzyme Preparations 
Induction cultures were prepared by making a 1:20 dilution 
of an over~ight MHB culture in fresh medium (final volume 100 
ml) and incubating it at 35°C with shaking (150 rpm). Due to 
unavailability of 100 ml vessels. each 100 ml volume was 
dispensed into 10 ml aliquots in centrifuge tubes.. After two 
to three hours cefoxitin was added to the tubes to give a 
concentration of 1/4 the MIG or 100 mcg per ml, whichever was 
lesser. Incubation was continued for two to three hours after 
which protein synthesis was arrested by the addition of 0.1 ml 
of 1 mM solution of 8-hydroxyquinoline (Sigma Chemical Co., 
Missouri) to each centrifuge tube. The cells were then 
centrifuged at 3,000 x g for 20 min at ro~m temperature in an 
IEC Centra-4X centrifuge (International Equipment Company, 
Bedfordshire, England). The resultant cell pellets were 
combined and washed twice with 0.1 M phosphate buffer, pH 7.0, 
then resuspended in 3 ml of the same buff er and disrupted by 
sonication at 6 microns peak to peak for 40 to 120 sec at O~C 
in an MSE 150 watt ultrasonic disintegrator (Mk 2). Cell 
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debris was removed by centrifugation at 3,000 x g for 30 min. 
The cleared sonic extracts were distributed into three 
aliquots and frozen at -23°C. The protein content of an_ 
aliquot from each organism was determined using Bio-Rad 
reagent (Bio-Rad Laboratories, Richmond, Calif.) in a 
Multistat III Plus microcentrifugal analyser (Instrumentation 
Laboratory) with Validate N <Organon Technika 917613) as a 
standard. The same procedure was used for uninduced enzyme 
preparations except that cefoxitin was not added after two to 
three hours preincubation. For the purposes of this study 
these preparations were designated crude sonicates. 
Beta-lactamase activity was assessed to determine sample 
application volume for IEF by the semiquantitative method of 
Vecoli et al. (1983) as follows. 150 ul of 50 ug/ml 
nitrocefin solution was added to 50 ul of crude sonicate. The 
sample application volume was determined to be 1 ul of sample . 
for each second taken for the development of a pink colour. 
Some crude sonicates with insufficient beta-lactamase 
activity for IEF were concentrated as follows. The 
preparations were dialyzed overnight and centrifuged at 
25,000 x g using a high speed rotor in the Centra-4X 
centrifuge. (This rotor wo~ld only take volumes of less than 
1 ml and was therefore unsuitable for preparation of crude 
sonicates from 100 ml volumes of broth cultures). The 
supernatants were .concentrated in Centricon 10 
microconcentrators (Amicon Corporation, Danvers, 
Massachusetts). Some preparations required further 
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concentration by freeze drying. 
i. Beta-lactamase Assays 
Beta-lactamase assays were performed using a Beckman DB-GT 
grating spectrophotometer. Cephalosporinase activity was 
determined in UV spectrophotometric assays by the method of 
Gootz et al. (1982) using crude sonicates and 100 uM 
concentrations of each substrate. 0 Hydrolysis at 37.C was 
followed over one to ten minutes by monitoring the· change in 
the optical density (OD) of the drug at the wavelength 
associated with maximal absorbance for its beta-lactam ring. 
This was 264 nm for cephalothin and 2u3 nm for cefoxitin. 
Hydrolysis resulting in a change of< 0. 001 OD units could not 
be 'detected accurately in this assay. Organisms with an 
induction ratio of greater than 3.0 in the presence of 
k. 
cefoxitin were considered toAproducers of an inducible beta-
lactamase. 
Penicillinase activity was measured by a modification of 
the microiodometric method of Perret (1954) (Ross and 
O'Callaghan, 1975). Reaction mixtures containing 0.9 ml 0.1 M 
phosphate buffer (pH 7.0), 1.0 ml penicillin G (200 uM), 1.0 
ml iodine-starch solution and 0.1 ml crude sonicate were 
0 
maintained at 30.C for the duration of the assays. Absorbance 
at 620 nm was measured at O, 15, and 2'0 minutes. A commercial 
penicillinase preparation (BBL 11897) was used as a control. 
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j. Isoelectric Focussing and Inhibition Studies 
Beta-lactamases were focussed in agarose gels (105 x 230 x 
0.5 mm) containing pH 3 to 10 ampholytes (Pharmalyte, 
Pharmacia, Sweden) by the method of Vecoli et al. (1983). The 
gels were prepared by dissolving 2 g of AgaroseIEF (Pharmacia) 
and 24 g of sorbitol in 187 ml of deionised water by boiling 
with stirring until clear. The resultant solution was 
dispensed in 16.5 ml aliquots into test tubes and cooled to 65 
to 70 C. Using a syringe, 1.2 ml of ampholyte prewarmed to 
60 c; was gently added to each tube of agarose-sorbitol, 
mixed, and the gel poured onto a preheated spacer mold and 
overlaid with the hydrophilic surface of GelBond film (FMC 
Corpo.ration, Rocklaine, Maine) and a glass plate and left at 
room temperature for one hour to polymerize. After 
polymerization the molds were sealed with waterproof plastic 
adhesive tape (Scotch Brand Tape 471, 3M Company, St Paul, 
0 Minnesota) and the gels stored at 4 C until required. 
On site IEF facilities were unavailable for this study and 
equipment from other sources was used when it was available. 
~ In all the focussing was performed with three different sets 
of apparatus. These were (1) Pharmacia power supply (E CPS 
2,000/300) and Pharmacia flatbed apparatus (FBE 3,000) made 
available by Mr J. Presser (Forensic Science Department, Royal 
Hobart Hospital, Hobart), (2) Bio-Rad Model 3000/300 power 
supply 240 V, 50 Hz with Bio-Phoresis horizontal cell, loaned 
by Miss M. Degaris (Bio-Rad Laboratories Pty Ltd, NSW), and 
(3) Bio-Rad Model 3000/300 power supply 240 V, 50 Hz loaned by 
Miss M. Degaris (Bio-Rad Laboratories Pty Ltd, NSW) with LKB 
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Multiphor II Unit, loaned by Dr J. Sallis (Biochemistry 
Department, University of Tasmania). 
0 The gels were focussed across the width at 11.C with the 
constant power supply increased progressively from 8 W 
limiting through to 22 W limiting with 2,000 V limiting and 30 
mA limiting. The anode solution used was 1 M H3P04, and the 
cathode solution was 0.5 M NaOH. The pH gradient of the gel 
was measured using Electron isoelectric point markers pI 
calibration kit range 4.7 to 10.6 (BDH Chemicals Ltd, Poole, 
England). Focussing continued until the pI markers were seen 
to be sharply focussed and. the,current appeared .to be at a 
stable minimum, usually 7 to 9 mA. An average run took 55 
min. 
Inhibitor 'studies were performed by the method of Sanders 
et al. _(1986) on the agarose gel to distinguish between type I 
chromosomally-mediated enzymes and other types of enzymes. 
Each enzyme was focussed in triplicate. One sample was 
not exposed to inhibitors while the duplicate and triplicate 
samples were exposed to lithium clavulanate or cloxacillin in 
the following manner. Filter paper soaked with lithium 
clavulanate (1,000 uM) ·or cloxacillin (1,000 uM) was placed on 
the surfa·ce of the focussed gel. After 10 sec the- paper was 
removed, and the gel was overlaid with molten agar (MHA) 
containing 50 ug of nitrocephin per ml. After the agar 
hardened the beta-lactamases appeared as pink bands against a 
yellow background. By comparison of the pink band of the 
Wl~O\.~ 1AAibafol'S 
iftfiibited sample~with presence or absence of pink bands for 
151 
the samples exposed to the inhibitors the inhibition profile 
was readily determined. The developed gel was photographed 
within 60 min with a Polaroid MP-4 camera model 44-32 equipped 
with a magenta (Kodak CC30M) filter and Polaroid 669 film. 
The MISC antibiotic reference strains were used as 
controls for the method with MISC 103 ,(type IVa enzyme) and 
Misc 128 (type SHV-1 enzyme) used as internal controls for 
each plate to e~sure that discrepancies did not arise from use 
of the different sets of IEF apparatus. 
IEF studies were also performed in the absence of 
inhibitors to compare larger numbers of enzymes on the one 
gel. These were photographed by directly overlaying Ilfospeed 
Printing Paper (400065) with the gels and exposing them to 
light passed through a pale green microscope filter (type 
unknown) for 16 seconds. 
It was not practicable to perform the necessary genetic or 
biochemical studies to determine beyond doubt whether each 
beta~lactamase was chromosomally or plasmid mediated. 
Classification of the genetic origin was therefore based on 
IEF results which were considered in conjunction with 
substrate profile and inhibitor studi~s when necessary. Thus 
when an isolate produced ~ beta-lactamase with an isoelectric 
point which did not correspond to any of the known plasmid 
mediated beta-lactamases the unknown beta-lactamase was 
classified as chromosomtally mediated. If the beta-lactamase 
had an isoelectric point which was identical to a known 
plasmid mediated beta-lactamase it was necessary to compare 
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the substrate profiles and inhibitor results of the two beta-
lactamases to see if they were identical. 
k. Tests with Augmentin Discs 
Lawn cultures were prepared on Sensitest Agar or other 
substitute media for disc tests (see section d of materials 
and methods) by directly swabbing a colony of the test 
organism onto the agar surface. Ampicillin and augmentin 
discs were then placed at least 3.5 cm apart on the inoculated 
plates and the plates were incubated at the appropriate 
temperature for the organism. After overnight incubation the 
plates were inspected to compare the sizes of any inhibition 
zones. Synergy between amoxycillin and clavulanate was 
inferred if the inhibition zone around the augmentin disc was 
larger than the inhibition zone around the ampicillin disc. 
This was taken to be presumptive evidence that clavulanate 
inhibited the beta-lactamase of the organism and that the 
beta-lactamase had a significant role in resistance of the 
organism to beta-lactam antibiotics. 
1. %G+C Determination 
DNA base ratios were determined for !.· gleum R48, !.· 
gleum/Group Ilb R46 and Group Ilb R54. DNA was extracted as 
detailed by Blackall et al. (1985). A Pye Unicam SP8-200 
UV/VIS thermoprogrammed spectrophotometer (Pye Unicam Ltd, 
Cambridge, England) was used for the determination of the 
thermal denaturation profile. The type strain of E. coli UQM 
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1803, with a mol.% G+C of 51.7 (Blackall et al., 1985), was 
used as a reference strain. The mol% G+C was calculated from 
the formula of Mandel and Marmur (1968): 
%G+C(test) %G+C(std) + 2.08(Tm(test)-Tm(std)) 
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III. RESULTS 
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a. Presumptive Identifications 
The results of tests used to presumptively assign 
Flavobacterium strains to species are presented in Tables 21 
to 24. Strains R43, R44 and R58 were presumptively identified 
as!~ meningosepticum (Table 21). R43 and R44, which were 
isolated from the same freeze-dried culture received as NCTC 
10016, produced colony types which differed in size and hue of 
pigmentation with R43 producing bigger but paler colonies. 
Microscopic inspection showed a further difference with R44 
producing filaments in broth cultures. 
Strains R46, R48, R49, R54, R56 and U62 were similar to 
the published description of!· gleum (Table 22). Mol %G+C 
values for R46, R48 and U62 were within the range published 
for F. gleum (Holmes et al., 1984b) and Group Ilb but were 
higher than the published value for F. balustinum (Holmes et 
al. 1984a). Confirmation of these identifications is required 
as it is difficult to distinguish!: gleum from Group Ilb 
(Table 18) and some atypical biochemical reactions were 
detected. R46, which produced acid from ASS sucrose, differs 
from !_. gleum in this reaction and is therefore probably a 
strain of Group Ilb. This is one of the few reliable tests 
with which to distinguish these taxa. Holmes et al. (1984b) 
state that F. gleum may be distinguished from representative 
strains of Group Ilb by DNA:DNA hybridization, but 
confirmation at this level was not possible in this study. 
R48 produced acid from ASS salicin which makes it atypical of 
both!· gleum and Group Ilb, although Holmes et 91. (1984b) 
report one of 55 strains of Group Ilb being positive for this 
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test. If U62 is confirmed as !.· gleum it will be the first 
non-clinical strain of the species to be reported. 
R47 and Ul were presumptively identified as Group IIb. The 
non-clinical Ul was similar to the description of !.· balustinum 
but the name Group IIb was preferred because the description of 
!.· balustinum requires revision (Holmes and Owen, 1981). It 
therefore seemed prudent to avoid usetthis name pending such 
revision and determination of its %G+C. 
R55 and R59 were presumptively identified as F. odoratum 
(Table 23) and R42 and R51 were presumptively identified as F. 
multivorum and F. spiritivorum (Table 24). 
b. Antibiotic Susceptibility Tests 
0 
The results of the disc diffusion tests performed at 35 C 
0 . 
and 30 C are presented in Tables 25 and 26 respectively and 
the MIG results of strains selected on the basis of the disc 
tests are listed in Tables 28 and 37. The 35°C disc 
susceptibility results were interpreted in two groups as 
follows: 
Group (i): those antibiotics which are calibrated for the CDS 
method of Bell (1975, 1984) i.e. ampicillin, ticarcillin, 
moxalactam, cefotaxime, sulphamethoxazole, trimethoprim, 
gentamicin and norfloxacin, and 
Group (ii): the remaining antibiotics, which have not been 
calibrated for this method i.e. aztreonam, cefamandole, 
cefoperazone, cefoxitin, cefsulodin, ceftazidime, cefuroxime, 
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TABLE 21 
Some Characteristics ~ Strains Presumptively 
Identified ~ ~ meningosepticum 
Type strain * 
NCTC 
Test 10016 R43 R44 
Conspicuous pigment + 
Colony diameter in mm I.BO 1.55 1.30 
Filamentous rods + 
Indole production + + + 
Nitrite reduction + + + 
Urease 
ONPG + + + 
Esculin hydrolysis + + + 
Starch hydrolysis 
ASS glucose acid + + + 
ASS maltose acid + + + 
ASS trehalose acid + + + 
ASS salicin acid 
ASS arabinose 
ASS sucrose acid 
DNase + + + 
•;'( Data of Holmes (1987) 
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R58 
1.80 
+ 
+ 
+ 
+ 
+ 
+ 
-+ 
+ 
TABLE 22 
Some Characteristics of Strains Presumptively 
Identified~!..!_ gleum and Group Ilb 
F. gleum F. balu-
- --
stinum/ 
Test 
* 
U62 R46 R48 R47 R49 R54 R56 Ul@(Ilb)ll 
Conspicuous pigment + + + + + + + + + +/+ 
Indole production + + + + + + + + + +/+ 
Nitrite reduction 7/12 - + + + + -/d 
Urease 7/12 - + + + + -/d 
ONPG 9/12 + + + + + -/d 
Esculin hydrolysis + + + + + + + + + +/+ 
Starch hydrolysis 9/12 + + + + + + + -/d 
ASS glucose acid + + + + + (+) + + + +/+ 
ASS maltose acid + (+) + + + (+) + + -/+ 
ASS trehalose acid + + + (+) (+) (+) -/d 
ASS salicin acid + -/-
ASS arabinose 10/12 - + (+) -/d 
ASS sucrose acid + -/d 
DNase 10/12 + + + + + + + + +/d 
Mol% (G+C) 37.1 36.1 38.2 
Mol% (G+C) ~'<"36. 6- 1133.l/ 
38.6 35.0-38.5 
(+) Delayed positive reaction - taking at least 4 days 
incubation for urease and at least 6 days for ASS sugars. 
II Data of Holmes et al. (1984a), Group Ilb results are shown 
--
beside F. balus tin um i.e. F. balus tin um/ Ill:> 
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TABLE 22 (Continued) 
* Data of Holmes et al. (1984) - fractions (e.g. 7/12) 
indicate the number of positive results and the total number 
of strains tested for tests in which strain variability 
occurs. 
@ 01 was an unclassified strain which was included in Table 
22 because it was biochemically similar to F. balustinum 
d Variable 
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TABLE 23 
Some Characteristics _£!. Strains Presumptively 
Identified as F. odoratum 
F. odoratum 
Test NCTC 
11036 R55 R59 
Conspicuous pigment + + + 
Indole production 
Ni trite reduction + + + 
Urease + + + 
ONPG 
Esculin hydrolysis 
Starch hydrolysis 
ASS glucose acid 
ASS maltose acid 
ASS trehalose acid 
ASS salicin acid 
ASS arabinose 
ASS sucrose acid 
DNase + + + 
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TABLE 24 
Some Characteristics ~ Strains Presumptively 
Identified as F. multivorum and F. spiritivorum 
F. multi- F. spiriti- F. thal-
vorum vorum pophilum 
Test II R42 R51 II 
* 
Conspicuous pigment 
(24 h incubation) 
Indole production 
Nitrite reduction 
Urease + + + + + 
ONPG + + + + + 
Esculin hydrolysis + + + + + 
Starch hydrolysis 
ASS glucose acid + + + + + 
ASS adonitol acid + 
ASS maltose acid + + + + + 
ASS mannitol acid + + 
ASS trehalose acid + + + + + 
ASS salicin acid + + + + + 
ASS arabinose + + d + 
ASS sucrose acid + + + + + 
DNase d + + + d 
II Data of Holmes et al. (1984a) 
--
* 
Data of Holmes et al. (1983) 
--
d Variable 
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cephalothin, and erythromycin. Although the results of the 
routine 3-dimensional tests are included in Tables 25 and 26 
these are reviewed separately. 
It was necessary to develop interpretive criteria for the 
uncalibrated antibiotics (Group (ii) above). This was done by 
comparing MICs and annular radii for the uncalibrated 
antibiotics (with the assumption that MIC results constitute a 
reliable benchmark by which to calibrate disc tests). This 
approach was not possible however for cefuroxime as this drug 
was not included in the MIC study. It was therefore necessary 
to establish arbitrary criteria for cefuroxime which were· 
based on the assumption that the absence of an inhibition zone 
represented resistance and a large inhibition zone (annular 
radius ) 10 mm) was considered to indicate susceptibility. 
This approach identified what were assumed to be clear-cut 
extremes of resistance and susceptibility only, leaving the 
interpretation of annular radii between 0 and 10 mm in 
abeyance. Intermediate results between 0 and 10 mm were not 
evaluable. 
Attempts to calibrate other antibiotics indicated poor 
correlation of MICs and annular radii and as a consequence 
results which were not evaluable were obtained for some 
strains with each of the non-CDS antibiotics. This problem 
was greatest for tests with cephalothin, cefoperazone, 
cefoxitin, and ceftazidime, antibiotics for which 
comparatively large portions of the inhibition zone (i.e. > 3 
mm annular radius) were not evaluable. F. odoratum NCTC 
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11179 was a particular problem with cefoxitin disc testing. 
This strain grew to the edge of the cefoxitin disc (suggesting 
resistance) but was moderately susceptible by MIC testing. 
This result exemplifies the difficulty of providing accurate 
susceptibility results for Flavobacterium and suggested that 
any strain growing to the edge of a cefoxitin disc could not 
be assumed to be resistant to cefoxitin. 
With only 35 Flavobacterium strains included in the MIC 
study it was not considered worthwhile to statistically 
analyse the correlation of MIC and annular radius results. In 
view of the complexities arising from the variability of 
growth and the lack of sufficient numbers of results 
distributed among large, intermediate and small zone sizes and 
high, intermediate and low MIGs, it was obvious that the 
variation about regression lines would have been considerably 
greater than for the aerobic bacteria which are most 
frequently tested in clinical laboratories. Judging by 
impression, but nevertheless with some cert~inty, it appeared 
that the difficulty in accurately calibrating disc and MIC 
results for Flavobacterium paralleled similar difficulties 
which have been experienced in attempting to correlate the two 
techniques for anaerobes (Barry and Fay, 1974; Kwok et al., 
1975). A further complication was the possibility that agar 
dilution testing might not necessarily be an accurate 
reference method by which to compare disc results. This is 
suggested by the detection of resistance mostly by disc 
testing for antibiotics such as cefotaxime, ceftazidime and 
trimethoprim (Table 27). The discrepancies detected when 
comparing disc and MIC tests therefore failed to sustain the 
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assertion of other workers that disc tests are unreliable and 
MICs are reliable because disc tests give a false impression 
of susceptibility. 
The correlation of disc diffusion and MIC testing in this 
~tudy was poor and inconsistent for all Flavobacterium taxa, 
not just !· meningosepticum and Group Ilb, as previously 
reported in the literature (Maderazo et al., 1974; Von 
Graevenitz and Grehn, 1977; Aber~ al., 1978; Winslow and 
Pankey, 1982; Johny et al., 1983; Bruun, 1987). The 
antibiotics which had poorest correlation were ceftazidime, 
cefoperazone, chloramphenicol, cefotaxime, cefoxitin and 
trimethoprim (Table 27). 
Although the errors were not consistent it did appear that 
they were more antibiotic-dependent than method-dependent. 
For example in the 15 discrepancies for cefotaxime testing, 
resistance was detected by disc testing and not by MIC 
testing, whereas in 14 of 15 discrepancies with 
chloramphenicol the disc test failed to detect resistance as 
detected in the MIC test. That is, with certain antibiotics 
it was sometimes possible to predict the direction of a 
discrepancy for a specific antibiotic but it was not possible 
to make conclusions about either technique being prone to 
consistently indicate false susceptibility or false 
resistance. 
If, to simplify discussion, it is assumed that MIC results 
are an accurate reference technique, 64/525 (12.2%) disc tests 
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failed to indicate resistance and 56/525 (10.7%) disc tests 
failed to detect susceptibility or moderate susceptibility. 
The discrepancies for the disc test were consistent (i.e. 
missing only resistance or missing only susceptibility) for 
only three antibiotics (ampicillin, ticarcillin and 
cefotaxime) while for a further ten antibiotics (cephalothin, 
cefamandole, cefoperazone, ceftazidime, cefsulodin, cefoxitin, 
trimethoprim, gentamicin, erythromycin and chloramphenicol) 
the failures were inconsistent, failing to detect both 
susceptibility and resistance as determined by MIG tests. 
F. aquatile 
!.· aquatile NCIB 8694 is nutritionally fastidious and 
could not be tested on Sensitest agar. On cytophaga agar it 
failed to produce a lawn of growth after suspension in 
physiological saline. However direct swabbing of a colony 
onto cytophaga agar pr~duced sufficient growth to detect 
responses to antibiotic discs. Using this technique!.· 
aquatile exhibited confluent growth to the edges of discs 
containing moxalactam, cefotaxime, azt~eonam, trimethoprim and 
gentamicin. Unlike most other species of Flavobacterium 
(except!_. breve) !.· aquatile exhibited a zone of inhibition 
around the cefsulodin disc. Whether'or not this result could 
be interpreted as susceptibility to cefsulodin is uncertain 
because of the µnstandardized technique employed. However 
this was a very interesting result as cefsulodin is a narrow-
spectrum, essentially anti-pseudomonal antibiotic. 
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R 51 2.0 6,3• 1.8 1.8 3,1 0 2.5 0 2,0 .9.8 0 
llP 2242 l.5 4.1 1 . .3 J.1 1.7 .0 0 O.B 2.3 6.11 D 
NP 997 
MP 1207 
~p !.2:!2 
R 34 
R 46 
R 47 
1! -so 
R 54 
R 862 
u 58 
llP 7 
llP B 
llP 305 
llP "525 
llP '47 
MP 548 
MP 592-
llP 592 
llP .61.6 
llP :628 
llP 639 
MP 1098 
NP 1409 
llP 1846 
R 5 
R 19 
u 93 
u 105 
f. thalpophilu~ 4.2 7.3 3.7 4.5 6.0 3.7 3.5 3.1 5.C 10.j -2.3 2.6 8.7 5.9 5.B 6.0 0 B.6 
3.1 6.6 5.7 3.E 4.5 3.6 0 3.2 4.6 10.0 0 0 10.3 Z.5 b.9 6.B 1.2 10.0 
3.3 6.0 4.S ~.B 4.7 3.5 2,5 ~.1 3.4 10.l 0 3.7 10.9 6.B B.~ 5.l 0 11.5 
Group llD 
• 
Unidertt i ft ed 
4.6 E..S 0 7i0 0 
c _.D c :5. 3 0 
, o 2.0- o 5.r o 
2..7 6.2 0 7.7 0 
0 J.5 0 5.0 0 
D 0 0 2.6 0 
0 0 .0 3.4 D 
0 3.3 D 4.0 0 
D 0 0 6.0• 0 
0 0 0 7.6• c 
0 0 - 0 6.1• 0' 
0 1.l D 4. 9 0 
0 0.8 D 6.2• 0 
0 .0 'O -6.D 0 
0 D 'o 5.5• C 
o_ 1.3 o 6.5• o 
0 1. 9 0 3.3• 0 
~ 0.9 0 4.4 D 
c 0.6 0 4.4 0 
- 0 -1.0 0 6.2't 0 
.D.. o. - 0 5.3• 0 
0 5.5 1.8 8.0 7.5 0 0 5.3 4.7 11.5 l0.9 .6.0 9.0 
0 4.1 0 6.0• 10.1 0 0 1.2 11.1 6.5 7.B 5.1 6.9 
0 .6.B D 6.1 8.9 0 D 6.7 ll.2 8.9 11.9 6.7 6.5 
0 5,8 J.9 7.5 ti,.5 D .0 S.J 8.1 7.6 7.5 3.4 6.0 
D 5.2 D 4.7. .8.8 D - 0 8.4 8.6 B.3 B.D 5.4 S.B 
D 7 • .6 O 8.1 '141 2 • .6 D "3,.3 9.3 11.6 11.0 6.1 7.0 
0 3.1 D .. 5.7• 9.7 D 0 1.2 13.7 10.5 8.0 0 6.2 
D 1.8 0 B.4• 10.9 0 D 5.4 14.7 10,0 5.2 5.3 B.1 
0 2.5 D 6.1• 8.1- 0 0 0 11.7 2.6 2.5 0.1 3.9 
D 4.5 D 7.3 8.4 0 D 1.9 12.5 5.8 2.3 l.C 6.2 
0 0 0 3.2• 5.7 0 0 1.9 9.7 1.3 4.3 0 4.7 
j) 0 0 2.0 3.7 0 0 2.8 8.0 0.8 3.4 0.7 6.4 
0 D 0 2.6 4.8 0 D 3.7 8.8 1.2 4.5 0.8 6.0 
D D 0 3.7 S.8 0 0 2.6 10.5 1.4 6.1 0 5.7 
0 0 .D 3.0 5.2 D .D 3.1 10.1 1.1 l.6 0 3,6 
0 0 0 4.D S.B 0 
0 l.3 0 5.7• 6.1 0 
o o o _ 2.8 4.6 .o 
0 2.1 0 6.5• 8.8 0 
0 0 0 '2.2 6.2 0 
0 3.9 0 4.5• 7.5 0 
0 l.9 9.8 2.0 6.4 0.8 4.8 
0 2.1 8,1 9.B 7.3 4.1 8.6 
0 2.7 8.0 1.1 6.5 0.7 5.8 
0 1.3 11.0 1.7 2.1 1.3 4.1 
0 2.2 9.2 0 6.7 0 4.4 
0 O.l.11.6 7.2 J.9 1,9 6.2 
· 0 0 0 4.2 JI 0 3,1 D 4.3 _ 5.5 0 0 5.7 5.7 11.1 9.1 9.5 9,7 
1.1• s.5~ 4,2 11,9 4.4 3,9 14.6 s.2 8.1• 9,1 9.5 14,2 8.6 2.0 13.1 12.0 11.3 8.5 
19.8 20.B 12.S 16.8 7.3 14.4 J.o.S.13.D 14.9 13 • .6 9.8 1.6 1.8 6.8 17.5 10.4 9,1 9.8 
16.3 17.9 0 5.2 ~2 0 15.1 8.0 15.0 16.4 7 .. 1 .9.6 22.8 0 21.9 16.5 13.2 14.1 
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I8~bs ~ iconti'nued> 
Ri.as Diffusion-Antibiotic SusceJU.i!tl.1.1~ I~§1§ 
-----------------------------------------------------------------------------------------------------------------------
OR6AHISM . . - ANTIBIOTIC-
!AMP_ TlC KF - .FOX llA CXM MDX CTX CFP CAZ ,CFS ATll SF II E C CN NOR 
Altc 15997 'f. tirrenicu1 1 lS.9 U.ldl.612.-4lS.:S13..S 13.SJS.7 _17,3 13.8 13.B 0 14.0 1'5.0 14.0 1-4.2 13.5 11.3 
DSll 527 - .E._'!.legans __ __ -11.-.4 JA.7 _ -3.2_12.6_ OX 15.3 _ 011 12.5 
ATCC 17061 ~· johnsonae 4.6_ 6.7 o_ o o o . o .o o _ D _ o_ 4.s 1u o 18.0 11.1 s.-3 11.2 
~ zone 1ar9in distorted in 3-diiensional test 
11 enhancesent of both 9r0Mth and pigmentation in vlcinity Di antibiotic disc 
8!!.!!.!::!:l ar Bs&l.!::!:§ in mm 
!!!.!21 
8!!.11!2.iQtii;, §!::!:§£~E.ii!2.l~ s~sl!::!:S:!2.l~ B~aiai~n.i 
Aztreonam ATM > 11. 2 8.6-1-1.2 < 8~6 
Cefamandole MA > 7.6 5.7-7.6 < 5.7 
Cefopera.zone CFP > 6.6 3.1-6.6 < 3.1 
Cefcxitin FOX > 4.0 0-4.0 
Cefsulodin CFS ) 6.2 5.8-6.2 < 5.8 
Ceftazidime CAZ > 10.0 4.3-10.0 < 4.3 
** 
Cefurcxime CXM > 10.0 _0.1-10.0 0 
; 
Cepha.lothin KF > 9.5 5.3-9.5 < 5.3 
Erythrcrnycit"l E > 14.3 12.1-14.:S < 12. 1 
*** 
CDS Drugs l 6.0 ( 6.0 
----------------------------~----------------------~-------
** More precise calibration not possible because MIC testing 
of this drug was not performed. 
*** Ampicillin <AMP>, ticarcillin <TIC>, moxalactam <MDX>, 
cefotaxime <CTXl, sulphamethoxazole <SF>, trimethcprim <W>, 
chloramphenicol <C>, gentamicin <CNl, ncrfloxacin <NOR>. 
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-----------------------------------------------------------------------------------------------------------------------
mill ORGANISll ANTIBIOTIC 
CODE :AMP TIC KF FOX llA CXll llOX CTX CFP CAZ CFS ATll SF II "E c CN NOR 
-----------------------------------------------------------------------------------------------------------------------
R 40 .Grnup llb 14.8 15.9 16.315.3 10 • .0 16.5 15.8 18.9 24.3 .1U 12.2 8.3 4.6 14."3 13. 9 13. 6 5.1 14.7 
R 45 3.0 6.3 0 10.0 0 0 8.0 0 7-.3 JS 0 .0 - 1 • .6 7.9 1.6 11.1 A.2 8.3 
11 "37 .0 0.9 0 6.1 .0 0 S.l 0 5.9 _8.9 D .0 4 • .6 15.1 6.7 7.7 3.8 3.8 
u 39 1.1 2.J Ll 8.2 1.3 0 6 • .2 0 11..6 13.8 0 o- 7.2 4.2 2.0 4.5 6.9 6.9 
u 42 4.1 7.5 0 12 • .6 0 0 8.3 0 8.3 7.4 0 0 5.0 13.0 5.0. 7.0 6.1 12.4 
u 43 11.1 ll.S 6.817.IJ 4.0 l~l 19.6 ~.o 15 • .6 la.s o _ D 1.6 • .3 15.1 7.7 13.3 5.8 11.3 
u 70 7.1 8.6 2.9 10.1 0 ·3.7 6.7 .2. 8 3.8 1.1- 0 0 2.5 7.8 5.0 6.8 3.0 6.7 
"R 10 Unidentiiied 7.4 8.9 4.6 12.8 5.6 .2.2 11 • .3 1.2 14.6 15 • .6 0 0 6.0 14.S 12.0 11.3 8.1 7.7 
R 12 3.0 5.6 0 9.2 _ o 0 8.2 0 7.0 7.6 0 .0 0.9 15.0 2.0 11.6 6.7 a.a 
tL39 .0 • .6 1..6 0.8 6.0 1.1 .0 5.4 0 7~ U.1 0 0 7 • .0 12.3 ~."3 7.9 4.4 5.9 
u 1 0 5.6 1.2 J.2 0 0 5.0 0 8.3 8.2 0 D 0 13.7 11.3 11.9 4.0 9.6 
u 10 6.09' 9.8* 4.2 11.7 0 1.9 10.2 3.5 12.0 11.9 2.2 0 13.9 19.5 12.2 12.1 6.2 9.0 
u 33 1.7 6.7 0 4..6 0 0 0 0 0 0 0 - 0 9,0 18.0.12.l 15.5 12.2 12.0 
u 44 5.7~ 8.4~ 6.9 13.2 6.2 1.2 12.9 2.5 S.1 12.9 7.8 5.6 9.5 0 15.2 11.9 7.6 2.2 
NCIB 8694 f. aqua tile 12. 9 11 • .0 10.2 13. 0 9.3 11.1 0 0 8.1 .6.0 7.0 .0 10.0 0 12.7 15.6 0 10.1 
ATCC 29551 ~· aquatilis 0 0 0 4.5 0 0 0 0 0 0 0 0 10.0 0 12.0 9.0 0 3.8 
NCIB 10150 ~· jDhnsonae 3.5 5.9 .0 3.2 0 0 0 0 0 0 0 0 5.2 0 10.3 10.e 3.~ 9.8 
-----------------------------------------------------------------------------------------------------------------------
• zone 1ar9in distorted in 3-diiensinnal test 
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F. breve 
This was the most susceptible species tested at 35°C. The 
three strains varied-considerably from each other in zone 
sizes and MICs. This finding was suggestive of heterogeneity 
within the species. NCTC 11162 was the most resistant strain 
while the environmental strain U31 was the most susceptible. 
All three strains of F. breve were susceptible to cefoxitin, 
moxalactam, cef sulodin, aztreonam, sulphamethoxazole and 
chloramphenicol, and resistant to cefotaxime and gentamicin by 
disc testing. In MIC tests all strains were susceptible to 
cefsulodin, cefoxitin and imipenem, and susceptible or 
moderately susceptible to cefoperazone, ceftazidime, 
cefotaxime and chl~ramphenicol, and resistant to gentamicin. 
Susceptibility to cefsulodin was a distinctive feature of the 
species. 
The strains differed markedly in their response to 
ampicillin, ticarcillin, cephalothin, cefamandole, cefuroxime, 
cefoperazone, ceftazidime, aztreonam, trimethoprim and 
Discrepancies between disc and MIC results occurred with 
cefotaxime and trimethoprim. All strains were susceptible or 
moderately susceptible to cefotaxime by MIC testing but 
resistant by the disc diffusion method. NCTC 11162 was 
susceptible also to trimethoprim and erythromycin, and 
moderately Busceptible to cefoperazone by the ~IC method but 
resistant to trimethoprim and not evaluable to erythromycin 
and cefoperazone in the disc tests. 
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TABLE 27 
---
Failures to Correlate Disc Diffusion and MIC Results 
----
Disc Test Failed to Detect 
----No. of 
Antibiotic Failures:*' Susceptibility 
Resistance or Moderate 
Susceptibility 
Ampicillin 3 3 0 
Ticarcillin 5 5 0 
Cephalothin 5 3 2 
Cefamandole 3 2 1 
Cefoperazone 15 11 4 
Cef tazidime 16 4 12 
Cefsulodin ·2 1 1 
Cefotaxime 15 0 15 
Cefoxitin 14 12 2 
Trimethoprim 12 2 10 
Gentamicin 8 5 3 
Erythromycin 7 2 5 
Chloramphenicol 15 14 1 
* A failure is defined as any disc result which does not 
' 
agree with an MIC result. (MIC results are assumed to be 
correct). There are two classes of failures - errors 
(i.e. disc and MIC results are contradictory), and 
instances where the disc test was not evaluable but the 
MIC test clearly indicated susceptibility, moderate 
susceptibility or resistance. 
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8SEL ~il~iiQn 8niibigii£ £~a£~aiiai11tv I~aia 
~inim!::l.!!l InhiQiiQL~ £Qn£gniLEiiQna in ~sLml· 
ORGANISM 
Hm 11099 f. breve 
NCTC 11162 ' 
u 31 
NCTC ~0975 ~· 9.!~ 
NCTC 11432 ' 
R 48 
u 62 
KCTC 10~16 f. ;\l!t.ill5Qmtit:1:J! 
NCTC 10585 ' 
R 58 
MP Sl9 
l!P 969 
"'" 2347 
l!~TC ! 1 ~:;3 £. t:r It nrort.! 
Nm !!3'3 ' 
It? 1177 
!.lP !2!0 
!-:P 1324 
!!CTC 11C36 [. r;do!atui;i 
NC~C 11179 ' 
N:Tc !!!en • 
~ 25 
p !:9 
1::rc 113~: f. s:iir..itiv::r.i;:;i 
'4CTC 11327 ' 
R A! 
R ~! 
l:P 997 
l'!P 12C7 
I".? 1232 
u 58 
R 46 
R 5 
P. 19 
Group !Ib 
l!r.1 der.tl fi ed 
Ur.it:ent1f~ell 
ATtC 27853 f. aerusinosa 
ATCC 25922 l· t:cli 
NCCLS : Sus.r.ept1b!e 
1NTERPREUV.E : lllld • .Susceptible 
STANDARDS• : Rt1i1tant 
ANTIBIOTIC 
! AllP m KF ti:A I:FP CAZ CFS CTX m rox 1PM II Cll E c 
32 
16 32 32 
128 >128 128 
4 lh .16 
)128 }!28 >126 )128 
>128 >128 >128 )128 
>128 >128 >lZS >128 
)128 }.128 )128 ).128 
B 2 4 4 0.5 1 16 64 16 8 
32 J6 16 
0.5 16 
32 _ 4 4 2 B 64 0.5 16 
.32 
4 
J2 
32 
2 )128 0.25 0.06 0.06 16 0.25 16 
4 ms 64 >128 16 2 
4 >128 64 >128 8 2 
4 )128 64 )128 16 4 
4 )128 64 >128 32 64 
0.25 32 32 64 
0.25 B 16 32 
0.12 16 16 64 
0.25 32 126 64 
)128 >128 J.128 )128 - 32 )128 >128 64 l126 32 1.6 4 
2 
2 
2 
2 
2 
16 16 32 
}128 }128 )128 128 64 }128 )128 64 >128 16 32 32 32 64 
64 32 64 .64 128 64 32 16 b4 128 16 HZB B 16 
12B >128 126 .64 32 >128 >128 32 >128 16 32 6 8 32 
)128 )128 )129.)128 32 )128 >128. h4 )128 32 .... .Ji. 128 32 64 
64 32 64 !2e )128 >:2s 64 16 12s >12s 16 >128 16 64 
64 
32 
32 
64 
.1£ 
64 64 32 
64 32 32 
ii4 32 32 
12£ 128 .64 
~ 16 B 
.64 
64 
64 
32 
8 
8 HZB 
8 12B 
B 126 
4 H2B 
8 32 
16 f:4 
.8 126 
s £,4 
.16 }128 
2 ..,., vL .!6 
32 2 
16 D.5 
B 
32 C.5 
0.5 C.5 
16 32 
a 32 
64 32 
64 8 
:z 4 
32 
16 
64 
16 
a 
s 12s > .:ze >i2s }.!28 64 >!28 64 t:4 o. s 4 >128 120 4 32 
64 }12B }12& >1ZB >128 128 i.128 >128 >128 
~2 128 128 )128 >128 128 128 )126 )128 
6~ }128 }l2B )12B >:2s 128 l12B >126 >!28 
16 16 }128 )128 4 32 
8 1 )128 >lZS 0.25 16 
8 16 >126 )128 16 32 
6 4 )128 )128 li28 16 
2 0.25 >128 }128 16 8 
128 il2£ )128 ll2B i128 )128 ;128 }128 ~12B 
2 8 64 .!26 128 64 6~ 32 32 
64 )~28 6C c4 
c4 >128 6~ c4 
).128 >118 64 6' 
64 ) 128 64 .64 
l.128 }128 64 64 
122 }128 .64 64 
128 )128 64 32 
)128 )128 >128 >128 
)128 )128 }128 >128 
>128 }128 l126 )12B 
4 16 64 32 
126 16 )126 h4 )128 b4 16 
128 16 1128 64 >128 64 16 
64 4 >128 32 >128 b4 16 
64 16 l128 32 H28 32 8 
128 8 }126 32 126 
128 16 )128 ~2 )128 
32 8 }128 :6 64 
16 
16 
16 
16 
16 
16 
32 4 }128 128 }128 32 64 
4 1 :128 64 >128 8 64 
32 16 }!28 64 )128 32 >128 
32 8 16 4 1 0.5 0.5 
4 128 l:28 64 
! 128 !28 32 
o.5 16 12e 32 
4 64 >lZB 16 
128 128 64 
1zs 128 m 
64 128 128 
1 32 B 
C.25 32 128 
0.25 32 m 
B 32 1 
16 
32 
32 
16 
>128 
s 
16 >128 l128 
8 B 1 
B 2 2 16 8 >128 2 >128 
C.12 0.25 64 C.12 0.12 4 0.12 2 
4 HZB 128 
C.5 64 B 
0-8 0-16 0-8 0-8 0-16 0-8 0-16 .. 0-8 0-8 0-8 0-4 0-8 0-4 0-0.5 0-8 
16 .32-.64 li .16 .32 16 32 16-32 16 li B 8 1-4 16 
32+- 128+ 32+ 32+ 64+ 32+ 64+ 64+ 32+ 32+ 16+ 16+ 16+ 8+ 32+ 
• Thornsberry et &l. 11985Jj •• Barry et al. 119811 
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TABLE 28 (Continued) 
Symbols Used For Antibiotics 
AMP - arnpicillin 
TIC - ticarcillin 
KF - cephalothin 
MA - cef arnandole 
CFP - cef operazone 
CAZ - ceftazidirne 
CFS - cefsulodin 
CTX - cefotaxirne 
ATM - aztreonarn 
FOX - cefoxitin 
IPM - irnipenern 
W - trirnethoprirn 
CN - gentarnicin 
E - erythrornycin 
C - chlorarnphenicol 
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F. gleum 
The strains of this species were more homogeneous than 
other species. In disc tests (Table 25) all!· gleum strains 
were susceptible to trimethoprim and thloramphenicol while 
cefoxitin and norfloxacin also appeared to be very active with 
only one of six strains not susceptible. All strains were 
resistant to ampicillin, ticarcillin, cephalothin, 
cefamandole, cefuroxime, cefotaxime, cefsulodin, aztreonam, 
erythromycin and sulphamethoxazole, and all but one strain 
were resistant to gentamicin. Results varied for moxalactam 
and most could not be evaluated for cefoperazone and 
ceftazidime. 
In the MIC tests (Table 28) all strains were susceptible 
to ceftazidime and trimethoprim, and susceptible or moderately 
susceptible to cefoperazone, but resistant to 
ampicillin, ticarcillin, cephalothin, cefamandole, cefsulodin, 
cefotaxime, aztreonam, erythromycin and chloramphenicol. 
Susceptibility varied to cefoxitin, imipenem and gentamicin. 
Discrepancies occurred with chloramphenicol and gentamicin. 
The strains which were tested by both procedures were 
susceptible to chloramphenicol by disc testing but resistant 
by MIC testing and environmental strain U62 was just 
susceptible to gentamicin by disc testing (annular radius 6 
mm) but resistant by MIC testing. 
F. meningosepticum 
This is a very resistant species. In both disc and MIC 
tests only cefoxitin inhibited a majority of strains. In MIC 
tests all six strains were susceptible to trimethoprim. 
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However 19 of 21 strains tested by the disc method were 
resistant to this agent. 
MP969 was the most resistant strain and R58 the most 
susceptible. In disc tests all strains were resistant to 
ampicillin, ticarcillin, cephalothin, cefamandole, cefuroxime, 
cefotaxime, ceftazidime, cefsulodin, aztreonam and 
sulphamethoxazole, and most strains were resistant to 
moxalactam, trimethoprim, erythromycin, chloramphenicol, 
gentamicin and norfloxacin. Most cefoperazone disc tests 
could not be_ evaluated. 
In MIG tests only trimethoprim inhibited all six strains. 
These were resistant to ampicillin, ticarcillin, cephalothin, 
cefamandole, ceftazidime, cefsulodin, qztreonam, imipenem, 
erythromycin and chloramphenicol. Susceptibility varied for 
cefoperazone, cefotaxime, cefoxitin and gentamicin. 
Discrepancies occurred with cefotaxime, cefoperazone, 
trimethoprim, chloramphenicol and gentamicin. 
The ceftazidime disc test appeared to have taxonomic 
utility in distinguishing strains of !· meningosepticum from 
!· gleum and Group IIb. F. meningosepticum strains were much 
more resistant in this test having annular radii smaller than 
2.6 mm while the other taxa had annular radii greater than 3.7 
mm. It is possible that ceftazidime also has taxonomic 
utility in MIG tests. !· gleum and Group IIb strains had MIGs 
~ 4 mcg/ml while F. meningosepticum ceftazidime MIGs were~ 64 
mcg/ml. Since only two strains of Group IIb were included in 
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the MIG study this evidence cannot be regarded as being as 
comprehensive as that derived from the disc tests. 
F. multivorum 
In disc tests all strains of F. multivorum were 
susceptible to chloramphenicol, norfloxacin and trimethoprim, 
and most (14/15) were susceptible to sulphamethoxazole. All 
strains were resistant to aztreonam and most were resistant 
(i.e. at least 13/15) to cephalothin, cefamandole, cefotaxime, 
cefsulodin, erythromycin and gentamicin. Results varied most 
for ampicillin, ticarcillin, cefoperazone, moxalactam, 
cefoxitin, and the uncalibrated zone sizes for cefuroxime also 
varied considerably. 
In MIG tests all strains were susceptible to ceftazidime, 
1
and trimethoprim, and susceptible or moderately susceptible to 
cefotaxime, but resistant to aztreonam. Susceptibility varied 
to ampicillin, ticarcillin cephalothin, cefamandole, 
cefoperazone, cefsulodin, cefoxitin, imipenem, gentamicin, 
erythromycin and chloramphenicol. Strain MP 2324 was much 
more susceptible than the other strains and was resistant only 
to aztreonam and gentamicin by both disc and MIG techniques .• 
Apart from this strain, resistance to cefoxitin in MIG test 
and susceptibility to sulphamethoxazole in the disc test 
seemed to be reliable features by which to distinguish this 
species from!· meningosepticum, !· gleum and Group IIb. The 
only other strain which was an exception to this was MP 1213 
which was marginally resistant to sulphamethoxazole. 
Discrepancies occurred with ampicillin, cephalothin,. 
cefoxitin, cefamandole, cefotaxime, chloramphenicol and 
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gentamicin. 
F. odoratum 
This was a very resistant species. In both disc and MIC 
tests there was no agent to which all strains were 
susceptible. Cefoxitin was the most active agent by both 
techniques while chloramphenicol was equally effective only in 
the disc tests and imipenem was effective against four of the 
six strains included in the MIC tests. 
In the disc tests all strains were resistant to 
cefotaxime, cefamandole, cefoperazone, aztreonam and 
trimethoprim, and most strains were resistant to ampicillin, 
ticarcillin, cephafothin, cefuroxime, moxalactam, ceftazidime; 
cefsulodin, sulphamethoxazole~ gentamicin and norfloxacin. 
Erythromycin results were resistant or uncalibrated. If the 
comparatively susceptible, and therefore atypical, 
environmental strain U59 is excluded from consideration this 
species is characteristically resistant in disc tests to 
cephalQthin, cefuroxime, moxalactam, ceftazidime, cefsulodin, 
cefamandole, cefotaxime, aztreonam, cefoperazone and 
trimethoprim, with the latter two drugs being potentially 
useful taxonomic markers which differentiate F. odoratum from 
Group IIb and all other Flavobacterium species except !_. 
spiritivorum. Apart from variations _in the zone sizes for 
aztreonam and sulphamethoxazole there was little evidence of 
heterogeneity. 
In the MIC tests all strains were resistant to 
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cephalothin, cefamandole, cefoperazone, ceftazidime, 
cefsulodin, ,aztreonam, trimethoprim, and gentamicin. The high 
MIGs for trimethoprim (~ 128 ug/ml) were clearly different 
from other species and Group IIb (MIGs~ 16 ug/ml). 
Susceptibility varied to ampicillin, ticarcillin, cefotaxime, 
imipe~em, erythromycin and chloramphenicol. The environmental 
strain U59 was however much more susceptible and clearly 
different from the clinical strains. Discrepancies occurred 
with ampicillin, cephalothin, cefoxitin, ticarcillin, 
cefotaxime, gentamicin and chloramphenicol. 
F. -spiritivorum 
By both disc and MIG testing this species was the most 
resistant to the beta-lactam group of antibiotics and in 
resistance to all antibiotics was comp~rable to the other two 
very resistant species, F. meningosepticum and F. odoratum. 
In disc tests all five strains were susceptible to 
chloramphenicol, resistant to ampicillin, cephalothin, 
cefamandole, cefuroxime, cefotaxime, cefsulodin, aztreonam, 
erythromycin and moxalactam, and unevaluable for cefoxitin. 
Susceptibility varied to norfloxacin, sulphamethoxazole, 
ticarcil!in, trimethoprim and gentamicin. The zone sizes 
varied most for sulphamethoxazole, trimethoprim and gentamicin 
indicating strain heterogeneity in response to these agents. 
In MIG tests all strains were susceptible to trimethoprim 
only, and susceptible or moderately susceptible to 
ceftazidime. All strains were resistant to ampicillin, 
ticarcillin, cephalothin, cefamandole, cefoperazone, 
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aztreonam, cefoxitin, gentamicin and erythromycin. Resistance 
varied to cefotaxime, imipenem and chloramphenicol. 
Discrepancies occurred with· ticarcillin, cefotaxime, 
trimethoprim, chloramphenicol and gentamicin. 
F. thalpophilum 
Overall this species was similar to F. multivorum and F. 
spiritivorum but more susceptible, particularly to cefoxitin 
(by both disc and MIG tests) and ticarcillin (in disc tests 
only). 
By disc testing the three.!· thalpophilum strains were . 
susceptible to ticarcillin, norfloxacin and sulphamethoxazole 
but resistant to ampicillin, cefotaxime, moxalactam, 
ceftazidime, cefsulodin, aztreonam, erythromycin and 
gentamicin. Results varied for cefamandole, chloramphenicol, 
trimethoprim, cephalothin and cefoxitin. By MIG testing all 
strains were susceptible to trimethoprim, susceptible or 
moderately susceptible to ceftazidime, moderately susceptible 
to cefotaxime and cefoxitin, and resistant to ampicillin, 
ticarcillin, cephalothin, cefamandole, cefsulodin, aztreonam, 
imipenem, gentamic~n, erythromycin and chlo~amphenicol. 
Susceptibility varied to cefoperazone. D~screpancies occurred 
with ticarcillin, cephalothin, cefamandole, cefotaxime, 
trimethoprim and chloramphenicol. 
Group !lb Strains 
Twenty one strains of Group !lb were tested by the disc 
diffusion method but only two strains, U58 and R46, were 
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included in the MIC study because preference was given to 
establishing patterns for the described species. Twenty 
strains were susceptible to trimethoprim and 17 strains were 
susceptible to cefoxitin. All strains were resistant to 
ampicillin, cephalothin, cefamandole, cefuroxime, ~efotaxime, 
cefsulodin, aztreonam and erythromycin. Susceptibility varied 
for ticarcillin and sulphamethoxazole (19/21 strains 
resistant), cefoperazone, ceftazidime, chloramphenicol and 
norfloxacin. Three strains were marginally susceptible to 
gentamicin. As MIC studies were not performed on these 
strains it was not possible to tell if this was true 
susceptibility or false susceptibility of the type which has 
been previously reported with disc tests (Johny ~.!al., 1983' 
Unclassified Flavobacterium Strains 
Strain R5 was most similar to Group IIb, !.· gleum and F., 
meningosepticum in its disc antibiogram. The annular radius 
for ceftazidime was 5.5 mm which was a much larger annular 
radius than found in· F. meningosepticum strains in this study. 
It would therefore appear to be more nearly related to Group 
IIb and !.· gleum. In an earlier study this strain was found 
to be non-saccharolytic and therefore could not be classified 
within the existing taxonomic framework of the genus (Thomson, 
1982). 
Strain Rl9, which was cultured from a freeze-dried vial 
labelled F. breve NCTC 11099, was resubmitted to NCTC and 
reported to be an atypical strain of Group Ilb closely 
resembling!.· breve but atypical of that species in its 
ability to hydrolyse both esculin and starch (Thomson, 1982). 
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In this study its disc and MIG antibiograms were similar to F. 
breve NCTC 11099 indicating that it might be a mutant of that 
strain. 
Environmental strains U93 and Ul05 were very susceptible 
and therefore unlike other Flavobacterium strains, 
particularly in being susceptible to gentamicin. These two 
organisms had been previously referred to NCTC for an opinion 
where they were regarded as atypical strains of group IIb 
(Thomson, 1982). 
Taxonomic Reference Strains Not Belonging ~ the Redefined 
Genus Flavobacterium 
These strains were not received until after the MIC study 
had been completed and were therefore tested only by the disc 
diffusion method. 
"F. tirrenicum" ATCC 15977 
This organism was susceptible to all agents except 
aztreonam, to which it was resistant, and erythromycin, for 
which the result could not be calibrated. 
F. elegans DSM 527 
This flexibacter differed from typical Flavobacterium 
strains in being very susceptible to gentamicin. It was also 
susceptible to ampicillin, ticarcillin, cefoxitin, cefuroxime, 
cefotaxime, ceftazidime, sulphamethoxazole, and 
chloramphenicol. It was resistant to cephalothin, 
cefamandole, moxalactam, cefoperazone, cefsulodin, aztreonam, 
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trimethoprim, and norfloxacin. The erythromycin test was not 
evaluable. A conspicuous feature of this organism was that 
its growth and pigmentation were more conspicuous adjacent 
to the discs containing cefamandole, moxalactam, cefoperazone, 
cefsulodin, aztreonam and trimethoprim. It was not possible 
to determine if the increased pigmentation was merely an 
expression of the increased growth in the presence of 
antibiotics to which the organism was resistant or whether in 
fact the synthesis of pigment was stimulated by the 
antibiotics. 
C. aquatilis ATCC 29551 
This organism, which was tested at 30°C on blood-
supplemented se'nsi test Agar, appeared to be extremely 
resistant to beta-lactam antibiotics with only cefoxitin 
resulting in an inhibition zone. It also appeared to be 
resistant to trirnethoprim and gentamicin. 
C. johnsonae 
Strain ATCC 17061 was susceptible to ticarcillin, 
sulphamethoxazole, erythromycin, chloramphenicol and 
norfloxacin, and ~esistant to all other agents in the disc 
tests except cefoxitin, for which the test was not evaluable. 
Strain NCIB 10150, which was tested at 30°C on blood-
supplemented Sensitest Agar, appeared to be resistant to most 
beta-lactam antibiotics and trimethoprim. 
Other Disc Diffusion Results at 30°c 
The results of all disc tests at 30°C are presented in 
Table 26. There are no interpretive criteria for disc tests, 
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at this temperature and parallel MIC studies were not . 
performed. These tests were performed to provide a comparison 
of 37°C negative and 37°C positive strains. At 30°C there 
appeared to be considerable heterogeneity within Group Ilb and 
amongst the unclassified strains. R40 was the most 
susceptible Group Ilb strain and R45 and U39 were' the most 
resistant in these tests. U33 was the most resistant 
unclassified strain. 
c. Routine 3-Dimensional Results 
Because of the broad beta-lactam resistance of the 
. Flavobacterium strains the 3-dimensional test did not yield 
as much information as expected. In many cases there was no 
inhibition zone around beta-lactam discs or the zone was too 
small to detect 3-dimensional effects. This problem is 
apparent in Figs 8 and 9 where F. breve NCTC 11099 and 
Flavobacterium Rl9 show distinct zone distortions for 
ampicillin, ticarcillin and cefoperazone·but the zones for 
cephalothin, cefotaxime and cefuroxime are not quite larg~ 
enough to readily discern enzymatic drug inactivation. 
Cefamandole inactivation can ·only just be detected. The 
inability of the routine 3-dimensional test to detect many 
drug inactivations is confirmed in the 3D+CL tests (Table 32) 
in which both strains clearly inactivated cephalothin, 
cefoxitin and cefotaxime. 
Where inhibition zones were large enough to detect 3-
dimensional effects there was evidence of beta-lactamase 
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.' 
Fig. 8. Circular 3-dimensional inoculation. Zone 
distortions suggest that!.· breve NCTC 11099 
can readily inactivate the penicillins 
ampicillin (AMP) and ticarcillin (TIC), and to a 
limited extent cefoperazone (CFP) and perhaps 
cefotaxime (CTX). The small zones for CTX, 
cefamandole (MA' and cephalothin (KF) restrict 
the utility of the technique. 
Fig. 9. Flavobacterium Rl9 is capable of inactivating 
TIC, AMP, CFP and MA (note the flattening of the 
MA zone near the circular 3-dimensional 
inoculation). Zone sizes are too small for 
conclusions about KF and cefuroxime (CXM) 
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mediated inactivation of ampicillin, ticarcillin, cefamandole, 
cefoxitin and cefoperazone (Table 29). 
d. Special 3-Dimensional Tests (Including 3D+CL Technique) 
Since the utility of the 3-dimensional test was somewhat 
nullified by small inhibition zones in many of the routine 
disc tests (Tables 25 and 26), it was necessary to devise a 
more sensitive test to investigate the beta-lactamases of 
flavobacteria. To investigate the effectiveness of 
3-dimensional testing in detecting a range of known beta-
lactamases, each of the beta-lactamase-producing antibiotic 
reference strains was tested against a panel of beta-lactam 
antibiotics similar to that used in the disc tests. 
Ticarcillin was however replaced by carbenicillin which was 
found to be more beta-lactamase resistant and therefore a more 
discriminatory substrate. Three additional antibiotics were 
included - cephaloridine, cloxacillin and imipenem and 
cefsulodin was deleted. The antibiotic reference strains were 
tested by the more sensitive 3-dimensional technique ·in which 
either E. coli ATCC 25922 or S. aureus ATCC 25923 were used as 
assay organisms while the test strain was used for the 3-
dimensional inoculation (Figs 10 and 11). 
The results of this series of tests, which are presented 
in Table 30, indicated the 3-dimensional test distinguished 
characteristic patterns by which the reference beta-lactamases 
might be classified. No attempt was made to determine if· the 
patterns were solely enzyme-determined or whether other host 
cell activities also contributed to the effect. 
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TABLE 29 
Numbers of Strains Demonstrating Antibiotic Inactivation 
In Routine 3-Dimensional Tests 
(Results from Tables 25 and 26) 
Antibiotics * 
Tax on AMP TIC MA FOX CFP 
F. breve 1/3 1/3 1/3 0/3 1/3 
F. gleum 0/6 0/6 0/6 1/6 4/6 
F. meningosepticum 0/21 2/21 1/21 0/21 0/21 
F. multivorum 1/15 6/15 0/15 0/15 1/15 
F. odoratum 3/9 1/9 0/9 0/9 0/9 
F. spiritivorum 0/5 2/5 0/5 0/5 0/5 
F. thalpophilum 0/3 0/3 0/3 0/3 0/3 
Group Ilb 0/28 0/28 0/28 10/28 8/28 
Unclassified 3/11 3/11 0/11 0/11 1/11 
* 
AMP - ampicillin 
TIC - ticarcillin 
MA cefamandole 
FOX - cefoxi tin 
CFP - cefoperazone 
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Fig. 10. 
Fig. 11. 
0 Special' 3-dimensional test with lawn of 
susceptible strain of !· coli (ATCC 25922) as 
assay organism and!· coli MISC 100, which 
produces Richmond and Sykes Class IIIa (TEM) 
beta-lactamase, in the straight-line 3-
dimensional inoculation. The stability of 
moxalactam (MOX) and vulnerability of 
ampicillin (AMP) to the TEM beta-lactamase are 
apparent from the zone margins adjacent to the 
3-dimensional inoculation. 
K. pneumoniae MISC 99, which produces a 
Richmond and Sykes Class IVa beta-lactamase, 
demonstrates powerful broad spectrum hydrolytic 
activity by inactivating ticarcillin (TIC) and 
cefuroxime (CXM). The assay organism is the 
same strain of E. coli as in Fig. 10. 
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TABLE 30 
Antibiotic Inactivations Detected Using 3-Dimensional 
Technique Modifie~~ Increase Sensitivity: 
Antibiotic Reference Strains 
-------------------------------------------------------------------
STRAIN ENZYME: ANTIBIOTIC 
CODE TYPE*: AMP CAR KF FOX MA CXM MOX CTX CFP GAZ ATM CR OB IPM 
-------------------------------------------------------------------
MISC 99 I Va + + + + + + + - + + 
MISC 100 TEM + + + + + + + 
MISC 101 lb + - + + + + - + 
MISC 102 la - + + + - + -
MISC 103 IVb + + + + + + - + 
MISC 104 Ila + + -
MISC 105 TEM + + + + + - + + 
MISC 111 la + - + + + + - + -
MISC 112 
MISC 119 TEM 1 + + + + + - + -
MISC 120 TEM 2 + + + + - + + 
MISC 121 OXA-1 ..;. + 
MISC 122 OXA-2 - + + + + - + +/-
MISC 123 OXA-3 + + + + +/-
MISC 124 PSE-1 + + 
MISC 125 PSE-2 + + 
MISC 126 PSE-3 
MISC 127 HMS-1 + + + + + - + + 
MISC 128 SHV-1 + + + - + 
MISC 130 PSE-4 + + -
164 CD Id + + + +/- + 
------------------------------------------------------------------
* Enzyme nomenclature: Roman numerals indicate Richmond 
and Sykes nomenclature. Terms which are generally 
associated with particular substrate profiles have been 
used for plasmid-mediated beta-lactamases 
+/- Weakly positive result of unreliable reproducibility 
Antibiotic Symbols 
AMP - ampicillin CTX .- cefotaxime 
CAR - carbenicillin CFP - cefoperazone 
KF - cephalothin GAZ - ceftazidime 
FOX - cefoxitin ATM - aztreonam 
MA - cefamandole CR - cephaloridine 
CXM - cefuroxime OB - cloxacillin 
MOX - moxalactam IPM - imipenem 
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Although the more sensitive 3-dimensional technique was 
potentially useful for investigating the substrate profiles of 
beta-lactamase producing bacteria it was unsatisfactory 
because it yielded negative results for strain MISC 126 which 
produces the PSE-3 beta-lactamase. This beta-lactamase could 
however be detected by the clover leaf test. The clover leaf 
test on its own was also unsatisfactory because it failed to 
detect cephaloridine inactivation by the OXA-1 beta-lactamase 
of MISC 121 and cloxacillin inactivation by the OXA-2 beta-
lactamase of MISC 122. This information was provided by the 
3-dimensional test. It was therefore necessary to combine the 
two techniques (i.e. 3D+CL technique) to maximize the 
sensitivity of these investigations (Tables 31, 32, Fig. 12). 
The 3D+CL technique provided distinctive profiles for both 
the beta-lactamase reference strains and the study strains. 
Strain MISC 112, the 'enzymeless' control was negative for all 
substrates. The penicillinase producer MISC 104 was positive 
only for penicillin substrates. Cephalosporinase producers 
MISC 101, MISC 102, MISC 111 and 164CD inactivated a range of 
cephems and only one penicillin, ampicillin. Richmond and 
Sykes Class IV broad spectrum beta-lactamase producers, MISC 
99 and MISC 103, inactivated a wide range of substrates 
including carbenicillin and cefuroxime. Arbitrary 
interpretive criteria were developed from Table 31 to 
interpret the 3D+CL results. Penicillinase activity was 
regarded as demonstrable activity against either ampicillin, 
carbenicillin or cloxacillin. Since many of the strains 
showing penicillinase activity according to this criterion 
also showed activity against cephaloridine and/or cefoperazone 
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TABLE 31 
Antibiotic Inactivations Detected by Combination of 
3-Dimensional and Clover Leaf (3D+CL) Techniques 
Antibiotic Reference Strains 
STRAIN ENZYME: ANTIBIOTIC 
CODE TYPE : AMP CAR KF FOX MA CXM MOX CTX CFP GAZ ATM CR OB IPM 
MISC 99 
MISC 100 
MIS<; 101 
MISC 102 
MISC 103 
MISC 104 
MISC 105 
MISC 111 
MISC 112 
MISC 119 
MISC 120 
MISC 121 
MISC 122 
MISC 123 
MISC 124 
MISC 125 
MISC 126 
MISC 127 
MISC 128 
MISC 130. 
164 CD 
IVa 
TEM 
lb 
la 
IVb 
Ila 
TEM 
la 
TEM 1 
TEM 2 
OXA-1 
OXA-2 
OXA-3 
PSE-1 
PSE-2 
PSE-3 
HMS-1 
SHV-1 
PSE-4 
Id 
+ + + 
+ + + 
+ + 
+ 
+ + + + 
+/- + +I- + 
+ + + 
+ + 
+ + 
+ + + + 
+ + + + + 
+ + + + 
+ + + 
+/- + + 
+ + +/- + 
+ +/- + +/- + 
+ + 
+ - +/-
+ + + - +/- +/-
+ + + + 
+ + + + 
+ + 
+ + +/- + + 
+ + 
+ 
+ + 
- +/- + 
+ 
- +/- + 
+ + 
+ 
+ 
+ + 
+ 
+ 
+ 
+ 
+ 
+ 
+/-
+ + 
+ + 
+ + 
+ +/-
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ 
+ +/-
+ +/-
- +/- -
+ 
+ + 
+ 
+ a 
+/-
Antibiotic Symbols 
AMP - ampicillin 
TIC - ticarcillin 
KF - cephalothin 
FOX - cefoxitin 
MA - cefamandole 
CXM - cef uroxime 
MOX moxalactam 
CTX - cefotaxime 
CFP - cefoperazone 
GAZ - ceftazidime 
ATM - aztreonam 
CR - cephaloridine 
OB - cloxacillin 
IPM - imipenem 
+/- weakly positive result of unreliable reproducibility 
a the assay strain for the cloxacillin test was inhibited 
by Strain 164 CD 
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Fig. 12. 
Fig. 13. 
3D+CL test for cloxacillin. Assay strain is S. 
aureus ATCC 25923 and test strain in straight-
line 3-dimensional inoculation (almost no 
surface growth visible) and clover leaf 
inoculation (thick line of growth on surface of 
agar) is !· meningosepticum NCTC 10016. 
Indentations are more obvious for the more 
heavily inoculated clover leaf component of the 
test the for the 3-dimensional .component. 
3-dimensional tests involving Group Ilb MP 616 
~~d (from left) cefuroxime (CXM) and cefoxitin 
(FOX), cephalothin (KF) and cefoxitin, and only 
cefoxitin. Zone margin distortions are obvious 
only in the two-disc tests. 
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TABLE 32 
3D+CL Tests for Taxonomic Reference Strains 
and Selected Study Strains 
Substrate 
Organism AMP KF CAR FOX IPM TEM CR CFP CTX OB 
F. breve 
NCTC 11099 + + +* +* +* + +/- + + 
NCTC 11162 + + +/- + + 
U31 +/- + + + + + 
!.· gleum 
NCTC 10795 + + 
NCTC 11432 
U62 + + +/- + + 
R48 + 
R49 +/- + + 
R56 + + + 
!.· meningosepticum 
NCTC 10016 + + + +/- + + 
NCTC 10585 + + + +/- + 
R58 + + + + + +/- + 
MP816 + +/- + + + + 
MP819 + + + 
MP894 + + + + + 
MP969 + + +/- +/- +/- + 
MP970 + + + 
MP1702 + + + + +/- + + + + 
MP1742 + + + + + + + 
MP2347 + + .+ + + 
MP2348 + + + + + +/- + 
F. multivorum 
NCTC 11033 + 
NCTC 11343 + 
MP1177 + 
MP1210 - +/-
MP2324 
F. odoratum 
NCTC 11036 
NCTC 11179 
NCTC 11180 + + 
R25 + +/- + + + 
R59 + +/- +t- + + + 
U59 
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TABLE 32 (Continued) 
Substrate 
Organism AMP KF CAR - FOX IPM TEM CR CFP CTX OB 
F. spiritivorum 
-
NCTC 11386 +/- + 
NCTC 11387 + + 
R41 +/- + 
R51 +/- +/- + 
F. thalpophilum 
-
MP997 +'- + 
MP1207 +/-
MP1232 
Group Ilb 
R34 + + 
R46 +/- + 
R47 + + + + 
R50 +/- - +/-
R54 + +/-
R862 + + 
U58 + + + + + 
MP7 + + 
MP8 + +/- + +/- + + 
MP305 +/- + + + 
MP525 + + + + + + 
MP547 + + + + + + 
MP548 + + + + + + + 
MP582 + + 
MP592 + + + + + + 
MP616 + + + 
MP628 + + + + + + + 
MP639 +/- + + + 
MP1098 + + + + 
MP1409 +/- + + + + + + + 
MP1846 +/- + + + + - +/-
Unclassified 
U33 
RS + + 
Rl9 + +_ +* +~" -·k + + + 
!.· aquatile 
NCIB 8694 
"F. tirrenicum" 
ATCC 15997 
194 
TABLE 32 (Continued) 
Substrate 
· Organism AMP KF CAR FOX IPM TEM CR CFP CTX OB 
~· aquatilis 
ATCC 29551 + + + 
c. johnsonae 
-
NCIB 10150 + + + 
ATCC 17061 + 
F. elegans 
-
DSM 527 
+/- weakly positive result 
* 
test result reproduced 
AMP Ampicillin 
KF Cephalothin 
CAR Carbenicillin 
FOX Cefoxitin 
IPM Imipenem 
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+ + + + 
+ + + + 
+ +/- + 
of unreliable reproducibility 
five times 
TEM Temocillin 
CR Cephaloridine 
CFP Cefoperazone 
CTX Cefotaxime 
OB Cloxacillin 
these two cephalosporin substrates were regarded as 
insufficiently discriminatory to reliably indicate 
cephalosporinase activity. Cephalothin however appeared to be 
resistant to penicillinase activity and was regarded as a more 
reliable substrate with which to identify eephalosporinase 
activity. 
Most Flavobacterium 3D+CL patterns differed from those 
of the antibiotic reference strains suggesting that either the 
genus produced different beta-lactam.ases or that the patterns 
reflected the activities of multiple enzymes. This 
possibility is suggested by the IEF patterns (Table 36). 
Cloxacillin inactivation was a distinctive feature of the 
genus (84% of strains positive) and some strains produced 
positive 3D+CL results for cefotaxime (45%), cefoxitin (39%) 
and positive to marginally positive results for imipenem 
(19%). No strains appeared to be capable of temocillin 
inactivation in these tests. 
F. breve was heterogeneous in the 3D+CL tests and 
comparison of the F. breve 3D+CL patterns with those of the 
antibiotic reference strains suggested that the beta-
lactamases of the species were unlike the reference beta-
lactamases. Strain NCTC 11099 appeared to have the greatest 
enzymatic activity , exhibiting very broad spectrum activity 
against substrates such as ampicillin, carbenicillin, 
cloxacillin, cephalothin, cefoxitin, cefotaxime and imipenem. 
NCTC 11162 appeared to have predominantly penicillinase 
activity with positive 3D+CL results for ampicillin, 
carbenicillin, cloxacillin, cephaloridine and borderline 
activity against cefoxitin. The U31 beta-lactamase showed 
broad spectrum activity by the 3D+CL technique but with only 
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minimal penicillinase activity against ampicillin and no 
activity against carbenicillin compared to its stronger 
activity against cloxacillin. This strain also inactivated 
cefotaxime and imipenem. 
The gtrains of !· gleum showed considerable heterogeneity 
in the 3D+CL tests and none of the 3D+CL profiles were similar 
to those of the reference antibiotic strains. The negative 
results for NCTC 11432 preclud~d definite conclusions 
about its beta-lactamase. NCTC 10795, U62 and R49 inactivated 
cefoxitin, although in the case of U62 the level of 
inactivation appeared to be at the threshold of sensitivity of 
the technique. U62 and R56 inactivated cefotaxime. All 
strains except NCTC 11432 inactivated cloxacillin but only U62 
inactivated ampicillin. 
Eleven of the twelve strains of !· meningosepticum 
exhibited broad spectrum beta~lactamase activity with nine of 
the strains exhibiting activity against cefotaxime and/or 
cefoxitin. In general the beta-lactamases of F. 
meningosepticum appeared to be broader in spectrum than those 
of !· gleum with some strains inactivating carbenicillin, 
cephaloridine and cefoperazone. The 3D+CL tests were all 
negative for these substrates for !· gleum. In the strains 
tested it also appeared that!· meningosepticum possessed 
greater activity against cephalothin than either!.· gleum or 
Group IIb. An interesting feature of the 3D+CL tests was the 
clearly greater activity of the strains against cephalothin 
than against cefoperazone which is more vulnerable to 
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hydrolysis by most beta-lactamases. 
Most of the !· meningosepticum 3D+CL profiles were 
sufficiently different from those of the reference antibiotic 
strains to indicate that they were distinctly different beta-
lactamases. However the profiles for NCTC 10016, MP816, 
MP894, MP969 and MP969 could not be distinguished from those 
of the reference strains by 3D+CL testing. (For these strains 
it was necessary to consider the results of the inhibitor 
studies and isoelectric focussing in conjunction with the 
3D+3CL results to determine that all but strain MP816 
contained beta-lactamases which were different from the 
reference beta-lactamases. It was not possible however to 
exclude completely the possibility that MP816 contained the 
plasmid mediated OXA-2 beta-lactamase). 
The most active strain appeared to be MP1702 which had 
positive 3D+CL results for ampicillin, carbenicillin, 
cloxacillin, cephalothin, cephaloridine, cefoperazone, 
cefoxitin, cefotaxime and an equivocal result for imipenem. 
This strain appeared to belong to a group of strains (R58, 
MP1702, MP1742, MP2347 and MP2348) capable of inactivating 
carbenicillin and cefoxitin and/or cefotaxime as well as other 
more labile substrates. 
All strains of!· multivorum except MP2324 showed activity 
against only cloxacillin in the 3D+CL tests. In the routine 
3-dimensional tests however inactivation of ticarcillin was 
indicated for strains R42, MP1170, MP1210, MP1213, and MP1231 
while strain MP1177 appeared to inactivate both ampicillin and 
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ticarcillin. (The occasionally greater sensitivity of the 
routine 3-dimensional test, which appeared to arise from a 
synergistic effect of different beta-lactam antibiotics, is 
discussed elsewhere). 
The 3D+CL tests provided three different profiles of 
results for the F. odoratum strains. Strains NCTC 11036, NCTC 
11179 and U59 were negative for all substrates. NCTC 11180 
showed apparent penicillinase activity against ampicillin and 
cloxacillin. Strains R25 and R59 showed broad spectrum 
activity which extended to cefoxitin and cefotaxime. R59 was 
the only strain which had a 3D+CL pattern resembling a 
reference strain pattern, showing similarity to the OXA-3 
pattern. 
The four strains of !· spiritivorum exhibited 
activity against cloxacillin and cefotaxime. The activity 
against cefotaxime was only borderline for three of the four 
strains. Strain R51 appeared also to exhibit borderline 
activity against ampicillin. 
The three strains of F. thalpophilum were heterogeneous in 
the 3D+CL tests with MP1232 failing to exhibit beta-lactamase 
activity and MP997 and MP1207 exhibiting weak broad spectrum 
beta-lactamase activity. The 3D+CL patterns of MP997 and 
MP1207 were different from the patterns of the antibiotic 
reference strains. 
The 3D+CL patterns for the 21 strains of Group Ilb were 
heterogeneous. All strains exhibited inactivation of 
cloxacillin. Two strains, R862 and MP7, exhibited apparent 
penicillinase activity only with positive 3D+CL results· for 
ampicillin and cloxacillin. The other 19 strains produced 
broad spectrum beta-lactamases according to the 3D+CL tests, 
with 17 of the 19 strains showing activity against cefoxitin, 
cefotaxime and/or imipenem. None of the 3D+CL patterns for 
Group Ilb resembled the patterns of the antibiotic reference 
strains. Four strains, U58, MP547, MP592, and MP628, appeared 
capable of inactivating carbenicillin and six strains, R46, 
MP305, MP547, MP548, MP1409 and MP1846, appeared to inactivate 
imipenem. 
Of the unclassified strains, Rl9 had a similar 3D+CL 
pattern to !· breve NCTC 11099, strain R5 inactivated only 
cefotaxime and cloxacillin, and U33 was negative in all 3D+CL 
tests. R5 was therefore identical in these tests to Group Ilb 
strain R34, and F. spiritivorum strains NCTC 11386, NCTC 11387 
and R41. 
F. aquatile, "!.· tirrenicum", and!.· elegans were negative 
in all 3D+CL tests. The cytophagas, _g_. aquatilis and C. 
johnsonae, appeared to be very similar to many of the 
Flavobacterium strains in the phenotypic expression of beta-
lactamases with ability to hydrolyse carbenicillin, 
cloxacillin and cefotaxime and other more labile substrates. 
It was interesting that sometimes the routine 3-
dimensional test appeared to be more sensitive than the 3D+CL 
test. This phenomeno~ occurred only when more than one 
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antibiotic was being tested by the 3-dimensional test but only 
one antibiotic was being tested by the 3D+CL method. This 
effect is demonstrated clearly in Fig. 13 in which the 
cefoxitin 3-dimensional test is negative when only cefoxitin 
was tested against strain MP616 of Group Ilb but was positive 
when either a cephalothin or a cefuroxime disc was placed 
adjacent to the cefoxitin disc. When the plates were flooded 
with nitrocefin solution (50 mcg/ml) a red positive reaction 
only occurred around the cephalothin and cefuroxime discs. 
This indicated that these drugs may have caused beta-lactamase 
leakage and thus may have synergistically contributed to a 
positive 3-dimensional test. I 
-- -- - _ _j 
e. Hydrolysis Assays, Inhibitor Studies and Isoelectric 
Focussing Patterns 
Table 33 lists the results obtained with the antibiotic 
reference strains for (1) hydrolysis assays using penicillin, 
cephalothin and cefoxitin as substrates, (2) cefoxitin 
induction studies, and (3) inhibition studies using 
cloxacillin and lithium clavulanate. These tests provide 
sufficient in.formation to determine the broad substrate 
profiles of the beta-lactamases (i.e. penicillinases, 
cephalosporinases or broad spectrum beta-lactamases), and 
whether or not the enzymes belong to Class I of the Richmond 
and Sykes Classification of beta-lactamases (i.e. resistant to 
' 
clavulanate and, usually, inducible). The cefoxitin 
hydrolysis assays were performed on five strains (selected on 
the basis of 3D+CL tests) and induction studies were performed 
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on three organisms known to possess Class I beta-lactamases. 
One of the three organisms was fully derepressed for beta-
lac tamase production and therefore not inducible. 
To simplify determination of substrate profiles the ratio 
of the penicillin:cephalothin hydrolysis rates was calculated. 
This ratio does not have absolute meaning because of the 
different methodologies used to assay penicillin and 
cephalothin hydrolysis. However it proved to be a convenient 
means by which to compare different enzymes irrespective of 
the amount of enzyme synthesized by the host bacterium. The 
interpretive criteria for the ratios are provided at the 
bottom of Table 33. 
The isoelectric points presented in Table 34 generally 
agreed with published pl values for these strains. The 
activity of the OXA-1 and OXA-2 beta-lactamases was very low 
and the OXA-1 beta-lactamase could not be reliably detected. 
The results of hydrolysis assays using penicillin and 
cephalothin as substrates for selected study and taxonomic 
reference strains are presented in Table 35. If the criterion 
of inducibility is taken to be at least a three-fold increase 
in the hydrolysis rate for cephalothin, none of the study 
strains was found to produce an inducible beta-lactamase. 
The hydrolysis ratios indicated that the beta-lactamases 
of the study and taxonomic reference strains were mainly 
cephalosporinases or broad spectrum beta-lactamases with 
predominantly cephalosporinase activity (Table 35). The beta-
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.DRJIANISll ENZYl!E 1NDUCED I lMHIJIJED STR41N 
tDDE 
HYDROLYSIS RATE • 
SUBSTRATE5-~ ffYJIRDL YSIS BY 
MISC 99 
MISC_ 100 
MISC 101 
MISC 102 
llISC 102 
llISC 103_ 
. MISC 104, _ 
MISC 105 
MISC 111 
MISC 111 
IUSC 112 
_ MISC 112 
lllSC 119 
MISC 120 
MISC 121 
MISC 122 
llISC 123 
l!ISC 124 
MISC 125 
llISC 126 
llISC 127 
MISC 128 
MISC 130 
164 CD Ill 
164 CD 121 
164 CD 131 
164 CD 14l 
·!• pntUIDftiU 
t• coli 
~. ill! 
t. illlli! 
E • .cloacae 
---
·- !·- pneu1oniae 
f•. 1irabiUs 
!· pnt111oniae 
~·_cloacae P99• 
E._ cloacae p99• 
IV l 
111 a H£MI . -_ _ - _ 
l b 
l i 
l i 
lVb 
lI a 
Ill a H£111 
I a 
I a 
yes 
yes 
~· ~ p99- lacks enzyll! -
~· ~ p99-_ lacks enzyae yes 
t• coli lll ITEM 11 
t. COli 
~· ~ 
t· .ill! 
_t. coU 
f. aeruqinosa 
f. aeruqinosa 
f. aeruqinosa 
t• CDli 
t. col i 
f._ aeruqi nosa 
f. aeruqinosa 
f.. aer.uqinosa 
f. aeruqinosa 
f._aeruqinosa 
III ITEll_2J 
V IOXA-11 
V IOXA-21 
V IDXA-31 
lll IPS£-1l 
V IPSE-21 
Ill tPS£-31 
lll IHllS-.ll 
III ISHV-.ll 
III IPSE-41 
I 
l 
l 
I 
•Hydrolysis rate ln U1ol./min./19. protein 
2,810 - . 
17.,380 -
1,zso . 
'110,_ 
M.T.** 
-- 99 .B 
557 
556 
356 
M. T. 
6.8 
H. T. 
3,550 
121 080 _ 
1/JO 
33.6 
26.2 
2, 9l:iO 
50.9 
/JO 
1,090 
5,580 
31220 
3,540 
3,450 
1,950 
3,000 
KF~ Foxe RATIO 
34.6 
103.8 
m.1. 
261.1 
1640.3 
9.1 
4.3 
4.6 
494.4 
406.8 
1.2 
3.3 
54.9 
420.0 
"3.5 
81.2 
1b7.4 
4.0 --3.4 
0.4 
11.0 
129~5 
120.9 
0.7 
M.D,1ttt 
64.7 
28.8 
45.7 
3.4 9.9 
3.1 N.D. 8.5 
5.4 
3.0 
2.9 
l:i.b 
34.7 
5.0 
20,678.3 
18,488.3 
17,404.8 
. 171 692.D 
N.D. 548.1 
17.0 
20.7 
165.2 
160..S 
644.0 
3.2 0.2 
D.2 
0.1 
0.2 
~ Not tested lor activity on lEF too Meak to ~eterline jnhibition prof ilel 
.... Mo hydrolysis detected 
• Penicillin, a. Cephalothin, c Cefoxi'tin 
I Hydrolysis Ratio = Penicillin Jlydtolysis Rate 1x10-3 J 
tephalothin Hydrolysis Rate IUninducedl 
VALUES DERIVED FROM THE ABOVE TABL~: 
fil!1m TYPE HYDROLYSIS ~ 
CEPHALCSPORINAS£ !CLASS II LESS THAN 4 
POSSIBLE CEPHALOSPDRINASE 4 to 6 
PDSSI~LE .BROAD SPECTRUM -" to a 
BR~AD SPECTRUn ICL~SS lllJ .20 tc 644 
!l!OAD SPECTRUI! !CLASS IVJ . _ 11 iD 82 
!ROAD SPECTRUM ICL~SS Vl B to 46 
P£NICILLlNASE JCLASS lll -129.5 
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c 
?t 
?llS 
JS 
BS 
llS 
p 
CLOX CLAV 
+ 
+ 
N.T. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
N.l. 
+ 
+ 
+ 
+ 
+ 
+ 
TABLE 34 
Results of Isoelectric Focussing Studies 
for Beta-lactamase Reference Strains 
ENZYME SOURCE 
MISC 99 
MISC 100 
MISC 101 
MISC 102 
MISC 103 
MISC 104 
MISC 105 
MISC 111 
MISC 119 
MISC 120 
MISC 121 
MISC 122 
MISC 123 
MISC 124 
MISC 125 
MISC 126 
MISC 127 
MISC 128 
MISC 130 
164 CD 
K. pneumoniae 
E. coli 
E. coli 
E. cloacae 
K. pneumoniae 
P. mirabilis 
K. pneumoniae 
E. cloacae P99 
E. coli 
E. coli 
E. coli 
E. coli 
E. coli 
P. aeruginosa 
P. aeruginosa 
P. aeruginosa 
E. coli 
E. coli 
P. aeruginosa 
P. aeruginosa 
BETA-
LACTAMASE 
RSG\. ON& 
I Va 
Illa TEM 
lb 
la 
IVb 
Ila 
Illa TEM 
la 
III TEM-1 
III TEM-2 
V OXA-1 
V OXA-2 
V OXA-3 
III PSE-1 
V PSE-2 
III PSE-3 
III HMS-1 
III SHV-1 
III PSE-4 
I 
~ Richmond-Sykes nomenclature 
b Other name for beta-lactamase 
c Agarose gel used for IEF 
d Polyacrylamide gel used for IEF 
e Beta-lactamase not detected 
pl VALUES 
OTHER 
STUDIES 
THIS 
STUDY 
(A)c. (A)c (P)<i 
7.7 
5.6 
8.7 
8.5 
5.5 
6.4 
5.6 
7.9 
5.4 5.3 
5.6 
N. D.e 
3 
3 
7. 5 7. 6~ 
7.8 7.8 
7.1 7.2) 
5.7 5.5.; 
6.1 6.o• 
N.D. 6.8~ 
4.8 4.2:? 
4.8 3 
7. 6 7. 72-
5. 2 5. 2.3 
8.3 
7.6 
8 o 2 I ~'c 
5.4 1 
5. 6 :>. 
7.4~ 
7.5 
7.7 3 
8.0S" 
7 .1~. 3 
5. 7 ""·:; 
6 .1 ,_,, 
6. 9 :>.,.3 
5. 2 :i,J 
7. 6 ~. 3 
~.3 5.3 
8 4 Ii-
. ~ 
7.5 
* Superscripted figures refer to the following references: 
(1) Bush et al. (198J) 
(2) From Matthew (1979) 
(3) Vecoli et al. (1983) 
(4) Gates e~aI:'" (1986) 
(5) Labia et al. (1986) 
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lactamase preparations of !· meningosepticum and Group IIb 
were generally more active than those of the other species. 
Cefoxitin hydrolysis assays were performed on strains which 
appeared to inactivate the drug in 3-dimensional or 3D+CL 
tests. 
Penicillin hydrolysis assay results were far more variable 
than cephalothin hydrolysis results. This is 'apparent from 
the four sets of results for!· meningosepticum R58. Whereas 
the cephalothin hydrolysis results are similar in magnitude 
the rate of hydrolysis of penicillin by enzyme preparation 1 
is more than ten times greater than that of preparation 2. 
Several possible explanations may be offered. In the case of 
strain R58 the IEF results indicated the presence of multiple 
beta-lactamase bands (Table 36), some of which may have been 
responsible for penicillinase activity but have been inactive 
at the time preparation 4 was tested for penicillin 
hydrolysis. In the case of!· spiritivorum strains NCTC 11386 
ano NCTC 11387 grew very poorly at 35°C in MHB and required 
7.5 hours of shaking incubation to produce reasonable pellets 
for sonication. The cell-free preparations of these two 
strains were less active in the penicillin hy~rolysis assays 
than that of strain R41. Other strains which also grew poorly 
were!· breve U31, F. odoratum U59, NCTC 11179 and NCTC 11036, 
and F. gleum U62. 
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~1.r s.in,_a s.n& §.s:l.s.cte& St u.Q.y - S tr E:.i..!1.E. 
----------------------------------------------------------------------------------
STRf.IN CRGAt:!El~ HYDROLYSIS 1!A1£• HYDRO-
.CDDE - .SUBSTRATES' . .. 11'SIS· INTERPRET-Y . 
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-
pi. Kfo:: . Kfl• FOX• RATI011 ATION 
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-
---------------------------------------------------------------------------------
- -- - ' -- --- -
NCTt .11D99·-.:-: -:.-_:f.~-"'::_,,, __ -:·:- .2&.B-o 'l.;!I :<3.2·· .. Y 6.4 ?BS 
- NCTC 11162 .. I .'..50., . 4.7-. 9.L. N.D. 10,.7 -- JS 
-- - - -
- UJ! ·. _ :37,.8. 13.1. :ll.Oo __ N.T. ·1,9 c 
NCTC 11432 · .. ~. gleuL __ -__ .. __ _ 69~D- 16 • .6 22.6 10.5. '1.2 . ?C 
u 62. 33.4 15.7 27.l 4.0 .2.l L 
NCTt 10016 I. •eni 119ose~ tit:l!ll . ..39 .• 1 50.B n.-5 N.D. 0.8 c 
NCT.C 1D51!5 .24.2 27.5--18.:3 .6.2 1.2 c 
U8 Ill 295.0. 32.9 .. 11.9 M. T. . 9.0 BS 
l2l .23.l ":30.:3 12.l N. T. 0.8 c 
13) 66.5 30.7 2Q.1J 11.8 2.2 c 
141 ll2.0 15.6. 17.6 N. T. 4.4 ?C 
llP 816. 72.2 61.0. M.T. 10.9- 1.2 t 
llP .819 I, -316.4 95.6 N.T .. N.ll. 3.3 c 
MP 894 66.9 52.5 N. T. 7.5 1.3 c 
llP 9.69 54.l ii5 • .1 N. l. 11.4 0.8 c 
MP 970 55 • .1 35.6 N. T. 12.7 1.5 c 
llP 1702 .5D.1 17.5 N.T. 11.9 1.8 c 
llP 1742 56.3 30.5 ·N. T. 3.5 1.8 c 
llP .1348 49,5 15.8 N.l. 7.9 1.9 c 
NCTC 11033 f. •ultlvim111 .. 27.7 2.6. 0.8 N. l. 10.7 J!S 
NCTC 11343 I 11.8 2.7 4.2 N. T. 4.4 !C - .. 
llP J21D 4.5 .1.7 2.3 N. T. 2.6 ,. ~ 
llP 2324 1L2 .8.3 1.7 N.T .. .l .. 3 .c 
N.ctC 11036 -I·~---. ll..6 .lD...1 .2.5 K.T. 1.8 c 
NCTC 11179 1.6..6 12.3 15.8 K. T. l.4 c 
NCTt .11180 11.9. 2.4 4.0 N.ll. 5.0 ?C 
u 59 7.4 2.7 3.6 N. T. 2.7 c 
ins 11.B .3.8 1.7 N. T. 4.7 ?C 
R 59 Ul 19.2 .11.0 ii.9 N.D. 1.7 c 
121 .37 .. .2 B • .2 8.6 4.S ?C 
NC1C 11386 111• .E• sp1ritivor111_ 15.5 2.B 2.6 M.T,9 5.4 ?C 
121 8.6 1.3 2.2 N.T .. 6..6 ?J!S 
me .11387 Ill lD.J "J.B -3.2 N. T •. · 2.9 c 
121 947 3.0 2.0 N.!. 3.2 c 
1t 41 .38.1 .2.:5 .l.D N.T .. 15.2 BS 
llP 1207 f • lll&lQDQllilUI .. 32.l 5.4. 5.6. N. T. 5.9 ?C 
KP 1232 46.6 7.0 7.8 N. T. 6.7 7B~ 
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I£2gbg ~~ <continued> 
----------------------------------------------------------------------------------
STRAIN ORGANISM HYDROLYSIS RATE• HYDRO-
CODE SUBSTRATES LYSIS INTERPRET-
pb KFc KFI• FOX• RATIO•x ATION 
tx10-:.1 
---------------------------------------------------------------------------------
u -58 Group Ilb 46.3 11.5 6.JJ N.T. 4. 0 ?C 
R 34 18.0 8.4 N. T. 2.7 2.1 c 
R 46 65.2 23.3 N. T. 20.9 2.8 c 
R 47 "39.5 26.3 N. T. 25.6 1.5 c 
R 862 32.1 10.B N. T. 6.4 3.0 c 
MP 7 20.5 26.B N.T. N.D. o.s c 
l!P 8 73.9 17.8 t:. T. 1.3 4.2 ?C 
llP 305 16.8 -3.D N. T. 2.3 5.6 ?C 
l!P 525 61.4 9.B N.T. N.D. 6.3 'BS 
MP 547 51.9 6.7 N. T. 1.6 7.7 ?BS 
MP 548 103.4 8.1 N.T. tl.D. 12.8 BS 
MP 582 .84.S 10.B li.1. 2.6 7.9 'BS 
MP 592 50.4 9.5 N.T. 10.7 5.3 ?C 
l'IP 616 118.9 3D.7 N.T. 72.9 3.9 c 
i'IP 628 49.9 54.1 N.T. 117.9 0.9 c 
l!P £39 51.9 8.8 Ii. T, N.ll. 5.9 'C 
llP 1098 96.6 9.5 N. T. 3.6 10.2 llS 
11p' 1846 79.4 8.6 K.i. 12.6 9.2 BS 
u l1r.i dent! fled 4.;,9 4.6 12. 0 Ii. T. 9.S BS 
R 19 { 11 Uni~er.hf ied 36.0 6.6 4.8 N.T. 5.5 'C 
121 44.7 5.2 9.2 N.T. 9.0 BS 
l.TCC 15912 'E· t1rrH1r1:;' 6.2 N.!l. N.i. N.D. r.13h ?P 
DS~ 527 E· £1egans 17.5 :.H.O N.T. N.D. 0.6 c 
me 11061 ~· jchnsor1ae 8.8 7.0 tl. T. 3.7 1.3 c 
Nm 10150 6.3 e.o N.T. 11.ll. o.a c 
---------------------------------------------------------------------------------
b 
hy(rolys1s rate in umcl/11nlf9 protein 
per.it! I lln 
~ephaloth1n l!Ulinduced enzy1e preparat:onl 
cephalothin (1nd11ted enzyite preparation! 
e~fo~I tit. 
f1911res 1n parentheses denote d1fierer.t beta-la.c:tamase preparations 
"' not tested 
no hydrolysis detected 
hydrclysis ratio a ptnlc!llln hydrolyE!! rate tx10-~1 
·cep~.alt:thin hydrolysis rate lur.1ndutedl 
INTERPRETATION OF HrllROL~SIS RATlDS BASED ON TABLE 33 
IC = cephilosporinase = <4i ?C = 4 to 6; ?BS = 6 to a; 
P = penic1ll1nase = >1Z9.5i BS = brnad spectru; = B to 6441 
?(')7 
The inhibitor studies (Table 36) indicate that almost all 
the beta-lactamases of these strains were inhibited by lithium 
clavulanate but not by cloxacillin. The exceptions were the 
pl 8.2 band of!.· spiritivorum NCTC 11387, the pl 7.4 band of 
F. multivorum, the pl 8.2 band of!.· thalpophilum, and 
possibly the major band of F. breve NCTC 11162 at pl 7.8 and 
three minor bands at 6.8, 7.3 and 8.4. 
The beta-lactamase isoelectric patterns of the strains 
studied showed considerable yariation in isoelectric points 
indicating differences in the beta-lactamases of the species 
and sometimes differences within the species (Table 36). Some 
strains such as F. meningosepticum NCTC 10585 and R58, and F. 
gleum U62 produced multiple bands, others produced single 
bands, and some produced beta-lactamases which were too 
inactive to detect by IEF. 
Because different sets of IEF apparatus in different 
laboratories were used and because some weakly reactive beta-
lactamase bands were difficult to visualise it was necessary 
to focus enzyme preparations repeatedly (in some cases eight 
times) to obtain reliable comparisons of the pl values. Some 
beta-lactamase bands lost activity during storage at -23oC and 
could not be detected when IEF was repeated at a subsequent 
time. Some bands which lost detectable activity after 7 
months frozen storage were the pl 5.8 band of F. spiritivorum 
R41, the pl 7.4 band of!.· multivorum NCTC 11033 and NCTC 
11343, all bands of _£:.. thalpophilum MP1207 (major band was pl 
5.8), all bands of!.· breve NCTC 11162 (major bands pl 5.8, 
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7.85), all bands of!.· odoratum R59 (major band pI 6.7). This 
phenomenon suggested that the beta-lactamases of at least some 
strains of the genus are not preserved by storage at this 
temperature. It also raises doubts about the values obtained 
in tests such as hydrolysis assays and indicates the 
desirability of working with freshly prepared enzyme 
preparations when studying the beta-lactamases of 
Flavobacterium. (This was not possible in this study owing to 
constraints of time and availability of equipment). 
The possibility of beta-lactamase deterioration is also 
suggested by the appearance of new beta-lactamase bands after 
seven months frozen storage. In Fig. 16 three strains exhibit 
bands not detected with fresher enzyme preparations. The 
strains and new pI values are: 
F. spiritivorum NCTC 11386: pis 5.4, 5.5, 6.9, 7.4 
F. multivorum MP1210: pis 5.4, 5.7, 5.8, 6.5, 6.~, 1·4 
F. multivorum MP2324: pis 5.4, 5.5~ 5.8, 6.5, 6.9 
The new bands were interpreted to be breakdown products. The 
similar pI values and weak nitrocephin activity indicate beta-
lactamase activity and chemical similarity. Whether this 
phenomenon represented breakdown of the initially detected 
beta-lactamase or breakdown of cellular debris to which the 
beta-lactamases were attached was not investigated. 
Another phenomenom which requires investigation is the 
effect of zinc ions on IEF patterns. In Fig. 17 it can be 
seen that when 20 ul of 2 mM ZnS04 was added to 1 ml of the 
beta-lactamase preparation of Group IIb MP1409 there was loss 
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of a minor beta-lactamase band. Similarly ZnS04 was added to 
the preparations of!: meningosepticum NCTC 10016, MP 894, 
MP969, MP970, MP2348 and Group llb MP582 but did not alter the 
IEF patterns. 
The beta-lactamases of F. breve strains exhibited only low 
activity on IEF with none of the beta-lactamase bands being 
detected after less than 45 minutes exposure to nitrocefin and 
beta-lactamase activity not being detected for NCTC 11099. 
This low activity made it difficult to determine inhibitor 
results on the agarose gels. Delayed nitrocephin reactions 
resulted in pre-diffusion of cloxacillin and clavulanate 
overlays thereby decreasing the concentrations of these 
inhibitors in the vicinity of the beta-lactamase bands and 
reducing the selectivity of inhibition of this procedure. 
Strains NCTC 11162 and U31 differed in their IEF beta-
lactamase patterns. NCTC 11162 produced two major beta-
lactamase bands at pl 5.75 and pl 7.85 while U31 produced a 
beta-lactamase at pl 9.3 (approximately). The latter beta-
lactamase could not be sharply focussed making it difficult to 
establish a reliable isoelectric point. This phenomenon, 
which occurred with several of the beta-lactamases in this 
study, has been observed in other studies in which it has been 
attributed to unusually large beta-lactamase molecules or to 
the binding of the enzymes to larger molecules such as 
membrane fragments (Marre ~al., 1982; Medeiros, 1984). In 
this study this type of IEF band had the appearance of a 
diffuse pink blob of hydrolysed nitrocephin and is therefore 
referred to as a 'blobby' beta-lactamase. For such diffuse 
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TABLE 36 
Results of Isoelectric Focussing and Inhibitor 
Studies for Selected Flavobacterium Strains 
------------------------------------------------------------
ORGANISM pI VALUES INHIBITED 
AND BY 
STRAIN CODE MAJOR BANDS MINOR BANDS CLOX CLAV 
------------------------------------------------------------
F. breve 
NCTC 11099 N.D.o... 
NCTC 11162 5.8 t -
7.85 6.8, 7.3, 8.4 .... + 
u 31 (9.3)'" 7.7, 10.05, 10.6 + 
F. gleum 
NCTC 11432 10.6 4.9, 5.2 + 
u 62' 10.6 5.1, 5.9, 6.45, 7.45 - + 
R 49 (9.6)c 7.7 + 
F. meningosepticum 
NCTC 10016 (9.8) 7.7 + 
NCTC 10585 8.6 5.8, 6 .1, 6.75, + 
8.0, 8.2 + 
R 58 8.6 6.75, 8.0, 8.2, 10.6 - + 
MP 816 8.6 6 . f1 ' 7 .1, 7.7 + 
MP 819 7.8 + 
MP 894 (9.8) + 
MP 969 8.6 s.o,5.,;, 6.6, 10.6 + 
MP 970 8.1 6. 6' 7.1 + 
MP 1702 7.9 7. 7' 10.6 + 
MP 1742 7.9 7 .1, 7.6 + 
MP 2348 (9.8) + 
F. multivorum 
NCTC 11033 9.3 + 
7.4 ? ?b 
NCTC 11343 9.2 + 
MP 1210 5.8 7.4 ? ? 
MP 2324 7.4 + 
F. odoratum 
NCTC 11036 7.7 + 
NCTC 11179 7.7 + 
NCTC 11180 5.3 + 
u 59 N.D. 
R 25 (4.9) + 
R 59 6.7 4.9, 5.3, 7.7 + 
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TABLE 36 (continued) 
------------------------------------------------------------
ORGANISM pI VALUES INHIBITED 
AND BY 
STRAIN CODE MAJOR BANDS MINOR BANDS CLOX CLAV 
------------------------------------------------------------
F. spiritivorum 
NCTC 11386 5.8 7 
8.2 + 
NCTC 11387 N.D.a 
R 41 5.8 
F. thalpophilum 
MP 1207 5.8 5.3, 5.6 + 
8.2 
MP 1232 N.D. 
Group Ilb 
u 58 8.2 4.9 
R 34 8.8 7 .1, 7. 7' 8.1 
R 46 8.6 9.2 
R 47 9.2 
R 862 8.5 5.65, 8.25, 9.1 
MP 7 8.6 
MP 8 10.4 
MP 305 10.2 8.3 
MP 525 9.2 
MP 547 9.2 8.4 
MP 548 9.2 7.7 
MP 582 9.2 
MP 592 8.8 
MP 616 8.7 
MP 628 8.6 
MP 639 9.2 
MP 1098 9.0 
MP 1409 9.2 8.4 
MP 1846 10.2 
Unclassified 
R 5 8.6 (9.3), 10.6 
R 19 N.D. 
F. elegans 
DSM 527 8.0 7.6 + 
("!, tirrenicum" ATCC 15922, ~· johnsonae ATCC 17061 and 
NCIB 10150 N.D.) 
N.D.a: no beta-lactamase detected by IEF 
?b inhibitor result equivocal due to delayed 
visualisation of beta-lactamase 
( )c poorly focussed beta-lactamase 
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bands it was not possible to obtain precise isoelectric 
points. 
Clavulanate inhibited the U31 beta-lactamase and the 
beta-lactamase of NCTC 11162 with a pl of 5.75. However 
inhibitor results for the NCTC 11162 beta-lactamase with a pl 
of 7.85 were equivocal, but seemingly more resistant to 
clavulanate than to cloxacillin. Delayed nitrocefin reactions 
such as observed with this band are not sufficiently reliable 
for accurate determination of inhibitor studies by this method 
and a more concentrated enzyme preparation than could be 
prepared in this study is required. 
' Strains NCTC 11432 and U62 of !.· gleum had major bands 
at pl 10.6, while the third strain tested, R49, had a diffuse 
'blobby' band at approximately pl 9.8. 
!.· meningosepticum exhibited five different major beta-
lactamase bands - at pl values of 7.8 (MP819), 7.9 (MP 1702, 
MP1742), 8.1 (MP970), 8.6 (NCTC 10585, R58, MP816, MP969) and 
a 'blobby' beta-lactamase at 9.8 (NCTC 10016, MP984, MP2348). 
F. multivorum was also heterogeneous by IEF with the four 
strains tested having different isoelectric points - NCTC 
11033 (pl 9.3), NCTC 11343 (pl ~.2, probably the same as the 
pl 9.3 band), MP1210 (pl 5.8) and MP2324 (pl 7.4). The latter 
enzyme was resistant to inhibition by clavulanate. Strains 
NCTC 11033 and MP1210 shared a minor band at pl 7.4 which was 
possibly resistant to clavulanate and thus may have been the 
same as that beta-lactamase detected in MP2324. If so, it is 
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probably a chromosomal cephalosporinase of the type thought to 
be produced in small amounts by virtually all bacteria 
(Matthew and Harris, 1976). 
The beta-lactamases of F. odoratum were also 
heterogeneous. Strains NCTC 11036 and NCTC 11179 possessed a 
common beta-lactamase with an isoelectric point of 7.7. The 
beta-lactamase of NCTC 11180 had isoelectric point of 5.3. 
R25 possessed a 'blobby' type of beta-lactamase which did not 
focus to a sharp band and had an isoelectric point of pl 4.9. 
This acidic isoelectric point indicated it was a different 
type of enzyme from the 'blobby' beta-lactamases with alkaline 
pls in !· meningosepticum, !.· gleum and Group Ilb. R59 was 
the only strain of F. odoratum to exhibit multiple beta-
lactamase bands having a major band at pl 6.7 and minor bands 
at pl values of 4.9, 5.3 and 7.7. It was interesting that the 
isoelectric points of these minor bands were identical to 
those of the other beta-lactamases detected in the other F. 
odoratum strains tested. No beta-lactamase bands were 
detected by IEF for strain 059. 
The beta-lactamase preparations of!.· spiritivorum were 
relatively inactive and the beta-lactamase of NCTC 11387 could 
not be detected by IEF. The two other strains included in the 
IEF studies, NCTC 11386 and R41, appeared to share a common 
beta-lactamase which was very similar to that of F. multivorum 
MP 1210. Both NCTC 11386 and R41 shared a beta-lactamase with 
an isoelectric point of 5.8, while NCTC 11386 also possessed a 
second beta-lactamase of pl 8.2. This latter beta-lactamase 
was resistant to inhibition by clavulanate but was inhibited 
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by cloxacillin and was very similar to the cephalosporinase of 
F. multivorum MP 2324. The beta-lactamases of pl 5.8 were 
inhibited by clavulanate but not by cloxacillin. 
Two strains of !.· thalpophilum were included in the 
IEF study, one of which (MP1232) did not produce a beta-
lactamase detectable by IEF. MP1207 had a major band at pl 
5.8. In addition to minor bands at pl 5.3 and 5.6 it produced 
a minor band at pl 8.2 which was resistant to clavulanate and 
was probably a chromosomal cephalosporinase. This band 
appeared to be similar to the clavulanate-resistant bands at 
pl 8.2 in F. spiritivorum NCTC 11386 and F. multivorum at pl 
7;4 
Group Ilb exhibited greatest heterogeneity in its beta-
lactamases with major bands at pl 8.2 (U58), 8.5 (R862), 8.6 
(R46, MP7, MP628), 8.7 (MP616), 8.8 (R34, MP592), 9.0 
(MP1098), 9.2 (MP525, MP547, MP548, MP582, MP639, MP1409), 
10.2 (MP305, MP1846) and 10.4 (MPS). 
The unclassified strain R5 appeared to have the same beta-
lactamase at pl 8.6 as some strains of F. meningosepticum and 
Group Ilb. !_. elegans DSM 527 produced a major band (pl 8.0) 
and a minor band (pl 7.6) which were resistant to clavulanate. 
These bands were different from all Flavobacterium beta-
lactamases tested in this study. 
Beta-lactamases could not be detected by IEF for "F. 
tirrenicum" ATCC 15922 and C. johnsonae strains ATCC 17061 and 
NCIB 10150. 
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Fig. 14. Isoelectric focussing of beta-lactamases of !· 
multivorum by method of Sanders ~al. (1986) 
using nitrocefin agar and inhibitor-based 
characterization system. Lane 1: pl markers 
(double blue bands are'pl 4.75, 4.85, other 
bands are 5.65, 5.92, 6.45, 7.3, 8.3, and 10.6; 
lanes 2, 8, 14: reference beta-lactamases (type 
IVb and SHV-1); lanes 3, 9, 15: NCTC 11033; 
lanes 4, 10, 16: NCTC 11343; lanes 5, 11, 17: 
MP 1210; lanes 6, 12, 18: MP 2324. Lanes 8 to 
12 were treated with cloxacillin (1,000 uM) and 
lanes 14 to 18 were treated with lithium 
clavulanate (1,000 uM) for 10 sees before being 
overlaid with nitrocefin agar. At the time of 
photographing only the pl 9.3 bands of NCTC 
11033 and NCTC 11343 were visible. All other 
bands appeared one hour later. 
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Fig. lS. Isoelectric focussing of beta-lactamases of !_. 
meningosepticum and unclassified strain RS. 
Lane 1: pl markers; lanes 2, 8, 14: reference 
beta-lactamases IVb and SHVl; lanes 3, 9, lS: 
NCTC 10016; +anes 4, 10 16: NCTC 10S8S; lanes S, 
11, 17: RS8; lanes 6, 12, 18: RS. Inhibitors: 
lanes 8 to 12 treated with cloxacillin and 
lanes 14 to 18 treated with clavulanate as per 
Fig. 14. Note poorly focussed band of NCTC 
10016 and identity of major band of NCTC 10S8S, 
RS8 and RS and some minor bands of NCTC 10S8S 
and RS8. 
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Fig. 16. Isoelectric focussing of beta-lactamases. Lanes 
1 and 18: pI markers; 
reference beta-lactamases: 
lanes 2 (type Ia), 7 (Ib), 12 fPSE-1), 17 (OXA-
3); 
F.. meningosepticum: lanes 3 (MP816), 4 (MP970), 
11 (MP969); Group IIb: lanes 5 (MP 628). 6 
(R34); 
F. multivorum: lanes 8 (MP2324~, 14 (MP1210); 
F. spiritivorum: lanes 9 (NCTC 11386) 1 lO (R41); 
!· thalpophilum: lane 13 (MP1207); F. breve: 
lane 15 (NCTC 11162); F. odoratum: lane 16 
(R59). 
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Fig. 17. Isoelectric focussing of beta-lactamases. Lanes 
1 and 18: pl markers; 
reference beta-lactamases: 
lanes 2 (type la), 15 (PSE-1); and 10 MISC 
126 (host of PSE-3) showing only host 
Pseudomonas beta-lactamase bands. 
Group Ilb: lanes 3 (R862), 4 (R47), 5 (MP305), 6 
(MP525), 7 (MP548), 8 (MP1409), 9 (MP1409 with 
ZnS04 added); 
lane 11: F. tirrenicum ATCC 15997; 
..£· johnsonae: lanes 12 (ATCC 17061), 13 (NCIB 
10150) 
lane 14: F. elegans DSM 527; 
!.: meningosepticum: lanes 16 (NCTC 10016), 17 
(NCTC 2324), 
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f. Investigations of Mechanisms 
Preliminary evidence about the roles of beta-lactamases 
and permeability in the resistance of Flavobacterium strains 
to beta-lactam antibiotics was obtained by combining 
clavulanate (2 mcg/ml) and EDTA (1 mM) with selected beta-
lactam antibiotics. Three-fold lowering of MIGs in the 
presence of clavulanate or EDTA or an increased inhibition 
zone for augmentin compared to ampicillin was regarded as a 
significant synergistic effect and presumptive evidence for 
beta-lactamase activity or a p~rmeability barrier being 
involved in resistance to beta-lactam antibiotics. 
This approach failed to implicate low permeabilit~ as a 
significant factor in resistance. F. breve strain U31 was · 
inhibited by 0.5 mM EDTA, making invalid the testing of this 
strain at lmM EDTA. 
Clavulanate however significantly increased susceptibility 
of a number of strains of Flavobacterium to ampicillin, 
cefamandole and cefotaxime. These tests were invalidated for 
four strains, !_.breve U31 and F. multivorum strains NCTC 
11033, NCTC 11343 and MP1177, which were inhibited by 2 mcg/ml 
clavulahate. Although U31 appeared to be synergistically 
inhibited in the augmentin disc test the remaining two strains 
of F. breve were indifferent to the effects of clavulanate in 
all tests. (This was further evidence of heterogeneity in 
this species). All strains of I· gleum were unaffected by 
clavulanate. Most strains of !_. meningosepticum were more 
susceptible in the presense of clavulanate. Only NCTC 10016 
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TABLE 37 
Agar Dilution Antibiotic Susceptibility Tests 
Effects of Clavulanate and EDTA 
Minimum Inhibitory Concentrations in mcg/ml. 
ORGANISM 
F. breve 
NCTC 11099 
NCTC 11162 
U 31 · ~': and -I:~': 
.!.· gleum 
NCTC 10795 
NCTC 11432 
R 48 
u 62 
MA + MA + MA + CTX+ CTX+ CTX+ 
:MA CLAV EDTA CLAV+ CTX CLAV EDTA CLAV+ 
EDTA EDTA 
16 8 16 16 
128 64 64 32 
8 0.12~0.06~0.06 
>128 128 
>128 128 
>128 >128 
>128 >128 
128 > 128 
>128 >128 
>128 /128 
>'128 >128 
4 
32 
2 4 
8 16 
2 
8 
2 ~0.06 ~0.06 ~0.06 
64 
64 
64 
64 
64 
32 
64 
32 
64 
64 
64 
128 
128 
16 
128 
128 
.!.· meningosepticum 
NCTC 10016 
NCTC 10585 
R 58 
MP 819 
MP 969 
MP 2347 
F. odoratum 
NCTC 11036 
NCTC 11179 
NCTC 11180 
R 25 
R 59 
u 59 
F. multivorum 
NCTC 11033 * 
NCTC 11343 ~': 
MP 1177 -1: 
MP 1210 
MP 2324 
F. spiritivorum 
NCTC 11386 
NCTC 11387 
R 41 
R 51 
> 128 
> 128 
32 
64 
128 
32 > 128 
8 >128 
4 32 
64 
32 
8 
16 
32 
16 
8 64 
64 
8 >128 
8 64 
>128 
> 128 
> 128 
> 128 
> 128 
64 
> 128 
>128 
>128 
>128 
>128 
64 
32 0.12 
32 0.12 
32 0.12 
64 32 
4 0.12 
64 8 
128 16 
128 16 
32 8 
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>128 >128 
>128 >128 
128 >128 
>128 >128 
>128 >128 
64 64 
64 0.25 
64 0.12 
64 32 
64 64 
4 0.5 
32 8 
64 32 
64 64 
32 8 
128 
64 
32 
64 
64 
32 
8 128 
8 128 
8 16 
8 64 
8 128 
2 64 
32 16 32 
)128 128 128 
>128 >128 128 
>128 >128 >128 
128 128 128 
32 16 32 
16 ,< 0. 06 16 
8 ,< 0. 06 4 
4 0.25 4 
8 4 8 
1 0.25 1 
32 4 16 
32 16 32 
16 4 16 
32 4 16 
16 
8 
8 
8 
8 
2 
32 
128 
> 128 
7128 
128 
32 
8 
0.12 
2 
4 
0.5 
4 
16 
8 
4 
TABLE 37 (continued) 
MA + MA + MA + CTX+ CTX+ CTX+ 
ORGANISM :MA CLAV EDTA CLAV+ CTX CLAV EDTA CLAV+ 
EDTA EDTA 
F. thalpophilum 
MP 1207 32 8 32 16 16 2 16 4 
MP 1232 64 0.12 64 16 16 0.12 16 4 
Group Ilb 
--
u 58 >128 >128 >128>128 64 64 64 64 
R 46 >128 >128 >128 )128 64 64 64 64 
Unclassified 
R 5 >128 >128 > 128 >128 >128 64 >128 >128 
R 19 8 4 4 2 2 0.5 1 0.5 
s. aureus 
ATCC 25923 0.5 0.25 0.5 0.12 1 0.5 1 0.25 
E. coli 
-
--
ATCC 25922 0.5 1 1 1 ~ o. 06 ~0.06 ~0.06 ,<0.06 
---------------------------------------------------------------
* strain was inhibited by 2 mcg/ml clavulanate 
~·d~ strain was inhibited by 1 mM EDTA 
MA Cef am.andole MA Cefam.andole 
CLAV Lithium Clavulanate CLAV Lithium Clavulanate 
CTX Cef otaxime CTX Cefotaxime 
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TABLE 38 
Disc Tests for Amoxycillin-Clavulanate Synergy 
ORGANISM 
AND 
STRAIN CODE 
SYNERGY WITH 
AMOXYCILLIN/ 
CLAVULANATE 
F. breve 
031 
F. gleum 
F. meningosepticum 
NCTC 10585, R58, MP816, 
MP819, MP969, MP970, 
MP1702, MP1742, MP2347, 
MP2348 
F. multivorum 
MP1210 
F. odoratum 
R59 
F. spiritivorum 
NCTC 11386, NCTC 11387, 
R41, R51 
F. thalpophilum 
MP997, MP1232 
Group Ilb 
R34 
Unclassified 
033 
C. aquatilis ATCC 29551 
C. johnsonae ATCC 17061 
C. johnsonae NCIB 10150 
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NO 
SYNERGY 
NCTC 11099, NCTC 11162 
NCTC 10795, NCTC 11432 
062, R48, R49,,R56 
NCTC 10016, MP894 
NCTC 11033, NCTC 11343, 
MP1177, MP2324 
NCTC 11036, NCTC 11179, 
NCTC 11180, R25, 059 
MP1207 
058, R46, R47, R862, 
MP7, MPS, MP305, MP525, 
MP547, MP548, MP582, 
MP592, MP616, MP628, 
MP639, MP1098, MP1846 
R5, Rl9 
F. aquatile NCIB 8694 
"F. tirrenicum" ATCC 15922 
F. elegans DSM 527 
and MP984 did not become more susceptible to ampicillin and 
the MIC of R58 was reduced only two-fold to cefotaxime. Three 
strains of F. multivorum (NCTC 11033, NCTC 11343 and MP1177) 
were inhibited by 2mcg/ml clavulanate and could not validly be 
tested in the cephem study. Strain MP2324 was however more 
susceptible to the cephalosporins in the presence of 
clavulanate but unaffected by clavulanate in the augmentin 
disc test. The results ,for strain MP1210 were the opposite -
clavulanate was synergistic with ampicillin but produced no 
effect with the cephalosporins. No strains of F. odoratum 
increased in susceptibility to the cephalosporins and only 
strain R59 was more susceptible to ampicillin in the presence 
of clavulanate. All strains of F. spiritivorum were more 
susceptible in the presence of clavulanate although not always 
significantly so. Strain MP1207 of !· thalpophilum was 
unaffected by clavulanate whereas strains MP997 and MP1232 
were synergistically inhibited. Only one strain of Group Ilb, 
R34, became more susceptible in the presence of clavulanate, 
all other strains being unaffected. (Thus Group llb and !· 
gleum differed from !· meningosepticum in generally being 
unaffected by clavulanate). Unclassified strains RS and Rl9 
were unaffected but U33 became more susceptible to ampicillin 
in the presence of clavulanate. The three strains of 
Cytophaga were more susceptible to ampicillin in the presence 
of clavulanate but F. aquatile, "F. tirrenicum" and F. elegans 
were unaffected. 
Some unexpected results occurred when both clavulanate and 
EDTA were added to the cephalosporins. F. multivorum MP1177 
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had an MIC of 0.12 mcg/ml· to cefamandole plus clavulanate. 
However when EDTA was added the MIC increased 8-fold to 32 
mcg/ml. This suggested that EDTA interfered with either the 
inhibitory effect of the clavulanate or with the synergistic 
effect of clavulanate on cefamandole. Similar results 
occurred with cefotaxime for this strain of F. multivorum as 
well as strain NCTC 11033 and F. thalpophilum MP1232. 
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IV. DISCUSSION 
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A future revision of Flavobacterium as a taxonomically 
coherent genus was foreshadowed by Weeks (1974) who divided it 
into two distinct sections: Section I comprising nonmotile 
strains of low %G+C, and Section II comprising motile and 
nonmotile strains of high %G+C. This division separated 
organisms which were genetically different and therefore 
clearly unrelated. Prior to 1974 the lack of incisive and 
sensitive chemical and genetic techniques precluded 
recognition of the two sections within Flavobacterium. 
Following Weeks' 'interim and pragmatic arrangement' 
(Weeks, 1974) a consensus was reached pn the taxonomic limits 
of Flavobacterium. Hayes (1977), McMeekin and Shewan (1978), 
and Holmes and Owen (1979) proposed that the genus be 
restricted to the Section I-type organisms of Weeks (1974), 
and in 1980 an international symposium confirmed the 
acceptability of the redefined genus (Reichenbach and Weeks, 
1981). The symposium was, in effect, a mandate delivered by 
leading workers with Flavobacterium which should have 
guided other microbiologists in the taxonomic handling of 
Flavobacterium. In 1982, in recognition of the increasing 
taxonomic interest in Flavobacterium the ICSB formed a 
subcommittee for Flavobacterium, Cytophaga and a~lied 
bacteria. Widespread recognition of the redefined genus 
should have been complete in 1984 when Holmes et al. (1984a) 
endorsed the redefined genus Flavobacterium in the traditional 
and authoritative 'bible' of bacteriologists, Volume 1 of 
Bergey's Manual of Systematic Bacteriology. 
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At this point it may have seemed that the major 
taxonomic work was done. The case for the redefined 
genus had been carefully researched, well argued, and widely 
circulated. All that remained for the completion of the work 
was the rejection of names of Flavobacterium species which no 
longer conformed to the genus description. This could have 
been achieved, albeit tediously, by individually transferring 
the species incertae sedis (Table 10) to more appropriate 
genera and then formally requesting the Judicial Commission of 
the ICSB to reject the original names. 
In retrospect it can be seen that the failure to promptly 
perform 'this final piece of taxonomic housekeeping was most 
unfortunate and was'partly responsible for perpetuating the 
confusion and taxonomic mismanagement which has been 
associated traditionally with the genus. Much of the recent 
taxonomic laxity stems from the increased interest in yellow-
pigmented bacteria by aquatic, environmental and industrial 
microbiologists who publish reports of Flavobacterium strains 
which either do not conform to the redefined genus description 
or have not been identified sufficiently to warrant inclusion 
-in the genus. For example, in 1987 the publications reviewed 
in Microbiology Abstracts : Section B, Bacteriology (Cambridge 
Scientific Abstracts, Bethesda, Md) mentioned F. heparinum 
I -
(transferred to Cytophaga by Christensen, 1980) in two 
abstracts, "!· dehydrogenans", "!· keratolyticus", and "F. 
saccharophilum" (not validly published names) in one abstract 
each, and Flavobacterium species (no further details) in ten 
abstracts. These examples indicate the lack of taxonomic 
rigor which has continued to be associated with the genus. 
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It is now fourteen years since Weeks first delineated the 
low %G+C strains as a distinct taxonomic entity. Considering 
the remarkable pace at which twentieth century science has 
progressed, particularly in disciplines such as bacterial 
taxonomy where genetic and molecular approaches have rapidly 
advanced knowledge in spectacular and unprecedented fashion, 
fourteen years seems a long t~me. In this period genetic and 
chemical studies have advanced our understanding of 
Flavobacterium to such an extent that interest is now focussed 
on the relationship of the genus to the anaerobic genus 
Bacteroides. Such a concept was not envisaged at the time of 
the 1980 symposium and certainly could not have been seriously 
considered when Weeks grappled with the confusing taxonomy of 
Flavobacterium in 1974. Viewed in this context it is 
regrettable that the recent taxonomic publications and 
scientific insights should have had so little impact outside 
taxonomic circles. 
The solution to this problem is not immediately obvious. 
Part of the problem is common to all sciences - i.e. the 
inability of the masses to keep abreast of new advances in 
specialised disciplines. However there is a more fundamental 
aspect to the problem which should not arise. It seems that a 
number of scientists (and editors of journals) need to be 
reminded that scientific names have precise meanings, and that 
generic and species names should not be used without checking 
first that they are correct. In the case of Flavobacterium it 
is·incorrect to use the generic name without verifying that an 
229 
organism is nonmotile, nonfermentative, oxidase- and 
phosphatase-positive and is of low %G+C. (An approximate %G+C 
value can be determined conveniently by the UV test of 
McMeekin, 1977). If the %G+C is unknown terms such as 
'Flavobacterium-like' and 'flavobacteria' should be used 
instead of unsubstantiated scientific names. 
Apart from the nomenclatural· problems and the anachronism 
of some high %G+C species of Flavobacterium remaining in the 
Approved Lists (Skerman et al., 1980) there are further 
taxonomic problems within the redefined &enus which require 
attention. One problem is that the recent taxonomic advances 
have involved primarily clinical strains. This has led to an 
imbalance in the taxonomic framework of the redefined genus by 
promoting impetus in a 37°C-positive direction and has created 
some problems in the identification of nonclinical strains. 
Within the taxonomic framework certain species appear to 
be genetically and phenotypically related and it is likely 
that distinct groups within the genus will eventually attain 
generic status pending the discovery of suitable phenotypic 
markers by which to define them (Bauwens and De Ley, 1981; 
Holmes and Owen, 1981; Ya buuchi et al. , 1983; Holmes, Owen and 
McMeekin, 1984). Some of the species are genetically 
heterogeneous and their subdivision into further species is 
warranted also but not yet possible because of the lack of 
convenient phenotypic markers which can be correlated with 
genetic differences. 
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The indistinct nature of the Flavobacterium/Cytophaga 
boundary is another blurred taxonomic terrain requiring 
additional characters to clarify relationships. Until 
suitable tests are found gliding motility will remain the sole 
determinant of the boundary. This is unsatisfactory because 
undue emphasis is given to a single test for which some 
strains yield atypical results. 
The taxonomic utility of antibiotic resistance in 
Flavobacterium has not been evaluated systematically. There 
are however sound theoretical reasons for supposing that the 
antibiotic resistance patterns of the genus may indicate 
~ 
taxonomic relationships. Holmes( (1984a) suggest that 
antibiotic resistance in the genus is largely controlled by 
chromosomal genes. If this is true antibiotic resistance 
patterns may be specific and stable for individual taxonomic 
units. This hypothesis pres~pposes that (1) the genes for 
antibiotic resistance will always be expressed, and (2) that 
there are significant differences between the species. Even 
if these requirements are met the probability of taxonomically 
distinct resistance patterns is not absolute as differences 
may be masked by other factors. For example the same 
resistance genes may be expressed at different levels in 
different strains of the same species, and other factors such 
as different growth rates, altered target sites and 
differences in permeability may lead to strain-to-strain 
variability in antibiotic susceptibility tests. Thus, 
although antibiotic resistance patterns have theoretical 
taxonomic potential for Flavobacterium their utility may be 
reduced by the interplay of other factors which mask the 
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phenotypic expression of the resistance genes. 
There is however evidence of antibiotic resistance 
patterns in Flavobacterium being taxonomically useful. In one 
numerical taxonomic study Jooste ~ al. (1985) was able to 
delineate a cluster containing Group Ilb from another cluster 
containing !· balustinum and !· indoltheticum only when 
antibiot~c susceptibility tests were included in the analysis. 
This points towards the practical utility of antibiograms in 
taxonomic analysis of flavobacteria and suggests that further 
more detailed investigation may yield new phenotypic mark~rs. 
However a problem with this approach is the added 
complication that, as previously mentioned, the quality of the 
published antibiotic susceptibility data for Flavobacterium 
appears to be less accurate than comparable data for other 
more frequently encountered clinical taxa. Future studies 
must be hampered by unresolved problems such as the poor 
correlation between disc and MIC susceptibility testing 
techniques and the difficulties associated with testing 
strains which do not grow at 35°C. 
These problems may be avoided however if tests can be 
used to detect the presence of specific products of 
chromosomal genes for resistance. Such specific products 
might include antibiotic inactivating enzymes. Tests for gene 
products would be more sensitive than antibiograms because 
they should yield information irrespective of temperature of 
incubation and whether or not resistance is phenotypically 
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expressed. This approach has already been applied to beta-
lactamase analysis and as a taxonomic tool has been found to 
be sensitive to subspecies level for some organisms. 
Information about beta-lactamases in Flavobacterium is 
limited to three reports - three enzymes of F. 
meningosepticum, one of F. odoratum, and one of an organism 
referred to as Flavobacterium strain 80 (%G+C unknown). These 
beta-lactamases are quite distinctive and differ from the 
beta-lactamases produced by the majority of clinically 
occurring bacteria. These initial reports therefore strongly 
indicate that the beta-lactamases of the genus may prove to be 
useful chemotaxonomic markers. 
a. Susceptibility Testing 
In this study it was necessary to establish interpretive 
criteria for the antibiotics which were not calibrated for the 
CDS method of disc diffusion testing. This was achieved by 
the matching of results of disc and MIC tests for all the 
uncalibrated drugs except cefuroxime, which was not included 
in the MIC study. For cefuroxime it was therefore necessary 
to provide arbitrary interpretive criteria. While the 
clinical significance of these arbitrary criteria is unproven 
their use can be justified to some extent in that: 
(i) the validity of any disc test is questionable for 
Flavobacterium (Maderazo !:.! al., 1974; Von Graevenitz and 
Grehn, 1977; Aber et al., 1978; Winslow and Pankey, 1982; 
Johny et al., 1983). 
(ii) this is a taxonomic study and therefore comparisons of 
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inhibition zone sizes are relevant irrespective of their 
clinical implications and 
(iii) the arbitrary interpretive criteria proposed for 
cefuroxime were cautiously and conservatively selected to 
minimize the likelihood of strains being incorrectly judged as 
either susceptible or resistant. 
The study was further complicated by the inability of some 
0 
strains of Flavobacterium to grow at 35, C or to grow on 
Sensitest agar which meant that for some strains there was no 
standardized method of performing antibiotic susceptibilities. 
However it was essential to obtain antibiotic susceptibility 
data to provide an impression of the wide range of organisms 
of the genus even if it meant that for some organisms it was 
not possible to directly compare test results with data from 
other studies. In particular it was important to obtain 
information about!.· aquatile, the type species. Probably 
because of the technical difficulties presented by this 
organism there are no published antibiotic susceptibility data 
for it. 
In spite of the problems encountered the antibiotic 
susceptibility results provided clear evidence of similarities 
and differences between the taxa and evidence of heterogeneity 
within some species and Group IIb. Both disc and MIC tests 
confirmed that the genus is characterized by multiple 
antibiotic resistance and that F. odoratum and F. 
meningosepticum are especially resistant and therefore likely 
to present very serious therapeutic problems in life-
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threa teIJ.ing infections. In all taxa there were some s,trains' 
which yielded contradictory results for disc and MIC tests. 
Unlike other studies the results of this study did not suggest 
that only disc tests give a false impression of 
susceptibility. Discrepancies between disc and MIC results 
showed no consistency and both techniques had similar failure 
rates in missing resistance. Disc test~ appeared to miss. 
resistance in 64 tests and MICs appeared to miss resistance in 
56 tests (Table 27). However without a reliable benchmark it 
was not pos~ible to judge which was the more accurate 
technique or if either technique was satisfactory. It is 
therefore not possible from these results to recommend either 
technique as optimal for the testing of Flavobacterium. 
The antibiotics ~hich were most frequently associated with 
discrepancies were ceftazidime, chloramphenicol, cefotaxime, 
cefoxitin and trimethoprim. This is disturbing because these 
are agents which have been touted as exhibiting superior 
activity against Flavobacterium spp. in general and F. 
meningosepticum in particular (Aber et al., 1978; Dhawan et 
al., 1980; Johny et al., 1983; Macfarlane et al., 1g85; Schell 
et· al., 1985; Gilardi, 1987). Since empiric anti-Gram-
negative therapy is usually inappropriate for Flavobacterium 
infections it is important that optimal susceptibility testing 
procedures be established. Recommendations to use MICs (Johny 
et al., 1983) or to provide more stringent interpretive 
criteria for disc diffusion tests (Bruun, 1987) are based on 
the assumption that MIC testing provides definitive results. 
This has not been proven. All that previous studies have 
demonstrated is that with the organisms and drugs ~ested MICs 
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were more reliable in detecting resistance. With the 
organisms and drugs tested in this study this was not the case 
and it would therefore be premature and possibly dangerous to 
dismiss as spurious the resistance detected only in disc tests 
in this study. 
Given the difficulty of providing accurate susceptibility 
tests for this genus it is fortunate that Flavobacterium 
infections are rare. This however is poor consolation for the 
individuals involved when cases occur, particularly cases of 
neonatal meningitis due to !.· meningosepticum- In such cases 
there is a fatality rate of about 55% and most survivors 
suffer hydrocephalus (Von Graevenitz, 1981; Holmes, 1987). 
These are grim statistics which partly stem from a lack of 
ability of clinical laboratories to provide a reliable guide 
to therapy. It would therefore seem appropriate to take the 
question of improved susceptibility testing of the genus off 
Q4 
the academic backburner and recognise itAan important and 
practical research priority. 
Because susceptibility results tended to be method-
dependent it was difficult to identify antibiotics of 
taxonomic or clinical utility. Nevertheless broad groupings 
of organisms which corresponded to described taxa were 
identified on the, basis of their responses to antibiotics and 
this confirmed that antibiotic resistance is an integral and 
specific featu~e of the species and Group !lb and indicated 
that even more specific data, such as knowledge of resistance 
mechanisms, would be of value in examining the taxonomic 
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relationships of the genus. 
b. Beta-lactamases 
Since no comparable study had been undertaken previously 
it seemed important to detect and catalogue as many beta-
lactamases as possible from representative strains of the 
genus Flavobacterium. For many strains the level of beta-
lactamase activity was low making detection difficult by 
isoelectric focussing. Nevertheless many different beta-
lactamases were detected within the genus. 
As none of the beta-lactamases detected resembled known 
plasmid mediated beta-lactamases and none were inducible with 
cefoxitin, they were judged to be constitutive and 
chromosomally mediated. This assumption- is supported by the 
scanty evidence for plasmids in Flavobacterium (Holmes, Owen 
and McMeekin, 1984) and is more plausible than the alternative 
which is that Flavobacterium contains a co~pletely new series 
of-plasmid mediated beta-lactamases. 
3-dimensional testing was included in this study to 
investigate, by indirect means but using procedures available 
to most routine bacteriology laboratories, the beta-lactamases 
and underlying mechanisms of beta-lactam resistance in 
Flavobacterium and related species. 
There were several advantages in this-approach. 
Technically there were the advantages of speed, cheapness, 
convenience and versatility. From the biological viewpoint 
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the use of whole cells for tests meant that the organism's 
array of defence mechanisms was intact at the time it 
encountered an antibiotic and that its beta-lactamases were in 
pristine condition. This is not the case in conventional 
beta-lactamase analysis using cell-free enzyme preparations, 
in which the regulatory organisation of the cell envelope is 
lacking and the activity of the enzyme preparations may have 
been impaired by adverse effects during harvesting, 
purification, freezing and thawing. (In this study 
significant, but unquantified, losses of activity occurred in 
some beta-lactamase preparations). Thus it can be argued that 
techniques such as the 3-dimensional and clover leaf tests are 
more sensitive and biologically more meaningful than 
conventional methods for investigating the antibiotic-beta-
lactamase encounter. 
At present the more intimate details of how the bacterial 
cell mounts its defence against beta-lactam antibiotics are 
largely unknown. Where are beta-lactamases located within the 
periplasm and what are their concentrations in the vicinity of 
porins and PBPs? How many PBPs need to be attacked to cause 
cell death? By what route and at what rate does a particular 
beta-lactam antibiotic enter the periplasm? Our limited 
understanding of these matters cannot yet be translated into 
practical application so that we may determine the 
significance, extent and effectiveness of each of the known 
components of the bacterium's defence against beta-lactam 
antibiotics. However there is no doubt that the interplay of 
these factors is crucial. Conventional analysis of beta-
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lactamases using 1·~ .. cell-free enzyme preparations which 
cannot take into account these factors must yield artificial 
and at times misleading ~nformation about an organism's 
response to beta-lactam antibiotics and for this reason must 
be recognised as of limtted utility. 
Tests involving whole cells must therefore more accurately 
portray what happens when a bacterium encounters a beta-lactam 
antibiotic and thus more closely mimic the in vivo therapeutic 
situation. This does not however mean that the conventional 
tests are without substantial value. A majo~ defect of whole 
cell techniques arises from the inherent uncertainties 
associated with attempts to accurately analyse one function of 
a living organism while dealing with the total entity. One 
cellular property (e.g. a permeability barrier) may mask the 
effect of another (e.g. beta-lactamase activity) and it may be 
necessary to resort to cell-free preparations to investigate 
the property of interest. Another problem with whole cell 
tests is that it will not be obvious if the organism possesses 
a single or multiple resistance mechanisms (e.g. one or 
multiple beta-lactamases). Thus~a case for both approaches 
can be advocated and it would seem prudent to combine them to 
obtain maximum information. Used in this way the simpler 
whole cell approach could be used as a convenient screening 
procedure to determine which more labour-intensive and 
expensive conventional investigations might be most 
profitable. 
In this study the routine 3-dimensional tests were of 
limited value because many Flavobacterium strains were so 
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resistant that inhibition zones were either non-existent or 
too small to detect 3-dimensional zone distortions. Although 
these tests indicated possible beta-lactamase mediated 
antibiotic inactivations, including inactivation of the 'beta-
lactamase resistant' cefoxitin, there were too many gaps in 
the data to draw conclusions about the genus as a whole. 
The more sensitive 3-dimensional tests and clover leaf 
tests provided greater sensitivity but were not sufficiently 
comprehensive on their own. Discrepancies between the two 
methods may have arisen from differences in inocula, inability 
to reproducibly control inoculum density, and the different 
modes of inoculation. In the 3-dimensional test the inoculum 
is inserted into the agar whereas in the clover leaf test the 
inoculum is streaked onto the surface of the agar. The 
significance of the latter technical difference is however 
unclear in tests in which cell lysis permits beta-lactamases 
to diffuse through the agar. 
Prior to this study there had not been an attempt to 
calibrate either the 3-dimensional technique or the clover leaf 
test against a range of well-characterized beta-lactamases. 
Because this study contained only small numbers of reference 
strains it has not been established to what degree 3D+CL 
profiles can vary when the same beta-lactamases are expressed 
in different hosts. However Table 31 indicates that the 
technique is a valuable screening procedure which indicates 
the substrate profile of an organism's beta-lactamase(~j. 
Verification of the reliability of this technique to 
240 
demonstrate substrate inactivations could be accomplished by 
using the HPLC technique of Aldous ~al. (1985) which was 
similarly used to investigate the reliability of 3-dimensional 
testing. 
The 3D+CL technique provided much information about the 
beta-lactamases of the genus Flavobacterium. Comparison of 
the Flavobacterium profiles with those of the antibiotic 
reference strains confirmed the data obtained by more 
conventional testing procedures which indicated that 
Flavobacterium appears to contain distinctive, perhaps unique, 
beta-lactamases. A striking feature was the 3D+CL evidence 
indicating cloxacillin hydrolysis by almost all the 
Flavobacterium strains. This information, when combined with 
the results of conventional hydrolysis assays and the 
inhibitor studies, suggested that if the beta-lactamases are 
chromosomally mediated they probably belong to class IV of the 
Richmond and Sykes (1973) classification. This conclusion 
appears to be the same as that of Raimondi~ al. (1986), who 
concluded that the beta-lactamase of !· meningosepticum 
belongs to class IV of Sykes and Matthew (1976). (Actually 
Sykes and Matthew did not propose a classification, so it may 
be assumed that Raimondi et al. were referring to the Richmond 
and Sykes classification). It also suggested that hydrolytic 
activity against cloxacillin may be a distinctive 
characteristic of the genus Flavobacterium. Approximately 
half the strains appeared to inactivate cefotaxime, less 
strains appeared to inactivate cefoxitin and a small number 
appeared to be capable of inactivating imipenem. These 3D+CL 
results may be regarded as presumptive evidence of 
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infrequently detected enzymatic activity against antibiotics 
which are resistant to hydrolysis by most bacterial beta-
lactamases. The 3D•CL test failed to detect any strains of 
Flavobacterium with beta-lactamases capable of inactivating 
temocillin. 
[; 
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• I An interesting feature of the 3D+CL tests was the ggest10rl:J 
of comparatively greater penicillinase activity in 
Flavobacterium beta-lactamases than was apparent from the 
hydrolysis assays which tested cell-free enzyme preparations. 
This was attributed to the difference between testing intact 
whole cells and cell-free enzyme preparations and was indirect 
evidence for a selective permeability barrier which allows 
penicillins to penetrate more readily into the periplasm than 
cephalosporins. Such a barrier would explain why the 
predominantly cephalosporinase activity of the cell-free 
assays was less strongly expressed in the 3D+CL tests. The 
penicillins, which penetrated the outer membrane more readily 
were more able to encounter the Flavobacterium beta-lactamases 
and were thus inactivated to a far greater extent in the 3D+CL 
tests. This hypothesis is consistent with findings that 
cephalosporins tend to enter cells through porins whereas in 
some species (!. coli and !· cloacae) penicillins enter cells 
through both porin and non-porin pathways (Komatsu et al., 
1981; Sawai, Hiruma et al., 1982; Yamaguchi et al., 1985). In 
cells with narrow restrictive porins or low amounts of outer 
membrane proteins penicillins can still enter the periplasm 
via non-porin routes. Beta-lactam antibiotics which have low 
intrinsic rates of penetration such as cefoperazone, 
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The role of the beta-lactamases in determining antibiotic 
resistance appeared to vary. For some strains the levels of beta-
lactamase activity in hydrolysis assays did not correlate well 
with MIC values. Synergy studies with lithium clavulanate and 
beta-lactam antibiotics clearly demonstrated diminished 
susceptibility of some strains which may well have arisen from 
beta-lactamase inhibition. However since clavulanate may 
also exert a synergistic effect through mechanisms other than 
beta-lactamase inhibition (Clarke and Zemcov, 1984; Tausk and 
Stratton, 1986; Bakken et al., 1987) these results cannot be 
regarded as unequivocal evidence for a significant role of 
beta-lactamases in resistance. The synergy studies indicated 
that beta-lactamases have little or no role in beta-lactam 
resistance in!.· aquatile, !.· gleum, "F. tirrenicum", !.· 
elegans, most strains of F. odoratum and Group Ilb. The 
positive, and therefore somewhat ambiguous, synergy tests 
suggested that beta-lactamases may be important for beta-
lactam resistance in F. meningosepticum, F. spiritivorum, and 
possibly!.· multivorum, F. thalpophilum, C. aquatilis and C. 
johnsonae. 
The negative synergy tests suggested minimal involvement 
of beta-lactamases in resistance. This appeared to indicate 
tha~ other factors such as permeability were likely to be 
important determinants of resistance to beta-lactam 
antibiotics. However when EDTA was used in synergy.studies to 
investigate its outer membrane-permeabilizing effects it was 
found to be ineffective. While this may indicate that 
permeability is not a significant factor in resistance in 
Flavobacterium an alternative explanation is that 
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moxalactam, cefuroxime, cefotaxime and aztreonam are 
selectively exc~uded (Jaffe et al., 1982; 1983) and these are 
agents to which many Flavobacterium strains were resistant in 
this study. This reasoning is further supported by the 
multiple antibiotic resistance of most strains of 
Flavobacterium which extends to other classes of antibiotics 
such as aminoglycosides, quinolones, macrolides and 
chloramphenicol. Multiple resistance of this nature is often 
caused by impermeability of the outer membrane. 
The conclusion to be drawn from °::~sed 
penicillinase activity detected by the 3D+CL technique is 
that Flavobacterium beta-lactamases perform differently when 
they are in their natural environment - i.e. within or 
immediately adjacent to the host bacterial cell where other 
bacterial activities can regulate the antibiotic-beta-lactamase 
encounter. However the results from assays using frozen or 
freeze dried enzyme extracts obtained from sonicated cells may 
differ from 3D+CL results bec~use of enzyme denaturation and the 
omission of that cellular organisation which is an integral part 
of the beta-lactamase-antibiotic interaction of the 
Flavobacterium cell. 
Deficiencies in conventional hydrolysis assays have been 
recognised for some time e.g. their inability to detect the slow 
hydrolysis of beta-lactamase 'stable' antibiotics by class I 
beta-lactamases (Vu and Nikaido, lq85). 
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Flavobacteriu~ has an outer membrane arranged to conceal 
or protect portals of antibiotic entry similar to that thought 
to produce resistance to gentamicin and polymyxin B in P. 
, 
cepacia (Moore and Hancock, 1986). The resistance to 
different classes of antibiotics by Flavobacterium is highly 
suggestive of a mechanism involving limited permeability. The 
evidence of this study therefore points towards an EDTA-
resistant mechanism being implicated. 
It is possible that a higher concentration of EDTA may 
have increased permeability. Malouin and Lamothe (1987) 
report that 1 mM EDTA increased cell permeability in four 
species of Bacteroides without inhibiting cell growth. F. 
breve U31 was inhibited by 0.5 mM EDTA and it was decided not 
to investigate the possibility that other "Flavobacterium 
strains require a higher concentration of EDTA to increase 
permeability. 
c. F. aquatile 
The taxonomic position of !· aquatile is controversial 
with several lines of evidence pointing to a closer 
relationship with Cytophaga than with Flavobacterium (H~yes, 
1977; Bauwens and De Ley, 1981; Oyaizu and Komagata, 1981; 
Thomson et al., 1981; Paster et al., 1985). It has been 
suggested that !· aquatile may eventually be accomodated in a 
genus which also contains "F. pectinovorum", "F. tirrenicum" 
and~· johnsonae (Bauwens and De Ley, 1981; Holmes and Owen, 
1981-; Holmes et al., 1'183; Yabuuchi et a_l., 1983; Holmes, Owen 
etal., 1984). 
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In this study only limited information about the response 
of !.· aquatile to antibiotics could be obtained. Technical 
difficulties arising from its fastidious growth requirements 
prevented the preparation of qell-free beta-lactamase 
preparations with detectable activity. Furthermore the 
antibiogram for this organism could not be produced using a 
recognised, standardized susceptibility testing procedure. 
However, by using cytophaga agar, a heavy inoculum and 
incubation at 30°C it was possible to determine that F. 
aquatile is quite different from the majority of 
Flavobacterium strains, "!.· tirrenicum", !_. elegans and the 
Cytophaga strains included in this study. The species to 
which !.· aquatile showed greatest similarity was !.· breve. 
Both species were much more susceptible to antibiotics than 
the other species of Flavobacterium and Cytophaga, and were 
distinctive in their susceptibility to cefsulodin. Although 
!.· aquatile was clearly different from the majority of 
Flavobacterium strains there was nevertheless an underlying 
background of common features which suggested that it might be 
an atypical member of the genus. In particular it appeared to 
be resistant to (i.e. was not inhibited by) aztreonam, 
cefotaxime, gentamicin, moxalactam or trimethoprim. 
Resistance to these agents, in particular gentamicin, is a 
characteristic of many Flavobacterium strains, (and also the 
Cytophaga strains of this study). However!_. aquatile is 
qistanced in its relationship to these organisms by its 
inability to inactivate cloxacillin in the 3D+CL tests and its 
overall greater susceptibility. 
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Its resistance mechanisms were not elucidated. The 3D+CL 
tests were negative for all substrates, a finding which 
suggested that enzymatic drug inactivation was not involved in 
its resistance to beta-lactam antibiotics. The possibility of 
limited outer membrane permeability being a resistance 
mechanism is suggested by the absence of detectable beta-
lactamase activity and because!: aquatile showed greater 
resistance to antibiotics which have low intrinsic rates of 
penetration and have been shown to be selectively excluded by 
other bacteria with low outer membrane permeability i.e. 
aztreonam, cefoperazone, cefotaxime, ceftazidime and 
moxalactam (Jaffe~ al., 1982, lq83). Electron microscopic 
observations of F. aquatile indicate that it possesses a loose 
or disrupted outer membrane (Thomson et al-., 1981). This may 
be an explanation for its greater overall susceptibility to 
antibiotics. It would be interesting if other susceptible 
strains of Flavobacterium, e.g. !.· breve 031, !.· odoratum U59 
and!.· multivorum MP2324, also possess similar outer 
membranes. This would constitute evidence for a role of the 
outer membrane in the antibiotic resistance of the genus. 
The impact of these results on our understanding of the 
taxonomy of Flavobacterium is two-fold. Firstly the greater 
susceptibility of !.· aquatile is further information 
adding weight to the view that its choice as type species of 
Flavobacterium was inappropriate. The second point is that 
antibiotic testing failed to support the concept that!.· 
aquatile is more closely related to Cytophaga than to 
Flavobacterium. Becaus~ only three strains of Cytophaga were 
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studied the point cannot be made higher than that. However 
the' impression obtained from this study was that most 
Flavobacterium strains and Cytophaga are more closely related 
to one another than they are to !· aquatile. !· aquatile 
therefore would seem to be an outlier of the entire 
Flavobacterium-Cytophaga complex rather than an organism 
located within the complex somewhere near the ill-defined 
boundary between Flavobacterium and Cytophaga. 
d. F. breve 
These results of antibiotic susceptibility tests, 3D+CL 
tests, IEF and hydrolysis assays indicated heterogeneity 
within F. breve and, if the beta-lactamases are chromosomally 
mediated, comprise additional evidence of genetic 
heterogeneity within the species. The phenotypic expression 
of this heterogeneity was detectable_ by both susceptibility 
tests and beta-lactamase analysis.· Antibiotic studies were 
therefore most promising for investigating taxonomic 
relationships within!· breve and have provided new phenotypic 
markers. F. breve is more susceptible than other species of 
Flavobacterium, !· &quatile excepted, and the three strains 
differed markedly from each other in susceptibility to most 
antibiotics. Further studies of a wider range of strains of 
F. breve should now be undertaken to correlate differences in 
antibiograms and beta-lactamases with genetic heterogeneity. 
Because of the low activity of the beta-lactamase preparations 
of this species consideration should be given to developing 
optimal analytical procedures with greater sensitivity than 
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those used in this study. Sato et al. (1985) achieved 150-
fold purification of a beta-lactamase extract from a strain of 
F. odoratum using column chromatography. 
In assessing the contribution of these beta-lactamases to 
resistance the higher penicillinase activity of the NCTC 11162 
preparation correlated with increased resistance to ampicillin 
and ticarcillin. This indicated a possible role of its beta-
lactamase(s) in resistance to beta-lactam antibiotics. 
However, apart from the inestimable tests for environmental 
strain U31 which was susceptible to clavulanate, there was no 
evidence of synergy when clavulanate was added to beta-lactam 
antibiotics. The apparently high and very broad spectrum 
activity of beta-lactamases of this species detected by 3D+CL 
testing does not necessarily imply a role in resistance as the 
enzymes detected by this test may have been released during 
cell lysis and therefore made no contribution to the survival 
of the host cell. Without more detailed physiological data it 
is difficult to attribute a precise role in resistance to the 
beta-lactamases of F. breve. 
Overall the beta-lactamases of .!'.· breve appear to be 
Richmond and Sykes class IV beta-lactamases. In the absence 
of evidence to the contrary they are assumed to be 
chromosomally determined. In cell-free suspensions they are 
inhibited by clavulanate but not by cloxacillin and appear to 
be capable of inactivating cloxacillin. The beta-lactamases 
btL-
of NCTC 11099 and U31 appear to~extremely broad in spectrum of 
activity with hydrolytic activity against cefotaxime and 
imipenem and, in the case of NCTC 11099, cefoxitin. This 
249 
indicates that these enzymes are oxyiminocephalosporinases 
(Mitsuhashi, 1985) which belong to class IV of Richmond and 
Sykes (1973). Although the beta-lactamase of NCTC 11162 has 
borderline activity against cefoxitin by the 3D+CL technique 
it is not certain if it is an oxyiminocephalosporinase as this 
equivocal result is not supported by demonstrable activity 
against cefotaxime or imipenem. 
F. breve NCTC 11162, !· multivorum MP1210, !· spiritivorum 
NCTC 11386 and F. thalpophilum MP1207 each produced a beta-
lactamase with a pI of 5.8. Apart from the beta-lactamase 
preparation of F. multivorum MP1210 which was too inactive to 
be tested accurately, all of these enzymes were'resistant to 
inhibition by clavulanate. They were therefore different from 
the beta-lactamase of F. odoratum GN14053 reported by Sato et 
al. (1985) which also had a pI of 5.8. In the 3D+CL tests the 
beta-lactamase of F. breve NCTC 11162 was much more active 
than the beta-lactamases of F. multivorum MP1210, !· 
spiritivorum NCTC 11386 and!· thalpophilum MP1207. This 
suggested that it was either a different enzyme or that all 
strains possessed the same type of enzyme but the cells of F. 
breve NCTC 11162 could be more readily made to leak beta-
lactamases into their external environment. The latter 
hypothesis is less likely from taxonomic considerations. There 
is no evidence of a close relationship between!· breve and 
the proposed genus Sphingobacterium (!_. multivorum, 
.E:_.spiritivorum and !: thalpophilum) and these species 
represent the lower and upper extremities of the range of 
%G+C values of the genus (Holmes, Owen and McMeekin, lq84). 
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Furthermore the hydrolysis assays indicate that the beta-
lactamase of F. breve NCTC 11162 is a different enzyme because 
it possesses greater penicillinase activity. 
Strain NCTC 11162 also produced a beta-lactamase with a pI 
of 7.85 as a major band. Low level activity made it difficult 
to determine the inhibition profile but this enzyme appeared 
to be resistant to clavulanate and could not be induced with 
cefoxitin. It was unlike other beta-lactamases detected in 
this study. In all NCTC 11162 appeared to possess two unique 
beta-lactamases. 
IEF results indicated that strain U31 possessed a weakly 
reactive, diffuse, 'blobby' beta-lactamase with pI of 9.3. 
Hirai et al. (1980) reported a beta-lactamase in!· cepacia 
GN11164 with a pI of 9.3, a similar substrate profile 
(hydrolysing ampicillin, cloxacillin, cefotaxime, cefuroxime 
and most other cephalosporins but not cefoxitin), and also 
resistant to inhibition by clavulanate. It differed from the 
beta-lactamase of F. breve in being inducible and in being 
inhibited by cloxacillin. 
The heterogeneity of !· breve in this study contrasts with 
the finding of Jooste ~al. (1985) that in a numerical 
taxonomic study 10 strains of !· breve formed a well defined 
and distinct cluster only when susceptibility tests were 
included in the analysis. Possibly this may reflect the 
different antibiotics tested by Jooste et al. However it is 
quite clear from the small number df strains in this study 
that F. breve contains organisms which differ greatly from one 
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another in their responses to antibiotics. If these 
differences are chromosomally coded it is important that the 
antibiograms and beta-lactamases of a larger collection of 
strains be systematically investigated to determine the 
taxonomic implications. 
e. F. gleum 
How are routine clinical laboratories to identify this 
organism? The published guidelines (Holmes, Owen et al., 
1984~ are inadequate to distinguish !.· gleum from Group IIb. 
DNA:DNA hybridization is required for a definitive 
identification. In this study the only strains which could 
safely be regarded as F. gleum were NCTC 10795 and NCTC 11432. 
Four other strains were presumptively identified as!.· gleum 
but could not be confirmed. Until a less frustrating means of 
identification is provided, clinical microbiologists might be 
advised to use terms such '!.· gleum-like' and 'F. gleum/Group 
IIb complex' for organisms resembling the spec;es description 
of F. gleum. 
Both!.· gleum and the!.· gleum-like strains in this study 
were homogeneous in their antibiograms apart from their 
variability to imipenem. Their antibiograms were 
indistinguishable from Group IIb. However in 3D+CL tests and 
isoelectric focussing the strains were heterogeneous. The 
significance of the heterogeneity cannot be evaluated until it 
is known whether or not the strains actually belong to F. 
gleum. 
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Strains NCTC 10795, U62 and R49 appeared to possess 
oxyiminocephalosporinases of Richmond and Sykes Class IV. The 
3D+CL results for NCTC 11432 were negative and precluded 
definite conclusions about its beta-lactamase. 
Isoelectric points were determined for three strains. 
NCTC 11432 and'U62 exhibited a major beta-lactamase band at pI 
10.6. Four other organisms exhibited beta-lactamase bands at 
pI 10.6. These were minor bands, not major bands, and were 
prod~ced by!· breve U31, !· meningosepticum R58 and MP967, 
and unclassified strain RS. This may constitute evidence that 
these organisms are related. If U62 is confirmed as a strain 
of F. gleum the beta-lactamase at pI 10.6 might prove useful 
in confirming identification of this species. Routine 
clinical laboratories however are not normally equipped to 
determine the isoelectric points of beta-lactamases, so it 
would still be necessary to refer the strain to a reference 
laboratory. It may be that U62 is not a strain of !· gleum. 
In 3D+CL testing strain NCTC 11432 was inactive whereas U62 
inactivated arnpicillin, cloxacillin, cephalothin, cefotaxime 
and (weakly) cefoxitin. The reason for these differences was 
not investigated and the possibility that the two strains are 
fundamentally different cannot be discounted. 
Synergy studies with clavulanate failed to demonstrate a 
role for beta-lactamases in the resistance to beta-lactam 
antibiotics of F. gleum or F. gleum-like strains. 
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Strain R49 had a major beta-lactamase band at 
approximately 9.6. This was one of the diffuse 'blobby' beta-
lactamases similar to those found at a pI of approximately 9.8 
in some strains of F. meningosepticum (NCTC 10016, MP894 and 
·MP2348) and at 9.3 in F. breve U31. It is possible that these 
enzymes are the same. They could not be sharply focussed to 
determine a precise isoelectric point and accuracy in IEF 
tends to decline at extremes of pH. 
f. F. meningosepticum 
The high resistance of this species to antibiotics was 
confirmed. Cefoxitin was more active than other antibiotics 
but was not effective against all strains. Experience with 
cefoxitin in neonatal and pediatric meningitis caused by other 
pathogens has been disappointing (Sanders and Sanders, 1987) 
so the value of cefoxitin for treating neonatal meningitis 
caused by !· meningosepticum would not seem to be great. 
Although augmentin (amoxycillin-clavulanic acid) was more 
active than ampicillin against many strains of !· 
meningosepticum penetration of clavulanic acid into CSF is 
unreliable, sometimes failing t6 attain a concentration of 
0.05 mcg/ml (Gould and Wise, 1987; Decazes et al., lq87). 
Augmentin does not appear to be a therapeutic solution either. 
Therapy for this infection therefore remains a problem. 
-
Effective antibiotics are lacking, =-u~ and there are major 
technical problems in providing accurate susceptibility tests 
for !· meningosepticum. It therefore seems that until more 
effective agents are discovered and the laboratory problems 
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are overcome the outlook will continue to be bleak for infants 
developing meningitis due to this pathogen. 
Ceftazidime exhibited potential taxonomic utility for 
differentiati~g !· meningosepticum from !· gleum and Group 
IIb; and trimethoprim also appeared useful in distinguishing 
these taxa, but only in disc tests. 
Raimondi et al. (1986) studied the beta-lactamases of 
seven strains of F. meningosepticum and reported three_ broad 
spectrum beta-lactamases, with predominantly penicillinase 
activity, and isoelectric points of 7.65, 7.8 and 7.9. The 
beta-lactamase of strain NCTC 10585 was constitutive and all 
beta-lactamases were inhibited by clavulanic acid, cloxacillin 
and pCMB and were classified as belonging to class IV of Sykes 
and Matthew (1976). 
In this study the IEF results confirmed the reported 
heterogeneity of beta-lactamases by Raimondi et al. (1986). 
However the strain which was common to both studies, NCTC 
10585, had a pI of 8.6 for its major band 'in this study 
whereas Raimondi et al. (1986) reported a range of pI values 
of 7.65 to 7.9 for the major bands of!· meningosepticum and 
the beta-lactamase of NCTC 10585 (pI not stated), would have 
been in this lower pI range. Most of the other isoelectric 
points in this study (range pI 7.8 to 9.8) differed from those 
reported by Raimondi et al. (1986). 
' --
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Four strains had beta-lactamases with an isoelectric point 
of 8.6. These were NCTC 10585, R58, MP816 and MFqnq. These 
strains were generally similar in their MIGs to beta-lactam 
antibiotics, hydrolysis ratios, in rate bf cefoxitin 
hydrolysis and 3D+CL profiles. Clavulanate synergy tests 
indicated that this beta-lactamase was involved in resistance 
to beta-lactam antibiotics. Three strains of Group IIb also 
appeared to produce this beta-lactamase (R46, MP7 and MP628) 
but, from clavulanate synergy studies, did not use it in 
resistance to beta-lactam antibiotics. 
Strains NCTC 10016, MP894 and MP2348 shared a 'blobby' 
beta-lactamase with a pI of approximately 9.8. These strains 
were similar in most tests except NCTC 10016 hydrolysed 
cefoxitin at a much lower rate. This beta-lactamase was 
distinctively different in appearance on an IEF gel from the 
beta-lactamases of other strains of !.· meningosepticum and 
served to delineate this group of strains. The only other 
beta-lactamase resembling this one was that of F. gleum R49 
with a pl of approximately 9.6. 
Strains MP1702 and MP1742 were very similar in most 
respects and shared a beta-lactamase with a pl of 7.9. This 
value was the highest pl reported by Raimondi et al. (1986). 
The beta-lactamase of strain MP819 had a pl of 7.8, a value 
also reported for!· meningosepticum by Raimondi et al., and 
MP970 possessed a beta-lactamase with a pl of 8.1. 
Most strains exhibited comparatively high levels of beta-
lactamase activity and all beta-lactamases were inhibited by 
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clavulanate but not by cloxacillin. This latter finding was 
in disagreement with that of Raimondi~ al. (1986' who 
report,ed the inhibition of beta-lactamases by cloxacillin. 
This discrepancy may reflect differences in methodology. 
Hydrolysis assays in this study showed the enzymes to be 
primarily cephalosporinases, whereas Raimondi et al. concluded 
that the beta-lactamases of .!.· meningosepticum are broad 
spectrum enzymes with predominantly penicillinase activity. 
The determination of substrate profile, like inhibitor 
studies, is method-dependent. The orthodox approach to 
penicillin and cephalosporin hydrolysis assays is to use 
different, and optimal, techniques for penam and cephem 
substrates (Richmond and Sykes, 1973). Raimondi~ al. 
performed both penicillin and cephalosporin hydrolysis using 
the same technique, the spectrophotometric technique of Samuni 
(1975), whereas in this study a spectrophotometric technique 
was used for cephem hydrolysis assays and a microiodometric 
technique for the penicillin hydrolysis assays. The different 
techniques used may have contributed to the different results 
obtained in the two studies. 
The beta-lactamases of nine of the 11 strains of F. 
meningosepticum hydrolysed cefoxitin (Table 35). The two 
strains for which activity was not detected were NCTC 10016 
and MP 819. This finding adds support to previous evidence 
loo\6 
that NCTCidiffers from the majority of F. meningosepticum 
strains (McMeekin et al., 1972; Sottile et al., 1973; Owen and 
Snell, 1976; Callies and Mannheim, 1980; Fautz ~al., 1981; 
Thomson, 1982; Ursing and Bruun, 1987). The ability to 
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hydrolyse cefoxitin did not however necessarily confer 
resistance to this agent as only two of the nine strains, MP 
894 and MP 969, were resistant. 
In contrast to the results of the hydrolysis assays and 
more in keeping with the interpretation of Raimondi~ al. 
(19,86), eleven of the twelve strains tested by the 3D+CL 
technique exhibited broad spectrum beta-lactamase activity. 
The substrate profiles obtained by this method, coupled with 
other parameters, suggested that all strains of F. 
meningosepticum produced Richmond and Sykes Class IV beta-
lactamases and in nine of the strains the beta-lactamases were 
oxyiminocephalosporinases. In general the beta-lactamases of 
!.· meningosepticum appeared to be broader in spectrum than 
those of!.· gleum and!_. gleum-like strains, with some strains 
of F. meningosepticum conspicuously inactivating 
carbenicillin, cephaloridine and cefoperazone. F. 
meningosepticum also seemed to possess greater activity 
against cephalothin, a finding which was not apparent from the 
susceptibility tests and hydrolysis assays. Further strains 
need to be investigated to determine whether or not this is a 
real difference as it may have taxonomic significance. 
The greater apparent penicillinase activity indicated by 
the 3D+CL tests may arise from a selective outer membrane 
which impeded entry of cephems into the periplasm. 
The 3D+CL technique showed good correlation with the 
hydrolysis assays for cefoxitin hydrolysis by NCTC 10585, R58, 
MP1702, MP1742 and MP2348, and in detecting no cefoxitin 
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hydrolysis by NCTC 10016 and MP819. However it failed to 
detect cefoxitin hydrolysis by the beta-lactamases of MP816, 
MP894, MP969 and MP970. This may indicate that in cells of 
these four strains the capability to inactivate cefoxitin is 
not expressed, perhaps because of a permeability barrier, or 
that for these strains there was no lysis of cells or 
permeabilizing effect which released beta-lactamase into the 
external environment. Another possibility is error in the 
3D+CL technique. 
Another interesting 3D+CL result was thejsu;;~st~~:~~~~~~;~J 
enzymatic activity of the strains against cephalothin compared 
to cefoperazone, an antibiotic which is usually more 
vulnerable to beta-lactamase hydrolysis. This effect might be 
due to differences in porin permeabilities for cephalosporins. 
Yoshimura and Nikaido (1985) report that the diffusion rates 
of beta-lactam antibiotics through porin channels in E. coli, 
and other bacteria, are determined by factors such as 
molecular size, charge, the presence of exceptionally bulky 
side chains and hydrophobicity. Both cephalothin and 
cefoperazone are monoanionic compounds but cefoperazone, with 
a molecular weight of 644 and a substituted ureido group on 
the alpha-carbon of the position-7 side chain, has a 
particularly slow penetration rate. Cephalothin, with a 
molecular weight of only 395, is thus able to penetrate faster 
and therefore encounter the beta-lactamases of F. 
meningosepticum at a significantly greater rate than 
cefoperazone and thereby produce 3D+CL results in which 
cephalothin is apparently inactivated faster than 
259 
cefoperazone. This hypothesis infers that the 3D+CL test 
detects periplasmic beta-lactamase activity as well as 
extracellular activity. 
These investigations confirm that strain NCTC 10016 
differed from the majority of strains of F. meningosepticum 
and is therefore an unrepresentative choice for type strain of 
the species. 
The apparent sharing of a common beta-lactamase by some 
strains of !· meningosepticum and the!· gleum/Group IIb 
complex is interesting. Apart from the difference in hue of 
pigmentation these taxa are very similar. Has undue emphasis 
been placed on the paler pigmentation of !· meningosepticum, 
and if so, how valid is the current species description? The 
beta-lactamase with a pl of 8.6 needs further investigation as 
if it is chromosomally mediated it may have very important 
taxonomic implications. Other evidence which points away from 
an intimate relationship between these strains of F. 
I 
15 
meningosepticum and the !· gleum/Group Ilb complex ~ their 
distinctly different results in the synergy tests with 
clavulanate and their differences in susceptibility to 
ceftazidime. These results, which are however subject to the 
inaccuracies introduced by using whole cells in tests, suggest 
that the currently accepted taxonomic arrangement is correct 
and that these are distinctly different taxonomic groups. It 
is difficult to weigh these opposing lines of evidence. 
Because of the genetic heterogeneity of F. meningosepticum 
(Sottile~ al., 1973; Owen and Snell, 1976; Callies and 
Mannheim, 19~0; Ursing and Bruun, 1987) it is recognised that 
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the present classification does not contain full and correct 
information, and certainly greater weight should be given to 
information about a specific gene product such as a 
chromosomal beta-lactamase than to results of whole cell 
tests. It is therefore important that this beta-lactamase and. 
the strains which produce it be investigated in greater depth. 
g. Flavobacterium Species Belonging to the Proposed Genus 
Sphingobacterium (!_. multivorum, 
F. spiritivorum and F. thalpophilum) 
These three species exhibited similar patterns of 
antibiotic resistance with!_. spiritivorum being generally 
more resistant, particularly in the disc tests, and!_. 
thalpophilum being more susceptible, particularly to cefoxitin 
and (in disc tests) to ticarcillin. 
Although Table 15 indicates that strains of!_. multivorum 
have been previously reported to be susceptible to 
erythromycin, the 15 strains tested in this study were 
resistant apart from strain MP 2324 which was an exceptionally 
susceptible strain for this species. This strain would be an 
ideal one from which to derive antibiotic resistant mutants by 
subculturing onto antibiotic gradient plates. By comparing 
the outer membrane proteins, PBPs and antibiotic-inactivating 
enzymes of the mutants and MP2324 it might be possible to 
elucidate the resistance mechanisms of this species, and 
perhaps the genus. Such information could be invaluable, not 
only from a taxonomic viewpoint, but also because it might 
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lead to the development of antibiotics which can evade the 
formidable resistance mechanisms of Flavobacterium and other 
bacteria. 
The beta-lactamases of the three species all exhibited low 
levels of activity in hydrolysis assays, 3D+CL tests and 
isoelectric focussing. Although there was evidence of 
heterogeneity within the species this group of organisms 
appeared to constitute a cohesive taxonomic unit in which 
there were common beta-lactamases (e.g. pl values of 5.8, 7.4 
and 8.2). This suggested that arguments for the proposed genus 
Sphingobacterium, containing these three species and "S. 
mizutae", are soundly based. However the delineation of 
species boundaries within the genus may require future 
modification after further strains are studied and the extent 
and taxonomic impact of the intra-species heterogeneity is 
evaluated. 
The principal beta-lactamases of the proposed genus appear 
to belong to Richmond and Sykes Class IV. These were 
difficult enzymes with which to work because of their low 
levels of activity. To detect these enzymes by IEF it was 
necessary to concentrate preparations to the extent where low 
level chromosomal cephalosporinases (pI values '.4, 8.2) which 
were resistant to clavulanate were sometimes detected. In the 
case of the highly susceptible !.· multivorum MP2324 the only 
beta-lactamase detected was its cephalosporinase with minimal 
and basal activity. The lack of a major beta-lactamase, as 
found in most other strains, probably explains the increased 
susceptibility of this strain to beta-lactam antibiotics. 
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The low levels of beta-lactamase production of these 
organisms suggests that a mechanism other than beta-lactamases 
is involved in resistance to beta-lactam antibiotics but does 
not necessarily mean that beta-lactamases have no role in 
resistance. 
The beta-lactamases detected in!· multivorum are possibly 
related to the beta-lactamases of other organisms. The three 
strains tested by IEF produced a beta-lactamase with a pl of 
7.4. The inhibition profile could be detected unequivocally 
for strain MP2324 only, but it did seem that all strains 
produced the same enzyme, an enzyme with predominantly 
cephalosporinase activity which is inhibited by cloxacillin. 
Sawai et al. (1968) reported a similar enzyme in~· fragilis 
1604E - a constitutively produced chromosomally mediated 
cephalosporinase which is inhibited by cloxacillin. If these 
enzymes are identical it would constitute strong evidence for 
a relationship_ between these two sphingolipid-producing 
species. 
The beta-lactamase of F. multivorum with a pl of 9.2 needs 
to be compared to the beta-lactamase of Group Ilb strains 
MP525, MP547, MP548, MP582, MP639, and MP1409. Group Ilb is a 
large, diverse collection of organisms and, although 
unsuspected from phenotypic characters, the possibility of P 
some strains being related to !· multivorum cannot be 
dismissed without sufficient evaluation. 
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h. F. odoratum 
The range of G+C values for!· odoratum is 4.7 mol% making 
this species the most genetically diverse species of the 
genus. It is even more diverse than the heterogeneous Group 
Ilb (range 3.5 mol%). Holm~s, 
~VWA,~ 
suggest that the genetic~of 1· 
Owen and McMeekin (1984) 
odoratum is sufficient to 
warrant subdivision into two or three species. However such 
revision is not possible at present because phenotypic 
characters which correlate with genetic differences are 
lacking. 
This species was very resistant to antibiotics with only 
cefoxitin, chloramphenicol (in disc tests only), and imipenem 
showing moderate activity and no single agent effective 
against all strains. Susceptibility tests showed 
environmental strain U59 to be much more susceptible to 
antibiotics and therefore atypical. This strain, like !· 
multivorum MP2324, offers potential as a susceptible control 
strain for research into resistance mechanisms. 
Susceptibility testing appeared to yield taxonomically 
useful information as F. odoratum and F. meningosepticum 
differed from all other flavobacteria in having high MICs to 
ceftazidime (~ 64 ug/ml) and differed from each other in 
trimethoprim MICs - !· meningosepticum being susceptible (MIC 
~4 ug/ml) and F. odoratum being highly resistant (MIC ~ 128 
ug/ml). 
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Only low levels of beta-lactamase were detected with 
strain U59 having no activity detectable by IEF. The other 
five strains produced beta-lactamases with predominantly 
cephalosporinase activity. In the 3D+CL testing NCTC 11180 
appeared to possess greater penicillinase activity than was 
apparent in the hydrolysis assays. This result may have been 
due to low outer membrane permeability for cephalosporins 
leading to only the penicillinase activity of its beta-
lactamase being expressed. Diminished permeability may also 
explain the negative 3D+CL tests for strains NCTC 11036 and 
NCTC 11179. R59 was the only strain to be synergistically 
inhibited by clavulanate, and only in combination with 
amoxycillin (i.e. augmentin). This suggested that its beta-
lactamase may be.involved in resistance to penicillins but not 
to cephems. If so, this is indirect evidence of,a selectively 
permeable outer membrane which excludes cephems but permits 
entry of penicillins to the periplasm. 
Strains NCTC 11036 and NCTC 11179 had a single beta-
lactamase band with an isoelectric point of 7.7, and R59 had a 
minor band with the same pl. This was also the pl of a minor 
band in each of!_. meningosepticum NCTC 10016, !_. gleum R49, 
F. breve U31 and Group Ilb strains R34 and MP548. Perhaps 
with more sensitive methods this beta-lactamase might be found 
to occur widely throughout Flavobacterium and thereby 
constitute a genus-specific beta-lactamase. Raimondi et al. 
(1986) report a beta-lactamase of!.· meningosepticum with a pl 
of 7.65. Although this value is numerically similar to 7.7 
the discrepant ranges for pl values of !.· meningosepticum in 
the two studies prevents direct comparison of these beta-
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lactamases. However the possibility of a beta-lactamase 
specific for the genus Flavobacterium should be explored and 
is further reason to seek more sensitive techniques by which 
to investigate the beta-lactamases of the genus. 
Strain NCTC 11180 produced a beta-lactamase with an 
isoelectric point of 5.3 and R59 had a minor beta-lactamase 
band with this pl. In the light of the genetic evidence of a 
relationship between Bacteroides and Flavobacterium it is 
interesting that Olsson-Liljequist ~ al. (1980) report a 
cephalosporinase of~· uniformis with a pl of 5.3. This 
enzyme has broad cephalosporinase activity and hydrolyses 
cefuroxime and cefoxitin. It therefore seems to be similar to 
many of the Flavobacterium beta-lactamases detected in this 
study. 
~· uniformis was previously regarded as a subspecies of B. 
fragilis and thus produces sphingolipids (Holdeman et al., 
1984) and has more biochemical characteristics in common with 
the proposed genus Sphingobacterium than with!_. odoratum. 
(B. uniformis is positive for esculin hydrolysis, indole 
production, and acid production from arabinose,glucose, 
lactose, maltose, raffinose and sucrose). !· odoratum, on the 
other hand, is biochemically more similar to B. fragilis and 
B. vulgatus. However a relationship between !· odoratum and 
B. fragilis or~· ·vulgatus is not strongly suggested as these 
organisms share negative, rather than positive, biochemical 
tests and both Bacteroides species produce sphingolipids 
whereas F. odoratum does not. 
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Further, but tenuous, evidence of a relationship with 
Bacteroides is the report of Eley and Greenwood (1986) that 
five strains of B. fragilis have beta-lactamases with a pl of 
5.3. However these beta-lactamases appear to be different as 
~ 
they~inhibited by both cloxacillin and clavulanic acid, , 
whereas that of NCTC 11180 is inhibited by only clavulanic 
acid. 
The G+C ranges for the above-mentioned species of 
Bacteroides are similar to those found in the upper G+C range 
for Flavobacterium - B. uniformis (45-48 mol%), !· fragilis 
(41-44 mol%) and!· vulgatus (40-42 mol%) (Holdeman et al., 
. --
' 1984). This is further evidence of a relationship between 
these species and the proposed genus Sphingobacterium (r~nge 
39.6-45 mol%) rather than a rel~tionship with F. odoratum 
(31.4-36.1 mol~). 
!.· odo~atum R59 produced a beta-lactamase with a pl of 
6.7. In a review of anaerobic bacteria Nord (1986) cites 21 
reported isolates of B. ovatus and four isolates of B. 
0 
thetaiot~icron which also produce beta-lactamases with a pl 
0 
of 6. 7. (!, thetaiot,icron is another species which produces 
sphingolipids and has a G+C range (40-43 mol %) similar to the 
proposed genus SphingobacteriumJ Bello et al. (1987) report 
inactivation of cefotaxime, cefoperazone and ceftazidime by 
the beta-lactamases of A. calcoaceticus strain 4 and ~· putida 
strain 5 but insufficient details of these beta-lactamases are 
provided to compare these beta-lactamases with that of F. 
odoratum R59. 
267 
F. odoratum R25 also produced a beta-lactamase which had a 
diffuse band at pI 4.9. Strain R59 also produced a minor band 
at this pI, as did !.· gleum NCTC 11432 and Group IIb U58. 
However the minor bands were sharply focussed in contrast to 
that of R25. Whether or not the sharply focussed minor bands 
were the same enzyme as the diffuse band of F. odoratum R25 is 
unknown. 
The beta-lactamase of F. odoratum R25 could also be 
compared to beta-lactamases of Bacteroides. Eley and 
Greenwood (1986) report a beta-lactamase of~· fragilis 107 
with a pI of 4.9. Like that of!.· odoratum R25 this enzyme is 
poorly inhibited by cloxacillin but strongly inhibited by 
clavulanic acid. It causes slow hydrolysis of cefoxitin, and 
moxalactam but does not hydrolyse imipenem. These results are 
similar to the 3D+CL results of R25. Nord (1986) cites six 
additional references in which!· fragilis is reported to 
produce a beta-lactamase with a pI of 4.9, plus two referencei 
for B. vulgatus and one reference for B. distasonis. 
Lacroix et al. (1984) report a beta-lactamase of B. bivius 
which is inhibited by clavulanic acid but not by cloxacillin 
and on IEF produces a 'streak band' with a pI of approximately 
4.8 to 5.0. This beta-lactamase slowly inactivates cefoxitin, 
ceftizoxime and moxalactam and is regarded as belonging to the 
Group II beta-lactamases of Bacteroides of Timewell et al. 
(1981). These are broad spectrum beta-lactamases which occur 
in B. asaccharolyticus, B. melaninogenicus, B. bivius and B. 
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ovatus. The diffuse 'blobby' band of the beta-lactamase of F. 
odoratum R25 seems to be very similar to the 'streak band' of 
the beta-lactamase of B. bivius. This similarity, and the 
additional species of Bacteroides just mentioned, help to 
focus attention on the more important organisms to investigate 
when studying the relationship between Flavobacterium and 
Bacteroides. 
The G+C values of two of these species are in the same 
range as Flavobacterium species - ~· bivius (40 mol %) and B. 
melaninogenicus (36-40 mol%). The G+C range of B. 
asaccharolyticus (50-51 mol%) however is slightly above that 
of Flavobacterium and ~· asaccharolyticus is also more 
susceptible to antibiotics than the other above-mentioned 
species of Bacteroides. 
The significance of isoelectric points of the minor bands 
of strain R59 being identical to those of the major beta-
lactamase bands of the other strains of F. odoratum needs to 
be determined. This finding indicates a relationship between 
strikingly different strains of F. odoratum. It may mean that 
the beta-lactamases of F. odoratum can serve as taxonomic 
markers of subspecies within the species, or, should the 
species be recognised as a separate genus, as markers of 
species within the genus. 
The beta-lactamases of F. odoratum differed between 
strains and differed from the F. odoratum beta-lactamase 
described by Sato ~al. (1985) which was not inhibited by 
clavulanic acid. In this study the different beta-lactamases 
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were not expressed phenotypically in routine susceptibility 
tests but differences between the strains could be detected in 
the 3D+CL tests in which there were three profiles. Strains 
NCTC 11036, NCTC 11179 and U59 were negative for all 
substrates. NCTC 11180 showed apparent penicillinase activity 
against ampicillin and cloxacillin which, in conjunction with 
the other parameters, suggested it produces a Richmond and 
Sykes Class IV beta-lactamase. Strains R25 and R59 possessed 
broad spectrum activity extending to cefoxitin and cefotaxime 
and therefore probably produce• an oxyiminocephalosporinase of 
I- - -- -
Richmond and Sykes Class IV. \ ______ ~hi~~!e of enz~atic \ 
activity was not however expressed in cefoxitin hydrolysis 
assays. This suggests that the 3D+CL tests were a more 
sensitive test of substrate profile than hydrolysis assays. 
The next stage in this research should be an attempt to 
correlate the different beta-lactamases with the genetic 
heterogeneity of the species. This would necessitate studying 
a larger number of strains. However if a correlation can be 
made, the 3D+CL tests for ampicillin, cefotaxime and 
cloxacillin (and possibly additional substrates) constitute 
very simple and convenient characterization tests by which to 
delineate different taxonomic groups within F. odoratum. 
i. Group Ilb 
The search for taxonomic groups within Group IIb has not, 
in general, been a rewarding task (Price and Pickett, 1981; 
Shewan and McMeekin, 1983; Yabuuchi ~al., 1986). However 
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Owen and Holmes (1978) and Holmes, Owen et al. (1984) 
delineated !· balustinum (a species consisting of a single 
strain) and !· gleum (a species which requires DNA:DNA 
hybridization analysis to identify it) from within Group IIb. 
The latter workers suggest that further species descriptions 
based on strains of Group IIb are imminent. 
In this study it was not possible to define discrete 
subgroups within Group IIb. In disc susceptibility tests 
Group IIb was heterogeneous, generally resistant, with no 
single agent effective against all strains. Trimethoprim and 
cefoxitin were the most effective agents, and moxalactam 
resistance was greater than expected from the literature. 
The level of beta-lactamase activity was generally high 
and comparable to that of !· meningosepticum. The beta-
lactamases of Group IIb, like those of !· meningosepticum, 
were heterogeneous by both IEF and 3D+CL testing. All Group 
IIb beta-lactamases were inhibited by clavulanate but not by 
cloxacillin. In 3D+CL testing all strains inactivated 
cloxacillin, a finding which in conjunction with the routine 
beta-lactamase analyses suggested that Group IIb produces 
Richmond and Sykes class IV beta-lactamases. Two strains, 
R862 and MP7, exhibited only penicillinase activity. The 
remaining strains however produced broad spectrum beta-
lactamases, with 17 of 19 strains exhibiting activity in 3D+CL 
tests against cefoxitin, cefotaxime and/or imipenem, and thus 
appeared to produce oxyiminocephalosporinases. Clavulanate 
synergy tests were negative for all strains except R34 
suggesting that the beta-lactamases of Group IIb are not a 
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major determinant of resistance to beta-lactam antibiotics. 
There were nine different isoelectric points for the major 
bands of the beta-lactamases of Group IIb. Although some 
bands were associated with groups of strains, particularly pI 
values 8.6 and 9.2, with one exception it was not possible to 
find common phenotypic characters wit~ which to delineate 
subgroups. The exception was strains MP305 and MP 1846 which 
produced a beta-lactamase with a pI of 10.2, had similar 3D+CL 
profiles with both inactivating cefoxitin and imipenem, and 
had similar antibiograms, differing only in susceptibility to 
erythromycin. 
One Group IIb beta-lactamase was identical in its 
isoelectric point to other Flavobacterium beta-lactamases in 
this study. Strains R46, MP7 and MP628 produced a beta-
lactamase of pI 8.6. Other organisms producing beta-
lactamases with this pI were!.· meningosepticum strains NCTC 
10585, R58, MP816, MP969, and the asaccharolytic unclassified 
strain RS. In view of the phenotypic differences among these 
organisms it is difficult to establish the level of 
relationship and its implications for the current taxonomic 
framework. Perhaps, as indicated by Bruun (1982, 1983), 
Thomson (1982) and Hayward and Sly (1984), Flavobacterium does 
not comprise taxonomically discrete species, but rather 
consists of a collection~trganisms in which phenotypic 
patterns merge into each other but certain patterns occur more 
frequently and correspond to the described taxa. The 
significance of a beta-lactamase which occurs independently of 
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species boundaries is consistent with this hypothesis. 
j. Taxonomic Implications for the Flavobacterium/Cytophaga 
Complex 
In this study representative strains of Flavobacterium 
produced beta-lactamases which appeared to belong to Richmond 
and Sykes Class IV. Many of the beta-lactamases hydrolysed at 
least one of the supposedly beta-lactamase-stable antibiotics 
cefoxitin, cefotaxime and imipenem and were therefore regarded 
as oxyiminocephalosporinases. Although the beta-lactamase 
preparations of Cytophaga strains were too inactive for 
isoelectric focussing, the antibiograms and 3D+CL patterns for 
these strains suggested that _g_. aquatilis and _g_. johnsonae 
also produced oxyiminocephalosporinases and were therefore 
Sl)rcu.,;s 
more closely related to the majority of Flavobacteriumiin 
their beta-lactamases and antibiograms strains- than !.· 
aquatile, the type species of the genus. Further studies 
should focus more closely on the beta-lactamases of these 
genera to determine whether or not they share particular 
chromosomal beta-lactamases. The finding of a common beta-
lactamase in strains of Flavobacterium and Cytophaga would 
suggest a closer relationship than previously suggested and 
would indicate that the 'ill-defined' boundary between the 
genera is an artificial one. 
Some of the beta-lactamases of F. odoratum and F. 
multivorum appeared tQ resemble beta-lactamases reported in 
Bacteroides species. If these genera share the same beta-
lactamases it might mean that radical reconstructive taxonomic 
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reforms would need to be considered. It is therefore 
important that the implications of this finding be thoroughly 
investigated. 
Within Flavobacterium the analysis of beta-lactamases 
appeared to be a taxonomic tool of great sensitivity. There 
was considerable heterogeneity within the various species and 
Group !lb. Marre et al. (1982) report that IEF of chromosomal 
beta-lactamases is specific to the subspecies level in ~· 
pneumophila. Since subspecies have not been defined for 
Flavobacterium, perhaps beta-lactamase analysis.might be 
helpful in defining subspecies. There is however wider 
genetic and phenotypic variation within Flavobacterium than is 
usually associated with the subspecies level and therefore 
beta-lactamase analysis could also be employea to investigate 
the wider taxonomic problems of the genus. 
One of the problems which has not been satisfactorily 
addressed is the significan~e of atypical strains. Bruun 
(1982, 1983), Thomson (1982) and Hayward and Sly (1984) were 
unable to assign atypical strains to recognised taxa. The 
heterogeneity of beta-lactamases in Flavobacterium parallels 
the biochemical heterogeneity encountered by these workers. 
Bruun (1982) compared Flavobacterium to "the green fluorescent 
pseudomonads where very many different biochemical patterns 
occur gradually merging into each other, but with some 
occurring more frequently than others; a situation which makes 
subdivision into stable, recognizable species extremely 
difficult". The validity of this analogy is strengthened by 
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the heterogeneity of the beta-lactamases encountered in this 
study. 
The occurrence of beta-lactamases which appear to cross 
species boundaries could be considered as evidence that the 
present species descriptions are unsoundly based. This would 
explain why it is so difficult to accomodate 'atypical' 
strains in the current taxonomic framework of the genus. 
Whether or not the species should be redefined, and whether or 
not there actually are discrete species within Flavobacterium 
are moot points. However in view of the more major taxonomic 
issues at the genus level these questions should ~~ probably 
be placed on the taxonomic backburner for the time being. 
More important questions involve the relationships of the 
genus to Cytophaga and Bacteroides. Until these matters have 
been dealt with satisfactorily the taxonomic framework of the 
redefined genus should be left as it is. 
How then does the heterogeneity of the beta-lactamases and 
other antibiotic tests impact on our broader understanding of 
the taxonomy of the genus? 
Four genetic and phenotypic groups containing species of 
Flavobacterium have been delineated as prospective genera 
(Bauwens and De Ley, 1981; Holmes and Owen, 1981; Holmes et 
al., 1983; Yabuuchi et al., 1983; Holmes, Owen et al., 1984). 
The first of these, which con ta ins F. aqua tile, "!.. 
pectinovorum", "!.· tirrenicum" and C. johnsonae, is the least 
satisfactory arrangement when examined by the antibiotic data 
of this study. The antibiograms and 3D+CL tests suggested 
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that!.· aquatile, "!.· tirrenicum" and ..Q_. johnsonae differed 
substantially from each other and that ..Q_. johnsonae was more 
closely related to the majority of Flavobacterium strains than 
to the organisms of this group. 
The other groups however appear to be taxonomically more 
coherent. These are: 
Group 2: F. odoratum 
Group 3: F. balustinum, F. breve, F. gleum, F. meningosepticum 
and Group Ilb 
Group 4: !.· multivorum, !.· spiritivorum, !· thalpophilum. 
With one possible exception, the results of this study 
supported this division of species into groups. The 
assignment of !· breve to Group 3 would appear less clear cut 
when considered in the light of its interactions with 
antibiotics. This species was much more susceptible to 
antibiotics than the other species of Group 3 and Group II. 
Susceptibility to cefsulodin in particular differentiated F. 
breve from the other members of the group. Furthermore the 
beta-lactamases of !· breve generally appeared to be different 
from those of F. meningosepticum and the!· gleum/Group IIb 
~omplex. By IEF the only similarity was the minor band of 
strain 031 which had the same pI as the major bands of F. 
gleum NCTC 11432 and !.· gleum-like strain 062, and the minor 
bands of four strains of !.· meningosepticum (R58, MP816, MP969 
and MP1702) and the unclassified strain RS. 
Overall it appears that antibiotic investigations, and 
particularly beta-lactamase analysis, have considerable 
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potential for evaluating taxonomic relationships within the 
Flavobacterium/Cytophaga complex. The 3D+CL test proved to be 
a sensitive, convenient and comparatively rapid procedure 
which can be used as a screen for unusual beta-lactamases and 
to establish which substrates should be included in 
conventional hydrolysis assays. Since IEF of beta-lactamases 
is beyond the capabilities of most routine laboratories it is 
important that the results obtained by IEF be correlated with 
more convenient tests such as antibiograms and 3D+CL tests. 
The taxonomic utility of an~ibiograms .is a further reason 
to find ways to overcome the poor correlation between disc and 
MIC susceptibility procedures for Flavobacterium. The 
technical problems, which seem to be greater for this genus 
than for most other clinically occurring genera, may arise 
from the different ways in which ~he organism-antibiotic 
encounter occurs in each method. The differences may perhaps 
be exacerbated by factors such as unusual resistance 
mechanisms (e.g. oxyiminocephalosporinases, EDTA-resistant 
permeability barriers) and suboptimal growth of strains on 
routine susceptibility media at·.~~ 37°C. However the clinical 
need for a reliable susceptibility test far exceeds the 
taxonomic need since the high level o~ multiple antibiotic 
resistance of the genus makes clinicians more dependent than 
ever on the laboratory for an accurate guide to therapy. 
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V. CONCLUSIONS 
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1. Antibiotic susceptibility testing was useful in delineating 
F. aquatile, F. breve, F. meningosepticum and F. odoratum. 
2. Representative strains of Flavobacterium and Cytophaga 
appeared to produce Richmond and Sykes Class IV beta-
lactamases. Many of these beta-lactamases were unusual in 
their ability to hydrolyse at least one of the purportedly 
beta-lactamase-stable antibiotics cefoxitin, cefotaxime and 
, I I 
imipenem. This indicated that these ~1 enzymes} · could be 
further classified as oxyiminocephalosporinases. 
3. Most species of Flavobacterium were heterogeneous in 
antibiotic susceptibility patterns and in the types of beta-
lactamases they produced. Since Class IV beta-lactamases 
are chromosomally mediated this suggested that the beta-
lactamases might prove to be phenotypic markers which can be 
correlated with the genetic variability which has been 
previously reported in some species. 
4. The antibiotic susceptibility pattern of!· aquatile, the 
type species of the genus, was very different from the 
patterns of most other strains of Flavobacterium. This was 
further evidence that it is an inappropriate choice for type 
species. 
5. The beta-lactamase of!· meningosepticum NCTC 10016, the 
type strain of the species, was different from the beta-
lactamases of most other strains of !· meningosepticum. 
This was further evidence that NCTC 10016 is an 
unrepresentative type strain for the species. 
')"'IQ 
6. Similarities in the susceptibility patterns and beta-
lactamases of F. multivorum, !_.spiritivorum and F. 
thalpophilum was further evidence that these species are 
related to each other and are different from other 
Flavobacterium species and added support for the proposal 
that these species be accomodated in a separate genus. 
7. Antibiotic susceptibility patterns and beta-lactamase 
analysis were not useful in delineating subgroups within 
Group Ilb. 
8. Clavulanate synergy studies indicated that beta-lactamases 
may be involved in the resistance to beta-lactam antibiotics 
of!_. meningosepticum, !.· multivorum, !_. spiritivorum, F. 
thalpophilum, ~· aquatilis and ~· johnsonae, but not 
significantly involved in the resistance of!.· aquatile, F. 
gleum, most!· odoratum and Group IIb strains, "F. 
tirrenicum" and F. elegans. 
9. By combining the 3-dimensional and clover leaf tests it was 
possible to screen strains rapidly for unusual beta-
lactamases. This approach is cheaper, faster, more 
versatile and more suited to routine microbiology 
laboratories than more conventional methods for 
investigating the substrate profiles of beta-lactamases. 
280 
VI. BIBLIOGRAPHY 
281 
ABER, R.C., WENNERSTEN, C. and MOELLERING, R.C. Jr. (1978) 
Antimicrobial susceptibility of flavobacteria. Antimicrob. 
Agents Chemother. 14: 483-487. 
AGAR, J.F. (1985) Problems and changing patterns of 
resistance with gram-negative bacteria. Rev. Inf. Dis. 7 
(Suppl. 4): S545-S551. 
AGARWAL, K.C. and RAY, M. (1971) Meningitis in a newborn due 
to Flavobacterium meningosepticum. Ind. J. Res. 59: 1006-
1009. 
ALDOUS, S., CARPENTER, J. and THOMSON, K. (1985) Agar 
antibiotic levels in three-dimensional susceptibility 
testing. J. Microbiol. Meth. 4: 195-202. 
ALTMANN, G. and BOGOKOVSKY, B. (1971) In-vitro sensitivity of 
Flavobacterium meningosepticum to antimicrobial agents. J. 
Med. Microbiol. 4: 296-299. 
AMERICAN TYPE CULTURE COLLECTION (1980) Catalogue of Strains 
I, 14th ed. Rockville, Maryland: p 77. American Type 
Culture Collection. 
AMBLER, R.P. (1980) The structure of beta-lactamases. Philos. 
Trans. R. Soc. Lond. (Biol.) 289: 321-331. 
ANACKER, R.L. and ORDAL, E.J. (1959) Studies on the 
myxobacterium Chondrococcus columnaris. I. Serological 
typing. J. Bacteriol. 78: 25-32. 
ANDERSON, E.S. (1968' The ecology of transferable drug 
resistance in Enterobacteria. Ann. Rev. Microbiol. 22: 
131-181. 
ANDREMONT, A., GERBAUD, G., TANCREDE, C. and COURVALIN, P. 
Desavantage ecologique chez Escherichia coli: role d'un 
plasmide conferant la resistance a l'erythromycine. 
Proceedings Reunion Interdisciplinaire de Chimiotherapie 
282 
Antiinfectieuse. Societe francaise de Microbiologie, ' 
Paris 1982, p 50. 
ANDREONI, S. (1986' Isolamento di Flavobacterium odoratum da 
materiali di provenienza umana. Quad. Sclavo Diagn. 22: 
318-329. 
ANDREWS, P. (1964) Estimation of molecular weights of 
proteins by Sephadex gel filtration. Biochem. J. 91: 222-
233. 
ARANOFF, S.C. and SHLAES, D.M. (1987) Factors that influence 
the evolution of beta-lactam resistance in beta-lactamase-
inducible strains of Enterobacter cloacae and Pseudomonas 
aeruginosa. J. Infect. Dis. 155: 936-941. 
'AVORN, J., HARVEY, K., SOUMERAI, S.B., HERXHEIMER, A., 
PLUMRIDGE, R. and BARDELAY, G. (1987) Information and 
education as determinants of antibiotic use: report of 
Task Force 5. Rev. Infect. Dis. 2_ (Suppl. 3): 286-296. 
BAKKEN, J.S. and SANDERS, C.C. (1987) New developments in 
bacterial resistance mediated by beta-lactamases. ISI 
Atlas of Science:Pharmacology 1: 87-90. 
BAKKEN, J.S., SANDERS, C.C. and THOMSON, K.S. (1987) 
Selective ceftazidime resistance in Escherichia coli: 
association with changes in outer-membrane protein. J. 
Infect. Dis. 155: 1220-1225. 
BARBER, M. and KUPER, S.W.A. (1951) Identific~tiqn of 
Staphylococcus pyogenes by the phosphatase reaction. J. 
Pathol. Bacteriol. 63: 65-68. 
BARRY, A.L. and FAY, G.D. (1974) Evaluation of four disk 
diffusion methods for antimicrobic susceptibility tests 
with anaerobic Gram-negative bacilli. Am. J. Clin. 
283 
' 
Pathol. 61: 592-598. 
BARRY, A.L., JONES, R.N. and THORNSBERRY, C. (1981) 
Cefsulodin: antibacterial activity and tentative 
interpretive zone standards for disk susceptibility test. 
Antimicrob. Agents Chemother. ~: 525-529. 
BATCHELOR, F.R., DOYLE, F.P., NAYLER, J.H.C. and ROLINSON, 
G.N. (1959' Synthesis of penicillin: 6-aminopenicillanic 
acid in penicillin fermentations. Nature 183: 257-258. 
BAUERNFEIND, A. (1986) Classification of beta-lactamases. 
Rev. Infect. Dis. 8 (Suppl. 5): 470-479. 
BAUWENS, M. (1980) Intragenic and intergeneric similarities 
of ribosomal ribonucleic acid cistrons of Flavobacterium. 
Antonie van Leeuwenhoek J. Microbiol. Serol. 46: 95. 
BAUWENS, M. and DE LEY, J. (1981) Improvements in the taxonomy 
of Flavobacterium by DNA:rRNA hybridizations. In: 
Reichenbach and Weeks (editors), The Flavobacterium-
Cytophaga Group (Proceedings of the International 
Symposium on Yellow-Pigmented Gram-Negative Bacteria of 
the Flavobacterium-Cytophaga Group, Braunschweig July 8 to 
11, 1980). Verlag Chemie, Weinheim: pp~7-31. 
BELL, S.M. (1975) The CDS disc method of antibiotic 
sensitivity testing (Calibrated Dichotomous Sensitivity 
Test). Pathology]__ (4), Suppl. 
BELL, S.M. (1984) Antibiotic sensitivity testing by the CDS 
method. In: Clinical Microbiology Update Programme No. 
21. (Editor, N. Hartwig). New South Wales Branch of the 
Australian Society for Microbiology. 
BELLO, H., NORAMBUENA, R., MONDACA, M.A., MONTOYA, R. and 
ZEMELMAN, R. (1987) Inactivation of some third-generation 
cephalosporins by beta-lactamases of non-fermentative 
284 
Gram-negative.bacteria isolated from freshwater of a 
remote environment. Lett. Appl. Microbiol. 5: 123-126. 
BERGEY, D.H., BREED, R.S., MURRAY, E.G.D. and HITCHENS, A.P. 
(1939) Bergey's Manual of Determinative Bacteriology, 5th 
edition. Balliere, Tindall and Cox, London. 
BERGEY, D.H., HARRISON, F.C., BREED, R.S., HAMMER, B.W. and 
HUNTOON, F.M. (1923) Bergey's Manual of Determinative 
Bacteriology, lst edition. Balliere, Tindall and Cox, 
London. 
BERGSTROM, S., OLSSON, O. and NORMARK, S. (1982) Common 
evolutionary origin of chromosomal beta-lactamases in 
enterobacteria. J. Bacteriol. 150: 528-534. 
BLACKALL, L.L., HAYWARD, A. and SLY, L.I. (1985) Cellulytic 
and dextranolytic gram-negative bacteria: revival of the 
genus Cellvibrio. J. Appl. Bact. ~: 81-97. 
BREED, R.S., MURRAY, E.G.D. and SMITH, N.R. (1957) Bergey's 
Manual of Determinative Bacteriology, 7th edition. 
Williams and Wilkins Co. Baltimore, Maryland. 
BRIDGES, K. and LOWBURY, E.J.L. (1977) Drug resistance in 
relation to use of silver sulphadiazine cream in a burns 
unit. J. Clin. Path. 30: 160-164. 
BRIVE, C., BARTHELEMY, M., BOUANCHAUD, D.H. and LABIA, R. 
(1977) Microheterogeneite en electrofocalisation 
analytique de beta-lactamases d'origine plasmidique. Ann. 
Microbiol. 128B: 309-317. 
BRODY, J.A., MOORE, H. and KING, E.O. (1958) Meningitis 
caused by an unclassified gram-negative bacterium in 
newborn infants. Am. Med. Assoc. J. Dis. child. 96: 1-5. 
BROGDEN, R.N. and HEEL, R.C. (1986) Aztreonam A review of its 
285 
antibacterial activity, pharmacokinetic properties and 
therapeutic use. Drugs l!= 96-130. 
BROWN, A.G. (1981) New naturally occurring beta-lactam 
antibiotics and related compounds. J. Antimicrob. 
Chemother. 7: 15-48. 
BROWN, A.G. (1982) Beta-lactam nomenclature. J. Antimicrob. 
Chemother. 10: 365-368. 
BROWN, A.G. and READING, C. (1983) The Beta-lactam 
antibiotics. Culture 2: 1-4. 
BRUUN, B. (1987) Antimicrobial susceptibility of 
Flavobacterium meningosepticum strains identified by DNA-
DNA hybridization. Acta Path. Microbial. Scand. Sect B 95: 
95-101. 
BRUUN, B. and URSING, J. (1987) Phenotypic characterization 
of Flavobacterium meningosepticum strains identified by 
DNA-DNA hybridization. Acta Path. Microbial. Immunol. 
Scand. Sect. B, 22_: 41-47. 
BUCKWOLD, F.J. and RONALD, A.R. (1979) Antimicrobial misuse -
effects and suggestions for control. J. Antimicrob. 
Chemother. 5: 129-136. 
BULGER, R.J., ROBERTS, C.E. and SHERRIS, J.C. (1967) Changing 
incidence of antibiotic resistance among Staphylococcus 
aureus, Escherichia coli, Aerobacter-Klebsiella, and 
Pseudomonas encountered in a reaching hospital over a 7-
year period. Antimicrobial Agents and Chemotherapy - 1966. 
American Society for Microbiology, Ann Arbor, pp 42-44. 
BURNAKIS, T.G., MIODUCH, H.J., LEBAR, W.D. and YALAMANCHI, 
R.R. (1986) Sepsis from Flavobacterium meningosepticum, 
an uncommon pathogen with unusual susceptibility patterns. 
286 
South. Med. J. 79: 518-519. 
BUSH, K., TANAKA, K., BONNER, D.P. and SYKES, R.B. (1985) 
Resistance caused by decreased penetration of beta-lactam 
antibiotics into Enterobacter cloacae. Antimicrob. Agents 
Chemother. 27: 555-560. 
BUSH, K. and SYKES, R.B. (1986) Methodology for the study of 
beta-lactamases. Antimicrob. Agents Chemother. lQ_: 6-10. 
CABRERA, H.A. and DAVIS, G.H. (1961) Epidemic meningitis of 
the newborn caused by Flavobacterium. I. Epidemiology and 
bacteriology. Am. J. Dis. Child. 101: 289-295. 
CALLIES, E. and MANNHEIM, W. (1978) Classification of the 
Flavobacterium-Cytophaga complex on the basis of 
respiratory quinones and fumarate respiration. Int. J. 
Syst. Bacteriol. ~: 14-19. 
CALLIES, E. and MANNHEIM, W. (1980) Deoxyribonucleic acid 
relatedness of some menaquinone producing Flavobacterium 
and Cytophaga strains. Antonie v. Leeuwenhoek~: 41-49. 
CALLIHAN, D.R., YOUNG, F.E. and CLARK, V.L. (1984) Presence 
of two unique genes encoding macrolide-lincosamide-
streptogramin resistance to members of the Bacteroides 
fragilis group as determined by DNA-DNA homology. J. 
Antimicrob. Chemother. 14: 329-338. 
CARTWRIGHT, S.J. and WALEY, S.G. (1984) Purification of beta-
lactamases by affinity chromatography on phenylboronic 
acid-agarose. Biochem. J. 221: 505-512. 
CARTY, C.E. and LITCHFIELD, C.D. (1978) Characterization of a 
new marine sedimentary bacterium as Flavobacterium 
oceanosedimentum sp. nov. Int. J. Syst. Bacteriol. 28: 
561-566. 
287 
' 
CHANDRIKA, T. and ADLER, S.P. (1982) A case of neonatal 
meningitis due to Flavobacterium meningosepticum 
successfully treated with rifampicin. Pediatr. Infect. 
Dis. 1: 40-41. 
CHEN, H.Y. and WILLI~MS, J.D. (1982) Temocillin compared to 
ampicillin against Haemophilus influenzae and with other 
penicillins against intestinal aerobic Gram-negative rods. 
J. Antimicrob. Chemother. 10: 279-287. 
CHEN, H.Y. and WILLIAMS, J.D. (1985) The activity of 
temocillin against Enterobact~riaceae, Pseudomonas and 
Haemophilus influenzae. Drugs~ (Suppl. 5): 85-90. 
CHEUNG, B.A. and WESTHOFF, D.C. (1983) Isolation and 
identification of ropy bacteria in raw milk. J. Diary Sci. 
66: 1825-1834, 
CHRISTENSEN, P. (1980) Description and taxonomic status of 
Cytophaga heparina (Payza and Korn) comb. nov. (basionym: 
Flavobacterium heparinum Payza and Korn 1956). Int. J, 
Syst. Bacteriol. ~: 473-475. 
CLARKE, A.M. and ZEMCOV, S.J.V. (1984) Clavulanic acid in 
combination with ticarcillin: an in vitro comparison with 
other beta-lactams. J. Antimicrob. Chemother. 13: 121-128. 
CONN, H.J. (1957) Staining methods. In: Manual of 
Microbiological Methods. Society of American 
Bacteriologists, London. McGraw-Hill. 
CONNER, C.S. (1985) Beta-lactamase inhibitors. Drug Intell. 
Clin. Pharm. 19: 475-476. 
CORNELIS, G. and ABRAHAM, E.P. (1975) Beta-lactamases from 
Yersinia enterocolitica. J. Gen. Microbiol. 87: 273-284. 
COURVALIN, P., OUNISSI, H. and ARTHUR, M. (1985) Multiplicity 
of macrolide-lincosamide-streptogramin antibiotic 
288 
resistance determinants. J. Antimicrob. Chemother. 16 
(Suppl. A): 91-100. 
COWAN, S.T. and STEEL, K.J. (1970) Manual for the 
Identification of Medical Bacteria. The Syndics of the 
Cambridge University Press, London. 
COYLE-GILCHRIST, M.M., CREWE, P. and ROBERTS, G. (1976) 
Flavobacterium meningosepticum in the hospital 
environment. J. Clin. Path. 29: 824-826. 
CRUMP, J. and CANSDALE, S. (1982) Enterobacter resistant to 
amoxycillin/clavulanate. Lancet l= 500. 
CROSSLEY, K.B. (1986) Vancomycin. In: PETERSON, P.K. and 
VERHOF, J. (Editors), The Antimicrobial Agents Annual 1. 
Elsevier, Amsterdam: pp 205-212. 
CUCHURAL, G.J., MALAMY, M.H. and TALLY, F.P. (1986) 
Beta-lactamase-mediated imipenem resistance in Bacteroides 
fragilis. Antimicrob. Agents Chemother. lQ_: 645-648. 
CULLMANN, W. (1985) Hydrolysis of third-generation 
cephalosporins by Enterobacter cloacae beta-lactamase. 
Eur. J. Clio. Microbiol. 4: 607-609. 
CULLMANN, W., DALHOFF, A. and DICK, W. (1984) Nonspecific 
induction of beta-lactamas~ in Enterobacter cloacae. J. 
Gen. Microbiol. 130: 1781-1786. 
CURTI, J.T. (1975) Antibiotics and Gram-negative bacteremia. 
J.A.M.A. 231: 1361-1363. 
DAVIS, J.M., PEEL, M.M. and GILLIANS, J.A.· (1979) 
Colonization of an amputation site by Flavobacterium 
odoratum after gentamicin therapy. Med. J. Aust. 2: 703-
704. 
DECAZES, J.M., BURE,~., WOLFF, M., KITZIS, M.D., PANGON, B. 
289 
and MODAI, J. (1987) Bactericidal activity against 
Haemophilus influenzae of cerebrospinal fluid of patients 
given amoxicillin-clavulanic acid. Antimicrob. Agents 
Chemother. 31: 2018-2019. 
DEES, S.B., CARLONE, G.M., HOLLIS, D. and MOSS, C.W. (1985) 
Chemical and phenotypic characteristics of Flavobacterium 
thalpophilum compared with those of other Flavobacterium 
and Sphingobacterium species. Int. J. Syst. Bacteriol. 
35: 16-22. 
DEES, S.B., MOSS, C.W., WEAVER, R.E. and HOLLIS, D. (1979) 
Cellular fatty acid composition of Pseudomonas 
paucimobilis and Groups IIk-2, Ve-1 and Ve-2. J. Clin. 
Microbiol. 10: 206-209. 
DHAWAN, V.K., RAJASHEKARIAIAH, K.R., METZGER, W.I., RICE, T.W. 
and KALLICK, C.A. (1980) Spontaneous bacterial 
peritonitis due to a Group IIk-2 strain. J. Clin. 
Microbiol. 11: 492-495. 
DIXSON, S. and ANDREW, J.H. (1985) The in vitro activity of 
the newer beta-lactam antibiotics against 124 strains of 
Gram-negative bacilli. Pathology 17: 636-639. 
DU MOULIN, G. (1979) Airway colonization by Flavobacterium in 
an intensive care unit. J. Clin. Microbial. 10:· 155-160. 
EECKELS, R., VANDEPITTE, J. and SEYNHAEVE, V. (1965) Neonatal 
infections with Flavobacterium meningosepticum. Belgisch 
Tijdschrift voor Geneeskunde ~: 244-256. 
ELEY, A. and GREENWOOD, D. (1986) Beta-lactamases of type 
culture strains of the Bacteroides fragilis group of 
strains that hydrolyse cefoxitin, latamoxef and imipenem. 
J. Med. Microbiol. 21: 49-57. 
ELIOPOULOS, G. M. (1986\ Penicillins. In: PETERSON, P.K. and 
290 
VERHOF, J. (Editors), The Antimicrobial Agents Annual 1. 
Elsevier, Amsterdam: pp 144-163. 
FAINSTEIN, V. and BODEY, G.B. (1985) Single-agent therapy for 
infections in neutropenic cancer patients. Am. J. Med. 
!..J... Suppl 2A: 83-88. 
FASS, R.J. and HELSEL, V.L. (1985) In vitro activity of 
carumonam. Antimicrob. Agents Chemother. ~: 834-836. 
FAUTZ, E., GROTJAHN, L. and REICHENBACH, H. (1981) Hydroxy 
fatty acids as valuable chemosystematic markers in gliding 
bacteria and flavobacteria. In: Reichenbach and Weeks 
(editors), The Flavobacterium-Cytophaga Group (Proceedings 
of the International Symposium on Yellow-Pigmented Gram-
negative Bacteria of the Flavobacterium-Cytophaga Group, 
Braunschweig July 8 to 11, 1980). Verlag Chemie, 
Weinheim, pp 127-133. 
FAUTZ, E. and REICHENBACH, H. (1980) A simple test for 
flexirubin-type pigm~nts. F.E.M.S. Microbiology Letters 
8: 87-91. 
FEELEY, T.W., DU MOULIN, G.C., HEDLEY-WHYTE, J. BUSHNELL, L.S., 
GILBERT, J.P. and FEINGOLD, D.S. (1975) Aerosol polymyxin 
and pneumonia in seriously ill patients. New Eng. J. Med. 
293: 471-475. 
FERLAUTO, J.J. and WELLS, D.H. (1981) Flavobacterium 
meningosepticum in the neonatal period. Southern Med. J. 
(Birmingham, Alabama) J..!!..: 757-759. 
FINLAND, M. (1970) Changing ecology of bacterial infections as 
related to antibacterial therapy. J. Infect. Dis. 122: 
419-431. 
FINLAND, M. (1971) Changing prevalence of pathogenic bacteria 
291 
in relation to time and the introduction and use of 
antimicrobial agents. In: Bacterial Infections. Bayer 
Symposium III. Springer Verlag, pp 4-18. 
FINLAND, M, JONES, W.F. Jr and BARNES, M.W. (1959) Occurrence 
of serious bacterial infections since introduction of 
antibacterial agents. J. Am. med. Ass. 170: 2188-2197. 
FLEMING, A. (1929) On the antibacterial action of cultures of 
a penicillium, with special reference to their use in the 
isolation of B. influenzae. Br. J. exp. Path. _!Q: 226. 
FLOREY, H.W. (1955) Antibiotic production of a versatile 
fungus (James D. Bruce Memorial Lecture; American College 
of Physicians.) Ann. intern. Med. 43: 480-490. 
FLOREY, H.W. (1956' The medical aspects of the development of 
resistance to antibiotics. Giorn. Microbiol. 2: 361-370. 
FREID, M.A. and VOSTI, K.L. (1968) The importance of 
underlying disease in patients with gram-negative 
bacteraemia. Arch. Int. Med. 121: 410-420. 
FREIMER, E.H., DONABEDIAN, H., RAEDER, R. and RIBNER, B.S. 
(1985) Empirical use of imipenem as the sole antibiotic in 
the treatment of serious infections. J. Antimicrob. 
Chemother. 16: 499-507. 
FRENEY, J., HANSEN, W., PLOTON, C., MEUGNIER, H., MADIER, S., 
BORNSTEIN, N. and FLEURETTE, J. (1987) Septicemia caused 
by Sphingobacterium multivorum. J. Clin. Microbiol. 25: 
1126-1128. 
FUCHS, P.C., BARRY, A.L., JONES, R.N. and THORNS~ERRY, C. 
(1984) Temocillin: in vitro activity against 734 selected 
clinical isolates, including beta-lactamase producing-
strains. Diagn. Microbiol. Infect. Dis. 2: 55-63. 
FUJII,T., SATO, K., MIYATA, K., INOUE, M. and MITSUHASHI, S. 
292 
(1986). biochemical properties of beta-lactamase produced 
by Legionella gormanii. Antimicrob. Agents Chemother. 29: 
925-926. 
GAL, S., TOTH-MARTINEZ, B. and KISS, L. (1983) Use of 
chromatofocussing for separation of beta-lactamases. III. 
Beta-lactamases of the Bacillus cereus 569/H strain. J. 
Chromatgr. 264: 170-173. 
GAMAN, W., CATES, C., SNELLING, C.F.T., LANK, B. and RONALD, 
A.R. (1976) The emergence of gentamicin and carbenicillin-' 
resistant Pseudomonas aeruginosa in a hospital environment. 
Antimicrob. Agents Chemother. 9: 474-480. 
GARDNER, P., BENNETT, J.V., BURKE, J.P., MCGOWAN, J.E. Jr, and 
WENZEL, R.P. (1980) Nosocomial management of resistant 
Gram-negative bacilli [editorial]. J. Infect. Dis. 141: 
415-417. 
GARROD, L.P., LAMBERT, H.P. and O'GRADY, F. (1973). 
Antibiotics and Chemotherapy Fourth Edition. Churchill 
Livingstone, London, pp 257-274. 
GATES, M.L., SANDERS, C.C., GOERING, R.V. and SANDERS JR, W.E. 
(1986) Evidence for multiple forms of type I chromosomal 
beta-lactamase in Pseudomonas aeruginosa. Antimicrob. 
Agents Chemother. 30: 453-457. 
GEORGE, R.M., COCHRAN, C.P. and WHEELER, W.E. (1961) Epidemic 
meningitis of the newborn caused by flavobacteria. Am J. 
Dis. Children 101: 50/296-58/304. 
GILARDI, G.L. (1987) Identification of glucose-nonfermenting 
Gram-negative rods. Department of Laboratories, North 
General Hospital, 1919 Madison Avenue, New York, New York 
10035. 
293 
GILL, F.A. and HOOK, E.W. (1965) Changing patterns of 
bacterial resistance to antimicrobial drugs. Amer. J. Med. 
39: 780-795. 
GIORGI, W., MORITA, T. and VIANNA, S.S.S. (1975) Endocardite 
purulenta em bovino produiza por Flavobacterium 
meningosepticum. 0 Biol6gico i!_: 357-358. 
GODFREY, A.J. and BRYAN, L.E. (1984) Resistance of 
Pseudomonas aeruginosa to new beta-lactamase-resistant 
beta-lactams. Antimicrob. Agents Chemother. ~: 485-488. 
GOOTZ, T.D. and SANDERS, C.C. (1983) Characterization of beta-
lactamase induction in Enterobacter cloacae. Antimicrob. 
Agents Chemother. 23: 91-97. 
GOOTZ, T.D., SANDERS, C.C. and GOERING, R.V. (1982) 
Resistance to cefamandole: derepression of beta-lactamase 
by cefoxitin and mutation in Enterobacter cloacae. J. 
Infect. Dis. 146: 34-42. 
GOULD, I.M. and WISE, R. (1986) Beta-lactamase inhibitors. 
In: PETERSON, P.K. and VERHOF, J. (Editors), The 
Antimicrobial Agents Annual 1. Elsevier, Amsterdam: pp 
51-65. 
GOULD, I.M. and WISE, R. (1987) Beta-lactamase inhibitors. 
In: PETERSON, P.K. and VERHOF, J. (Editors), The 
Antimicrobial Agents Annual 2. Elsevier, Amsterdam: pp 
58-69. 
GOLDSTEIN, F.W., GUTMAN, L., WILLIAMSON,R., COLLATZ, E. and 
ACAR, J.F. (1983) In vivo and in vitro emergence of 
simultaneous resistance to both beta-lactam and 
aminoglycoside antibiotics in a strain of Serratia 
marcescens. A. Microbiol. Paris 134A: 329-337. 
GRAVENKEMPER, C.F., BENNETT, J.V., BRODIE, J.L. and KIRBY, 
294 
W.M.M. (1965) Dicloxacillin. In vitro and pharmacologic 
comparisons with oxacillin and·cloxacillin. Archs intern. 
Med. 116: 340-345. 
GREENBERG, R.N., REILLEY, P.M., LUPPEN, K.L. ET AL (1985) 
Aztreonam therapy for Gram-negative pneumonia. Am. J. Med. 
78: 31-33. 
GREENWOOD, D. (1981) In vitro veritas? Antimicrobial 
susceptibility tests and their clinical relevance. J. 
Infect. Dis. 144: 380-385. 
GREENWOOD, D. (1986) An overview of the response of bacteria 
to beta-lactam antibiotics. Rev. Infect. Dis. ~ Suppl. 5: 
S487-S495. 
GRIFFITH, R.S. and BLACK, H.R. (1964) Cephalothin - a new 
antibiotic. Preliminary and clinical studies. J. Am. 
med. Ass. 189: 823-828. 
GUTMANN, L. and WILLIAMSON, R.A. (1983) A model system to 
demonstrate that beta-lactamase-associated antibiotic 
trapping could be a potential means of resistance. J. 
Infect. Dis. 148: 316-321. 
HANCOCK, R.E.W. (1986) Intrinsic resistance of Pseudomonas 
aeruginosa. J. Antimicrob. Chemother. 18: 653-659. 
HARRISON, F.C. (1929) The discoloration of halibut. Can J. 
Res. 1: 214-239. 
HAYES, P.R. (1977) A taxonomic study of flavobacteria and 
related gram-negative yellow pigmented rods. J. Appl. 
Bacterial. 43: 345-367. 
HAYES, P.R., MCMEEKIN, T.A. and SHEWAN, J.M. (1979) In: 
Identification Methods for Microbiologists Second Edition. 
The Society for Applied Bacteriology Technical Series No. 
295 
14. Skinner, F.A. and Lovelock, D.W. (eds). Academic 
Press, London and New York. 
HAYWARD, A.C. (1975) Systematics of dextran-hydrolysing 
bacteria from soil. Proc. Soc. Gen. Microbiol. 3: 11. 
HAYWARD, A.C. and SLY, L. I. (1984) Characterization of a 
dextranolytic biotype of Flavobacterium multivorum 
from soil. J. Appl. Bacteriol. 57: 505-516. 
HAZUKA, B.T., DAJANI, A.S., TALBOT, K. and KEEN, B.M. (1977) 
Two outbreaks of Flavobacterium meningosepticum type E in 
a neonatal intensive care unit. J. Clin. Microbial. 6: 
450-455. 
HENRICHSEN, J. (1972) Bacterial surface translocation: a 
survey and a classification. Bacteriol. Rev. 36: 478-503. 
HIRAI, K., IYOBE, S., INOUE, M. and MITSUHASHI, S. (1980) 
Purification and properties of a new beta-lactamase from 
Pseudomonas cepacia. Antimicrob. Agents Chemother. 17: 
355-358. 
HIRSCH, B.E., WONG, B., KIEHN, T.E. and ARMSTRONG, D. (1986\ 
Flavobacterium meningosepticum bacteremia in an adult 
with acute leukemia. Diagn. microbial. Infect. Dis. 4: 
65-69. 
HOBOT, J.A., CARLEMALM, E., VILLIGER, W. and KELLENBERG, E. 
(1984) Periplasmic gel: new concept resulting from the 
reinvestigation of bacterial cell envelope ultrastructure 
by new methods. J. Bacteriol. 160: 143-152. 
HOLDEMAN, L.B., KELLEY, R.W. and MOORE, W.E.C. (1984) 
Bacteroides. In: KRIEG, N.R. and HOLT, J.G. (editors) 
Bergey's Manual of. Systematic Bacteriology Volume 1. 
Williams and Wilkins, Baltimore pp 604-631. 
HOLMES, B. (1987) Identification and distribution of 
296 
Flavobacterium meningosepticum in clinical material. 
J. Appl. Bacteriol. ~: 29-41. 
HOLMES,B., HOLLIS, D.G., STEIGERWALT, A.G., PICKETT, M.J. and 
BRENNER, D.J. (1983) Flavobacterium thalpophilum, a new 
species recovered from human clinical material. Int. J. 
Syst. Bacteriol. 33: 677-682. 
HOLMES, B. and OWEN, R.J. (1979) Proposal that Flavobacterium 
breve be substituted as the type species of the genus in 
place of Flavobacterium aquatile and emended description 
of the genus Flavobacterium: status of the named species 
of Flavobacterium. Request for an opinion. Int. J. Syst. 
Bacteriol. 29: 416-426. 
HOLMES, B. and OWEN, R.J. (1981) Emendation of the genus 
' Flavobacterium and the status of the genus. Developments 
after the 8th edition of Bergey's Manual. In: Reichenbach and 
Weeks (editors), The Flavobacterium-Cytophaga Group 
(Proceedings of the International Symposium on Yellow-
Pigmented-Gram-negative Bacteria of the Flavobacterium-
Cytophaga Group, Braunschweig July 8 to 11, 1980). 
Verlag Chemie, Weinheim, pp 17-26. 
HOLMES, B., OWEN, R.J. and HOLLIS (1982) Flavobacterium 
spiritivorum, a new specie~ isolated from human clinical 
specimens. Int. J. Syst. Bacteriol. 32: 157-165. 
HOLMES, B., OWEN, R.J. and MCMEEKIN, T.A. (1984a) Genus 
Flavobacterium Bergey, Harrison, Breed, Hammer and Huntoon 
1923, 97AL. In: KRIEG, N.R. and HOLT, J.G. (editors) 
Bergey's Manual of Systematic Bacteriology Volume 1. 
Williams and Wilkins, Baltimore pp 353-361. 
HOLMES, B., OWEN, R.J., STEIGERWALT, A.G. and BRENNER, D.J. 
297 
(1984b) Flavobacterium gleum, a new species found in human 
clinical specimens. Int. J. Syst. Bacteriol. ~: 21-25. 
HOLMES, B., OWEN, R.J. and WEAVER, R.E. (1981) Flavobacterium 
multivorum, a new species isolated from human clinical 
specimens, and previously known as Group Ilk, biotype 2. 
Int. J. Syst. Bacteriol. ~: 21-34. 
HOLMES, B., PINNING, C.A. and DAWSON, C.A. (1986) A 
probability matrix for the identification of Gram-
negative, aerobic, non-fermentative bacteria that grow on 
nutrient agar. J. Gen. Microbiol. 132: 1827-1842. 
HOLMES, B., SNELL, J.J.S. and LAPAGE, S.P. (1978) Revised 
description, from clinical strains, of Flavobacterium 
breve (Lustig) Bergey et al., 1923 and proposal of the 
neotype. Int. J. Syst. Bacteriol. 28: 201-208. 
HOLMES, B., SNELL, J.J.S. and LAPAGE, S.P. (1979) 
Plavobacterium odoratum: a species resistant to a wide 
range of antimicrobial agents. J. Clin. Path. 32: 73-77. 
HOLMES, B., STEIGERWALT, A.G., WEAVER, R.E. and BRENNER, D.J. 
(1986) Weeksella virosa gen. nov., sp. nov. (formerly 
Group IIf), found in human clinical specimens. System. 
Appl. Microbiol. 8: 185-190. 
HOLMES, B., STEIGERWALT, A.G., WEAVER, R.E. and BRENNER, D.J. 
(1986) Weeksella zoohelcum sp. nov. (formerly Group IIj), 
from human clinical specimens. System. Appl. Microbiol. 8: 
191-196. 
HOWARTH, T.T., BROWN, A.G. and KING, T.J. (1976) Clavulanic 
acid, a novel beta-lactam isolated from Streptomyces 
clavuligerus. J •. Chem. Soc. Chem. Communications 7:266-
267. 
HUGH, R. and LE~FSON, E. (1953) The taxonomic significance of 
298 
fermentative versus oxidative metabolism of carbohydrates 
by various gram-negative bacteria. J. Bacteriol. 66: 24-
26. 
HUSSON, M.O., IZARD, D., BOUILLET, L. and LECLERC, H. (1985) 
Comparative in-vitro activity of ciprofloxacin against 
nonfermenters. J. Antimicrob. Chemother. 15: 457-462. 
IGARI, J., KOSAKAI, N. and OGURI, T. (1983) An in vitro study 
of susceptibility of Flavobacterium meningosepticum to 
antibiotics. Jpn J. Antibiot. 36: 111-116. 
JACKSON, G.G. (1979) Antibiotic policies, practices and 
pressures. J. Antimicrob. Chemother. 5: 1-4. 
JAFFE, A., CHABBERT, Y.A. and SEMONIN, O. (1982) Role of porin 
proteins OmpF and OmpC in the permeation of beta-lactams. 
Antimicrob. Agents Chemother. 22: 942 948. 
JAFFE, A., CHABBERT, Y.A. and DERLOT, E. (1983) Selection and 
characterization of beta-lactam-resistant Escherichia coli 
K-12 mutants. Antimicrob. Agents Chemother. 23: 622-625. 
JANSON, J. (1975) Studies on dextran-degrading enzymes. 
Isolation and identification of a dextranase-producing 
strain of Cytophaga johnsonii and studies on the formation 
of the surface-bound enzyme. J. Gen. Microbiol. 88: 205-
208. 
JAURIN, B. and GRUNDSTROM, T. (1981) AmpC cephalosporinase of 
Escherichia coli K-12 has a different evolutionary origin 
from that of beta-lactamases of the penicillinase type. 
Proc. Natl. Acad. Sci. USA 78 4897-4901. 
JOHNY, M., KHUFFASH, F.A. and ELHAG, K.M. (1983) 
Antimicrobial treatment of Flavobacterium meningosepticum 
infe'ction. Ann. Trop. Paediatr. 3: 125-128. 
299 
JOOSTE, P.J., BRITZ, T.J. and DE HAAST, J. (1985) A numerical 
taxonomic study of Flavobacterium-Cytophaga strains from 
dairy sources. J. Appl. Bacteriol. 22_: 311-323. 
J,0'RGENSEN, J.H. (1985) Susceptibility test methods which may 
be able to predict the emergence of resistance to newer 
beta-lactam antibiotics. Chemioterapia ~: 7-13. 
JORGENSEN, P.E. (1985) The clover-leaf test and inactivation 
of beta-lactam antibiotics by Gram-negative rods. 
Chemother. 31: 95-101. 
JOUVENOT, M., DESCHASEAUX, M., MICHEL-BRIAND, Y. and ADESSI, 
G.L. (1984) Beta-lactamase with high molecular weight: . 
_evidence for an interaction with neuraminic acid-~ontain­
ing structures. J. Antimicrob. Chemother. 14: 549-552. 
JOUVENOT, M., DESCHASEAUX, M., ROYEZ, M., MOUGIN, C., COOKSEY, 
R.C., MICHEL-BRIAND, Y. and ADESSI, G.L. (1987) Molecular 
hybridization versus isoelectric focussing to determine 
TEM-type beta-lactamases in Gram-negative bacteria. 
Antimicrob. Agents Chemother. ~: 300-305. 
KELSEY, M.C., EMMERSON, A.M. and DRABU, Y. (1982) 
Flavobacterium meningosepticum ventriculitis: in vivo and 
in vitro results with the combinations rifampicin-
erythromycin and mezlocillin-cefoxitin. Eur. J. Clin. 
Microbiol. 1: 138-143. 
KING, E.O. (1959) Studies on a group of previously 
unclassified bacteria associated with meningitis in 
infants. Am. J. Clin. Path. 31: 241-247. 
KING, A. GRANSDEN, W.R. and PHILLIPS, I. (1983) The effect of 
clavulanic acid on the susceptibility to ticarcillin of 
Enterobacteriaceae and Pseudomonas aeruginosa that produce 
chromosomially and plasmid-determined beta-lactamases. In: 
300 
SPITZKY, K.M. and KARRER, K (editors), Proceedings 13th 
ICC, Vienna, Vol. 2, 89/56. Egermann, Vienna. 
\ 
KISS, L., GAL, S., TOTH-MARTINEZ, B.L. and PETRIKOVICS, I. 
(1983) Use of chromatofocussing for separation of beta-
lactamases. II. Beta-lactamase of a characterized 
Pseudomonas aeruginosa strain. J. Chromatogr. 262: 379-
384. 
KJELLANDER, J. and MYRBACH, K.E. (1964) A simple test for 
penicillinase production. Acta Pathol. Microbiol. Scand. 
61: 494. 
KLASTERSKY, J. (1985) Nosocomial infections due to Gram-
negative bacilli in compromised hosts: considerations for 
prevention and therapy. Rev. I~f. Dis. 7 Suppl. 4: 552-
558. 
KNOTT-HUNZIKER, V., PETURSSON, S., JAYATILAKE, G.S., WALEY, 
S.G., JAµRIN, B., and GRUNDSTROM, T. (1982) Active sites 
of beta-lactamases. The chromosomal beta-lactamases of 
Pseudomonas aeruginosa and Escherichia coli. Biochem. J. 
201: 621-627. 
KOHUT, P. (1979) Isolation of bacteria designated as "Group 
M-4f" (Flavobacterium odoratum) from clinical materials. 
Bratisl. Lek. Listy. 2l_: 65-70. 
KOMATSU, Y., MURAKAMI, Kand NISHIKAWA, T. (1981) Penetration 
of moxalactam into its target proteins in Escherichia coli 
Kl2: comparison of a highly moxalactam-resiJtant mutant 
with its parent strain. Antimicrob. Agents Chemother. 20: 
613-619. 
KONO, M., SASATU, M. and MAKINO, K. (1980) R-plasmid 
conferring resistance to ampicillin, carbenicillin and 
301 
erythromycin in a Flavobacterium odoratum str~in. 
Microbios. Lett. 14: 55-58. 
KORFMANN, G., KLIEBE, C. and WIEDEMANN, B. (1986) Reta-lactam 
antibiotics and selection of resistance: speculation on 
the evolution of plasmids. J. Antimicrob. Chemother. 18 
(Suppl C): 113-121. 
KOSMIDIS, J., HAMILTON-MILLER, J.M.T., GILCHRIST, J.N.G., 
KERRY, D.W. and BRUMFITT, W. (1973) Cefoxitin, a new 
semi-synthetic cephamycin: an in vitro and in vivo 
comparison with cephalothin. Br. med. J. 4: 653-655. 
KOVACS, N. (1956\ Identification of Pseudomonas pyocyanea by 
the oxidase reaction. Nature, Lond. 178: 703. 
KNUDSEN, E.T., BROWN, D.M. and ROLINSON, G.N. (1962) A new 
orally effective penicillinase-stable penicillin -·BRL 
1621. Lancet 2: 632-634. 
KNUDSEN, E.T., ROLINSON, G.N. and SUTHERLAND, R. (1967) 
~arbenicillin: a new semisynthetic penicillin active 
against Pseudomonas pyocyanea. Br. med. J. 3: 75-78. 
KWOK, Y.Y., TALLY, F.P., SUTTER, V.L. and FINEGOLD, S.M. 
(1975) Disk susceptibility testing of slow-growing 
anaerobic bacteria. Antimicrob. Agents Chemother. 7: 1-7. 
LABIA, R., BARTHELEMY, M. and MASSON, J.M. (1976) Multiplicity 
of beta-lactamases; an isoenzyme problem? Compte rendu de 
l'Academie des Sciences 283D: 1597-1600. 
LACEY, R.W. (1980) Ecology of antibiotic resistance. In: 
SELWYN, S. The Beta-lactam Antibiotics: Penicillins and 
Cephalospo~ins in Perspective. Hodder and Stoughton, 
London, pp 224-244. 
LACROIX, J., LAMOTHE, F. and MALOUIN, F. (1984) Role of 
Bacteroides bivius beta-lactamase in beta-lactam 
302 
susceptibility. Antimicrob. Agents Chemother. 26: 694-698~ 
- ' -
LAPAGE, S.P. and OWEN, R.J. (1973) Flavobacterium 
meningosepticum from cases of meningitis in Botswana and 
England. J. Clin. Path. 26: 747-749. 
LE FRANCOIS, M. and BAUM, J.L. (1976) Flavobacterium 
endophthalmitis following keroplasty. Use of a tissue 
culture medium-stored cornea. Arch. Ophthalmol. ~: 1907-
1909. 
' LEVESQUE, R., LETARTE, R., PECHERE, J. (1983) Comparative 
study of the beta-lactamase activity found in 
Achromobacter. Can. J. Microbiol. 29: 819-826. 
LEVINE, M.E., PICKETT, M.J. and MANDEL, M. (1980) Taxonomy of 
nonfermentative bacilli: the IIk-2 group. Gurr. Microbiol. 
4: 41-44. 
LEVY, S.B. (1982) Microbial resistance to antibiotics: an 
evolving and persistent problem. Lancet~: 83-88. 
LIVERMORE, D.M. (1985) Do beta-lactamases 'trap' 
cephalosporins? J. Antimicrob. Chemother. 15: 511-521. 
LIVERMORE, D.M., RIDDLE, S.J. and DAVY, K.W.M. (1986) 
Hydrolytic model for cefotaxime and ceftriaxone resistance 
in beta-lactamase derepressed Enterobacter cloacae. J. 
Infect. Dis. 153: 619-622. 
LOWBURY, E.J.L., BABB, J.R. and ROE, E. (1972) Clearance from 
a hospital of Gram-negative bacilli that transfer 
carbenicillin resistance to Pseudomonas aeruginosa. Lancet 
2: 941-945. 
LUDWIG, W., SCHLEIFER, K.H., REICHENBACH, H. and STACKEB~ANDT, 
E. (198J) A phylogenetic analysis of the myxobacteria 
Myxococcus fulvus, Stigmatella aurantiaca, Cystobacter 
303 
fuscus, Sorangium cellulosum and Nannocystis exedens. 
Arch. Microbiol. 135: 58-62. 
MCGOWAN, J.E. (1983) Antimicrobial resistance in hospital 
organisms and its relation to antibiotic use. Rev. 
Infect. Dis.5: 10~3-1048. 
MCMEEKIN, T.A. (1977) Ultraviolet light sensitivity as an aid 
for the identification of gram-negative, yellow-pigmented 
rods. J. Gen. Microbiol. 103: 149-151. 
MCMEEKIN, T.A., STEWART, '0.B. and MURRAY, J.G. (1972) The 
Adansonian taxonomy and the deoxyribonucleic acid-base 
composition of some gram-negative, yellow-pigmented rods. 
J. Appl. Bacteriol. 45: 321-333. 
MACFARLANE, D.E., BAUM-THUREEN, P. and GRANDON, I. (1985) 
Flavobacterium odoratum ventriculitis treated with 
intraventricular cefotaxime. J. Infect. 11: 233-238. 
MADERAZO, E.G., BASSARIS, H.P. and QUINTILIANI, R. (1974) 
Flavobacterium meningosepticum meningitis in a newborn 
infant - treatment with intraventricular erythromycin. J. 
Ped~atr. 85: 675-676. 
MALOUIN, F. and LAMOTHE, F~ (1986) The role of beta-lactamase 
and the permeability barrier on the activity of 
cephalosporins against members of the Bacteroides fragilis 
group. Can. J. Microbiol. 33: 262-266. 
MANDEL, M. and MARMUR, J. (1968) Use of ultraviolet 
absorbance temperature profile for determining the guanine 
and cytosine content of DNA. Meth. Enzym9l. 12B: 95-206. 
MANI, R.M., KURUVITA, K.C., BATLIWALA, P.M., DAMLE, P.N., 
SHIRGAONKAR, G.V., SONI, R.P. and VYAS, P.R. (1978) 
Flavobacterium meningosepticum as an opportunist. J. 
Clin. Path. 31: 220-222. 
304 
MARRE, R., MEDEIROS, A.A. and PASCULLE, A.W. (1982) 
Characterization of the beta-lactamases of six species of 
Legionella. J. Bacteriol. 151: 216-222. 
MATTHEW, M. (1979' Plasmid-mediated beta-lactamases of Gram-
negative bacteria: properties and distribution. J. 
Antimicrob. Chemother. 5: 349-358. 
MATTHEW, M. and HARRIS, A.M. (1976) Identification of beta-
lactamases by analytical isoelectric focussing: 
correlation with bacterial taxonomy. J. Gen. Microbiol. 
94: 55-67. 
MATTHEW, M., HARRIS, A.M., MARSHALL, M. and ROSS, G.W. (1975) 
The use of analytical isoelectric focussing for detection 
and identification of beta-lactamases. J. Gen. Microbiol. 
88: 169-178. 
MATTHEW, M., HEDGES, R.W. and SMITH, J.T. (1979) Types of 
beta-lactamases determined by plasmids in Gram-negative 
bacteria. J. Bacteriol. 138: 657-662. 
MEDEIROS, A.A. (1984) Beta-lactamases. Br. Med. Bull. 40: 18-
27. 
MEDEIROS, A.A., COHENFORD, M. and JACOBY, G. (1985) Five novel 
plasmid-determined beta-lactamases. Antimicrob. Agents 
Chemother. 27: 715-719. 
MINAMI, S., MATSUBARA, N. YOTSUJI, A., ARAKI, H., WATANABI, 
Y., YASUDA, T., SAIKAWA, I. and MITSUHASHI, S. (1983) 
Induction of cephalosporinase production by various 
penicillins in Enterobacteriaceae. J. Antibiot. 36: 1387-
1395. 
MINAMI, S., YOTSUJI, A., INOUE, M. and MITSUHASHI, S. (1980) 
Induction of beta-lactamase by various beta-lactam 
antibiotics in Enterobacter cloacae. Antimicrob. Agents 
Chemother. 18: 382-385. 
MITSUHASHI, S. (1985) Program Abstr. no SL-2. 14th Int. Congr. 
Chemother. 
MITSUYAMA, J., HIRUMA, R., YAMAGUCHI, A. and SAWAI, T. (1987) 
Identification of porins in outer membrane of Proteus, 
Morganella and Providencia spp. and their role in outer 
membrane permeation of beta-lactam?• Antimicrob. Agents 
Chemother. 31: 379-384. 
MIZUTA, S., IMAMURA, K., DATEKI, N., SUDA, M., KANETOUGU, K. 
and TASAKI, K. (1974) Three cases of neonatal meningitis 
due to Flavobacterium meningosepticum. J. Pediatr. 
Practice (in Japanese) ~: 1134-1140. 
MONTEIL, H., LE FAOU, A. and LAURENT, B. (1979) Study of 
Flavobacterium strains isolated in Strasbourg at an 
intensive care ~nit. Characterization of a new serotype 
(G) of Flavobacterium meningosepticum. Med. Mal. Infect. 
9: 124-128. 
MOORE, R.A. and HANCOCK, R.E.W. (1986) Involvement of outer 
membrane of Pseudomonas cepacia in aminoglycoside and 
polymyxin resistance. Antimicrob. Agents Chemother. 30: 
923-926. 
MORI, R. (1888) Ueber pathogene Bacterien im Canalwasser. Z. 
Hyg. 4: 47-54. 
MOSS, C.W. and DEES, S.B. (1978) Cellular fatty acids of 
Flavobacterium meningosepticum and Flavobacterium species 
gp. IIB. J. Clin. Microbiol. 8: 771-774. 
MUNCH-PETERSON, E. and BOUNDY,C. (1962) Yearly incidence of 
penicillin resistant staphylococci in man since 1942. 
Bull. Wld. Hlth. Org. 26: 241-250. 
306 
MURAKAMI, K. and YOSHIDA, T. (1985) Covalent binding of 
moxalactam to cephalosporinase of Citrobacter freundii. 
Antimicrob. Agents Chemother. 27: 727-732. 
MURRAY, B.E. and MOELLERING, R.C. Jr (1978) Patterns and 
mechanisms of antibiotic resistance. Med. Clin. North Am. 
62: 899-923. 
NADARAJAH, M. and TAN, T.H. (1979) Flavobacterium 
meningosepticum infections. Singapore Med. J. lQ_: 293-
296. 
NAYLER, J.H.C. (1987) Resistance to beta-lactams in Gram-
negative bacteria: relative contributions of beta-
lactamase and permeability limitations. J. Antimicrob. 
Chemother. 19: 713-732. 
NIKAIDO, H. (1981) Outer membrane permeability of bacteFia: 
resistance and accessibility of targets. In: SALTON, M. 
and SHOCKMAN, G.D. (editors) Beta-lactam Antibiotics. 
Academic Press, New ~ork, pp 249-260. 
NIKAIDO, H. (1985) Role of permeability barriers in resistance 
to beta-lactam antibiotics. Pharmac. Ther. 27: 197-231. 
NOLTE, G. and SUSSMUTH, R. (1987) Purification and 
characterisation of chloramphenicol acetyltransferase from 
Flavobacterium CB60. J. Gen. Microbiol. 133: 2115-2122. 
NORD, C.E. (1986) Mechanisms of beta-lactam resistance in 
anaerobic bacteria. Rev. Infect. D~s. ~(Suppl. 5): 543-
548. 
" NORDSTROM, K. and SYKES, R.B. (1974) Induction kinetics of 
beta-lactamase bfosynthesis in Pseudomonas aeruginosa. 
Antimicrob. Agents Chemother • .§_: 734-740. 
NORMARK, S. and LINDBERG, F. (1985) Evolution of resistance 
307 
to penicillin and cephalosporin antibiotics. Bioessays 3: 
22-26. 
NORRBY, S.R. (1986) Penems and carbapenems. In: PETERSON, 
P.K. and VERHOF, J. (Editors), The Antimicrobial Agents 
Annual 1. Elsevier, Amsterdam: pp 138-143. 
OBERHOFER, T.R. (1979) Growth of nonfermentative bacteria at 
42oC. J. Clin. Microbiol. 10: 800-804. 
O'CALLAGHAN, C.H., MORRIS, A., KIRBY, S.M. and SHINGLER, A.H. 
(1972) Novel method for detection of beta-lactamases by 
using a chromogenic cephalosporin substrate. Antimicrob. 
Agents Chemother. _!: 283-288. 
O'CALLAGHAN, C.H., MUGGLETON, P.W., KIRBY, S.M. and RYAN, D.M. 
(1968) Inhibition of beta-lactamase decomposition of 
cephaloridine and cephalothin by other cephalosporins. In: 
Antimicrobial Agents and Chemotherapy. Hobby, G.L. 
(editor) American Society for Microbiology, Bethesda pp 
337-343. 
O'DONNELL, E.D., FREIMER, E.H., GILARDI, G.L. and RAEDER,R. 
(1982) Comparative in vitro activities of N-formimidoyl 
thienamycin and moxalactam against nonfermentative 
aerobic Gram-negative rods. Antimicrob. Agents Chemother. 
21: 673-675. 
OKONOGI, K., KUNO, M. and HIGASHIDE, E. (1986) Induction of 
beta-lactamase in Proteus vulgaris. J. Gen. Microbiol. 132: 
143-150. 
OLSSON-LILJEQUIST, B., DORNBUSCH, K. and NORD, C.E. (1980) 
Characterization of three different beta-lactamases from 
the Bacteroides fragilis group. Antimicrob. Agents 
Chemother. 18: 220-225. 
OLSEN, H. (1966) The importance of temperature for the growth 
308 
of Flavobacterium meningosepticum. Acta Path. Microbiol. 
Scand. 67: 291-302. 
OLSEN, H. (1969) Flavobacterium meningosepticum isolated from 
outside hospital surroundings and during routine 
examination of patient specimens. Acta Path. Microbiol. 
Scand. 75: 313-322. 
OLSEN, H., FREDERIKSEN, W.C. and SIBONI, K.E. (1965) 
Flavobacterium meningosepticum in 8 non-fatal cases of 
post-operative bacteraemia. Lancet 1: 1294-1296. 
OLSEN, H. and RAVN, T. (1971) Flavobacterium meningosepticum 
isolated from ,the genitals. Acta Path. Microbiol. Scand. 
Sect. B, 79: 102-106. 
OWEN, R.J. and HOLMES, B. (1978) Heterogeneity, in the 
characteristics of deoxyribonucleic acid from 
Flavobacterium odoratum. F.E.M.S. Microbiol. Lett. 4: 41-
46. 
OWENy R.J. and HOLMES, B. (1981) Identification and 
classification of Flavobacterium species from clinical 
sources. In: Reichenbach and Weeks (editors), The 
Flavobacterium-Cytophaga Group (Proceedings of the 
International Symposium on Yellow-Pigmented Gram-negative 
Bacteria of the Flavobacterium-Cytophaga Group, 
Braunschweig, July 8 to 11, 1980). Verlag Chemie, Weinheim, 
pp 39-50. 
OWEN, R.J. and LAPAGE, S.P. (1974) A comparison of strains of 
King's group Ilb of Flavobacterium with Flavobacterium 
meningosepticum. Antonie van Leeuwenhoek J. Microbiol. 
Serol. 40: 255-264. 
OWEN, R.J. and SNELL, J.J.S. (1976) Deoxyribonucleic acid 
309 
reassociation in the classification of flavobacteria. J. 
Gen. Microbiol. 93: 89-102. 
OYAIZU, H. and KOMAGATA, K. (1981) Chemotaxonomic and 
phenotypic characterization of the strains in 
Flavobacterium-Cytophaga complex. J. Gen. Appl. Microbiol. 
27: 55-107. 
PASTER, B.J., LUDWIG, W.G., WEISBURG, W.G., STACKEBRANDT, E., 
RESPELL, R.B., HAHN, C.M., REICHENBACH, H., STETTER, K.O. 
and WOESE, C.R. (1985) A phylogenetic grouping of the 
bacteroides, cytophagas and certain flavobacteria. Syst. 
Appl. Microbiol • .§_: 34-42. 
' PECHERE, J. and LEVESQUE, R. (1983' Beta-lactamases: clinical 
and genetic perspectives. J. Antimicrob. Chemother. 12: 
529-534. 
PEDERSEN, S.S., PRESSLER, T., JENSEN, T., ROSDAHL, V.T., 
BENTZON, M., HOIBY, N. and KOCH, C. (1987) Combined 
imipenem/cilastatin and tobramycin therapy of 
multiresistant Pseudomonas aeruginosa in cystic fibrosis. 
J. Antimicrob. Chemother. 19: 101-107. 
PERRET, C.J. (1954) Iodometric assay of penicillinase. Nature 
(London) 174: 1012-1013. 
PERRY, L.B. (1973) Gliding motility in some non-spreading 
flexibacteria. J. Appl. Bacteriol. 36: 227-232. 
PHELPS, D.J., CARLTON, D.D., FARRELL, C.A. and KESSLER, R.E. 
(1986) Affinity of cephalosporins for beta-lactamases as 
a factor in antibacterial efficacy. Antimicrob. Agents 
Chemother. 29: 845-848. 
PHILLIPS, I. (1986) Resistance as a cause of treatment 
failure. J. Antimicrob. Chemother. ~ (Suppl. C): 255-260. 
PICHINOTY, F., BARATTI, J., KAMMOUN, S., ALLAIS, J.J., 
310 
ASSELINEAU, J., RICHARD, C., DENIS, M., RICHAUD, P. and 
MUTAFTSCHIEV, S. (1985) Isolation and description of 
strains of Flavobacterium multivorum of telluric origin. 
Ann. Inst. Pasteur. Microbiol. 136A: 359-370. 
PICKETT, M.J., LEVINE, M.G. and MANDEL, M. (1981) Yellow-
pigmented nonfermentative bacilli: taxonomy of the IIk-2 
group. In: Reichenbach and Weeks (editors), The 
Flavobacterium-Cytophaga Group (Proceedings of the 
International Symposium on Yellow-Pigmented Gram-
negative Bacteria of the Flavobacterium-Cytophaga 
Group, Braunschweig, July 8 to 11, 1980). Verlag Chemie, 
Weinheim, pp 51-62. 
PLOTKIN, S.A. and MCKITRICK, J.C. (1966) Nosocomial 
meningitis of the newborn caused by a Flavobacterium. 
J.A.M.A. 198: 662-664. 
POTVLIEGE, C., DEJAEGHER-BAUDUIN, C., HANSEN, W. and DRATWA, 
M. (1984) Flavobac~erium multivorum Septicemia in a 
hemodialyzed patient. J. Clin. Microbiol. 19: 568-569. 
PRICE, K.W. and PICKETT, M.J. (1981) Studies of clinical 
isolates of flavobacteria. In: Reichenbach and Weeks 
(editors), The Flavobacterium-Cytophaga Group (Proceedings 
of the International Symposium on Yellow-Pigmented 
Gram-negative Bacteria of the Flavobacterium-Cytophaga 
Group, Braunschweig, July 8 to 11, 1980). Verlag Chemie, 
Weinheim, pp 63-77. 
QUINN, J.P., DUDEK, E.J., DIVINCENZO, C.A., LUCKS, D.A. and 
LERNER, S.A. (1986) Emergence of resistance to imipenem 
during therapy for Pseudomonas aeruginosa infections. J. 
Infect. Dis. 154: 289-294. 
311 
RAIMONDI, A., MOOSDEEN, F. and WILLIAMS, J.D. (1986) 
Antibiotic resistance pattern of Flavobacterium 
meningosepticum. Eur. J. Clin. Microbiol. 5: 461-463. 
READING, C. (1981) The biochemistry and mode of action of 
Augmentin. In: LEIGH, D.A. and ROBINSON, O.P.W. (editors), 
Augmentin. Clavulanate-potentiated amoxycillin. 
Proceedings of an international symposium. Montreux, 
Switzerland 17 July, 1981. Published by excerpta Medica 
for Beecham Pharmaceuticals International Division, pp 5-21. 
REICHENBACH, H., KOHL, W. and ACHENBACH, H. (1981) The 
flexirubin-type pigments, chemosystematically useful 
compounds. In: Reichenbach and Weeks (editors), The 
Flavobacterium-Cytophaga Group (Proceedings of the 
International Symposium on Yellow-Pigmented Gram-
negative Bacteria of the Flavobacterium-Cytophaga 
Group, Braunschweig, July 8 to 11, 1980). Verlag Chemie, 
Weinheim, pp 101-108. 
REICHENBACH, KOHL, W., BOTTGER-VETTER, A. and ACHENBACH, H. 
(1980) Flexirubin-type pigments in Flavobacterium. Arch. 
Microbiol. 126: 291-293. 
REIG, M. a~d BAQUERO, F. (1984) Limitations in the use of the 
clover leaf test in Bacteroides species. Eur. J. Clin. 
Microbiol. 3: 561-562. 
RELLA, M. and HAAS, D. (1982) Resistance of Pseudomonas 
aeruginosa PAO to nalidixic acid and low levels of beta-
lactam antibiotics: mapping of chromosomal genes. 
Antimicrob. Agents Chemother. ~: 242-249. 
RICHARD, C., MONTEIL, H., LE FAOU, A. and LAURENT, B. (1979) 
/ ' Ptude de souches de Flavobacterium isolees a Strasbourg 
dans un service de reanimation m~dicale. 
312 
Individualisation d'un nouveau s~rotype (G) de 
Flavobacterium meningosepticum. Mal. Med. Infect. 9: 124-
128. 
RICHMOND, M. (1981) Beta-lactam Antibiotics. The background to 
their use as therapeutic agents. Paddon and Brooks 
Limited, Tunbridge Wells, Kent, England. 
RICHMOND, M.H. and SYKES, R.B. (1973) The beta-lactamases of 
Gram-negative bacteria and their possible physiological 
role. Adv. Microbiol. Physiol . .2_: 31-88. 
RIOS, I., KLIMEK, J.J., MADERAZO, E. and QUINTILIANI, R. 
(1978) Flavobacterium meningosepticum meningitis: report 
of selected aspects. Antimicrob. Agents Chemother. 14: 
444-447. 
RODRIGUEZ, V., INAGAKI, J. and BODEY, G.P. (1973) Clinical 
pharmacology of ticarcillin (alpha-carboxyl-3-
thienylmethyl penicillin, BRL-2228). Antimicrob. Agents 
Chemother. 4: 31-36. 
ROE, E. and LOWBURY, E.J.L. (1972) Changes in antibiotic 
sensitivity patterns of of Gram-negative bacilli in burns. 
J. Clin. Path. 25: 176-178. 
ROGERS, D.E. (1959) The changing pattern of life-threatening 
microbial disease. N. Engl. J. Med. 261: 677-683. 
ROLINSON, G.N. and STEVENS, S. (1961) Microbiological studies 
on a new broad-spectrum penicillin, "Penbritin". Br. med. 
J •. 2: 191-196. 
ROLINSON, G.N., STEVENS, S., BATCHELOR, F.R., WOOD, J.C. and 
CHAIN, E.B. (1960) Bacteriological studies on a new 
penicillin - BRL 1241. Lancet 2: 564-567. 
ROSS, G.W. and O'CALLAGHAN, C.H. (1975) Antibiotics. In: 
313 
HASH, J.E. (editor) Methods in Enzymology Volume XLIII, 
Academic Press, New York, pp 69-85. 
RUBIN, S.J., GRANATO, P.A. and WASILAUSKAS, B.L. (1985) 
Glucose-nonfermenting Gram-negative bacteria. In: 
LENNETTE, E.H. (editor in chief) Manual of Clinical 
Microbiology. American Society for Microbiology, 
Washington D.C. pp 342-346. 
SAINO, Y., INOUE, M. and MITSUHASHI, S. (1984) Purification 
and properties of an inducible cephalosporinase from 
Pseudomonas maltophilia GN 12873. Antimicrob. Agents 
Chemother. 25: 362-365. 
SAINO, Y., KOBAYASHI, F., INOUE, M. and MITSUHASHI, S. (1982) 
Purification and properties of inducible penicillin beta-
lactamase isolated from Pseudomonas maltophilia. 
Antimicrob. Agents Chemother. 22: 564-570. 
SAMUNI, A. (1975) A direct spectrophotometric assay and 
determination of Michaelis constants for the beta-
lactamase reaction. Analyt. Biochem . ..§1_: 17-26. 
SANDERS, C.C. (1983) Resistance to Beta-lactam Antibiotics. 
New Challenges from Old Enzymes. T~e Upjohn Company. 
SANDERS, C.C. (1984a) Failure to detect resistance in 
antimicrobial susceptibility tests. A "very major" error 
of increasing concern. Antimicrob. Newslett. 1: 27-31. 
SANDERS, C.C. (1984b) Inducible beta-lactamases and non-
hydrolytic resistance mechanisms. J. Antimicrob. Chemother. 
13:1-3. 
SANDERS, C.C~ (1984c) Emerging problems of resistance to the 
newer cephalosporins: clinical significance. Intern. med. 
5: 37-43. 
SANDERS, C.C. (1987) Chromosomal cephalosporinases 
314 
responsible for multiple resistance to newer beta-lactam 
antibiotics. Ann. Rev. Microbiol. 41: 573-593. 
SANDERS, C.C. and SANDERS JR, W.E. (1979) Emergence of 
resistance to cefamandole: possible role of cefoxitin-
inducible beta-lactamases. Antimicrob. Agents Chemother. 
15: 792-797. 
SANDERS, C.C. and SANDERS JR, W.E. (1985) Microbial 
resistance to newer generation beta-lactam antibiotics: 
clinical and laboratory implications. J. Infect. Dis. 
151: 399-406. 
SANDERS, C.C. and SANDERS JR, W.E. (1986a) .Trapping and 
hydrolysis are not mutually exclusive mechanisms for beta-
lactamase-mediated resistance. J. Antimicrob. Chemother. 
17: 121-122. 
SANDERS, C.C. and SANDERS JR, W.E. (1986b) The 
cephalosporins and cephamycins. In: PETERSON, 
P.K. and VERHOF, J. (Editors), The Antimicrobial Agents 
Annual 1. Elsevier, Amsterdam: pp 66-90. 
SANDERS, C.C. and SANDERS JR, W.E. (1986c) Type I beta-
lactamases of Gram-negative bacteria: interactions with 
beta-lactam antibiotics. J. Infect. Dis. 154: 792-800. 
SANDERS, C.C., SANDERS JR, W.E. and GOERING, R.V. (1982) In 
vitro antagonism of beta-lactam antibiotics by cefoxitin. 
Antimicrob. Agents Chemother. 21: 968-975. 
SANDERS, C.C., SANDERS JR, W.E., GOERING, R.V. and MCCLOSKEY, 
R.V. (1987) Leakage of beta-lactamase: a second mechanism 
for antibiotic potentiation by amdinocillin. Antimicrob. 
Agents Chemother. 2!= 1164-1168. 
SANDERS, C.C., SANDERS JR, W.E., GOERING, R.V. and WERNER, V. 
315 
(1984) Selection of multiple antibiotic resistance by 
quinolones, beta-lactams, and aminoglycosides with special 
reference to cross-resistance between unrelated drug 
classes. Antimicrob. Agents Chemother. 26: 797-801. 
SANDERS, C.C., SANDERS JR, W.E. and MOLAND, E.S. (1986) 
Characterization of beta-lactamases in situ on 
polyacrylamide gels. Antimicrob. Agents Chemother. 30: 
951-952. 
SANDERS, C.C. and WATANAKUNAKORN, C. (1986) Emergence of 
resistance to beta-lactams, aminoglycosides, and quinolones 
during combination therapy for infection due to Serratia 
marcescens. J. Infect. Dis. 153: 617-619. 
SARGENT, M.G. (1968) Rapid fixed-time assay for penicillinase. 
J. Bacterial. 95: 1493-1494. 
SATO, K., FUJII, T., OKAMOTO, R., INOUE, M. and MITSUHASHI, S. 
(1985) Biochemical properties of beta-lactamase produced 
by Flavobacterium odoratum. Antimicrob. Agents Chemother. 
27: 612-614. 
SAWAI, T., HIRUMA, R., KAWANA, N., KANEKO, M., TANIYASU, F. and 
INAMI, A. (1982) Outer membrane permeation of beta-lactam 
antibiotics in Escherichia coli, Proteus mirabilis and 
Enterobacter cloacae. Antimicrob. Agents Chemother. 22: 
585-592. 
SAWAI, T., KANNO, M. and TSUKAMOTO, K. (1982) Characterization 
of eight beta-lactamases of Gram-negative bacteria. J. 
Bacterial. 152: 567-571. 
SAWAI, T., MITSUHASHI, S. and YAMAGISHI, S. (1968) Drug 
resistance of enteric bacteria. XIV. Comparison of beta-
lactamases in Gram-negative rod bacteria resistant to 
alpha-aminobenzyl penicillin. Jap. J. Microbiol. 12: 423-
316 
434. 
SCHELL, R.F., FRANCISCO, M., BIHL, J.A. and LEFROCK, J.L. 
(1985) The activity of ceftazidime compared with those of 
aztreonam, newer cephalosporins and SCH 29482 against 
nonfermentative Gram-negative bacilli. Chemother. 31: 
181-190. 
SELIGMANN, R., KOMARoy, M. and REITLER, R. (1963) 
Flavobacterium meningosepticum in Is~ael. Br. Med. J. 2: 
1528-1529. 
SELWYN, S. (1980) The Beta-lactam Antibiotics: Penicillins and 
Cephalosporins in Perspective. Hodder and Stoughton, 
London. 
SHERRIS, J.C. (1970) The epidemiology of drug resistance. 
Proceedings of the Sixth International Conference on 
Nosocomial Infections. Center for Disease Control, 
Atlanta, pp 50-60. 
SHEWAN, J.M. and MCMEEKIN, T.A. (1983) Taxonomy (and ecology) 
of Flavobacterium and related genera. Ann. Rev. Microbiol. 
37: 233-252. 
SHULMANN, B.H. and JOHNSON, M.S. (1944) A case of meningitis 
in a premature infant due to a proteolytic gram-negative 
bacillus. J. Lab. Clin. Med. 29: 500-507. 
SIMPSON, I.N. and PLESTED, S.J. (1983) The origin and 
properties of beta-lactamase satellite bands as seen in 
isoelectric focussing. J. Antimicrob. Chemother. 12: 127~ 
131. 
SIMS, M.A. (1974) Flavobacterium meningosepticum: a probable 
cause of meningitis in a cat. Vet. Ree. 95: 567-569. 
SIROT, D., SIROT, J., LABIA, R., MORAND, A., COURVALIN, P., 
317 
DARFEUILLE-MICHAUD, A., PERROUX, R. and CLUZEL, R. (1987) 
Transferable resistance to third-generation cephalosporins 
in clinical isolates of Klebsiella pneumoniae: 
identification of CTX-1, a novel beta-lactamase. J. 
Antimicrob. Chemother. 20: 323-334. 
SKERMAN, V.B.D., MCGOWAN, V. and SNEATH, P.H.A. (1980) 
Approved lists of bacterial names. Int. J. Syst. 
Bacteriol. 30: 225-420. 
SLOCOMBE, B., EASKER, M.J., BENTLEY, P.H., CLAYTON, J.P., 
COLE, M., COMBER, K.R., DIXON, R.A., EDMONDSON, R.A., 
JACKSON, D., MERRIKIN, D.J. and SUTHERLAND, R. (1981) BRL 
17421, a novel beta-lactam antibiotic, highly resistant to 
beta-lactamases, giving high and prolonged serum levels in 
humans. Antimicrob. Agents Chemother. ~: 38-46. 
SMALLEY, D.L. (1982) Endotoxin-like activity in Pseudomonas 
paucimobilis (Group IIK biotype 1) and Flavobacterium 
multivorum (Group IIK biotype 2). Experientia ~: 1483-
1484. 
SOTTILE, M.I., BALDWIN, J.N. and WEAVER, R.N. (1973) 
Deoxyribonucleic acid hybridization studies on 
Flavobacterium meningosepticum. Appl. Microbiol. 26: 535-
539. 
SPRATT, B.G. (1975) Distinct penicillin binding proteins 
involved in the division, elongation, and shape of 
Escherichia coli. Proc. Natl. Acad. Sci. USA 72: 2999-
3003. 
SPRATT, B.G. (1977) The mechanism of action of mecillinam. 
J. Antimicrob. Chemother. l (Suppl B): 13-19. 
STAMM. W.E., COLELLA, J.J., ANDERSON, R.L. and DIXON, R.E. 
(1975) Indwelling arterial catheters as a source of 
318 
nosocomial bacteremia. An outbreak caused by 
Flavobacterium species. N. Engl. J. Med. 292: 1099-1102. 
STARKEY, D.H. and GREGORY, E. (1971) Fluctuations in 
antibiotic resistances of Gram-negative rods in one 
hospital, 1961-70, with comment on kanamycin-neomycin 
relationships. Can. Med. Assoc. J. 105: 587-590. 
STEERS, E., FOLTZ, E.L. and GRAVES, B.S., with the assistance 
of RIDEN, J. (1959' An inocula replicating apparatus for 
routine testing of bacterial susceptibility to 
antibiotics. Antimicrob. Agents Chemother. 2_: 307-311. 
STRANDBERG, D.A., JORGENSEN, J.H. and DRUTZ, J.D. (1983) 
Activities of aztreonam and new cephalosporins against 
infrequently isolated gram-negative bacilli. Antimicrob. 
Agents Chemother. ~: 282-286. 
STUTZER, M. (1923) Zur Frage Uber die Faulnisbakterien im 
Darm. Zentralbl. Bakteriol. Parasitenkd. Infektionskr. 
Hyg. Abt. 1 Orig. 91: 87-90. 
STUTZER, M. and KWASCHNINA, A. (1929) In: Aussaaten aus den 
Fazes des Menschen gelbe Kolonien bildende Bakterien 
(Gattung Flavobacterium u.a.). Zentralbl. Bakteriol. 
Parasitenkd. Inrektionskr. Hyg. Abt. 1 Orig. 113: 219-225. 
SYKES, R.B. (1982) The classification and terminology of 
enzymes that hydrolyse beta-lactam antibiotics. J. Infect. 
Dis. 145: 762-765. 
SYKES, R.B. and BONNER, D.P. ·(1985) Aztreonam: the first 
monobactam. Am. J. med. ~ (Suppl A): 2-10. 
SYKES, R.B. and MATTHEW, M. (1976) The beta-lactamases of 
Gram-negative bacteria. J. Antimicrob. Chemother. 2: 115-
157. 
319 
" SYKES, R.B. and NORDSTROM, K. (1972) Microiodometric 
determination of beta-lactamase activity. Antimicrob. 
Agents Chemother • ..!.= 94-99. 
SYKES, R.B. and SMITH, J.T. (1979) Biochemical aspects of 
beta-lactamases from Gram-negative organisms. In: 
Hamilton-Miller, J.M.T. and Smith, J.T. (editors) Beta-
lactamases. Academic Press pp 639-401. 
TAUSK, F. and STRATTON, C.W. (1986) Effect of clavulanic acid 
on the activity of ticarcillin against Pseudomonas 
aeruginosa. Antimicrob. Agents Chemother. 30: 584-589. 
TERES, D. (1974) I.C.U. acquired pneumonia due to 
Flavobacterium meningosepticum. .J.A.M.A. 228: 732-733. 
THEN, R.L. and ANGHERN, P. (1982) Trapping of nonhydrolyzable 
cephalosporins by cephalosporinases in Enterobacter cloacae 
and Pseudomonas aeruginosa as a possible resistance 
' ' 
mechanism. Antimicrob. Agents Chemother. 21: 711-717. 
THEN, R.L. and ANGHERN, P; (1985) Ways to overcome 
cephalosporinase-mediated beta-lactam resistance in 
Enterobacter cloacae. Chemioterapia IV: 83-89'. 
THEN, R.L. and ANGHERN, P. (1986) Multiply ~esistant mutants 
of Enterobacter cloacae selected by beta-lactam 
antibiotics. Antimicrob. Agents Chemother.lQ_: 684-688. 
THOMSON, K.S. (1982) A ta~onomic study of some Gram-negative 
yellow-pigmented rods. MSc. Thesis, University of 
Tasmania. 
' THOMSON, K.S. and MCMEEKIN, T.A. (1981) A comparison of some 
gram-negative, yellow-pigmented rods from ~nvironmental 
and clinical sources. In: Reichenbach and We~ks 
(editors), The Flavobacterium-Cytophaga Group 
(Proceedings of the International Symposium on Yellow-
320 
Pigmented Gram-Negative Bacteria of the Flavobacterium-
Cytophaga Group, Braunschweig July 8 to 11, 1980). Verlag 
Chemie, Weinheim pp 91-100. 
THOMSON, K.S., MCMEEKIN, T.A. and THOMAS, C.J. (1981) 
Electron microscopic observations of Flavobacterium 
aquatile NCIB 8694 (=ATCC 11947) and Flavobacterium 
meningosepticum NCTC 10016 (=ATCC 13253). Int. J. Syst. 
Bacteriol. 31: 226-231. 
THOMSON, K.S., MEJGLO, Z.A., PEARCE, G.N. and REGAN, T.J. 
(1984) 3-dimensional susceptibility testing of beta-lactam 
antibiotics. J. Antimicrob. Chemother. 13: 45-54. 
THOMSON, K.S. and WARD, P. (1986) 3-dimensional induction 
testing of beta-lactam antibiotics. Abstracts of the 
Annual Meeting of the American Society for Microbiology, 
Washington D.C. p 270. 
THORNSBERRY, C., ANHALT, J., BARRY, A.L., COTTON, J.L., 
GERLACH, E.H., JONES, R.N., MOELLERING, R.C. and NORTON, 
R.A. (1985) National Committee for Clinical Laboratory 
Standards. Methods for dilution of antimicrobial 
susceptibility tests for bacteria that grow aerobically; 
Approved Standard. NCCLS publication M7-A. Villanova, Pa.: 
NCCLS. 
THORNSBERRY, C. and KIRVEN, L.A. (1978) Beta-lactamases of 
the Legionnaire~s bacterium. Curr. Microbiol. 1: 51-54. 
" TIMEWELL, R.M., PHILLIPS, I., SODERHOLM, J. and NORD, C. 
(1981) Isoelectric focussing of Bacteroides 
melaninogenicus group beta-lactamases. Antimicrob. Agents 
Chemother. 19: 700-704. 
TIPPER, D.J. (1985) Mode of action of beta-lactam antibiotics. 
:i? 1 
Pharmac. Ther. 27: 1-35. 
TIPPER, D.J. and STROMINGER, J.L. (19{.,5) Mechanism of action 
of penicillins: a proposal based on their structural 
similarity to acyl-D-aianyl-D-alanine. Proc. natn. Acad. 
Sci. U.S.A. 54: 1133-1141. 
TOMASZ, T. (1986) Penicillin-binding proteins and the 
antibacterial effectiveness of beta-lactam antibiotics. 
Rev. Infect. Dis.~ (Suppl 3): S260-278. 
TONIN, E. and TOMASZ, A. (1986) Beta-lactam-specific resistant 
mutants of Staphylococcus aureus. Antimicrob. Agents 
Chemother. 30: 577-583. 
/ 
TUNER, K., LINDQVIST, L. and NORD, C. (1985) Purification and 
properties of a novel beta-lactamase from Fusobacterium 
nucleatum. Antimicrob. Agents Chemother. _?2: 943-947. 
URSING, J. and BRUUN, B. (1987) Genetic heterogeneity of 
Flavobacterium meningosepticum demonstrated by DNA-DNA 
hybridization. Acta Path. Microbiol. Scand. Sect. B, 95: 
33-39. 
VANDEPITTE, J., BEECKMANS, C. and BUTTIAUX, R. (1958) Quatre 
cas de meningite a Flavobacterium meningosepticum. Revue 
de la question a propos de deux nouvelles observations 
congolaises. Ann. Soc. Belge Med. Trop. 45: 57-72. 
VAN LANDUYT, H.W., LAMBERT, A., BOELAERT, J. and GORDTS, B. 
(1986) In vitro activity of BRL 36650, a new penicillin. 
Antimicrob. Agents Chemother. ~: 362-366. 
VECOLI, C., PREVOST, F.E., VERVERIS, J.J., MEDEIROS, A.A. and 
O'LEARY, G.P. (1983) Comparison of polyacrylamide and 
agarose gel thin-layer isoelectric focussing for the 
characterization of beta-lactamases. Antimicrob.·Agents 
Chemother. 24: 186-189. 
322 
VON GRAEVENITZ, A. (1981) Clinical significance and 
antimicrobial susceptibility of flavobacteria. In: 
Reichenbach and Weeks (editors), The Flavobacterium-
Cytophaga Group (Proceedings of the International 
Symposium on Yellow-Pigmented Gram-negative Bacteria of 
the Flavobacterium-Cytophaga Group, Braunschweig, July 8 
to 11, 1980). ,verlag Chemie, Weinheim, pp. 153-164. 
VON GRAEVENITZ, A. and BUCHER, C. (1982) The effect of N-
formimidoyl thienamycin, ceftazidime, cefotiam, 
ceftriaxone and cefotaxime on non-fermentative Gram-
negative rods, Aeromonas, Plesiomonas and Enterobacter 
agglomerans. Infection l_Q: 293-298. 
VON GRAEVENITZ, A. and GREHN, M. (1977) Susceptibility 
studies on Flavobacterium II-b. F.E.M.S. Microbial. 
Lett. 2: 289-292. 
VU, H. and NIKAIDO, H. (1985) Role of beta-lactam hydrolysis 
in the mechanism of resistance of a beta-lactamase-
cons ti tutive Enterobacter cloacae strain to expanded-
spectrum beta-lactams. Antimicrob. Agents Chemother. 27: 
393-398. 
WATSON, K.C., KROGH, J.G. and JONES, D.T. (1966) Neonatal 
meningitis caused by Flavobacterium meningosepticum type 
F. J. Clin. Path. 19: 79-80. 
WAXMAN, D.J., AMANUMA, H. and STROMINGER, J.L. (1982) Amino 
acid sequence homologies between Escherichia coli 
penicillin-binding protein 5 and class 5 beta-lactamases. 
FEBS Lett. 139: 159-163. 
WAYNE, L.G. (1982) Actions of the Judicial Committee on 
Systematic Bacteriology on requests for opinions published 
323 
between July 1979 and April 1981. Int. J. Syst. 
Bacteriol. 32: 464-465. 
WEAVER, R.E., TATUM, H.W. and HOLLIS, D.G. (1972) The 
identification of unusual pathogenic gram-negative 
bacteria. Atlanta, Georgia, U.S.A.: Centre for Disease 
Control. 
WEBER, K. and OSBORN, M. (1969) The reliability of molecular' 
weight determination by dodecylsulfate-polyacrylamide gel 
electrophoresis. J. Biol. chem. 244: 4406-4412. 
WEBSTER, J.A. and HUGH, R. (1979) Flavobacterium aquatile and 
Flavobacterium meningosepticum: glucose nonfermenters with 
similar flagellar morphologies. Int. J. Syst. Bacteriol. 
29: 333-338. 
WEEKS, O.B. (1955) Flavobacterium aquatile (Frankland and 
Frankland) Bergey et al. type species of the genus 
Flavobacterium. J. Bacteriol. 69: 649-658. 
WEEKS, O.·B. (1974) The genus Flavobacterium. In: Buchanan, 
R.E. and Gibbons, N.E. (editors) Bergey's Manual of 
Determinative Bacteriology, 8th edition. Williams and 
Wilkins Co. Baltimore, Maryland pp 357-363. 
WEEKS, O.B. (1981) Preliminary studies of the pigments of 
Flavobacterium breve NCTC 11099 and Flavobacteriurn 
odoratum NCTC 11036. In: Reichenbach and Weeks (editors), 
The Flavobacterium-Cytophaga Group (Proceedings qf the 
International Symposium on Yellow-Pigmented Gram-
negative Bacteria of the Flavobacterium-Cytophaga 
Group, Braunschweig, July 8 to 11, 1980). Verlag Chemie, 
Weinheim, pp 109-114. 
WEINSTEIN, L. (1985) Gram-negative bacterial infections: a 
look at the past,. a view of the present, and a glance at 
324 
the future. Rev. Infect. Dis. !_ Suppl. 4: 538-
544. 
WEISBLUM, B. (1984) Inducible erythromycin resistance in 
bacteria. Br. Med. Bull. 40: 47-53. 
WEISBURG, W.G., OYAIZU, Y., OYAIZU, H. and WOESE, C.R. (1985) 
Natural relationships between bacteroides and 
flavobacteria. J. Bacteriol. 164: 230-236. 
WELCH, W.D. and SOUTHERN, P.M. (1984) Unusual susceptibility 
of methicillin-resistant Staphylococcus aureus to 
erythromycin, clindamycin, gentamicin and tetracycline at 
30 degr. C but not at 35 degr. C. J. Clin. Microbiol. 19: 
831-833. 
WERNER, V., SANDERS, C.C., SANDERS JR, W.E. and GOERING, R.V. 
(1985) Role of beta-lactamases and outer membrane 
proteins in multiple beta-lactam resistance of 
Enterobacter cloacae. Antimicrob. Agents Chemother. 27: 
455-459. 
WERTHAMER, S. and WEINER, M. (1972) Subacute bacterial 
endocarditis due to Flavobacterium meningosepticum. Am. J. 
Clin. Path. 57: 410-412. 
WHITEHEAD, J.E.M. (1973) Bacterial resistance: changing 
patterns of some common pathogens. Br. Med. J. ii: 224-
228. 
WILLIAMS, J.D. (1977) Changing antibiotic susceptibility of 
common bacteria. Practitioner 17: 102-108. 
WILLIAMS, J.D. (1986) Aztreonam. In: PETERSON, 
P.K. and VERHOF, J. (Editors), The Antimicrobial Agents 
Annual 1. Elsevier, Amsterdam:pp 41-50. 
WILSON, G.S. and MILES, A. (1985) Topley and Wilson's 
325 
Principles of Bacteriology, Virology and Immunity, Volume 
1, Sixth Edition, Edward Arnold (Publishers) Ltd, london, 
pp 203-209. 
WINSLOW, D.L. and PANKEY, G.A. (1982) Successful therapy 
with rifampin - Flavobacterium meningosepticum meningitis 
developing while on erythromycin therapy. Del. med. J. 
54: 575-580. 
WINSTON, D.J., MCGRATTAN, M.A. and BUSUTTIL, R.W. (1984) 
Imipenem therapy of Pseudomonas aeruginosa and other 
serious bacterial infections. Antimicrob. Agents 
Chemother. 26: 673-677. 
WOESE, C.R., STACKEBRANDT, E., M~CKE, T.J. and FOX, G.E. 
(1985) A phylog,enetic definition ot the major eubacterial 
taxa. System. Appl. Microbiol • ..§_: 143-151. 
WOODRUFF, W.A., PARR JR, T.R., HANCOCK, R.E.W., HANNE, L., 
NICAS, T.I. and IGLEWSKI, B. (1986) Expression in 
Escherichia coli and function of porin protein F of 
Pseudomonas aeruginosa. J, Bacteriol. 167: 473-479. 
YABUUCHI, E., KANEKO, T., YANO, I., MOSS, C.W. and MIYOSHl, N. 
(1983) Sphingobacterium gen. nov., Sphingobacterium 
spiritivorum comb. nov., Sphingobacterium multivorum comb. 
nov., Sphingobacterium mizut~e sp. nov., and 
Flavobacterium indologenes sp. nov.: Glucose-nonfermenting 
Gram-negative rods in CDC Groups IIk-2 and I!b. Int. J. 
Syst. Bacteriol. 23: 580-598. 
~ABUUCHI, E., YANO, I., KANEKO, T. and OHYAMA, A. (1981) 
Classification of group IIk-2 and related bacteria. In: 
Reichenbach and Weeks (editors), The Flavobacterium-
Cytophaga Group (Proceedings of the International 
Symposium on Yellow-Pigmented Gram-Negative Bacteria of 
326 
the Flavobacterium-Cytophaga Group, Braunschweig July 8 to 
11, 1980). Verlag Chemie, Weinheim pp 79-80. 
YAMAGUCHI, A., TOMIYAMA, N., HIRUMA, R. and SAWAI, T. (1985) 
Difference in pathway of Escherichia coli outer membrane 
permeation between penicillins and cephalosporins. FEBS 
Lett. 181: 143-148. 
YAMAKADO, M., TAGAWA, H., TANAKA, S. and MACHI!, K. (1975) A 
case of subacute bacterial endocarditis tjue to 
Flavobacterium meningosepticum. J. Jap. Soc. Intern. Med. 
64: 816-820. 
YOCUM, R.R., WAXMAN, D.J., RASMUSSEN, J.R. and STROMINGER, 
J.L. (1979) Mechanism of penicillin action: penicillin and 
substrate bind covalently to the same active site serine 
in two bacterial D-alanine carboxypeptidases. Proc. Natl. 
Acad. Sci. USA 76: 2730-2734. 
YOKOTA, T. and AZUMA, E. (1980) Biochemical aspects of 
bacterial resistance to new beta-lactam drugs non-
hydrolyzable by beta-lactamases. In: MITSUHASHI, A., 
ROSIVAL, L. and KREMERY, V. (editors), Antibiotic 
Resistance: Transposition and other mechanisms. Springer-
Verlag, New York: pp. 333-337. 
YOSHIMURA, F. and NIKAIDO, H. (1983) Purification and 
properties of Pseudomonas aeruginosa porin. J. biol. Chem. 
258: 2308-2314. 
YOSHIMURA, F. and NIKAIDO, H. (1985) Diffusion of beta-lactam 
antibiotics through the porin channels of Escherichia coli 
K-12. Antimicrob. Agents Chemother. !}_: 84-92. 
YOTSUJI, A., MINAMI, S., I~OUE, M. and MITSUHASHI, S. (1983) 
Properties of novel beta-lactamase produced by Bacteroides 
327 
fragilis. Antimicrob. Agents Chemother. 24: 925-929. 
YOUNG, L.S. (1985) Ceftazidime in the treatment of nosocomial 
sepsis. Am. J. Med. JJ_ Suppl. 2A: 89-95. 
YOUSEF, S.Y., BROOME-SMITH, J.K. and SPRATT, B.G. (1985) Lysis 
of Escherichia coli by beta-lactam antibiotics: deletion 
analysis of the role of penicillin-binding proteins lA and 
lR. J. Gen. Microbiol. 131: 2839-2845. 
YPHANTIS, D.A. (1964) Equilibrium ultracentrifugation of 
dilute solutions. Biochem. 3: 297-317. 
ZAJC-SATLER, J., GUBINA, M. and KREMZAR, B. (1979) 
Characteristics of a Flavobacterium strain isolated in a 
patient with multiple traumas. Zdrav. Vestn. 48: 651-655. 
ZAPPULA, F., GATTI, M., ROCCHI, G., TANAS, R., VARIOLI, 0. and 
BECCARI, A. (1979) Infection by Flavobacterium 
meningosepticum in a 19-month-old girl. Minerva Pediatr. 
31: 679-682. 
328 
VII ADDENDUM 
329 
Since completion of this thesis the author received a 
reprint of: 
FUJII, T., SATO, K., YOKOTA, E., MAEJIMA, T., INOUE, M. and 
MITSUHASHI, S. (1988) Properties, of a broad spectrum 
beta-lactamase from Flavobacterium meningosepticum 
GN14059. J. Antibiot. XLI: 81-85. 
These workers report production of a broad spectrum beta-
lactamase by !: meningosepticum GN14059. The enzyme has an 
isoelectric point of 5.1, significant hydrolytic activity 
against various beta-lactam antibiotics including 
oxyiminocephalosporins and aztreonam, and is inhibited by 
clavulanic acid, sulbactam, imipenem and cephamycins. Fujii 
~al. classify the enzyme as a unique CXase type I. 
Apart from the more acidic isoelectric point, this beta-
lactamase appears to be similar to the beta-lactamases of F. 
meningosepticum reported by Raimondi~ al. (1986) and the 
enzymes encountered in this study. The lower isoelectric 
point suggests that the heterogeneity of beta-lactamases 
within the species is even greater than suggested by the 
results of this study. It is also interesting that the pI 
value of 5.1 for the beta-lactamase of strain GN14059 is 
similar to the pI values obtained in this study for the beta-
lactamase of F. odoratum R25 (4.9) and the minor beta-
lactamase bands of F. odoratum R59 (4.9, 5.3), !· 
meningosepticum MP969 (5.0), F. gleum NCTC 11432 (4.9, 5.2) 
and Group IIb U58 (4.9). 
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APPENDIX 1 
Abbreviations - Names of Microorganisms 
Genus 
Achromobacter 
Acinetobacter 
Aeromonas 
Alcaligenes 
Bacillus 
Bacteroides 
Cardiobacterium 
Chlamydia 
Citrobacter 
Cytophaga 
Species Abbreviations 
A. xylosoxidans 
A. calcoaceticus 
A. salmonicida 
A. denitrificans 
A. faecal is 
B. cereus 
B. stearothermophilus 
B. subtilis 
B. asaccharolyticus 
B. bivius 
B. distasonis 
B. fragilis 
B. melaninogenicus 
B. ovatus 
B. thetaiotamicron 
B. uniformis 
B. vulgatus 
c. hominis 
c. trachomatis 
c. di versus 
c. freundii 
c. aqua tilis 
c. johnsonae 
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Genus 
Enterobacter 
Escherichia 
Flavobacterium 
Flexibacter 
Haemophilus 
Klebsiella 
Legionella 
APPENDIX 1 (Continued) 
Species Abbreviations 
c. lytica 
c. marinoflava 
c. salmonicolor 
E. cloacae 
E. coli 
F. aqua tile 
F. balustinum 
F. breve 
F. gleum 
F. indologenes 
F. meningosepticum 
F. multivorum 
F. odoratum 
"F. pectinovorum" 
F. spiritivorum 
F. thalpophilum 
"F. tirrenicum" 
F. elegans 
H. influenzae 
K. aerogenes 
K. oxytoca 
K. pneumoniae 
L. dumoffi 
L. gormanii 
L. longbeachae 
1. micdadei 
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APPENDIX 1 (Continued) 
Genus Species Abbreviations 
1---~--------------------------------------------------------
L. pneumophila 
Morganella M. morganii 
Neisseria N. gonor:rhoeae 
N •. meningitidis 
Proteus P. mirabilis 
P. vulgar is 
Providencia P. rettgeri 
P. stuartii 
Pseudomonas :e. aeruginosa 
P. cepacia 
P. mal tophilia 
:e. pseudomallei 
P. putida 
P. thomasii 
,Rhodopseudomonas R. capsulata 
R. sphaeroides 
Salmonella s. typhimurium 
Serratia s. marcescens 
"Sphingobacterium" .. s. mizutae" 
Staphylococcus s. aureus 
Streptococcus s. faecal is 
s. faecium 
s. pneumoniae 
s. uberis 
Yersinia Y. enterocolitica 
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AIDS 
ATCC 
CDC 
CSF 
CXase 
DHP-I 
EDTA 
HPLC 
IEF 
M 
mA 
mM 
mcg (or ug) 
MHA 
MHB 
MIG 
MW 
NCCLS 
NCTC 
OD 
Omp 
PBP 
pCMB 
pI 
SDS-PAGE 
APPENDIX 2 
Other Abbreviations 
acquired immunodeficiency syndrome 
American Type Culture Collection 
Centres for Disease Control 
'cerebrospinal fluid 
oxyiminocephalosporin beta-lactamase 
dihydropeptidase-I 
ethylenediaminetetraacetate 
high pressure liquid chromatograph 
isoelectric focussing 
Molar [CD_s _____ - - ---- c:~iibr~~eci~~-icho~~~m~-~~--~rc11~~I 
milliampere 
millimolar 
microgram 
Mueller-Hinton agar 
Mueuller-Hinton broth 
minimum inhibitory concentration 
molecular weight 
National Committee for Clinical Laboratory 
Standards 
National Collection of Type Cultures 
optical density 
outer membrane protein 
penicillin binding protein 
p-chloromercuribenzoate 
isoelectric point 
Sodium dodecyl-sulphate polyacrylamide gel 
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'. electrophoresis 
i 
ug 
ul 
uM 
APPENDIX 2 (Continued) 
Other Abbreviations 
microgram 
microlitre 
micromolar 
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